HLA DR, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, HLA DR

Aarnisalo J, Veijola R, Vainionpaa R, Simell O, Knip M, Ilonen J. Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes. Diabetologia 51: 769-772 (2008). *
Abad S, Monnet D, Caillat-Zucman S, Mrejen S, Blanche P, Chalumeau M, Mouthon L, Dhote R, Brezin AP. Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype data. Ocul. Immunol. Inflamm. 16: 3-8 (2008).
Abanmi A, Harthi FA, Baqami RA, Assaf SA, Zouman A, Arfin M, Tariq M. Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Arch. Dermatol. Res. 298: 347-352 (2006). *
Abbas M, Bobo LD, Hsieh YH, Berka N, Dunston G, Bonney G, Apprey V, Quinn TC, West SK. Human leukocyte antigen (HLA)-B, -DRB1 and -DQB1 allotypes associated with disease and protection in trachoma endemic villages. Invest. Ophthalmol. Vis. Sci. 50: 1734-1738 (2009). *
Abbott WG, Tsai P, Leung E, Trevarton A, 'Ofanoa M, Hornell J, Gane EJ, Munn SR, Rodrigo AG. Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans. J. Virol. 84: 621-629 (2010). *
Abdallah H, Leffler D, Dennis M, Kelly CP. Refractory celiac disease. Curr. Gastroenterol. Rep. 9: 401-405 (2007).
Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, Martin MP, Davis S, Schenk M, Chanock SJ, Hartge P, Carrington M, Wang SS. Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia Feb 11 [Epub ahead of print] (2010).
Abida O, Zitouni M, Kallel-Sellami M, Mahfoudh N, Kammoun A, Ben Ayed M, Masmoudi A, Mokni M, Fezzaa B, Ben Osman A, Kammoun MR, Turki H, Makni H, Gilbert D, Joly P, Tron F, Makni S, Masmoudi H. Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: anti-desmoglein 1 antibody-positive healthy subjects bear protective alleles. Br. J. Dermatol. 161: 522-527 (2009). *
Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J. Leukoc. Biol. 66: 562-566 (1999). *
Abraham M, Karni A, Dembinsky A, Miller A, Gandhi R, Anderson D, Weiner HL. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J. Autoimmun. 30: 21-28 (2008). *
Abraham RS, Wen L, Marietta EV, David CS. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model. J. Immunol. 166: 1370-1379 (2001). *
Abreu MT, Yang H. Is genetic testing in IBD ready for prime time? Am. J. Gastroenterol. 99: 316-318 (2004). *
Abreu-Velez AM, Loebl AM, Howard MS. Autoreactivity to sweat and sebaceous glands and skin homing T cells in lupus profundus. Clin. Immunol. 132: 420-414 (2009). *
Abulafia-Lapid R, Afentoulis M, Vandenbark AA. Peptide therapy for anti-CD4 autoimmunity in HIV-1 infection: toward the development of an autoimmune animal model. Vaccine 27: 3475-3480 (2009). *
Achkar JP, Dassopoulos T, Silverberg MS, Tuvlin JA, Duerr RH, Brant SR, Siminovitch K, Reddy D, Datta LW, Bayless TM, Zhang L, Barmada MM, Rioux JD, Steinhart AH, McLeod RS, Griffiths AM, Cohen Z, Yang H, Bromfield GP, Schumm P, Hanauer SB, Cho JH, et al. Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am. J. Gastroenterol. 101: 572-580 (2006). *
Achkar JP, Duerr R. The expanding universe of inflammatory bowel disease genetics. Curr. Opin. Gastroenterol. 24: 429-434 (2008). *
Achord JL, Gunn CH Jr, Jackson JF. Regional enteritis and HLA concordance in multiple siblings. Dig. Dis. Sci. 27: 330-332 (1982).
Adamopoulos AB. Inflammatory bowel disease (IBD) and the liver. Annals of Gastroenterology 19: 146-151 (2006). *
Adams KM, Yan Z, Stevens AM, Nelson JL. The changing maternal "self" hypothesis: a mechanism for maternal tolerance of the fetus. Placenta 28: 378-382 (2007).
Addous A, Mohamed AS, Ismail G, Al-Hashemy A. Post-transplant diabetes mellitus in kidney transplant recipients with special reference to association with HLA antigens. Saudi J. Kidney Dis. Transpl. 11: 559-562 (2000).
Adhiah AH, Jasim HA, Fadhil AM. HLA antigens and inflammatory bowel disease in a sample of Iraqi patients. East. Mediterr. Health J. 14: 1155-1163 (2008).
Affes H, Mahfoudh N, Kammoun A, Masmoudi A, Marrekchi S, Turki H, Makni H. HLA- A, B, DR and DQ alleles study in Tunisian patients with atopic dermatitis. Tunis. Med. 85: 834-838 (2007).
Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31: 49-53 (2000). *
Agarwal K, Jones DE, Bassendine MF. Genetic susceptibility to primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 11: 603-606 (1999).
Aggarwal C, Gupta S, Hahn T, Smiley S, Padmanabhan S, McCarthy PL Jr, Battiwalla M. Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies. Leuk. Lymphoma 49: 1494-1500 (2008).
Aggarwal R, Stamm L, Zhao W, Fernandez-Vina M, Senitzer D, Berka N. A novel HLA-B allele, B*4093, sharing sequences with B*4006 and B*0702 in an Asian Indian donor. Tissue Antigens 72: 492-494 (2008). *
Agrawal S, Gupta A, Yachha SK, Muller-Myhsok B, Mehrotra P, Agarwal SS. Association of human leucocyte-DR and DQ antigens in coeliac disease: a family study. J. Gastroenterol. Hepatol. 15: 771-774 (2000). *
Agrawal S, Khan F, Bharadwaj U. Human genetic variation studies and HLA class II loci. Int. J. Immunogenet. 34: 247-252 (2007). *
Agrawal S, Srivastava R, Sharma B, Pandya S, Misra R, Aggarwal A. IL1RN*2 allele of IL-1receptor antagonist VNTR polymorphism is associated with susceptibility to anklyosing spondylitis in Indian patients. Clin. Rheumatol. 27: 573-576 (2008). *
Ahlawat P, Srinivas NR. Allometric prediction of the human pharmacokinetic parameters for naveglitazar. Eur. J. Drug Metab. Pharmacokinet. 33: 187-190 (2008).
Ahlen MT, Husebekk A, Killie MK, Skogen B, Stuge TB. T cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells. Blood 113: 3838-3844 (2009). *
Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, Welsh KI, Marshall SE, Jewell DP. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 62: 527-535 (2003). *
Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J, Sato H, Ling KL, Barnardo M, Goldthorpe S, Walton R, Bunce M, Jewell DP, Welsh KI. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum. Mol. Genet. 12: 647-656 (2003). *
Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley ME, White DE, Rosenberg SA. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114: 1537-1544 (2009). *
Ahmed AR, Yunis EJ, Khatri K, Wagner R, Notani G, Awdeh Z, Alper CA. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. U.S.A. 87: 7658-7662 (1990). *
Ahn SY, Ingulli E. Acute poststreptococcal glomerulonephritis: an update. Curr. Opin. Pediatr. 20: 157-162 (2008).
Aihara H, Hiwatashi N. Salazosulfapyridine and 5-aminosalicylic acid agents for the treatment of ulcerative colitis. Nippon Rinsho 57: 2476-2480 (1999).
Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, Wong HL, Jacobson LP, Rabkin CS, Ambinder RF, Martinez-Maza O, Kaslow RA. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. J. Acquir. Immune Defic. Syndr. Aug 3 [Epub ahead of print] (2009).
Aizawa H, Kinouchi Y, Negoro K, Nomura E, Imai G, Takahashi S, Takagi S, Kakuta Y, Tosa M, Mochida A, Matsumura Y, Endo K, Shimosegawa T. HLA-B is the best candidate of susceptibility genes in HLA for Japanese ulcerative colitis. Tissue Antigens 73: 569-574 (2009). *
Ajonuma LC, Chan PK, Ng EH, Fok KL, Wong CH, Tsang LL, Tang XX, Ho LS, Lau MC, Chung CM, He Q, Huang HY, Yang DZ, Rowlands DK, Chung YW, Chan HC. Involvement of cystic fibrosis transmembrane conductance regulator (CFTR) in the pathogenesis of hydrosalpinx induced by Chlamydia trachomatis infection. J. Obstet. Gynaecol. Res. 34: 923-930 (2008).
Akaishi PM, Cruz AA, Silva FL, De Lourdes Veronesi Rodrigues M, Maciel LM, Donadi EA. The role of major histocompatibility complex alleles in the susceptibility of Brazilian patients to develop the myogenic type of Graves' orbitopathy. Thyroid 18: 443-447 (2008).
Akar A, Orkunoglu E, Sengul A, Ozata M, Gur AR. HLA class II alleles in patients with alopecia areata. Eur. J. Dermatol. 12: 236-239 (2002).
Akesson K, Carlsson A, Ivarsson SA, Johansson C, Weidby BM, Ludvigsson J, Gustavsson B, Lernmark A, Kockum I. The non-inherited maternal HLA haplotype affects the risk for type 1 diabetes. Int. J. Immunogenet. 36: 1-8 (2009). *
Akimoto S, Abe M, Ishikawa O, Takagi H, Mori M. HLA-DRB1 and DQB1 genes in anticentromere antibody positive patients with SSc and primary biliary cirrhosis. Ann. Rheum. Dis. 60: 639-640 (2001). *
Akisawa N, Maeda T, Iwasaki S, Onishi S. Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis. J. Hepatol. 26: 845-851 (1997). *
Akiyama Y, Tanaka M, Takeishi M, Adachi D, Mimori A, Suzuki T. Clinical, serological and genetic study in patients with CREST syndrome. Intern. Med. 39: 451-456 (2000). *
Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br. J. Dermatol. 155: 350-356 (2006). *
Aktas E, Ciftci F, Bilgic S, Sezer O, Bozkanat E, Deniz O, Citici U, Deniz G. Peripheral immune response in pulmonary tuberculosis. Scand. J. Immunol. 70: 300-308 (2009). *
Al Attia HM, Santhosh A. A probe into the HLA-DR and DQ of Arab patients with primary antiphospholipid (Hughes) syndrome. Rheumatol. Int. 28: 193-195 (2007). *
Al-Arfaj A. HLA-DR pattern of rheumatoid arthritis in Saudi Arabia. Ann. Saudi Med. 21: 92-93 (2001).
Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J. Hepatol. 48: 140-147 (2008). *
Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J. Hepatol. 45: 575-583 (2006). *
Al-Ghonaium A. Stem cell transplantation for primary immunodeficiencies: King Faisal Specialist Hospital experience from 1993 to 2006. Bone Marrow Transplant. 42 Suppl. 1: S53-S56 (2008).
Al-Harbi EM, Abbassi AJ, Tamim H, al-Jenaidi F, Kooheji M, Kamal M, al-Mahroos S, al-Nasir F, Motala AA, Almawi WY. Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients. Clin. Diagn. Lab. Immunol. 11: 292-296 (2004). *
Al-Heresh AM, Proctor J, Jones SM, Dixey J, Cox B, Welsh K, McHugh N. Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology (Oxford) 41: 525-530 (2002). *
Al-Jenaidi FA, Wakim-Ghorayeb SF, Al-Abbasi A, Arekat MR, Irani-Hakime N, Najm P, Al-Ola K, Motala AA, Almawi WY. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. J. Clin. Endocrinol. Metab. 90: 5104-5109 (2005). *
Al-Ola K, Mahdi N, Al-Subaie AM, Ali ME, Al-Absi IK, Almawi WY. Evidence for HLA class II susceptible and protective haplotypes for osteomyelitis in pediatric patients with sickle cell anemia. Tissue Antigens 71: 453-457 (2008). *
Al-Osaimi AM, Berg CL. Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. Am. J. Gastroenterol. 97: S85 (2002). *
Al-Swailem R, Al-Rayes H, Sobki S, Arfin M, Tariq M. HLA-DRB1 association in Saudi rheumatoid arthritis patients. Rheumatol. Int. 26: 1019-1024 (2006). *
Al-Tahan J, Sola R, Ruiz JR, Breidenassel C, Garc�a-Fuentes M, Moreno LA, Castillo M, Pietrzik K, Gonzalez-Gross M. Methylenetetrahydrofolate reductase 677CT polymorphism and cobalamin, folate, and homocysteine status in Spanish adolescents. Ann. Nutr. Metab. 52: 315-321 (2008).
Al-toma A, Verbeek WH, Mulder CJ. The management of complicated celiac disease. Dig. Dis. 25: 230-236 (2007).
Al-Tonbary Y, Abdel-Razek N, Zaghloul H, Metwaly S, El-Deek B, El-Shawaf R. HLA class II polymorphism in Egyptian children with lymphomas. Hematology 9: 139-145 (2004).
Alaez C, Gazit E, Ibarrola B, Yaron M, Livneh A, Avishai O, Gorodezky C. Distribution of HLA-B27 subtypes in ankylosing spondylitis in an Israeli population. Arch. Med. Res. 38: 452-455 (2007).
Alaez C, Lin L, Flores-A H, Vazquez M, Munguia A, Mignot E, Haro R, Baker H, Gorodezky C. Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexicans patients: a relationship between HLA and gender is suggested. BMC Med. Genet. 9: 79 (2008). *
Alaez C, Loyola M, Murguia A, Flores H, Rodriguez A, Ovilla R, Ignacio G, Amador R, Salinas V, Perez F, Rodriguez D, Morales Z, Llinguin G, Vazquez A, Altamirano A, Gorodezky C. Hematopoietic stem cell transplantation (HSCT): an approach to autoimmunity. Autoimmun. Rev. 5: 167-179 (2006).
Alaez C, Vazquez-Garcia MN, Gorodezky C. DQA1 and DQB1 promoter diversity and linkage disequilibrium with class II haplotypes in Mexican Mestizo population. Genes Immun. 2: 216-221 (2001). *
Alarida K, Harown J, Di Pierro MR, Drago S, Catassi C. HLA-DQ2 and -DQ8 genotypes in celiac and healthy Libyan children. Dig. Liver Dis. Oct 9 [Epub ahead of print] (2009).
Alavi K, Schwartz MZ, Palazzo JP, Prasad R. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. J. Pediatr. Surg. 35: 847-851 (2000).
Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J. Immunol. 162: 494-502 (1999). *
Albani S, Roudier J. Molecular basis for the association between HLA DR4 and rheumatoid arthritis. From the shared epitope hypothesis to a peptidic model of rheumatoid arthritis. Clin. Biochem. 25: 209-212 (1992).
Albanidou-Farmaki E, Deligiannidis A, Markopoulos AK, Katsares V, Farmakis K, Parapanissiou E. HLA haplotypes in recurrent aphthous stomatitis: a mode- of inheritance? Int. J. Immunogenet. 35: 427-432 (2008). *
Albuquerque RV, Hayden CM, Palmer LJ, Laing IA, Rye PJ, Gibson NA, Burton PR, Goldblatt J, Lesouef PN. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin. Exp. Allergy 28: 578-584 (1998).
Alcoceba M, Marin L, Balanzategui A, Sarasquete ME, Martin-Jimenez P, Chillon MC, Corral R, Perez-Persona E, Fernandez-Calvo FJ, Hernandez JM, Blade J, Lahuerta JJ, Gonzalez M, San Miguel JF, Garcia-Sanz R. The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease. Tissue Antigens 71: 548-551 (2008). *
Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 14: 245-251 (2008). *
Alexander T, Arnold R, Hiepe F. Immunoablation followed by autologous stem cell transplantation in lupus: a clinical update. Z. Rheumatol. 68: 205-213 (2009).
Alexander TH, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, Hammerschlag PE, Hannley M, Hughes GB, Moscicki R, Nelson RA, Niparko JK, Rauch SD, Telian SA, Brookhouser PE, Harris JP. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol. Neurotol. 30: 443-448 (2009).
Alexiou I, Germenis A, Ziogas A, Theodoridou K, Sakkas LI. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis. BMC Musculoskelet. Disord. 8: 37 (2007). *
Alexis NE, Brickey WJ, Lay JC, Wang Y, Roubey RA, Ting JP, Peden DB. Development of an inhaled endotoxin challenge protocol for characterizing evoked cell surface phenotype and genomic responses of airway cells in allergic individuals. Ann. Allergy Asthma Immunol. 100: 206-215 (2008).
Alexis NE, Zhou H, Lay JC, Harris B, Hernandez ML, Lu TS, Bromberg PA, Diaz-Sanchez D, Devlin RB, Kleeberger SR, Peden DB. The glutathione-S-transferase Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects. J. Allergy Clin. Immunol. 124: 1222-1228.e5 (2009). *
Alfaro M, Tapadinhas F, Neves A, Costa Trindade J. Atopy and autoimmunity - a case report. Rev. Port. Pneumol. 13: 729-735 (2007).
Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 7: 813-818 (2006).
Ali AA, Moatter T, Baig JA, Iqbal A, Hussain A, Iqbal MP. Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate - a hospital-based study. J. Pak. Med. Assoc. 56: 452-456 (2006).
Ali ME, Ahmed MU, Alam S, Rahman MH. HLA-A, -B and -DRB1 allele frequencies in the Bangladeshi population. Tissue Antigens 72: 115-119 (2008). *
Aliagaoglu C, Pirim I, Atasoy M, Egerci N, Aktas A. Association between alopecia areata and HLA class I and II in Turkey. J. Dermatol. 32: 711-714 (2005).
Alizadeh BZ, Eerligh P, van der Slik AR, Shastry A, Zhernakova A, Valdigem G, Bruining JG, Sanjeevi CB, Wijmenga C, Roep BO, Koeleman BP. MICA marks additional risk factors for type 1 diabetes on extended HLA haplotypes: an association and meta-analysis. Mol. Immunol. 44: 2806-2812 (2007). *
Alizadeh M, Babron MC, Birebent B, Matsuda F, Quelvennec E, Liblau R, Cournu-Rebeix I, Momigliano-Richiardi P, Sequeiros J, Yaouanq J, Genin E, Vasilescu A, Bougerie H, Trojano M, Martins Silva B, Maciel P, Clerget-Darpoux F, Clanet M, Edan G, et al. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann. Neurol. 54: 119-122 (2003). *
Alkim C, Balci M, Alkim H, Dagli U, Parlak E, Tezel A, Ulker A. The importance of peripheral immune cells in inflammatory bowel disease. Turk. J. Gastroenterol. 18: 82-88 (2007). *
Allcock RJ, Christiansen FT, Price P. The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15. Immunogenetics 49: 660-665 (1999). *
Allcock RJ, de la Concha EG, Fernandez-Arquero M, Vigil P, Conejero L, Arroyo R, Price P. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum. Immunol. 60: 1266-1273 (1999).
Allcock RJ, Price P, Gaudieri S, Leelayuwat C, Witt CS, Dawkins RL. Characterisation of the human central MHC gene, BAT1: genomic structure and expression. Exp. Clin. Immunogenet. 16: 98-106 (1999).
Allen DB, MacDonald MJ, Gottschall JL, Hunter JB. Autoimmune thyroid phenomena are not evidence for human lymphocyte antigen-genetic heterogeneity in insulin-dependent diabetes. Am. J. Med. Genet. 33: 405-408 (1989).
Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum. Immunol. 39: 41-48 (1994).
Allenspach K, Rufenacht S, Sauter S, Grone A, Steffan J, Strehlau G, Gaschen F. Pharmacokinetics and clinical efficacy of cyclosporine treatment of dogs with steroid-refractory inflammatory bowel disease. J. Vet. Intern. Med. 20: 239-244 (2006).
Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J. Natl. Cancer Inst. 99: 1462-1470 (2007). *
Allison MC, Poulter LW. Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease. Clin. Exp. Immunol. 85: 504-509 (1991). *
Almallah YZ, Ewen SW, El-Tahir A, Mowat NA, Brunt PW, Sinclair TS, Heys SD, Eremin O. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J. Clin. Immunol. 20: 68-76 (2000). *
Alper CA. The human immune response to hepatitis B surface antigen. Exp. Clin. Immunogenet. 12: 171-181 (1995).
Alper CA, Fleischnick E, Awdeh Z, Katz AJ, Yunis EJ. Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy. J. Clin. Invest. 79: 251-256 (1987). *
Alper CA, Larsen CE, Dubey DP, Awdeh ZL, Fici DA, Yunis EJ. The haplotype structure of the human major histocompatibility complex. Hum. Immunol. 67: 73-84 (2006). *
Alper CA, Marcus-Bagley D, Awdeh Z, Kruskall MS, Eisenbarth GS, Brink SJ, Katz AJ, Stein R, Bing DH, Yunis EJ, Schur PH. Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype. Tissue Antigens 56: 207-216 (2000). *
Alper CA, Xu J, Cosmopoulos K, Dolinski B, Stein R, Uko G, Larsen CE, Dubey DP, Densen P, Truedsson L, Sturfelt G, Sjoholm AG. Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency. J. Clin. Immunol. 23: 297-305 (2003).
Alpsoy E, Yilmaz E, Coskun M, Savas A, Yegin O. HLA antigens and linkage disequilibrium patterns in Turkish Behcet's patients. J. Dermatol. 25: 158-162 (1998).
Alsaeid K, Alawadhi A, Al-Saeed O, Haider MZ. Human leukocyte antigen DRB1*04 is associated with rheumatoid arthritis in Kuwaiti patients. Joint Bone Spine 73: 62-65 (2006). *
Alsaeid K, Haider MZ, Sharma PN, Ayoub EM. The prevalence of human leukocyte antigen (HLA) DR/DQ/DP alleles in Kuwaiti children with oligoarticular juvenile idiopathic arthritis. Rheumatol. Int. 26: 224-228 (2006). *
Alsaeid KM, Haider MZ, al-Awadhi AM, Srivastva BS, Ayoub EM. Role of human leukocyte antigen DRB1*0307 and DRB1*0308 in susceptibility to juvenile rheumatoid arthritis. Clin. Exp. Rheumatol. 21: 399-402 (2003).
Alsultan A, Goldenberg NA, Kaiser N, Graham DK, Hays T. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children. Pediatr. Blood Cancer 52: 626-630 (2009).
Alter M, Wittmann M, Volker B, Kapp A, Werfel T, Gutzmer R. Successful treatment of pemphigus foliaceus with rituximab: report of 3 cases. Hautarzt. 60: 743-748 (2009).
Alvarado-Guerri R, Cabrera CM, Garrido F, Lopez-Nevot MA. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an Eastern Andalusian population. Hum. Immunol. 66: 921-930 (2005).
Alvarez I, Collado J, Daura X, Colome N, Rodriguez-Garcia M, Gallart T, Canals F, Jaraquemada D. The rheumatoid arthritis-associated allele HLA-DR10 (DRB1*1001) shares part of its repertoire with HLA-DR1 (DRB1*0101) and HLA-DR4 (DRB*0401). Arthritis Rheum. 58: 1630-1639 (2008). *
Alvarez I, Lopez de Castro JA. HLA-B27 and immunogenetics of spondyloarthropathies. Curr. Opin. Rheumatol. 12: 248-253 (2000).
Alvarez-Ossorio L, Johannsen M, Russlies M, Kirchner H, Rink L. HLA-dependent heterogeneous T cell response to Mycoplasma arthritidis-derived superantigen (MAS). Med. Microbiol. Immunol. 185: 245-251 (1997).
Alves C, Toralles MB, Carvalho GC. HLA class II polymorphism in patients with type 1 diabetes mellitus from a Brazilian racially admixtured population. Ethn. Dis. 19: 420-424 (2009).
Alves C, Veiga S, Souza T, Toralles MB, da Silva-Bacellar AL. The role of the human histocompatibility antigens in the pathogenesis of neurological disorders. Rev. Neurol. 44: 298-302 (2007).
Alves NL, van Leeuwen EM, Remmerswaal EB, Vrisekoop N, Tesselaar K, Roosnek E, Ten Berge IJ, van Lier RA. A new subset of human naive CD8+ T cells defined by low expression of IL-7Ralpha. J. Immunol. 179: 221-228 (2007). *
Alves-Leon SV, Papais-Alvarenga R, Magalhaes M, Alvarenga M, Thuler LC, Fernandez Y Fernandez O. Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol. Scand. 115: 306-311 (2007).
Alves-Leon SV, Veluttini-Pimentel ML, Gouveia ME, Malfetano FR, Gaspareto EL, Alvarenga MP, Frugulhetti I, Quirico-Santos T. Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study. Arq. Neuropsiquiatr. 67: 643-651 (2009).
Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE, Kretowski A, Erlich HA, Fain PR, Rewers MJ, Eisenbarth GS. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes 57: 770-776 (2008). *
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 55: 1265-1269 (2006). *
Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J. Autoimmun. 25: S40-S45 (2005).
Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS. Extreme genetic risk for type 1A diabetes. Proc. Natl. Acad. Sci. U.S.A. 103: 14074-14079 (2006). *
Amano K, Amano K. Filter leukapheresis for patients with ulcerative colitis: clinical results and the possible mechanism. Ther. Apher. 2: 97-100 (1998).
Amar A, Brautbar C, Goldin E, Sherman L, Barmeir S, Shouval D, Hansen JA, Smith AG. Serological and molecular analysis of HLA in Israeli primary sclerosing cholangitis patients. Eur. J. Immunogenet. 19: 295-302 (1992).
Amarapurkar DN, Patel ND, Amarapurkar AD, Kankonkar SR. HLA genotyping in type-I autoimmune hepatitis in Western India. J. Assoc. Physicians India 51: 967-969 (2003).
Amela-Peris R, Aladro Y, Conde-Sendin MA, Alemany-Rodriguez MJ, Munoz-Fernandez C, Reyes-Yanez MP, Deniz-Naranjo MC, Sanchez-Garcia F. Familial multiple sclerosis in Canary Islands. Rev. Neurol. 39: 911-914 (2004).
Amicosante M, Berretta F, Dweik R, Saltini C. Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells. Immunology 128: e462-e470 (2009). *
Amirzargar A, Mytilineos J, Yousefipour A, Farjadian S, Scherer S, Opelz G, Ghaderi A. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Eur. J. Immunogenet. 25: 297-301 (1998). *
Amirzargar AA, Mohseni N, Shokrgozar MA, Arjang Z, Ahmadi N, Yousefi Behzadi M, Amanzadeh A, Shokri F. HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine. Iran. J. Immunol. 5: 92-99 (2008).
Amoli MM, Gonzalez-Gay MA, Zeggini E, Salway F, Garcia-Porrua C, Ollier WE. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. J. Rheumatol. 31: 2413-2417 (2004). *
Amria S, Hajiaghamohseni LM, Harbeson C, Zhao D, Goldstein O, Blum JS, Haque A. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition. Eur. J. Immunol. 38: 1961-1970 (2008). *
Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome. Semin. Arthritis Rheum. 31: 396-405 (2002). *
Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. Rheumatoid arthritis association in Colombian population is restricted to HLA-DRB1*04 QRRAA alleles. Genes Immun. 3: 56-58 (2002). *
Anaya JM, Correa PA, Mantilla RD, Jimenez F, Kuffner T, McNicholl JM. Rheumatoid arthritis in African Colombians from Quibdo. Semin. Arthritis Rheum. 31: 191-198 (2001). *
Anaya JM, Gomez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases? Clin. Dev. Immunol. 13: 185-195 (2006). *
Anaya JM, Mantilla RD, Correa PA. Immunogenetics of primary Sjogren's syndrome in Colombians. Semin. Arthritis Rheum. 34: 735-743 (2005). *
Anaya JM, Rivera D, Palacio LG, Arcos-Burgos M, Correa PA. D6S439 microsatellite identifies a new susceptibility region for primary Sjogren's syndrome. J. Rheumatol. 30: 2152-2156 (2003).
Ancuta C, Ancuta E, Iordache C, Ceausu M, Chirieac R. Immunohistochemical study of skeletal muscle in rheumatoid myositis. Rom. J. Morphol. Embryol. 50: 223-227 (2009).
Andersen RS, Sorensen RB, Andersen MH, Straten PT. CD8 T-cell responses against cyclin B1. Clin. Cancer Res. 15: 7106-7107 (2009). *
Anderson RP. Coeliac disease: current approach and future prospects. Intern. Med. J. 38: 790-799 (2008). *
Andersson EC, Svendsen P, Svejgaard A, Holmdahl R, Fugger L. A molecule basis for the HLA association in rheumatoid arthritis. Rev. Immunogenet. 2: 81-87 (2000).
Andersson Y, Hammarstrom ML, Lonnerdal B, Graverholt G, Falt H, Hernell O. Formula feeding skews immune cell composition toward adaptive immunity compared to breastfeeding. J. Immunol. 183: 4322-4328 (2009).
Ando T, Ishikawa T, Kato H, Yoshida N, Naito Y, Kokura S, Yagi N, Takagi T, Handa O, Kitawaki J, Nakamura N, Hasegawa G, Fukui M, Imamoto E, Nakamura C, Oyamada H, Isozaki Y, Matsumoto N, Nagao Y, Okita M, Nakajima Y, Kurokawa M, Nukina M, Ohta M, et al. Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. Int. J. Cancer 125: 2595-2602 (2009). *
Andrade RJ, Lucena MI, Alonso A, Garcia-Cores M, Garcia-Ruiz E, Benitez R, Fernandez MC, Pelaez G, Romero M, Corpas R, Duran JA, Jimenez M, Rodrigo L, Nogueras F, Martin-Vivaldi R, Navarro JM, Salmeron J, de la Cuesta FS, Hidalgo R. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 39: 1603-1612 (2004). *
Andras C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, Danko K. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J. Rheumatol. 35: 438-444 (2008).
Andreevskii TV, Sudomoina MA, Gusev EI, Boiko AN, Alekseenkov AD, Favorova OO. Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians. Mol. Biol. (Mosk.) 36: 643-648 (2002).
Andresdottir MB, Haasnoot GW, Persijn GG, Claas FH. HLA-B8, DR3: a new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathy. Clin. Transplant. 23: 660-665 (2009).
Androulakis IP, Nayak NN, Ierapetritou MG, Monos DS, Floudas CA. A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions. Proteins 29: 87-102 (1997). *
Angel CE, George E, Ostrovsky LL, Dunbar PR. Comprehensive analysis of MHC-II expression in healthy human skin. Immunol. Cell Biol. 85: 363-369 (2007). *
Anger T, Ekici AB, Daniel WG, Garlichs CD. Gene polymorphisms leading to calcified and stenotic aortic valves. Herz. 31: 635-643 (2006).
Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 52: 879-885 (2003). *
Anholts JD, Aneq M, Dirks HL, Tas A, Verduyn W, Oudshoorn M. Thirty-six novel HLA alleles: 7 HLA-A, 11 HLA-B, 15 HLA-C and 3 HLA-DRB1. Tissue Antigens 74: 424-428 (2009). *
Annese V, Piepoli A, Latiano A, Lombardi G, Napolitano G, Caruso N, Cocchiara E, Accadia L, Perri F, Andriulli A. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis. Colon Rectum 48: 57-64 (2005).
Antal Z, Jarchum I, DiLorenzo TP. HLA class I supertypes in type 1 diabetic children in an urban children's hospital. Ann. N. Y. Acad. Sci. 1150: 86-89 (2008). *
Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, Wendon J. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44: 34-43 (2006). *
Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J. Hepatol. 49: 845-861 (2008). *
Antonios D, Ade N, Kerdine-Romer S, Assaf-Vandecasteele H, Larange A, Azouri H, Pallardy M. Metallic haptens induce differential phenotype of human dendritic cells through activation of mitogen-activated protein kinase and NF-kappaB pathways. Toxicol. In Vitro 23: 227-234 (2009).
Aoyagi S, Akashi H, Kawara T, Ishihara K, Tanaka A, Kanaya S, Koga Y, Ishikawa R. Aortic root replacement for Takayasu arteritis associated with ulcerative colitis and ankylosing spondylitis - report of a case. Jpn. Circ. J. 62: 64-68 (1998). *
Appel H, Kuon W, Kuhne M, Wu P, Kuhlmann S, Kollnberger S, Thiel A, Bowness P, Sieper J. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis. Arthritis Res. Ther. 6: R521-R534 (2004). *
Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur. J. Immunol. 37: 1924-1937 (2007). *
Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127: 26-39 (2009). *
Arai T, Michalski JP, McCombs CC, Elston RC, McCarthy CF, Stevens FM. T cell receptor gamma gene polymorphisms and class II human lymphocyte antigen genotypes in patients with celiac disease from the west of Ireland. Am. J. Med. Sci. 309: 171-178 (1995).
Aranami T, Miyake S, Yamamura T. Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis. J. Immunol. 177: 5659-5667 (2006). *
Arato A, Savilahti E, Tainio VM, Klemola T. Immunohistochemical study of lymphoplasmacytic infiltrate and epithelial HLA-DR expression in the rectal and colonic mucosae of children with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 8: 172-180 (1989).
Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, Morato MJ, Correa-Oliveira R. Potential role of CD4+CD25high regulatory T cells in morbidity in Chagas disease. Front. Biosci. 12: 2797-2806 (2007).
Araujo MB, Leonardi LS, Boin IF, Leonardi MI, Magna LA, Donadi EA, Kraemer MH. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes. Transplant. Proc. 36: 953-955 (2004). *
Araujo MB, Leonardi LS, Leonardi MI, Boin IF, Magna LA, Donadi EA, Kraemer MH. Prospective analysis between the therapy of immunosuppressive medication and allogeneic microchimerism after liver transplantation. Transpl. Immunol. 20: 195-198 (2009).
Archbold JK, Macdonald WA, Gras S, Ely LK, Miles JJ, Bell MJ, Brennan RM, Beddoe T, Wilce MC, Clements CS, Purcell AW, McCluskey J, Burrows SR, Rossjohn J. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J. Exp. Med. 206: 209-219 (2009). *
Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, Builes J, Jaramillo D, Ceballos G, Uribe A, Rivera N, Rivera D, Fonseca I, Camargo M, Palacio G. Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum. Genet. 110: 334-342 (2002). *
Ardern-Jones MR, Black AP, Bateman EA, Ogg GS. Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells. Proc. Natl. Acad. Sci. U.S.A. 104: 5557-5562 (2007). *
Arellanes-Garcia L, Bautista N, Mora P, Ortega-Larrocea G, Burguet A, Gorodezky C. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocul. Immunol. Inflamm. 6: 93-100 (1998).
Aries PM, Witte T, Lamprecht P. Report on the 34th Meeting of the German Clinical Immunology Workgroup, Frankfurt, 03.-04.11.2006. Z. Rheumatol. 66: 63-64 (2007).
Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113: 451-463 (2004). *
Aringer M, Feierl E, Smolen J. Cytokine blockade - a promising therapeutic option in SLE. Z. Rheumatol. 67: 315-317 (2008).
Aristimuno C, Navarro J, de Andres C, Martinez-Gines MA, Gimenez-Roldan S, Fernandez-Cruz E, Sanchez-Ramon S. Expansion of regulatory CD8(+) T-lymphocytes and fall of activated CD8(+) T-lymphocytes after IV methyl-prednisolone for multiple sclerosis relapse. J. Neuroimmunol. 204: 131-135 (2008).
Arita S, Baba E, Shibata Y, Niiro H, Shimoda S, Isobe T, Kusaba H, Nakano S, Harada M. B cell activation regulates exosomal HLA production. Eur. J. Immunol. 38: 1423-1434 (2008). *
Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood 99: 2694-2702 (2002). *
Arnaiz-Villena A, Martinez-Laso J, Corell A, Allende L, Rosal M, Gomez-Reino JJ, Vicario JL. Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome. Eur. J. Immunogenet. 23: 211-219 (1996).
Arnaiz-Villena A, Martinez-Laso J, Serrano-Vela JI, Reguera R, Moscoso J. HLA-G polymorphism and evolution. Tissue Antigens 69 Suppl. 1: 156-159 (2007). *
Arnaiz-Villena A, Serrano-Vela JI, Reguera R, Perez-Saborido B, Moreno E, Moscoso J. A novel allele, HLA-G*010114, with a non-coding DNA base change in exon 2. Tissue Antigens 71: 258-259 (2008). *
Arnaiz-Villena A, Vargas-Alarcon G, Serrano-Vela JI, Reguera R, Martinez-Laso J, Silvera-Redondo C, Granados J, Moscoso J. HLA-E polymorphism in Amerindians from Mexico (Mazatecans), Colombia (Wayu) and Chile (Mapuches): evolution of MHC-E gene. Tissue Antigens 69 Suppl. 1: 132-135 (2007). *
Arnaud-Battandier F, Cerf-Bensussan N, Amsellem R, Schmitz J. Increased HLA-DR expression by enterocytes in children with celiac disease. Gastroenterology 91: 1206-1212 (1986).
Arnedo Valero M. HLA-B*5701 and hypersensitivity reactions to abacavir. Study methods and clinical relevance. Enferm. Infecc. Microbiol. Clin. 26 Suppl. 6: 34-39 (2008).
Arnett FC, Bias WB, McLean RH, Engel M, Duvic M, Goldstein R, Freni-Titulaer L, McKinley TW, Hochberg MC. Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies. J. Rheumatol. 17: 1029-1035 (1990).
Arnett FC, Bias WB, Reveille JD. Genetic studies in Sjogren's syndrome and systemic lupus erythematosus. J. Autoimmun. 2: 403-413 (1989).
Arnett FC, Gourh P, Shete S, Ahn CW, Honey R, Agarwal SK, Tan FK, McNearney T, Fischbach M, Fritzler MJ, Mayes MD, Reveille JD. Major histocompatibility complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases � Ann. Rheum. Dis. Jul 12 [Epub ahead of print] (2009).
Arnett FC, Hamilton RG, Reveille JD, Bias WB, Harley JB, Reichlin M. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum. 32: 413-419 (1989).
Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum. 39: 1362-1370 (1996).
Aron Y, Polla BS, Bienvenu T, Dall'ava J, Dusser D, Hubert D. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am. J. Respir. Crit. Care Med. 159: 1464-1468 (1999). *
Aron Y, Swierczewski E, Lockhart A. A simple and rapid micromethod for genomic DNA extraction from jugal epithelial cells. Application to human lymphocyte antigen typing in one large family of atopic/asthmatic probands. Allergy 49: 788-790 (1994).
Arrizabalaga, Rodriguez-Alcantara, Castaner, Ocampo, Podzamczer, Pulido, Riera, Sanz, Pascual-Bernaldez, Dal-Re; the EPI109839 Study Group. Prevalence of HLA-B*5701 in HIV-infected patients in Spain (results of the EPI study). HIV Clin. Trials 10: 48-51 (2009).
Artac H, Kara R, Reisli I. In vivo modulation of the expressions of Fas and CD25 by intravenous immunoglobulin in common variable immunodeficiency. Clin. Exp. Med. Sep 3 [Epub ahead of print] (2009). *
Asakura H, Sugimura K, Funakoshi K. Molecular pathoimmunology of ulcerative colitis. Nippon Rinsho 54: 1170-1175 (1996).
Asakura H, Tsuchiya M, Aiso S, Watanabe M, Kobayashi K, Hibi T, Ando K, Takata H, Sekiguchi S. Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis. Gastroenterology 82: 413-418 (1982).
Asherson RA, Giampaolo D, Strimling M. A case of adult-onset Satoyoshi syndrome with gastric ulceration and eosinophilic enteritis. Nat. Clin. Pract. Rheumatol. 4: 439-444 (2008).
Ashida T, Ayabe T, Murakami M, Taruishi M, Okano S, Takemura S, Obara T, Kitamori S, Shibata Y, Okamura K, et al. Analysis of subsets of colonic mucosal lymphocyte in ulcerative colitis by two color flow cytometry. Nippon Shokakibyo Gakkai Zasshi 87: 1822-1828 (1990).
Ashman RF, Schaffer FM, Kemp JD, Yokoyama WM, Zhu ZB, Cooper MD, Volanakis JE. Genetic and immunologic analysis of a family containing five patients with common-variable immune deficiency or selective IgA deficiency. J. Clin. Immunol. 12: 406-414 (1992).
Aslanian FM, Marques MT, Matos HJ, Pontes LF, Porto LC, Azevedo LM, Filgueira AL. HLA markers in familial lichen sclerosus. J. Dtsch. Dermatol. Ges. 4: 842-847 (2006). *
Assassi S, Del Junco D, Sutter K, McNearney TA, Reveille JD, Karnavas A, Gourh P, Estrada-Y-Martin RM, Fischbach M, Arnett FC, Mayes MD. Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum. 61: 1403-1411 (2009). *
Atan D, Turner SJ, Kilmartin DJ, Forrester JV, Bidwell J, Dick AD, Churchill AJ. Cytokine gene polymorphism in sympathetic ophthalmia. Invest. Ophthalmol. Vis. Sci. 46: 4245-4250 (2005). *
Atar D, Dyrberg T, Michelsen B, Karlsen A, Kofod H, M�lvig J, Lernmark A. Site-specific antibodies distinguish single amino acid substitutions in position 57 in HLA-DQ beta-chain alleles associated with insulin-dependent diabetes. J. Immunol. 143: 533-538 (1989).
Atik B, Skwor TA, Kandel RP, Sharma B, Adhikari HK, Steiner L, Erlich H, Dean D. Identification of novel single nucleotide polymorphisms in inflammatory genes as risk factors associated with trachomatous trichiasis. PLoS ONE 3: e3600 (2008). *
Atouf O, Benbouazza K, Brick C, Bzami F, Bennani N, Amine B, Hajja-Hassouni N, Essakali M. HLA polymorphism and early rheumatoid arthritis in the Moroccan population. Joint Bone Spine 75: 554-558 (2008). *
Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6: 583-588 (2000). *
Au WY, Fung A, Ma ES, Shek TW, Hawkins BR, Liang R. HLA associations, microsatellite instability and epigenetic changes in thyroid lymphoma in Chinese. Leuk. Lymphoma 48: 531-534 (2007).
Auger I, Ragni E, Reviron D, Rossi D, Roudier J. Immune response to 70 kD heat shock proteins and rheumatoid arthritis: implication of HLA-DRB1*0401. Clin. Exp. Rheumatol. 25: 933-934 (2007).
Auger I, Roudier C, Guis S, Balandraud N, Roudier J. HLA-DRB1*0404 is strongly associated with anti-calpastatin antibodies in rheumatoid arthritis. Ann. Rheum. Dis. 66: 1588-1593 (2007).
Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, Svensson B, Cantagrel A, Serre G, Roudier J. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum. 52: 3424-3432 (2005). *
Aureli A, Piancatelli D, Del Beato T, Sebastiani P, Melillo V, Marimpietri A, Sechi E, Di Loreto S. Holly's story: illustration of an attention deficit hyperactivity disorder case. Int. J. Immunopathol. Pharmacol. 21: 1049-1051 (2008).
Aureli A, Sebastiani P, Del Beato T, Marimpietri A, Melillo V, Sechi E, Di Loreto S. Investigation on the possible relationship existing between the HLA-DR gene and attention deficit hyperactivity disorder and/or mental retardation. Int. J. Immunopathol. Pharmacol. 21: 985-991 (2008).
Auricchio R, Granata V, Borrelli M, Troncone R; on behalf of the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP). Italian paediatricians' approach to coeliac disease diagnosis. J. Pediatr. Gastroenterol. Nutr. 49: 374-376 (2009).
Ausiello CM, Fedele G, Palazzo R, Spensieri F, Ciervo A, Cassone A. 60-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells. Microbes Infect. 8: 714-720 (2006). *
Autissier P, Soulas C, Burdo TH, Williams KC. Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A. Jan 22 [Epub ahead of print] (2010).
Auzinger G, Wendon J. Intensive care management of acute liver failure. Curr. Opin. Crit. Care 14: 179-188 (2008).
Avasarala JR, Chittur SV, George AD, Tine JA. Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2. BMC Med. Genomics 1: 2 (2008). *
Avila JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM, du Bois RM. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am. J. Respir. Cell. Mol. Biol. 20: 106-112 (1999). *
Avila-Portillo LM, Vargas-Alarcon G, Andrade F, Alarcon-Segovia D, Granados J. Linkage disequilibrium of HLA-DR3 and HLA-DR4 with HLA-B alleles in Mexican patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 12: 497-502 (1994).
Awata T, Kanazawa Y. Genetic markers for insulin-dependent diabetes mellitus in Japanese. Diabetes Res. Clin. Pract. 24: S83-S87 (1994).
Aycan Z, Berberoglu M, Adiyaman P, Ergur AT, Ensari A, Evliyaoglu O, Siklar Z, Ocal G. Latent autoimmune diabetes mellitus in children (LADC) with autoimmune thyroiditis and celiac disease. J. Pediatr. Endocrinol. Metab. 17: 1565-1569 (2004).
Aydogan K, Karadogan SK, Akdag I, Tunali S. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clin. Exp. Dermatol. 31: 424-429 (2006). *
Azar GA, Sekaly RP, Thibodeau J. A defective viral superantigen-presenting phenotype in HLA-DR transfectants is corrected by CIITA. J. Immunol. 174: 7548-7557 (2005). *
Azarpira N, Ramzi M, Aghdaie MH, Daraie M, Geramizadeh B. Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant. Exp. Clin. Transplant. 5: 693-697 (2007).
Azeredo EL, Neves-Souza PC, Alvarenga AR, Reis SR, Torrentes-Carvalho A, Zagne SM, Nogueira RM, Oliveira-Pinto LM, Kubelka CF. Differential regulation of Toll-like receptor-2, Toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology Jan 27 [Epub ahead of print] (2010). *
Aziz S, Muzaffar R, Zafar MN, Mehnaz A, Mubarak M, Abbas Z, Naqvi SA, Rizvi AH. Celiac disease in children with persistent diarrhea and failure to thrive. J. Coll. Physicians Surg. Pak. 17: 554-557 (2007).
B'chir Hamzaoui S, Harmel A, Bouslama K, Abdallah M, Ennafaa M, M'rad S, Ben Dridi M; le groupe tunisien d'etude sur la maladie de Behcet. Behcet's disease in Tunisia. Clinical study of 519 cases. Rev. Med. Interne. 27: 742-750 (2006).
Baadsgaard O, Fisher G, Voorhees JJ, Cooper KD. The role of immune system in the pathogenesis of psoriasis. J. Invest. Dermatol. 95: 32S-34S (1990). *
Babel N, Brestrich G, Gondek LP, Sattler A, Wlodarski MW, Poliak N, Bethke N, Thiel A, Hammer MH, Reinke P, Maciejewski JP. Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes. J. Am. Soc. Nephrol. 20: 344-352 (2009).
Babic-Naglic D. Early rheumatoid arthritis. Reumatizam 55: 26-33 (2008).
Baccala R, Smith LR, Vestberg M, Peterson PA, Cole BC, Theofilopoulos AN. Mycoplasma arthritidis mitogen. V beta engaged in mice, rats, and humans, and requirement of HLA-DR alpha for presentation. Arthritis Rheum. 35: 434-442 (1992).
Baccar A, Loueslati BY, Troudi W, Hmida S, Dridi A, Jridi A, Mrad K, Ben Romdhane K, Ben Ammar Elgaaied A. Are HLA DQB1 alleles correlated with breast cancer histopronostic parameters in Tunisia? Tunis. Med. 87: 372-374 (2009).
Bach JF. Current concepts of autoimmunity. Rev. Neurol. (Paris) 158: 881-886 (2002).
Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J. Autoimmun. 10: 375-386 (1997).
Bachmann C, Lehr D, Janhsen E, Sambach H, Muehlan H, von Gontard A, Bachmann H. Health related quality of life of a tertiary referral center population with urinary incontinence using the DCGM-10 questionnaire. J. Urol. 182: S2000-S2006 (2009).
Badenhoop K. Genetic markers in thyroid autoimmune diseases. Z. Arztl. Fortbild. Qualitatssich. 98 Suppl. 5: 13-15 (2004).
Badenhoop K, Donner H, Pani M, Rau H, Siegmund T, Braun J. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population. Exp. Clin. Endocrinol. Diabetes 107 Suppl. 3: S89-S92 (1999).
Badenhoop K, Kahles H, Seidl C, Kordonouri O, Lopez ER, Walter M, Rosinger S, Ziegler A, Bohm BO; Diabetes Genetics Consortium. MHC-environment interactions leading to type 1 diabetes: feasibility of an analysis of HLA DR-DQ alleles in relation to manifestation periods and dates of birth. Diabetes Obes. Metab. 11 Suppl. 1: 88-91 (2009). *
Badenhoop K, Schwarz G, Schleusener H, Weetman AP, Recks S, Peters H, Bottazzo GF, Usadel KH. Tumor necrosis factor beta gene polymorphisms in Graves' disease. J. Clin. Endocrinol. Metab. 74: 287-291 (1992).
Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Usadel KH, Gale EA, Bottazzo GF. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 445-448 (1989).
Badenhoop K, Tonjes RR, Rau H, Donner H, Rieker W, Braun J, Herwig J, Mytilineos J, Kurth R, Usadel KH. Endogenous retroviral long terminal repeats of the HLA-DQ region are associated with susceptibility to insulin-dependent diabetes mellitus. Hum. Immunol. 50: 103-110 (1996).
Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, Maat-Schieman ML, van Doorn P, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, van Duinen SG; Dutch IBM Study Group. Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology 63: 2396-2398 (2004).
Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Geboes K, Rutgeerts PJ. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116: 22-28 (1999). *
Baeten D, Steenbakkers PG, Rijnders AM, Boots AM, Veys EM, De Keyser F. Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker. Arthritis Rheum. 50: 444-451 (2004). *
Bahammam AS, Gadelrab MO, Owais SM, Alswat K, Hamam KD. Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome. Sleep Med. 9: 575-578 (2008).
Bahri R, Naji A, Menier C, Charpentier B, Carosella ED, Rouas-Freiss N, Durrbach A. Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance. J. Immunol. 183: 7054-7062 (2009).
Bai H, Cheng J, Gao X, Joyee AG, Fan Y, Wang S, Jiao L, Yao Z, Yang X. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J. Immunol. 183: 5886-5895 (2009). *
Baisch JM, Capra JD. Linkage disequilibrium within the HLA complex does not extend into HLA-DP. Scand. J. Immunol. 37: 499-503 (1993).
Baka Z, Buzas E, Nagy G. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res. Ther. 11: 238 (2009).
Bakke AC, Purtzer MZ, Wildin RS. Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX). Clin. Exp. Immunol. 137: 373-378 (2004). *
Bakker AH, Hoppes R, Linnemann C, Toebes M, Rodenko B, Berkers CR, Hadrup SR, van Esch WJ, Heemskerk MH, Ovaa H, Schumacher TN. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc. Natl. Acad. Sci. U.S.A. 105: 3825-3830 (2008). *
Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP, Everhart JE, Wiesner RH. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the national institute of diabetes and digestive and kidney diseases liver transplantation database. Hepatology 48: 878-888 (2008). *
Balandraud N, Roudier J, Roudier C. Epstein-Barr virus and rheumatoid arthritis. Autoimmun. Rev. 3: 362-367 (2004).
Balas A, Alonso-Nieto M, Sanchez-Gordo F, Garcia-Sanchez F, Vicario JL. Description of three new HLA-A*02 subtypes in Caucasians: A*0281, A*0289 and A*9224. Tissue Antigens 70: 515-516 (2007). *
Balas A, Aviles MJ, Alonso-Nieto M, Zarapuz L, Blanco L, Garcia-Sanchez F, Vicario JL. HLA-DQA1 introns 2 and 3 sequencing: DQA1 sequencing-based typing and characterization of a highly polymorphic microsatellite at intron 3 of DQA1*0505. Hum. Immunol. 66: 903-911 (2005).
Balas A, Bustamante L, Garcia-Sanchez F, Vicario JL. Sequencing of a novel HLA-DRB1*07 allele with a new polymorphism at amino acid position 21 (DRB1*0715). Tissue Antigens 71: 179-180 (2008). *
Balas A, Bustamante L, Garcia-Sanchez F, Vicario JL. The new HLA-C allele, Cw*0220, shows a new polymorphism at amino acid position 169. Tissue Antigens 71: 93 (2008). *
Balas A, Bustamante L, Garcia-Sanchez F, Vicario JL. HLA-A*020115 and HLA-Cw*030203 show new synonymous mutations in exon 4. Tissue Antigens 70: 340-341 (2007). *
Balas A, Bustamante L, Garc�a-Sanchez F, Vicario JL. New HLA polymorphism detection by molecular and serologic typing procedures. Complete coding region characterization of Cw*0525, Cw*0825, B*3950 and A*3219N alleles. Tissue Antigens 74: 553-554 (2009). *
Balas A, Garcia-Sanchez F, Bustamante L, Vicario JL. New HLA-A allele, A*0339, identified in a Spanish patient. Tissue Antigens 71: 478 (2008). *
Balas A, Garcia-Sanchez F, Vicario JL. HLA-B*4907 and B*490101 differs by residue 163 placed in a dominant serologic epitope. Tissue Antigens Dec 30 [Epub ahead of print] (2009). *
Balas A, Garcia-Sanchez F, Vicario JL. Sequencing of a new HLA-DRB1*16 allele (DRB1*1615) with valine at residue 86. Tissue Antigens Dec 30 [Epub ahead of print] (2009). *
Balas A, Garcia-Sanchez F, Vicario JL. Sequencing of a new HLA-C allele, HLA-Cw*0742, with a novel HLA polymorphism at exon 3. Tissue Antigens 68: 530-531 (2006). *
Balas A, Planelles D, Sanz GF, Montoro JA, Vicario JL. HLA-B*0777 allele differs from B*0707 by a single residue in the antigen binding groove. Tissue Antigens Oct 13 [Epub ahead of print] (2009). *
Balas A, Sanchez-Garcia F, Bustamante L, Garcia-Sanchez F, Vicario JL. HLA-A*68020103 shows an eight nucleotides deletion within intron 2 but has normal mRNA splicing and serological recognition. Tissue Antigens 70: 258-259 (2007). *
Balas A, Sanchez-Gordo F, Bustamante L, Garcia-Sanchez F, Vicario JL. Sequencing of new HLA-A*3025 and HLA-Cw*0221 alleles found in Caucasian donors. Tissue Antigens 72: 404-405 (2008). *
Balas A, Sanchez-Gordo F, Garcia-Sanchez F, Prat I, Vicario JL. HLA-B*9523 increases the extremely high B*15-group polymorphism. Tissue Antigens 69: 620-621 (2007). *
Balazs C, Feher J. Associations of autoimmune disorders in endocrine diseases. Orv. Hetil. 150: 1589-1597 (2009).
Balbir-Gurman A, Schapira D, Nahir M. Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis. Semin. Arthritis Rheum. 30: 242-248 (2001). *
Balducci-Silano PL, Layrisse Z, Dominguez E, Amaro R, Gunczler P, Lanes R, Zaro R. HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population. Eur. J. Immunogenet. 21: 405-414 (1994).
Balducci-Silano PL, Layrisse ZE. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population. Associations with other HLA-alleles. J. Autoimmun. 8: 425-437 (1995).
Baldwin GC, Mickelson EM, Hansen JA, Nisperos B, Antonelli P, Nepom BS, Nepom GT. Electrophoretic variation between class II molecules expressed on HLA-DRw8 homozygous typing cells reveals multiple distinct haplotypes. Immunogenetics 21: 49-60 (1985).
Baldwin HM, Ito-Ihara T, Isaacs JD, Hilkens CM. TNFalpha blockade impairs dendritic cell survival and function in rheumatoid arthritis. Ann. Rheum. Dis. Sep 22 [Epub ahead of print] (2009).
Ball R, Shadomy SV, Meyer A, Huber BT, Leffell MS, Zachary A, Belotto M, Hilton E, Bryant-Genevier M, Schriefer ME, Miller FW, Braun MM. HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination. Arthritis Rheum. 60: 1179-1186 (2009). *
Balladares S, Alaez C, Pujol J, Duran C, Navarro JL, Gorodezky C. Distribution of TAP gene polymorphisms and extended MHC haplotypes in Mexican Mestizos and in Seri Indians from northwest Mexico. Genes Immun. 3: 78-85 (2002). *
Ballardini G, Bianchi FB, Mirakian R, Fallani M, Pisi E, Bottazzo GF. HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease. Clin. Exp. Immunol. 70: 35-46 (1987). *
Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 2: 1009-1013 (1984).
Ban M, Sawcer SJ, Heard RN, Bennetts BH, Adams S, Booth D, Perich V, Setakis E, Compston A, Stewart GJ. A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients. J. Neuroimmunol. 143: 60-64 (2003).
Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y. Analysis of immune regulatory genes in familial and sporadic Graves' disease. J. Clin. Endocrinol. Metab. 89: 4562-4568 (2004). *
Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun. 5: 203-208 (2004). *
Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y. The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin. Endocrinol. (Oxf.) 57: 81-88 (2002). *
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. U.S.A. 100: 15119-15124 (2003). *
Ban Y, Greenberg DA, Concepcion ES, Tomer Y. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 12: 1079-1083 (2002).
Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J. Clin. Endocrinol. Metab. 85: 4639-4643 (2000). *
Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum. 62: 369-377 (2010). *
Banks KE, Anderson AL, Tang H, Hughes DE, Costa RH, McLachlan A. Hepatocyte nuclear factor 3beta inhibits hepatitis B virus replication in vivo. J. Virol. 76: 12974-12980 (2002). *
Bansil S, Cook SD, Rohowsky-Kochan C. Multiple sclerosis: immune mechanism and update on current therapies. Ann. Neurol. 37 Suppl. 1: S87-S101 (1995).
Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M. Major histocompatibility complex class I chain-related gene a polymorphisms and extended haplotypes are associated with familial alopecia areata. J. Invest. Dermatol. 126: 74-78 (2006). *
Barbatis C, Kelly P, Greveson J, Heryet A, McGee JO. Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man. J. Clin. Pathol. 40: 879-884 (1987). *
Barbeau WE, Bassaganya-Riera J, Hontecillas R. Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetes. Med. Hypotheses 68: 607-619 (2007).
Barbeau WE, Novascone MA, Elgert KD. Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidentified superantigen? Mol. Immunol. 34: 535-541 (1997).
Barcellos LF, May SL, Ramsay PP, Quach HL, Lane JA, Nititham J, Noble JA, Taylor KE, Quach DL, Chung SA, Kelly JA, Moser KL, Behrens TW, Seldin MF, Thomson G, Harley JB, Gaffney PM, Criswell LA. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet. 5: e1000696 (2009). *
Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, Swerdlin A, Pericak-Vance MA, Haines JL, Hauser SL; Multiple Sclerosis Genetics Group. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet. 72: 710-716 (2003). *
Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S, Garcia ME, Lincoln RR, Pericak-Vance MA, Haines JL, Hauser SL; Multiple Sclerosis Genetics Group. Genetic basis for clinical expression in multiple sclerosis. Brain 125: 150-158 (2002). *
Barcellos LF, Ramsay PP, Caillier SJ, Sawcer S, Haines J, Schmidt S, Pericak-Vance M, Compston DA, Gabatto P, Hauser SL, Oksenberg JR. Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis. Genes Immun. 9: 493-500 (2008). *
Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Ucelli A, Savettieri G, Lincoln RL, Deloa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum. Mol. Genet. 15: 2813-2824 (2006). *
Barcellos LF, Thomson G, Carrington M, Schafer J, Begovich AB, Lin P, Xu XH, Min BQ, Marti D, Klitz W. Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients. JAMA 278: 1256-1261 (1997).
Baretton GB, Aust DE. Intraepithelial neoplasia/dysplasia - histopathology in ulcerative colitis. Pathologe 29 Suppl. 2: 280-285 (2008).
Baricordi OR, Stignani M, Melchiorri L, Rizzo R. HLA-G and inflammatory diseases. Inflamm. Allergy Drug Targets 7: 67-74 (2008).
Barion LA, Tsuneto LT, Testa GV, Lieber SR, Persoli LB, Marques SB, Vigorito AC, Aranha FJ, Eid KA, Oliveira GB, Miranda EC, Souza CA, Visentainer JE. Association between HLA and leukemia in a mixed Brazilian population. Rev. Assoc. Med. Bras. 53: 252-256 (2007).
Barker JM. Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening. J. Clin. Endocrinol. Metab. 91: 1210-1217 (2006). *
Barker JM, Liu E. Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv. Pediatr. 55: 349-365 (2008).
Barker JM, Triolo TM, Aly TA, Baschal EE, Babu SR, Kretowski A, Rewers MJ, Eisenbarth GS. Two single nucleotide polymorphisms identify highest-risk diabetes human leukocyte antigen genotype: potential for rapid screening. Diabetes 57: 3152-3155 (2008). *
Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, Hoffenberg E, Nelson JC, Gottlieb PA, Rewers M, Eisenbarth GS. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 28: 850-855 (2005). *
Barland P. Antibodies to citrullinated peptides: current role in diagnosis, prognosis, and pathogenesis of rheumatoid arthritis. New Developments in Rheumatic Diseases 1: 6-9 (2004). *
Barnabe CC, Leclercq SA, Fitzgerald AA. The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation. Semin. Arthritis Rheum. 39: 55-60 (2009). *
Barnes DS. Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm (2002). *
Barnetche T, Constantin A, Cantagrel A, Cambon-Thomsen A, Gourraud PA. New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples. Arthritis Res. Ther. 10: R26 (2008). *
Barnetche T, Constantin A, Gourraud PA, Abbal M, Garnier JG, Cantagrel A, Cambon-Thomsen A. Microsatellite typing of the human leucocyte antigen region: analytical approach and contribution to rheumatoid arthritis immunogenetic studies. Tissue Antigens 68: 390-398 (2006). *
Baron M, Davignon JL. Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2. J. Immunol. 181: 5530-5536 (2008). *
Barr GD, Shale DJ, Jewell DP. Ulcerative colitis and sarcoidosis. Postgrad. Med. J. 62: 341-345 (1986). *
Barrera P, Balsa A, Alves H, Westhovens R, Maenaut K, Cornelis F, Fritz P, Bardin T, Ceu Maia M, Lopes-Vaz A, Pascual Salcedo D, de la Concha E, Radstake T, van de Putte LB, Migliorini P, Prudhomme JF, Charron D, Spyropoulou M, Mendes A, Spaepen M, et al. Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF). J. Rheumatol. 28: 968-974 (2001).
Barrera P, Faure S, Prud'homme JF, Balsa A, Migliorini P, Chimenti D, Radstake TR, van de Putte LB, Pascual-Salcedo D, Westhovens R, Maenaut K, Alves H, Lopes-Vaz A, Stravopoulos C, Spyropoulou M, Fritz P, Bardin T, Charron D, Lepage V, et al. European genetic study on rheumatoid arthritis: is there a linkage of the interleukin-1 (IL-1), IL-10 or IL-4 genes to RA? Clin. Exp. Rheumatol. 19: 709-714 (2001).
Bartolome MJ, Martinez-Taboda VM, Lopez-Hoyos M, Blanco R, Rodriguez-Valverde V. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis. Clin. Exp. Rheumatol. 19: 259-264 (2001).
Bartolozzi G, Falcini F, Volpi M, Taccetti G, Tafi L. Arthropathies related to HLA-B27. Pediatr. Med. Chir. 12: 561-574 (1990).
Barton A, Myerscough A, John S, Gonzalez-Gay M, Ollier W, Worthington J. A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis. Rheumatology (Oxford) 39: 63-66 (2000). *
Basak GW, Yasukawa S, Alfaro A, Halligan S, Srivastava AS, Min WP, Minev B, Carrier E. Human embryonic stem cells-derived blast cells expres HLA-antigens. J. Transl. Med. 7: 27 (2009). *
Baschal EE, Aly TA, Jasinski JM, Steck AK, Johnson KN, Noble JA, Erlich HA, Eisenbarth GS; Diabetes Genetics Consortium. The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes. Diabetes Obes. Metab. 11 Suppl. 1: 25-30 (2009). *
Baschal EE, Eisenbarth GS. Extreme genetic risk for type 1A diabetes in the post-genome era. J. Autoimmun. 31: 1-6 (2008).
Basinski TM, Holzmann D, Eiwegger T, Zimmermann M, Klunker S, Meyer N, Schmid-Grendelmeier P, Jutel M, Akdis CA. Dual nature of T-cell-epithelium interaction in chronic rhinosinusitis. J. Allergy Clin. Immunol. 124: 74-80.e1-e8 (2009).
Bassendine MF, Dewar PJ, James OF. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 26: 625-628 (1985). *
Bastian HM, Alarcon GS, Roseman JM, McGwin G Jr, Vila LM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford) 46: 683-689 (2007). *
Bats AS, Barbarino PM, Bene MC, Faure GC, Forges T. Local lymphocytic and epithelial activation in a case of autoimmune oophoritis. Fertil. Steril. 90: 849.e5-e8 (2008).
Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes. Eur. J. Immunogenet. 30: 223-227 (2003). *
Baudouin-Brignole F, Robert PY, Creuzot-Garcher C, Olmiere C, Delval L, Baudouin C. Evaluation of NAAGA efficacy in dry eye syndrome. J. Fr. Ophtalmol. 32: 613-620 (2009).
Baum H. Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim. Biophys. Acta 1271: 111-121 (1995).
Baumert TF. Novel vaccine strategies. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper�s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 58-59. October 20 - 21 (2003). *
Beall SS, Biddison WE, McFarlin DE, McFarland HF, Hood LE. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR V beta chain locus and HLA class II genes. J. Neuroimmunol. 45: 53-60 (1993).
Becerril EV, Fernandez RG, Torres LP, Lacomba MS, Galera JM. HLA B27 as predisposition factor to suffer age related macular degeneration. Cell. Mol. Immunol. 6: 303-307 (2009). *
Bechter K, Bindl A, Horn M, Schreiner V. Therapy-resistant depression with fatigue: a case of presumed streptococcal-associated autoimmune disorder. Nervenarzt. 78: 338-341 (2007).
Beckebaum S, Cicinnati V, Broelsch CE. Liver transplantation, rejection and disease recurrence. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 55-56. October 15-16 (2003). *
Becker H, Gaubitz M, Domschke W, Kucharzik T. Joint involvement in chronic inflammatory bowel disease - current diagnostics and treatment options. Z. Gastroenterol. 44: 497-502 (2006).
Beckingsale AB, Davies J, Gibson JM, Rosenthal AR. Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27. Br. J. Ophthalmol. 68: 741-745 (1984).
Bedlow AJ, Donaldson PT, McFarlane BM, Lombard M, McFarlane IG, Williams R. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis. J. Clin. Lab. Immunol. 30: 103-109 (1989).
Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum. Immunol. 65: 632-639 (2004).
Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 43: 71-77 (1994).
Begus-Nahrmann Y, Lechel A, Obenauf AC, Nalapareddy K, Peit E, Hoffmann E, Schlaudraff F, Liss B, Schirmacher P, Kestler H, Danenberg E, Barker N, Clevers H, Speicher MR, Rudolph KL. p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat. Genet. 41: 1138-1143 (2009). *
Behrens M, Trejo T, Luthra H, Griffiths M, David CS, Taneja V. Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J. Autoimmun. Jan 8 [Epub ahead of print] (2010).
Bejrachandra S, Kitayaporn D, Kaewkungwal J, Piya-Anant M, Permpikul P, Sirikong M, Siriboonrit U, Chandanayingyong D. HLA class II (DRB1, DQA1 and DQB1) allele and haplotype frequencies among HIV-infection discordant Thai couples. Asian Pac. J. Allergy Immunol. 22: 143-151 (2004).
Belic D, Ristic-Nikolic S, Damjan S, Ratkov I, Ceke M. Heredity of psoriasis. Med. Pregl. 57: 171-174 (2004).
Belicha-Villanueva A, McEvoy S, Cycon K, Ferrone S, Gollnick SO, Bangia N. Differential contribution of TAP and tapasin to HLA class I antigen expression. Immunology 124: 112-120 (2008). *
Belkahla R, Omezzine A, Kchok K, Rebhi L, Ben Hadj Mbarek I, Rejeb J, Ben Rejeb N, Slimane N, Nabli N, Ben Abdelaziz A, Boughzala E, Bouslama A. Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population. Ann. Cardiol. Angeiol. (Paris) 57: 219-224 (2008).
Bell J, Rassenti L, Smoot S, Smith K, Newby C, Hohlfeld R, Toyka K, McDevitt H, Steinman L. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet 1: 1058-1060 (1986).
Bell MJ, Abbott RJ, Croft NP, Hislop AD, Burrows SR. An HLA-A2-restricted T cell epitope mapped to the BNLF2a immune evasion protein of EBV that inhibits TAP. J. Virol. 83: 2783-2788 (2009). *
Bell SJ, Rigby R, English N, Mann SD, Knight SC, Kamm MA, Stagg AJ. Migration and maturation of human colonic dendritic cells. J. Immunol. 166: 4958-4967 (2001). *
Beltrami A, Rossmann M, Fiorillo MT, Paladini F, Sorrentino R, Saenger W, Kumar P, Ziegler A, Uchanska-Ziegler B. Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes. J. Biol. Chem. 283: 27189-27199 (2008). *
Ben Dror L, Barnea E, Beer I, Mann M, Admon A. The HLA-B*2705 peptidome. Arthritis Rheum. 62: 420-429 (2010). *
Benazet JF, Reviron D, Mercier P, Roux H, Roudier J. HLA-DRB1 alleles associated with rheumatoid arthritis in southern France. Absence of extraarticular disease despite expression of the shared epitope. J. Rheumatol. 22: 607-610 (1995).
BenMustapha-Darghouth I, Trabelsi S, Largueche B, Bejaoui M, Dellagi K, Barbouche MR. Prevalence of Pneumocystis jiroveci pneumonia in Tunisian primary immunodeficient patients. Arch. Pediatr. 14: 20-23 (2007).
Bennani N, Atouf O, Benseffaj N, Brick C, Essakalli M. HLA polymorphism and Behcet's disease in Moroccan population. Pathol. Biol. (Paris) 57: 403-409 (2009).
Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Stewart GJ. HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients. Hum. Immunol. 60: 886-893 (1999).
Bennetts BH, Teutsch SM, Heard RN, Dunckley H, Stewart GJ. TAP2 polymorphisms in Australian multiple sclerosis patients. J. Neuroimmunol. 59: 113-121 (1995).
Benoit S, Hamm H. Psoriasis in childhood and adolescence: clinical features and therapy. Hautarzt. 60: 100-108 (2009).
Bentley G, Higuchi R, Hoglund B, Goodridge D, Sayer D, Trachtenberg EA, Erlich HA. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 74: 393-403 (2009). *
Bentz EK, Hefler LA, Denschlag D, Pietrowski D, Buerkle B, Tempfer CB. A polymorphism of the interleukin-1 beta gene is associated with sperm pathology in humans. Fertil. Steril. 88: 751-753 (2007).
Benvenga S, Guarneri F, Vaccaro M, Santarpia L, Trimarchi F. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid 14: 964-966 (2004).
Benvenga S, Santarpia L, Trimarchi F, Guarneri F. Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 16: 225-236 (2006).
Berg L, Ronnelid J, Sanjeevi CB, Lampa J, Klareskog L. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Arthritis Res. 2: 75-84 (2000). *
Bergamaschi L, Leone MA, Fasano ME, Guerini FR, Ferrante D, Bolognesi E, Barizzone N, Corrado L, Naldi P, Agliardi C, Dametto E, Salvetti M, Visconti A, Galimberti D, Scarpini E, Vercellino M, Bergamaschi R, Monaco F, Caputo D, et al. HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun. Nov 12 [Epub ahead of print] (2009). *
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *
Berger CT, Carlson JM, Brumme CJ, Hartman KL, Brumme ZL, Henry LM, Rosato PC, Piechocka-Trocha A, Brockman MA, Harrigan PR, Heckerman D, Kaufmann DE, Brander C. Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences. J. Exp. Med. Jan 11 [Epub ahead of print] (2010). *
Bergfeldt L. HLA-B27-associated cardiac disease. Ann. Intern. Med. 127: 621-629 (1997). *
Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L, Dahlqvist SR. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res. Ther. 6: R303-R308 (2004). *
Bergseng E, Xia J, Kim CY, Khosla C, Sollid LM. Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease associated HLA-DQ2 molecule. J. Biol. Chem. 280: 21791-21796 (2005). *
Bergstrom TF, Josefsson A, Erlich HA, Gyllensten U. Recent origin of HLA-DRB1 alleles and implications for human evolution. Nat. Genet. 18: 237-242 (1998). *
Beri R, Peterlana D, Puccetti A, Simeoni S, Garzotti P, Biasi D, Caramaschi P, Tinazzi E, Lunardi C. HLA-DRB1 alleles and rheumatoid arthritis in northern Italy: lack of correlation with disease severity and extra-articular manifestations. Recenti Prog. Med. 96: 139-143 (2005).
Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, Hafler DA. IL-17 producing human peripheral regulatory T cells retain suppressive function. Blood 113: 4240-4249 (2009). *
Bernal W, Donaldson P, Underhill J, Wendon J, Williams R. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. J. Hepatol. 29: 53-59 (1998). *
Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J. Hepatol. 30: 237-241 (1999). *
Bernardo ME, Avanzini MA, Ciccocioppo R, Perotti C, Cometa AM, Moretta A, Marconi M, Valli M, Novara F, Bonetti F, Zuffardi O, Maccario R, Corazza GR, Locatelli F. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease. Cytotherapy 11: 825-836 (2009).
Bernardo ME, Avanzini MA, Ciccocioppo R, Perotti C, Cometa AM, Moretta A, Marconi M, Valli M, Novara F, Bonetti F, Zuffardi O, Maccario R, Corazza GR, Locatelli F. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease. Cytotherapy Aug 13 [Epub ahead of print] (2009).
Berndt U, Philipsen L, Bartsch S, Wiedenmann B, Baumgart DC, Hammerle M, Sturm A. Systematic high-content proteomic analysis reveals substantial immunologic changes in colorectal cancer. Cancer Res. 68: 880-888 (2008). *
Berntson L, Damgard M, Andersson-Gare B, Herlin T, Nielsen S, Nordal E, Rygg M, Zak M, Fasth A. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J. Rheumatol. 35: 2055-2061 (2008).
Berres ML, Schnyder B, Yagmur E, Inglis B, Stanzel S, Tischendorf JJ, Koch A, Winograd R, Trautwein C, Wasmuth HE. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis. Liver Int. 29: 536-543 (2009). *
Berson A, Freneaux E, Larrey D, Lepage V, Douay C, Mallet C, Fromenty B, Benhamou JP, Pessayre D. Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis. J. Hepatol. 20: 336-342 (1994).
Bertrams J. The HLA association of insulin-dependent (type I) diabetes mellitus. Behring Inst. Mitt. 75: 89-99 (1984).
Best I, Lopez G, Verdonck K, Gonzalez E, Tipismana M, Gotuzzo E, Vanham G, Clark D. IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population. Immunology 128: e777-e786 (2009).
Bettencourt BF, Santos MR, Fialho RN, Couto AR, Peixoto MJ, Pinheiro JP, Spinola H, Mora MG, Santos C, Brehm A, Bruges-Armas J. Evaluation of two methods for computational HLA haplotypes inference using a real dataset. BMC Bioinformatics 9: 68 (2008). *
Bettens F, Nicoloso de Faveri G, Tiercy JM. HLA-B51 and haplotypic diversity of B-Cw associations: implications for matching in unrelated hematopoietic stem cell transplantation. Tissue Antigens 73: 316-325 (2009). *
Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, McHugh NJ. Clinical and HLA-class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK adult-onset Caucasian myositis. Ann. Rheum. Dis. 68: 1621-1625 (2009).
Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Greggio NA, Sanzari M, Tedesco F, Pedini B, Boscaro M, Presotto F. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J. Clin. Endocrinol. Metab. 82: 932-938 (1997). *
Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. Ateneo. Parmense. 74: 9-33 (2003).
Bettinotti MP, Hartung K, Deicher H, Messer G, Keller E, Weiss EH, Albert ED. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 37: 449-454 (1993).
Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology (Am. Soc. Hematol. Educ. Program) 2003: 40-61 (2003). *
Bewry NN, Bolick SC, Wright KL, Harton JA. GTP-dependent recruitment of CIITA to the class II major histocompatibility complex promoter. J. Biol. Chem. 282: 26178-26184 (2007). *
Bhangle SD, Kramer N, Rosenstein ED. Spondyloarthropathy after ampullary carcinoma resection: "post-Whipple" disease. J. Clin. Rheumatol. 15: 241-243 (2009).
Bharat A, Kuo E, Steward N, Aloush A, Hachem R, Trulock EP, Patterson GA, Meyers BF, Mohanakumar T. Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann. Thorac. Surg. 86: 189-197 (2008).
Bhat KP, Turner JD, Myers SE, Cape AD, Ting JP, Greer SF. The 19S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription. Mol. Immunol. 45: 2214-2224 (2008). *
Bhatnagar A, Wig JD, Majumdar S. Immunological findings in acute and chronic pancreatitis. ANZ J. Surg. 73: 59-64 (2003). *
Bias WB, Urban MD, Migeon CJ, Hsu SH, Lee PA. Intra-HLA recombinations localizing the 21-hydroxylase deficiency gene within the HLA complex. Hum. Immunol. 2: 139-145 (1981).
Bieda K, Pani MA, van der Auwera B, Seidl C, Tonjes RR, Gorus F, Usadel KH, Badenhoop K. A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies type I diabetes susceptibility on high risk DQ haplotypes. Diabetologia 45: 443-447 (2002). *
Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castano L. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun. 7: 550-554 (2006). *
Bilbao JR, Martin-Pagola A, Calvo B, Perez de Nanclares G, Gepv-N, Castano L. Contribution of MIC-A polymorphism to type 1 diabetes mellitus in Basques. Ann. N. Y. Acad. Sci. 958: 321-324 (2002). *
Bilbao JR, Martin-Pagola A, Perez De Nanclares G, Calvo B, Vitoria JC, Vazquez F, Castano L. HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders. Ann. N. Y. Acad. Sci. 1005: 314-318 (2003). *
Bilbao JR, Martin-Pagola A, Vitoria JC, Zubillaga P, Ortiz L, Castano L. HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease. Tissue Antigens 60: 71-76 (2002). *
Bilbao JR, Villoslada P, Martin-Pagola A, Castano L. No evidence of pancreatic autoimmunity among patients with multiple sclerosis. Ann. N. Y. Acad. Sci. 1037: 133-137 (2004). *
Billen EV, Voorter CE, Christiaans MH, van den Berg-Loonen EM. Luminex donor-specific crossmatches. Tissue Antigens 71: 507-513 (2008). *
Billiard M. REM sleep behavior disorder and narcolepsy. CNS Neurol. Disord. Drug Targets 8: 264-270 (2009).
Binard A, Alassane S, Devauchelle-Pensec V, Berthelot JM, Jousse-Joulin S, Chales G, Le Henaff C, Thorel JB, Hoang S, Youinou P, Saraux A. Outcome of early monoarthritis: a followup study. J. Rheumatol. 34: 2351-2357 (2007).
Binder V, Orholm M. Familial occurrence and inheritance studies in inflammatory bowel disease. Neth. J. Med. 48: 53-56 (1996).
Bingham WF. The role of HLA B27 in the diagnosis and management of low-back pain and sciatica. J. Neurosurg. 47: 561-566 (1977).
Binzer S, Imrell K, Binzer M, Vang S, Rogvi-Hansen B, Hillert J, Stenager E. Multiple sclerosis in a family on the Faroe Islands. Acta Neurol. Scand. 121: 16-19 (2010).
Bioque G, Bouma G, Crusius JB, Koutroubakis I, Kostense PJ, Meuwissen SG, Pena AS. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 105-110 (1996).
Biral AC, Magalhaes RF, Wastowski IJ, Simoes R, Donadi EA, Simoes AL, Mendes-Junior CT, Tanaka AM, Kraemer MH. Association of HLA-A, -B, -C genes and TNF microsatellite polymorphism with psoriasis vulgaris: a study of genetic risk in Brazilian patients. Eur. J. Dermatol. 16: 523-529 (2006).
Bishof NA, Welch TR, Beischel LS, Carson D, Donnelly PA. DP polymorphism in HLA-A1,-B8,-DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus. Pediatr. Nephrol. 7: 243-246 (1993).
Bittencourt PL, Farias AQ, Porta G, Cancado EL, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J. Clin. Gastroenterol. 42: 300-305 (2008).
Bittencourt PL, Goldberg AC, Cancado EL, Porta G, Carrilho FJ, Farias AQ, Palacios SA, Chiarella JM, Abrantes-Lemos CP, Baggio VL, Laudanna AA, Kalil J. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am. J. Gastroenterol. 94: 1906-1913 (1999). *
Bittencourt PL, Palacios SA, Cancado EL, Carrilho FJ, Porta G, Kalil J, Goldberg AC. Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alpha -308 promoter polymorphism. Gut 51: 609-610 (2002). *
Bittencourt PL, Palacios SA, Cancado EL, Porta G, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am. J. Gastroenterol. 98: 1616-1620 (2003). *
Bittencourt PL, Palacios SA, Cancado EL, Porta G, Drigo S, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor alpha polymorphisms at position -308. J. Hepatol. 35: 24-28 (2001). *
Bittencourt PL, Palacios SA, Farias AQ, Abrantes-Lemos CP, Cancado EL, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 18: 1061-1066 (2003). *
Bitti PP, Murgia BS, Ticca A, Ferrai R, Musu L, Piras ML, Puledda E, Campo S, Durando S, Montomoli C, Clayton DG, Mander AP, Bernardinelli L. Association between the ancestral haplotype HLA A30B18DR3 and multiple sclerosis in central Sardinia. Genet. Epidemiol. 20: 271-283 (2001).
Bjarnason I, Helgason KO, Geirsson AJ, Sigthorsson G, Reynisdottir I, Gudbjartsson D, Einarsdottir AS, Sherwood R, Kristjansson K, Kjartansson O, Thjodleifsson B. Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis. Gastroenterology 125: 1598-1605 (2003). *
Bjorck S, Brundin C, Lorinc E, Lynch KF, Agardh D. Screening detects a high proportion of celiac disease in young HLA-genotyped children. J. Pediatr. Gastroenterol. Nutr. 50: 49-53 (2010).
Bjorkbacka H, Lavant EH, Fredrikson GN, Melander O, Berglund G, Carlson JA, Nilsson J. Weak associations between human leucocyte antigen genotype and acute myocardial infarction. J. Intern. Med. Dec 14 [Epub ahead of print] (2009). *
Bjorkland A, Totterman TH. Is primary biliary cirrhosis an autoimmune disease? Scand. J. Gastroenterol. Suppl. 204: 32-39 (1994).
Bjornvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jorgensen K, Njolstad PR, Ek J, Ascher H, Gudjonsdottir AH, Lie BA, Skinningsrud B, Akselsen HE, Ronningen KS, Sollid LM, Undlien DE. FOXP3 polymorphisms in type 1 diabetes and coeliac disease. J. Autoimmun. 27: 140-144 (2006).
Bjornvold M, Undlien DE, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE, Gervin K, Ronningen KS, Stene LC. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 51: 589-596 (2008). *
Black CM, Welsh KI, Fielder A, Hughes GR, Batchelor JR. HLA antigens and Bf allotypes in SLE: evidence for the association being with specific haplotypes. Tissue Antigens 19: 115-120 (1982).
Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J. Immunol. 169: 5595-600 (2002). *
Black M, Mignogna M, Scully C. Pemphigus vulgaris. Oral Dis. 11: 119-130 (2005). *
Black MH, Watanabe RM. A principal-components-based clustering method to identify multiple variants associated with rheumatoid arthritis and arthritis-related autoantibodies. BMC Proc. 3 Suppl. 7: S129 (2009). *
Blanco-Gelaz MA, Suarez-Alvarez B, Diaz-Pena R, Lopez-Larrea C. HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation. Mol. Immunol. 46: 1304-1311 (2009). *
Blank C, Sabri M, Di Lorenzo C. Pediatric gastric and duodenal disorders. Curr. Opin. Gastroenterol. 20: 551-555 (2004).
Blank N, Fiehn C, Lorenz HM. Radiographic healing of sarcoid bone erosion. Z. Rheumatol. 68: 763-765 (2009).
Blaschke S, Brandt P, Wessels JT, Muller GA. Expression and function of the C-class chemokine lymphotactin (XCL1) in Wegener's granulomatosis. J. Rheumatol. 36: 2491-2500 (2009).
Blaschke S, Viereck V, Schwarz G, Klinger HM, Guerluek S, Muller GA. Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis. Scand. J. Rheumatol. Feb 26 [Epub ahead of print] (2009). *
Blass S, Engel JM, Burmester GR. The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences. Z. Rheumatol. 60: 1-16 (2001).
Blau EB. Familial granulomatous arthritis, iritis, and rash. J. Pediatr. 107: 689-693 (1985).
Blomhoff A, Olsson M, Johansson S, Akselsen HE, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE, Lie BA. Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1(*)03 and DRB1(*)04 haplotypes. Genes Immun. 7: 130-140 (2006). *
Bloom S, Fleming K, Chapman R. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. Gut 36: 604-609 (1995). *
Bo X, Broome U, Remberger M, Sumitran-Holgersson S. Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut 49: 131-141 (2001). *
Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin. Liver Dis. 6: 347-359 (2002).
Boberg KM, Lundin KE, Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand. J. Gastroenterol. Suppl. 204: 47-58 (1994).
Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broome U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand. J. Gastroenterol. 36: 886-890 (2001). *
Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1996. Vox. Sang. 73: 105-130 (1997).
Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1996. Eur. J. Immunogenet. 24: 105-151 (1997).
Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1996. Hum. Immunol. 53: 98-128 (1997).
Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 49: 297-321 (1997).
Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1998. Vox. Sang. 77: 164-191 (1999).
Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1998. Tissue Antigens 53: 407-446 (1999). *
Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1998. Eur. J. Immunogenet. 26: 81-116 (1999).
Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1998. Hum. Immunol. 60: 361-395 (1999).
Boehm BO, Manfras B, Seidl S, Holzberger G, Kuhnl P, Rosak C, Schoffling K, Trucco M. The HLA-DQ beta non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease. Tissue Antigens 37: 130-132 (1991).
Boehm BO, Rosinger S, Sauer G, Manfras BJ, Palesch D, Schiekofer S, Kalbacher H, Burster T. Protease-resistant human GAD-derived altered peptide ligands decrease TNF-alpha and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitus. Mol. Immunol. 46: 2576-2584 (2009). *
Boehm BO, Seissler J, Gluck M, Manfras BJ, Thomas H, Schmidt K, Rudert WA, Usadel KH, Trucco M, Scherbaum WA. The level and the persistence of islet cell antibodies in healthy schoolchildren are associated with polymorphic residues of the HLA-DQ beta chain. Dis. Markers 9: 273-280 (1991).
Boehncke WH, Buerger C, Boehncke S. Co-morbidities in psoriasis vulgaris. Hautarzt. 60: 116-121 (2009).
Boehncke WH, Loeliger C, Kuehnl P, Kalbacher H, Bohm BO, Gall H. Identification of HLA-DR and -DQ alleles conferring susceptibility to pollen allergy and pollen associated food allergy. Clin. Exp. Allergy 28: 434-441 (1998). *
Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A. HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis. Int. J. Immunogenet. 33: 135-140 (2006). *
Bogunia-Kubik K, Lange A. Development of the HLA proficiency testing for Central and East Europe. Int. J. Immunogenet. 35: 409-416 (2008). *
Bogunia-Kubik K, Middleton P, Norden J, Dickinson A, Lange A. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Int. J. Immunogenet. 35: 207-213 (2008). *
Bohme J, Carlsson B, Wallin J, Moller E, Persson B, Peterson PA, Rask L. Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J. Immunol. 137: 941-947 (1986).
Bohmova K, Hladikova Z, Cerny M, Flajsmanova K, Vrabelova Z, Skramlikova T, Spalova I, Cerna M, Chudoba D, Pithova P, Stadlerova G, Bartaskova D, Faresjo M, Stechova K. Cord blood cytokine profile detection in neonates with T1D parents - monitoring of cellular auto-reactivity using protein microarray. Scand. J. Immunol. 66: 563-571 (2007). *
Bohn G, Hardtke-Wolenski M, Zeidler C, Maecker B, Sauer M, Sykora KW, Grigull L, Welte K, Klein C. Lethal graft-versus-host disease in congenital neutropenia caused by p14 deficiency after allogeneic bone marrow transplantation from an HLA-identical sibling. Pediatr. Blood Cancer 51: 436-438 (2008).
Boki KA, Drosos AA, Tzioufas AG, Lanchbury JS, Panayi GS, Moutsopoulos HM. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann. Rheum. Dis. 52: 517-519 (1993). *
Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum. 35: 749-755 (1992).
Bolognesi E, Dalfonso S, Rolando V, Fasano ME, Pratic� L, Momigliano-Richiardi P. MICA and MICB microsatellite alleles in HLA extended haplotypes. Eur. J. Immunogenet. 28: 523-530 (2001). *
Bolognesi E, Karell K, Percopo S, Coto I, Greco L, Mantovani V, Suoraniemi E, Partanen J, Mustalahti K, Maki M, Momigliano-Richiardi P. Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 61: 308-316 (2003). *
Bolsover WJ, Hall MA, Vaughan RW, Welsh KI, Ciclitira PJ. A family study confirms that the HLA-DP associations with celiac disease are the result of an extended HLA-DR3 haplotype. Hum. Immunol. 31: 100-108 (1991).
Bolstad AI, Wassmuth R, Haga HJ, Jonsson R. HLA markers and clinical characteristics in Caucasians with primary Sjogren's syndrome. J. Rheumatol. 28: 1554-1562 (2001).
Bolton DL, Minang JT, Trivett MT, Song K, Tuscher JJ, Li Y, Piatak M Jr, O'Connor D, Lifson JD, Roederer M, Ohlen C. Trafficking, persistence, and activation state of adoptively transferred allogeneic and autologous simian immunodeficiency virus-specific CD8+ T cell clones during acute and chronic infection of Rhesus macaques. J. Immunol. 184: 303-314 (2010).
Boms S, Sehr T, Jappe U, Enk A. First manifestation of psoriasis vulgaris in tumor necrosis factor receptor-associated periodic syndrome during treatment with etanercept. Hautarzt. 59: 653-655 (2008).
Bonanno CT, Cigna D, Danna C, D'Anna RP, Di Sano C, Matranga D, Raffa M, Impeduglia A, Salerno A. HLA class I and class II polymorphism in three Sicilian populations. Hum. Biol. 79: 339-354 (2007).
Bond E, Adams WC, Smed-Sorensen A, Sandgren KJ, Perbeck L, Hofmann A, Andersson J, Lore K. Techniques for time-efficient isolation of human skin dendritic cell subsets and assessment of their antigen uptake capacity. J. Immunol. Methods 348: 42-56 (2009). *
Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol. 20: 861-868 (2008).
Bonetti A, Reunanen K, Finnila S, Koivisto K, Wikstrom J, Sumelahti ML, Pirttila T, Elovaara I, Reunanen M, Saarela J, Peltonen L, Rantamaki T, Tienari PJ. A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes Immun. 5: 142-146 (2004). *
Bongi SM, Porfirio B, Rombola G, Palasciano A, Beneforti E, Bianucci G. Shared-epitope HLA-DRB1 alleles and sex ratio in Italian patients with rheumatoid arthritis. Joint Bone Spine 71: 24-28 (2004).
Bongiorno MR, Pistone G, de Giorgi V, Arico M. Clinical and immunohistochemical evaluation of the vulvar Langerhans cell histiocytosis. Dermatol. Ther. 21 Suppl. 3: S15-S20 (2008).
Bonnekoh B, Pommer AJ, Bockelmann R, Hofmeister H, Philipsen L, Gollnick H. Topo-proteomic in situ analysis of psoriatic plaque under efalizumab treatment. Skin Pharmacol. Physiol. 20: 237-252 (2007).
Boodhoo A, Wong AM, Williamson D, Voon D, Lee S, Allcock RJ, Price P. A promoter polymorphism in the central MHC gene, IKBL, influences the binding of transcription factors USF1 and E47 on disease-associated haplotypes. Gene Expr. 12: 1-11 (2004).
Boots AM, Hubers H, Kouwijzer M, den Hoed-van Zandbrink L, Westrek-Esselink B, van Doorn C, Stenger R, Bos ES, van Lierop MJ, Verheijden GF, Timmers M, van Staveren C. Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39 (aa263-275) epitope: an MHC anchor variant peptide for immune modulation. Arthritis Res. Ther. 9: R71 (2007). *
Borbulevych OY, Insaidoo FK, Baxter TK, Powell DJ Jr, Johnson LA, Restifo NP, Baker BM. Structures of MART-1(26/27-35) peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. J. Mol. Biol. 372: 1123-1136 (2007). *
Borchers AT, Uibo R, Gershwin ME. The geoepidemiology of type 1 diabetes. Autoimmun. Rev. Dec 4 [Epub ahead of print] (2009).
Borenstein SH, Graham J, Zhang XL, Chamberlain JW. CD8+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens. J. Immunol. 165: 2341-2353 (2000). *
Borghi A, Fogli E, Stignani M, Melchiorri L, Altieri E, Baricordi O, Rizzo R, Virgili A. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch. Dermatol. Res. 300: 551-559 (2008). *
Borgiani P, Vallo L, D'Apice MR, Giardina E, Pucci S, Capon F, Nistico S, Chimenti S, Pallone F, Novelli G. Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur. J. Dermatol. 12: 540-542 (2002). *
Borras SG, Cotorruelo C, Racca L, Recarte M, Garc�as C, Biondi C, Bottasso O, Racca A. Association of leprosy with HLA-DRB1 in an Argentinean population. Ann. Clin. Biochem. 45: 96-98 (2008).
Both M, Moosig F, Gross WL, Heller M. Large-vessel vasculitis: imaging and interventional therapy. Radiologe 49: 947-966 (2009).
Bottino C, Moretta L, Pende D, Vitale M, Moretta A. Learning how to discriminate between friends and enemies, a lesson from natural killer cells. Mol. Immunol. 41: 569-575 (2004). *
Bougacha-Elleuch N, Rebai A, Mnif M, Makni H, Bellassouad M, Jouida J, Abid M, Hammadi A. Analysis of MHC genes in a Tunisian isolate with autoimmune thyroid diseases: implication of TNF -308 gene polymorphism. J. Autoimmun. 23: 75-80 (2004).
Bouma G, Crusius JB, Garcia-Gonzalez MA, Meijer BU, Hellemans HP, Hakvoort RJ, Schreuder GM, Kostense PJ, Meuwissen SG, Pena AS. Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin. Exp. Immunol. 115: 294-300 (1999). *
Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand. J. Immunol. 43: 456-463 (1996).
Bouma G, Oudkerk Pool M, Crusius JB, Schreuder GM, Hellemans HP, Meijer BU, Kostense PJ, Giphart MJ, Meuwissen SG, Pena AS. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD). Clin. Exp. Immunol. 109: 175-179 (1997). *
Bouma G, Poen AC, Garcia-Gonzalez MA, Schreuder GM, Felt-Bersma RJ, Meuwissen SG, Pena AS. HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics 47: 451-455 (1998).
Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine 76: 654-657 (2009). *
Bourgarit A, Carcelain G, Samri A, Parizot C, Lafaurie M, Abgrall S, Delcey V, Vicaut E, Sereni D, Autran B; PARADOX Study Group. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. J. Immunol. 183: 3915-3923 (2009).
Bourgey MM, Calcagno GG, Tinto NN, Gennarelli DD, Margaritte-Jeannin PP, Greco LL, Limongelli MG, Esposito OO, Marano CC, Troncone RR, Spampanato AA, Clerget-Darpoux FF, Sacchetti L. HLA-related genetic risk for coeliac disease. Gut 56: 1054-1059 (2007). *
Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C, Galitzky J, Lafontan M, Karpe F, Frayn KN, Bouloumie A. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 117: 806-815 (2008). *
Boutwell CL, Rowley CF, Essex M. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by CTL escape mutations in HLA-B57 epitopes of capsid protein. J. Virol. 83: 2460-2468 (2009). *
Bouwman LH, Ling Z, Duinkerken G, Pipeleers DG, Roep BO. HLA incompatibility and immunogenicity of human pancreatic islet preparations cocultured with blood cells of healthy donors. Hum. Immunol. 66: 494-500 (2005).
Bovo P, Mirakian R, Merigo F, Angelini G, Cavallini G, Rizzini P, Bottazzo GF, Scuro LA. HLA molecule expression on chronic pancreatitis specimens: is there a role for autoimmunity? A preliminary study. Pancreas 2: 350-356 (1987).
Bowes J, Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 47: 399-402 (2008). *
Bowness P, Zaccai N, Bird L, Jones EY. HLA-B27 and disease pathogenesis: new structural and functional insights. Expert Rev. Mol. Med. 1: 1-10 (1999). *
Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543 (2000). *
Boykinova OB, Stoilova YD, Tsvetkova TZ, Baltadjiev IG. Epidemiological, immunological and clinical characteristics of acute hepatitis C. Folia Med. (Plovdiv.) 51: 61-69 (2009).
Boyton RJ. Regulation of immunity in bronchiectasis. Med. Mycol. 47 Suppl. 1: S175-S182 (2009).
Bradley DS, Nabozny GH, Cheng S, Zhou P, Griffiths MM, Luthra HS, David CS. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J. Clin. Invest. 100: 2227-2234 (1997). *
Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin. Immunopathol. 25: 3-18 (2003). *
Brand O, Gough S, Heward J. HLA , CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev. Mol. Med. 7: 1-15 (2005).
Brandao LC, Vatta S, Guimaraes R, Segat L, Araujo J, de Lima FJ, Arraes LC, Not T, Crovella S. Rapid genetic screening for major HLA risk haplotypes in patients with type 1 diabetes from North East Brazil. Hum. Immunol. Dec 22 [Epub ahead of print] (2009).
Brandao LR, Kletzel M, Boulad F, Kurtzberg J, Maloney K, Fligman I, Sison CP, Dimichele D. A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation. Pediatr. Blood Cancer 50: 1240-1246 (2008).
Brandhagen DJ, Gross JB Jr, Poterucha JJ, Germer JJ, Czaja AJ, Smith CI, Ribeiro AC, Guerrero RB, Therneau TM, Schiff E, Gordon FD, Wiesner RH, Persing DH. Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C. Am. J. Gastroenterol. 95: 2056-2060 (2000). *
Brandmaier AG, Leitner WW, Ha SP, Sidney J, Restifo NP, Touloukian CE. High-avidity autoreactive CD4+ T cells induce host CTL, overcome Tregs and mediate tumor destruction. J. Immunother. 32: 677-688 (2009).
Brant SR. Exposed: the genetic underpinnings of ulcerative colitis relative to Crohn's disease. Gastroenterology 136: 396-399 (2009). *
Bratke K, Maruschke L, Darowski M, Kuepper M, Braun A, Virchow JC, Lommatzsch M. A role for the neurotrophin receptor TrkB on maturing dendritic cells. J. Neuroimmunol. 189: 88-94 (2007).
Bratland E, Skinningsrud B, Undlien DE, Mozes E, Husebye ES. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 94: 5117-5124 (2009).
Braun J. Epidemiology and prognosis of ankylosing spondylitis. Radiologe 44: 209-210, 212-216 (2004).
Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 41: 58-67 (1998). *
Braun J, Zochling J, Baraliakos X, Alten RH, Burmester GR, Grasedyck K, Brandt J, Haibel H, Hammer M, Krause A, Mielke F, Tony HP, Ebner W, Gomor B, Hermann J, Zeidler H, Beck E, Baumgaertner M, Sieper J. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomized controlled trial. Ann. Rheum. Dis. 65: 1147-1153 (2006). *
Braun WE. HLA molecules in autoimmune diseases. Clin. Biochem. 25: 187-191 (1992). *
Breban M, Said-Nahal R, Hugot JP, Miceli-Richard C. Familial and genetic aspects of spondyloarthropathy. Rheum. Dis. Clin. North Am. 29: 575-594 (2003).
Breckpot K, Emeagi P, Dullaers M, Michiels A, Heirman C, Thielemans K. Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors. Hum. Gene Ther. 18: 536-546 (2007).
Breidert M, Janssen-Langenstein R, Hambrecht S. A 63 year old Turkish woman with recurrent pneumonia. Internist (Berl.) 48: 420-425 (2007).
Brennan P, Hajeer A, Ong KR, Worthington J, John S, Thomson W, Silman A, Ollier B. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 40: 1383-1386 (1997).
Brennan P, Ollier B, Worthington J, Hajeer A, Silman A. Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin? Lancet 348: 106-109 (1996). *
Breslin NP, Todd A, Kilgallen C, O'Morain C. Monozygotic twins with Crohn's disease and ulcerative colitis: a unique case report. Gut 41: 557-560 (1997). *
Brett PM, Yasuda N, Yiannakou JY, Herbst F, Ellis HJ, Vaughan R, Nicholls RJ, Ciclitira PJ. Genetic and immunological markers in pouchitis. Eur. J. Gastroenterol. Hepatol. 8: 951-955 (1996).
Breulmann B, Bantis C, Siekierka M, Blume C, Aker S, Kuhr N, Grabensee B, Ivens K. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin. Transplant. 21: 615-621 (2007). *
Brick C, Belgnaoui FZ, Atouf O, Aoussar A, Bennani N, Senouci K, Hassam B, Essakalli M. Pemphigus and HLA in Morocco. Transfus. Clin. Biol. 14: 402-406 (2007).
Brintnell W, Zeggini E, Barton A, Thomson W, Eyre S, Hinks A, Silman AJ, Worthington J. Evidence for a novel rheumatoid arthritis susceptibility locus on chromosome 6p. Arthritis Rheum. 50: 3823-3830 (2004). *
Broering R, Wu J, Meng Z, Hilgard P, Lu M, Trippler M, Szczeponek A, Gerken G, Schlaak JF. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J. Hepatol. 48: 914-922 (2008).
Broniarczyk-Dyla G, Prusinska-Bratos M, Dubla-Berner M, Arkuszewska C, Borowiec M, Kowalski ML, Woszczek G. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata. Arch. Immunol. Ther. Exp. (Warsz.) 50: 333-336 (2002).
Bronson PG, Ramsay PP, Thomson G, Barcellos LF; Diabetes Genetics Consortium. Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes. Diabetes Obes. Metab. 11 Suppl. 1: 74-83 (2009). *
Brooks AG, Boyington JC, Sun PD. Natural killer cell recognition of HLA class I molecules. Rev. Immunogenet. 2: 433-448 (2000).
Broome U. Autoimmune hepatitis and overlap syndromes. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 38-39. September 12 - 13 (2003). *
Broome U, Glaumann H, Hultcrantz R, Forsum U. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis. Scand. J. Gastroenterol. 25: 54-58 (1990).
Broome U, Grunewald J, Scheynius A, Olerup O, Hultcrantz R. Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis. J. Hepatol. 26: 527-534 (1997). *
Broome U, Hultcrantz R, Scheynius A. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis. Scand. J. Gastroenterol. 28: 126-130 (1993).
Brorsson C, Hansen NT, Lage K, Bergholdt R, Brunak S, Pociot F; Diabetes Genetics Consortium. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data. Diabetes Obes. Metab. 11 Suppl. 1: 60-66 (2009). *
Brown JJ, Ollier W, Thomson W, Bayat A. Positive association of HLA-DRB1*15 with Dupuytren's disease in Caucasians. Tissue Antigens 72: 166-170 (2008). *
Brown JJ, Ollier WE, Thomson W, Bayat A. Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int. J. Immunogenet. 35: 303-307 (2008). *
Brown M, Newton J, Harney SM, Wordsworth P. Challenges in mapping non-HLA-DRB1 major histocompatibility genes in rheumatoid arthritis: comment on the article by Vignal et al. Arthritis Rheum. 60: 2207 (2009). *
Brown MA. Genomewide screens in ankylosing spondylitis. Adv. Exp. Med. Biol. 649: 148-158 (2009).
Brown MA. Genetics of ankylosing spondylitis. Curr. Opin. Rheumatol. Jan 15 [Epub ahead of print] (2010).
Brown MA, Pile KD, Kennedy LG, Campbell D, Andrew L, March R, Shatford JL, Weeks DE, Calin A, Wordsworth BP. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum. 41: 588-595 (1998). *
Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr. Opin. Pediatr. 21: 523-528 (2009).
Brownlie RJ, Myers LK, Wooley PH, Corrigall VM, Bodman-Smith MD, Panayi GS, Thompson SJ. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein. Arthritis Rheum. 54: 854-863 (2006). *
Brozzetti A, Marzotti S, Tortoioli C, Bini V, Giordano R, Dotta F, Betterle C, De Bellis A, Arnaldi G, Toscano V, Arvat E, Bellastella A, Mantero F, Falorni A. Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. Eur. J. Endocrinol. Nov 2 [Epub ahead of print] (2009).
Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A, Caforio AL, Bergantin A, Tombini V, Moreo A, Ashtamkar L, Doria A, Shoenfeld Y, Livneh A. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus 14: 670-674 (2005).
Brum DG, Barreira AA, Louzada-Junior P, Mendes-Junior CT, Donadi EA. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil. J. Neuroimmunol. 189: 118-124 (2007).
Brum DG, Barreira AA, Santos AC, Kaimen-Maciel DR, Matiello M, Costa RM, Deghaide NH, Costa LS, Louzada-Junior P, Diniz PR, Comini-Frota ER, Mendes-Junior CT, Donadi EA. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Mult. Scler. Dec 7 [Epub ahead of print] (2009).
Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, Swenson LC, Tao I, Szeto S, Rosato P, Sela J, Kadie CM, Frahm N, Brander C, Haas DW, Riddler SA, Haubrich R, Walker BD, Harrigan PR, Heckerman D, Mallal S. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 4: e6687 (2009). *
Brunhuber T, Haybaeck J, Schafer G, Mikuz G, Langhoff E, Saeland S, Lebecque S, Romani N, Obrist P. Immunohistochemical tracking of an immune response in mammary Paget's disease. Cancer Lett. 272: 206-220 (2008).
Brunnler T, Bataille F, Hofstadter F, Birkenfeld G, Scholmerich J. 41-Year old patient with obscure diarrhea. Internist (Berl.) 50: 1149-1151, 1153-1154 (2009).
Brydak-Godowska J, Moneta-Wielgos J, Pauk-Domanska M, Drobecka-Brydak E, Samsel A, Kecik M, Kowalewski C, Mackiewicz W, Kecik D. Diagnostics and farmacological treatment of ocular cicatrical pemphigoid. Klin. Oczna. 107: 725-727 (2005).
Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, Palmgren J, Hillert J. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE 2: e664 (2007). *
Buc M, Bucova M, Javor J, Krivosikova M, Stuchlikova M, Shawkatova I, Michalkova D, Barak L, Jancova E, Petrek M. Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population. Endocr. Regul. 40: 1-6 (2006). *
Buc M, Fazekasova H, Cechova E, Hegyi E, Kolibasova K, Ferencik S. Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo. Eur. J. Dermatol. 8: 13-15 (1998).
Buchan GS, Lee R, Wilson M, Slobbe L, Buddle BM, Young SL. Strains of Mycobacterium avium differentially activate human dendritic cells. Immunol. Cell Biol. Aug 4 [Epub ahead of print] (2009). *
Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2: 222-228 (2001). *
Bucin D, Truedsson L, Hammarstrom L, Smith CI, Sjoholm AG. C4 polymorphism and major histocompatibility complex haplotypes in IgA deficiency: association with C4A null haplotypes. Exp. Clin. Immunogenet. 8: 233-241 (1991).
Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu. Rev. Immunol. 22: 625-655 (2004). *
Bugawan TL, Angelini G, Larrick J, Auricchio S, Ferrara GB, Erlich HA. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Nature 339: 470-473 (1989). *
Bugawan TL, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM, Petrone A, Buzzetti R, Pozzilli P, Erlich HA. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens 59: 452-469 (2002). *
Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Burgner D, Stewart GJ. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients. Eur. J. Hum. Genet. 13: 815-822 (2005). *
Buhl A, Weickert U, Teichmann J, Riemann JF. Rare cause of cholestatic hepatitis. Internist (Berl.) 46: 1035-1037 (2005).
Bui HH, Schiewe AJ, von Grafenstein H, Haworth IS. Structural prediction of peptides binding to MHC class I molecules. Proteins 63: 43-52 (2006). *
Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7: 153 (2006). *
Bukulmez H, Fife M, Tsoras M, Thompson SD, Twine NA, Woo P, Olson JM, Elston RC, Glass DN, Colbert RA. Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case-control study. Arthritis Res. Ther. 7: R285-R290 (2005). *
Bulwin GC, Walter S, Schlawinsky M, Heinemann T, Schulze A, Hohne W, Krause G, Kalka-Moll W, Fraser P, Volk HD, Lohler J, Milford EL, Utku N. HLA-DR alpha 2 mediates negative signalling via binding to Tirc7 leading to anti-inflammatory and apoptotic effects in lymphocytes in vitro and in vivo. PLoS ONE 3: e1576 (2008). *
Burfoot RK, Jensen CJ, Field J, Stankovich J, Varney MD, Johnson LJ, Butzkueven H, Booth D, Bahlo M, Tait BD, Taylor BV, Speed TP, Heard R, Stewart GJ, Foote SJ, Kilpatrick TJ, Rubio JP. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens 71: 42-50 (2008). *
Burgos-Vargas R. Spondyloarthropathies and psoriatic arthritis in children. Curr. Opin. Rheumatol. 5: 634-643 (1993).
Burkhardt H, Huffmeier U, Spriewald B, Bohm B, Rau R, Kallert S, Engstrom A, Holmdahl R, Reis A. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis. Arthritis Rheum. 54: 82-89 (2005). *
Burkhardt Soares S, Kukuk S, Brandt AS, Fehr A, Roth S. Retroperitoneal fibrosis. Urologe. A. 47: 489-500 (2008).
Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS, Gopalakrishnan B, Cai J, Brand DD, Yoshida S, Cummings OW, Wilkes DS. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J. Clin. Invest. 117: 3498-3506 (2007). *
Burt BM, Plitas G, Nguyen HM, Stableford JA, Bamboat ZM, Dematteo RP. Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell function. Hum. Immunol. 69: 469-474 (2008).
Busch R, Rinderknecht CH, Roh S, Lee AW, Harding JJ, Burster T, Hornell TM, Mellins ED. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207: 242-260 (2005). *
Buschhausen L, Kruis W, Aymaz S, Weber M, Krakamp B. Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates. Med. Klin. (Munich) 101: 791-795 (2006).
Buske-Kirschbaum A, Kern S, Ebrecht M, Hellhammer DH. Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain Behav. Immun. 21: 92-99 (2007).
Butler MG, Hodes ME, Conneally PM, Biegel AA, Wright JC. Linkage analysis in a large kindred with autosomal dominant transmission of polyglandular autoimmune disease type II (Schmidt syndrome). Am. J. Med. Genet. 18: 61-65 (1984).
Buttari B, Profumo E, Mancinelli R, Cesta Incani U, Tosti ME, Attilia ML, Ceccanti M, Rigano R. Chronic and acute alcohol exposure prevents monocyte-derived dendritic cells from differentiating and maturing. Int. J. Immunopathol. Pharmacol. 21: 929-939 (2008).
Butzkueven H, Chapman J, Cristiano E, Grand'Maison F, Hoffmann M, Izquierdo G, Jolley D, Kappos L, Leist T, Pohlau D, Rivera V, Trojano M, Verheul F, Malkowski JP. MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult. Scler. 12: 769-774 (2006). *
Buyse I, Sandkuyl LA, Zamani Ghabanbasani M, Gu XX, Bouillon R, Bex M, Dooms L, Emonds MP, Duhamel M, Marynen P, et al. Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population. Diabetologia 37: 808-817 (1994).
Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin. Exp. Immunol. 121: 480-483 (2000). *
Cabrera-Gomez J, Ramon-Perez L, Saiz A, Llerena-Fernandez P, Fernandez-Fernandez L, Ercilla G, Grass-Fernandez D, Robinson-Agramonte M, Romero-Garc�a K, Mac�as-Betancourt R, Galvizu-Sanchez R, Otero-Motola C, Sojo-Gomez M, Aguilar-Arias C, et al. Neuromyelitis optica and multiple sclerosis in sisters. Mult. Scler. 15: 269-271 (2009). *
Caffrey C, Hitman GA, Niven MJ, Cassell PG, Kumar P, Fry L, Mackintosh P, Gallagher R, Feighery C, Weir D, et al. HLA-DP and coeliac disease: family and population studies. Gut 31: 663-667 (1990). *
Cai J, Kohanof S, Terasaki PI. HLA-DR antibody epitopes. Clin. Transpl. 2006: 103-114 (2006).
Cai J, Terasaki PI, Anderson N, Lachmann N, Schonemann C. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Transplantation 88: 226-230 (2009).
Caillat-Zucman S, Daniel S, Djilali-Saiah I, Timsit J, Garchon HJ, Boitard C, Bach JF. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus. Hum. Immunol. 44: 80-87 (1995).
Caillat-Zucman S, Gimenez JJ, Wambergue F, Albouze G, Lebkiri B, Naret C, Moynot A, Jungers P, Bach JF. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int. 53: 1626-1630 (1998). *
Caillier SJ, Briggs F, Cree BA, Baranzini SE, Fernandez-Vina M, Ramsay PP, Khan O, Royal W 3rd, Hauser SL, Barcellos LF, Oksenberg JR. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J. Immunol. 181: 5473-5480 (2008). *
Cales P, Calot M, Voigt JJ, Oksman F, Cassigneul J, Vinel JP, Pascal JP. Familial autoimmune pathology comprising 2 cases of primary biliary cirrhosis. Gastroenterol. Clin. Biol. 7: 777-784 (1983).
Caliz R, Atsumi T, Kondeatis E, Amengual O, Khamashta MA, Vaughan RW, Lanchbury JS, Hughes GR. HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology (Oxford) 40: 31-36 (2001). *
Callander M, Haghighi S, Landtblom AM, Ahlgren CE, Nilsson SI, Rydberg L, Al Khoury H, Rosegren L, Andersen O. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis. Mult. Scler. 13: 441-445 (2007). *
Calvo B, Castano L, Marcus-Bagley D, Fici DA, Awdeh Z, Alper CA. The [HLA-B18, F1C30, DR3] conserved extended haplotype carries a susceptibility gene for IgD deficiency. J. Clin. Immunol. 20: 216-220 (2000). *
Calvo-Alen J, Reveille JD, Rodriguez-Valverde V, McGwin G Jr, Baethge BA, Friedman AW, Alarcon GS. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 12: 377-385 (2003).
Camacho RE, Wnek R, Fischer P, Shah K, Zaller DM, Woods A, La Monica N, Aurisicchio L, Fitzgerald-Bocarsly P, Koo GC. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1( *)01 transgene: a model of SCID-hu mouse for vaccine development. Exp. Hematol. 35: 1219-1230 (2007).
Camarena A, Juarez A, Mejia M, Estrada A, Carrillo G, Falfan R, Zuniga J, Navarro C, Granados J, Selman M. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am. J. Respir. Crit. Care Med. 163: 1528-1533 (2001). *
Cambon-Thomsen A, Roth MP. Genetics of autoimmune diseases. Rev. Prat. 44: 43-52 (1994).
Cameron PU, Mallal SA, French MA, Dawkins RL. Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum. Immunol. 29: 282-295 (1990).
Campbell JD, Buckland KF, McMillan SJ, Kearley J, Oldfield WL, Stern LJ, Gronlund H, van Hage M, Reynolds CJ, Boyton RJ, Cobbold SP, Kay AB, Altmann DM, Lloyd CM, Larche M. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J. Exp. Med. 206: 1535-1547 (2009). *
Campoli M, Chang CC, Oldford SA, Edgecombe AD, Drover S, Ferrone S. HLA antigen changes in malignant tumors of mammary epithelial origin: molecular mechanisms and clinical implications. Breast Dis. 20: 105-125 (2009).
Cancino-Diaz M, Ayala-Narvaez H, Burgos-Vargas R, Selene Reyes-Lopez A, Tovar-Castillo L, Dominguez-Lopez L, Granados Arreola J, Jimenez-Zamudio L, Garcia-Latorre E. Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects. Microb. Pathog. 28: 211-220 (2000). *
Candia L, Marquez J, Hernandez C, Zea AH, Espinoza LR. Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity? J. Rheumatol. 34: 374-379 (2007).
Candore G, Balistreri CR, Campagna AM, Colombo A, Cuppari I, DI-Carlo D, Grimaldi MP, Orlando V, Piazza G, Vasto S, Lio D, Caruso C. Genetic control of immune response in carriers of ancestral haplotype 8.1: the study of chemotaxis. Ann. N. Y. Acad. Sci. 1089: 509-515 (2006). *
Candore G, Campagna AM, Cuppari I, Carlo DD, Mineo C, Caruso C. Genetic control of immune response in carriers of the 8.1 ancestral haplotype: correlation with levels of IgG subclasses: its relevance in the pathogenesis of autoimmune diseases. Ann. N. Y. Acad. Sci. 1110: 151-158 (2007). *
Candore G, Lio D, Colonna Romano G, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun. Rev. 1: 29-35 (2002).
Candore G, Modica MA, Lio D, Colonna-Romano G, List� F, Grimaldi MP, Russo M, Triolo G, Accardo-Palumbo A, Cuccia MC, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed. Pharmacother. 57: 274-277 (2003).
Cano P, Fernandez-Vina M. Two sequence dimorphisms of DPB1 define the immunodominant serologic epitopes of HLA-DP. Hum. Immunol. 70: 836-843 (2009).
Cantaert T, Brouard S, Thurlings RM, Pallier A, Salinas GF, Braud C, Klarenbeek PL, de Vries N, Zhang Y, Soulillou JP, Tak PP, Baeten D. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheum. 60: 1944-1956 (2009). *
Cantaert T, Coucke P, De Rycke L, Veys EM, De Keyser F, Baeten D. Functional haplotypes of PADI4: relevance for rheumatoid arthritis-specific synovial intracellular citrullinated proteins and anti-citrullinated protein antibodies. Ann. Rheum. Dis. 64: 1316-1320 (2005). *
Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, Constantin A, Laroche M, Mazieres B. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 42: 1093-1100 (1999). *
Cao HX, Li M, Nie J, Wang W, Zhou SF, Yu XQ. Human leukocyte antigen DRB1 alleles predict risk and disease progression of immunoglobulin A nephropathy in Han Chinese. Am. J. Nephrol. 28: 684-691 (2008).
Cao HX, Zhao L, Zhou LX. HLA-DRB1 allele polymorphosm associated with susceptibility to leukemia in Han nationality of Gansu. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13: 788-792 (2005).
Cao MY, Thonnard J, Deggouj N, Gersdorff M, Philippe M, Osselaer JC, Tomasi JP. HLA class II-associated genetic susceptibility in idiopathic progressive sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 105: 628-633 (1996).
Caorsi C, Cappello P, Ceruti P, Amici A, Marchini C, Novelli F, Forni G, Giovarelli M. CCL16 enhances the CD8+ and CD4+ T cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2. Int. J. Immunopathol. Pharmacol. 21: 867-877 (2008).
Capittini C, Pasi A, Bergamaschi P, Tinelli C, De Silvestri A, Mercati MP, Badulli C, Garlaschelli F, Sbarsi I, Guarene M, Martinetti M, Salvaneschi L, Cuccia M. HLA haplotypes and birth weight variation: is your future going to be light or heavy? Tissue Antigens 74: 156-163 (2009). *
Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJ. Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog. 5: e1000552 (2009). *
Carbone J, Sarmiento E, Micheloud D, Rodriguez-Molina J, Fernandez-Cruz E. Elevated levels of activated CD4 T cells in common variable immunodeficiency: association with clinical findings. Allergol. Immunopathol. (Madr.) 34: 131-135 (2006).
Cardaba B, Pozo VD, Gallardo S, Palomino P, Posada M, Lahoz C. Genetic approaches in the understanding of toxic oil syndrome. Toxicol. Lett. 161: 83-88 (2006). *
Cardenas A, Kelly CP. Celiac sprue. Semin. Gastrointest. Dis. 13: 232-244 (2002).
Cardoso CB, Uthida-Tanaka AM, Magalhaes RF, Magna LA, Kraemer MH. Association between psoriasis vulgaris and MHC-DRB, -DQB genes as a contribution to disease diagnosis. Eur. J. Dermatol. 15: 159-163 (2005).
Cariappa A, Sands B, Forcione D, Finkelstein D, Podolsky DK, Pillai S. Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease. Gut 43: 210-215 (1998). *
Carlo-Stella N, Bozzini S, De Silvestri A, Sbarsi I, Pizzochero C, Lorusso L, Martinetti M, Cuccia M. Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome. Int. J. Immunopathol. Pharmacol. 22: 745-754 (2009).
Carrier CM, Mollen N, Rothman WC, Rodriguez de Cordoba S, Rey-Campos J, Ginsberg-Fellner F, Carpenter C, Rubinstein P. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships. Hum. Immunol. 24: 51-63 (1989).
Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Menard HA, Boire G. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies. Arthritis Rheum. 60: 698-707 (2009). *
Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748-1752 (1999). *
Carroll L, Frazer IH, Turner M, Marwick T, Thomas R. The receptor for advanced glycation end products glycine 82 serine polymorphism and the risk of cardiovascular events in rheumatoid arthritis. Arthritis Res. Ther. 9: R39 (2007). *
Carter CJ. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, Herpes simplex, Rubella, and Toxoplasma gondii. Schizophr. Bull. 35: 1163-1182 (2009).
Carthy D, Ollier W, Papasteriades C, Pappas H, Thomson W. A shared HLA-DRB1 sequence confers RA susceptibility in Greeks. Eur. J. Immunogenet. 20: 391-398 (1993).
Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal-Cortivo L, Caccavelli L, Mahlaoui N, Kiermer V, Mittelstaedt D, Bellesme C, Lahlou N, Lefrere F, Blanche S, Audit M, Payen E, Leboulch P, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-23 (2009). *
Caruso C, Palmeri P, Oliva L, Orlando A, Cottone M. HLA antigens in ulcerative colitis: a study in the Sicilian population. Tissue Antigens 25: 47-49 (1985).
Carvalho LS, Correa H, Silva GC, Campos FS, Baiao FR, Ribeiro LS, Faria AM, d'Avila Reis D. May genetic factors in fibromyalgia help to identify patients with differentially altered frequencies of immune cells? Clin. Exp. Immunol. 154: 346-352 (2008). *
Casati C, Camisaschi C, Novellino L, Mazzocchi A, Triebel F, Rivoltini L, Parmiani G, Castelli C. Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation. J. Immunol. 180: 3782-3788 (2008). *
Cassater D, Gambaro G, Fabris A, Cena C, Calabria S, Capelluto S, Lupo A. Henoch-Schonlein purpura and Crohn's disease in a family. J. Nephrol. 19: 387-390 (2006).
Cassia F, Carneiro S, Marques M, Pontes L, Filgueira A, Porto L. Psoriasis vulgaris and human leukocyte antigens. J. Eur. Acad. Dermatol. Venereol. 21: 303-310 (2007). *
Cassiani-Ingoni R, Cabral ES, Lunemann JD, Garza Z, Magnus T, Gelderblom H, Munson PJ, Marques A, Martin R. Borrelia burgdorferi induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression. J. Neuropathol. Exp. Neurol. 65: 540-548 (2006).
Castano-Rodriguez N, Diaz-Gallo LM, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun. Rev. 7: 322-330 (2008).
Castellano G, Woltman AM, Schlagwein N, Xu W, Schena FP, Daha MR, van Kooten C. Immune modulation of human dendritic cells by complement. Eur. J. Immunol. 37: 2803-2811 (2007). *
Castera L, Hatzfeld-Charbonnier AS, Ballot C, Charbonnel F, Dhuiege E, Velu T, Formstecher P, Mortier L, Marchetti P. Apoptosis-related mitochondrial dysfunction defines human monocyte-derived dendritic cells with impaired immuno-stimulatory capacities. J. Cell. Mol. Med. 13: 1321-1335 (2009). *
Castermans E, Baron F, Willems E, Schaaf-Lafontaine N, Meuris N, Gothot A, Vanbellighen JF, Herens C, Seidel L, Geenen V, Cheynier R, Beguin Y. Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. Haematologica 93: 240-247 (2008). *
Castillo-Rama M, Castro MJ, Bernardo I, Meneu-Diaz JC, Moreno Elola-Olaso A, Calleja-Antolin SM, Romo E, Morales P, Moreno E, Paz-Artal E. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Liver Transpl. 14: 554-562 (2008). *
Castro F, Acevedo E, Ciusani E, Angulo JA, Wollheim FA, Sandberg-Wollheim M. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Ann. Rheum. Dis. 60: 791-795 (2001). *
Castro FA, Haimila K, Sareneva I, Schmitt M, Lorenzo J, Kunkel N, Kumar R, Forsti A, Kjellberg L, Hallmans G, Lehtinen M, Hemminki K, Pawlita M. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population - a candidate gene approach. Int. J. Cancer 125: 1851-1858 (2009). *
Catalfamo M, Serradell L, Roura-Mir C, Kolkowski E, Sospedra M, Vives-Pi M, Vargas-Nieto F, Pujol-Borrell R, Jaraquemada D. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules. Int. Immunol. 11: 269-277 (1999). *
Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, Anderson S, Delmar J, Telles V, Song L, Castiblanco J, Clark RA, Dolan MJ, Ahuja SK. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS ONE 3: e3636 (2008). *
Catassi C, Kryszak D, Louis-Jacques O, Duerksen DR, Hill I, Crowe SE, Brown AR, Procaccini NJ, Wonderly BA, Hartley M D P, Moreci J, Bennett N, Horvath K, Burk M, Fasano A. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am. J. Gastroenterol. 102: 1454-1460 (2007). *
Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, Bitti P, Passiu G, Sorrentino R, Mathieu A. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology (Oxford) 41: 1375-1379 (2002). *
Cauza E, Hanusch-Enserer U, Etemad M, Koller M, Kostner K, Georg P, Dunky A, Ferenci P. HFE genotyping demonstrates a significant incidence of hemochromatosis in undifferentiated arthritis. Clin. Exp. Rheumatol. 23: 7-12 (2005).
Cavan DA, Jacobs KH, Penny MA, Kelly MA, Mijovic C, Jenkins D, Fletcher JA, Barnett AH. Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population. Diabetologia 36: 252-257 (1993).
Caversaccio M, Bonel HM, Carter R, Williams AP, Gadola SD. TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss. Eur. Arch. Otorhinolaryngol. 265: 1289-1292 (2008).
Cavestro GM, Frulloni L, Neri TM, Seghini P, Nouvenne A, Zanetti A, Bovo P, Di Mario F, Okolicsanyi L, Cavallini G. Association of HLA-DRB1*0401 allele with chronic pancreatitis. Pancreas 26: 388-391 (2003).
Cazzola M. Role of ferritin and ferroportin genes in unexplained hyperferritinaemia. Best Pract. Res. Clin. Haematol. 18: 251-263 (2005).
Cecconi V, Moro M, Mare SD, Dellabona P, Casorati G. Use of MHC class II tetramers to investigate CD4(+) T cell responses: problems and solutions. Cytometry A. 73A: 1010-1018 (2008).
Cecere A, Caiazzo R, Romano C, Gattoni A. Primary biliary cirrhosis. Clin. Ter. 149: 143-150 (1998).
Cecere A, Tancredi L, Gattoni A. Primary sclerosing cholangitis. Panminerva Med. 44: 313-323 (2002).
Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients. Int. J. Immunogenet. 35: 133-140 (2008). *
Celio S, Troxler H, Durka SS, Chladek J, Wildhaber JH, Sennhauser FH, Heizmann CW, Moeller A. Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma. Nitric Oxide 15: 226-232 (2006).
Cellier C, Patey N, Fromont-Hankard G, Cervoni JP, Leborgne M, Chaussade S, Barbier JP, Brousse N. In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome. Eur. J. Gastroenterol. Hepatol. 9: 1197-1203 (1997).
Cerna M. Genetics of autoimmune diabetes mellitus. Wien. Med. Wochenschr. 158: 2-12 (2008). *
Cerna M, Kolostova K, Novota P, Romzova M, Cejkova P, Pinterova D, Pruhova S, Treslova L, Andel M. Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions. Ann. N. Y. Acad. Sci. 1110: 140-150 (2007). *
Cervera I, Herraiz MA, Rom�n A, Vidart J, Martinez-Laso J. The novel HLA-G*01010302 allele differs from G*01010301 by a single nucleotide change in intron 5. Tissue Antigens 74: 463-464 (2009). *
Cha S, Choi CB, Han TU, Kang CP, Kang C, Bae SC. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. Arthritis Rheum. 56: 1454-1463 (2007). *
Chabas D, Foulon C, Gonzalez J, Nasr M, Lyon-Caen O, Willer JC, Derenne JP, Arnulf I. Eating disorder and metabolism in narcoleptic patients. Sleep 30: 1267-1273 (2007). *
Chakravarti A, Rusu D, Flamand N, Borgeat P, Poubelle PE. Reprogramming of a subpopulation of human blood neutrophils by prolonged exposure to cytokines. Lab. Invest. 89: 1084-1099 (2009). *
Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 31: 7-11 (2000). *
Chamot AM, Kahn MF. SAPHO syndrome. Z. Rheumatol. 53: 234-242 (1994).
Chan MM, Cheung BK, Li JC, Chan LL, Lau AS. A role for glycogen synthase kinase-3 in antagonizing mycobacterial immune evasion by negatively regulating IL-10 induction. J. Leukoc. Biol. 86: 283-291 (2009). *
Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC class II alleles in systemic lupus erythematosus. J. Rheumatol. 35: 77-83 (2008).
Chan SH, Lin YN, Wee GB, Koh WH, Boey ML. HLA class 2 genes in Singaporean Chinese rheumatoid arthritis. Br. J. Rheumatol. 33: 713-717 (1994).
Chan WK Dr, Cheung CC, Law HK Dr, Lau YL Dr, Chan GC Dr. Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function. J. Hematol. Oncol. 1: 9 (2008). *
Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J. Autoimmun. Dec 22 [Epub ahead of print] (2009).
Chang HK, Bang KT, Lee BH, Kim JH, Bae KW, Kim MJ, Kim SK. Concurrence of Sjogren's syndrome in a patient with Chlamydia-induced reactive arthritis; an unusual finding. Korean J. Intern. Med. 21: 116-119 (2006).
Chang JB, Zhou ZX, Xue R, Zhu GS, Tian YL, Zhao W. The relationship between alpha-IFN anti-virus treatment and HLA-DRB1*11 gene mononucleotide polymorphism. Zhonghua Gan Zang Bing Za Zhi 16: 646-648 (2008).
Chang JW, Tsai HL, Yang LY. Successful treatment of refractory septic arthritis caused by Salmonella and Staphylococcus aureus with preservation of graft function in a long-term renal transplant recipient by total withdrawal of immunosuppressants. Clin. Nephrol. 73: 72-75 (2010).
Chang LY, Chang IS, Chen WJ, Huang YC, Chen GW, Shih SR, Juang JL, Shih HM, Hsiung CA, Lin TY, Huang LM. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics 122: 1271-1276 (2008). *
Chang M, Li Y, Yan C, Callis-Duffin KP, Matsunami N, Garcia VE, Cargill M, Civello D, Bui N, Catanese JJ, Leppert MF, Krueger GG, Begovich AB, Schrodi SJ. Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun. 9: 176-181 (2008). *
Chang M, Rowland CM, Garcia VE, Schrodi SJ, Catanese JJ, van der Helm-van Mil AH, Ardlie KG, Amos CI, Criswell LA, Kastner DL, Gregersen PK, Kurreeman FA, Toes RE, Huizinga TW, Seldin MF, Begovich AB. A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. PLoS Genet. 4: e1000107 (2008). *
Chang Y, Fan TX, Santana Z, Day NK. Identification of a novel allele HLA-DQB1*0622. Tissue Antigens 70: 439-444 (2007). *
Chang YC, Chen TC, Lee CT, Yang CY, Wang HW, Wang CC, Hsieh SL. Epigenetic control of MHC-II expression in tumor-associated macrophages by decoy receptor 3. Blood 111: 5054-5063 (2008). *
Chantarangsu S, Mushiroda T, Mahasirimongkol S, Kiertiburanakul S, Sungkanuparph S, Manosuthi W, Tantisiriwat W, Charoenyingwattana A, Sura T, Chantratita W, Nakamura Y. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients. Pharmacogenet. Genomics 19: 139-146 (2009).
Chao MJ, Barnardo MC, Bu GZ, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Sadovnick AD, Ebers GC. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium. Hum. Mol. Genet. 16: 1951-1958 (2007). *
Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Montpetit A, Sadovnick AD, Knight JC, Ebers GC. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc. Natl. Acad. Sci. U.S.A. 105: 13069-13074 (2008). *
Chao MJ, Ramagopalan SV, Herrera BM, Lincoln MR, Dyment DA, Sadovnick AD, Ebers GC. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum. Mol. Genet. 18: 261-266 (2009).
Chapman RW. High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater? Hepatology 50: 671- 673 (2009). *
Chapman RW. The management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 5: 9-17 (2003).
Chapman RW. Viruses, protozoans and drugs as etiological factors in primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 73-74. October 15-16 (2003). *
Chapman RW, Kelly PM, Heryet A, Jewell DP, Fleming KA. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 29: 422-427 (1988). *
Charfi N, Chabchoub G, Mnif M, Elleuch Bougacha N, Jouida J, Ayadi H, Abid M. Predisposition to autoimmune thyroid diseases within a Tunisian multiplex family. Pathol. Biol. (Paris) 57: 378-382 (2009).
Charpin C, Balandraud N, Guis S, Roudier C, Toussirot E, Rak J, Lambert N, Martin M, Reviron D, Roudier J, Auger I. HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Clin. Exp. Rheumatol. 26: 627-631 (2008).
Charron DJ. New aspects of HLA: perspectives for rheumatoid arthritis. Clin. Exp. Rheumatol. 10: 293-296 (1992).
Chase K, Sargan D, Miller K, Ostrander EA, Lark KG. Understanding the genetics of autoimmune disease: two loci that regulate late onset Addison's disease in Portuguese water dogs. Int. J. Immunogenet. 33: 179-184 (2006). *
Chavez H, Beaudreuil S, Abbed K, Taoufic Y, Kriaa F, Charpentier B, Durrbach A. Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade. Transpl. Immunol. 17: 243-248 (2007).
Chazenbalk GD, Pichurin PN, Guo J, Rapoport B, McLachlan SM. Interactions between the mannose receptor and thyroid autoantigens. Clin. Exp. Immunol. 139: 216-224 (2005). *
Chazouilleres O. Primary sclerosing cholangitis and biliary malignancy: a glimmer of hope? J. Hepatol. 40: 857-859 (2004). *
Chedid A, Mendenhall CL, Moritz TE. The antigenic heterogeneity of the bile duct epithelium in alcoholic liver disease. VA Cooperative Study Group 275. Arch. Pathol. Lab. Med. 123: 411-414 (1999). *
Chelala C, Duchatelet S, Joffret ML, Bergholdt R, Dubois-Laforgue D, Ghandil P, Pociot F, Caillat-Zucman S, Timsit J, Julier C. PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits. Diabetes 56: 522-526 (2007). *
Chemli J, Braham N, Selmi H, Boughattas S, Zbidi A, Essoussi AS, Harbi A. Graves's disease in children and adolescent: study of seven cases. Tunis. Med. 86: 728-734 (2008).
Chen B, Xu X, Ji M, Lin G. Myeloid/NK cell acute leukemia. Int. J. Hematol. 89: 365-367 (2009).
Chen CJ, Yen JH, Tsai WC, Wu CS, Chiang W, Tsai JJ, Liu HW. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol. Lett. 55: 1-3 (1997).
Chen D, Radford-Smith G, Dipaolo MC, McGowan I, Jewell DP. Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acid. J. Clin. Immunol. 16: 237-241 (1996).
Chen L, Zhong M, Chen WV, Amos CI, Fan R. A genome-wide association scan for rheumatoid arthritis data by Hotelling's T2 tests. BMC Proc. 3 Suppl. 7: S6 (2009). *
Chen MJ, Chu CC, Lin PY, Yang KL. Sequence-based typing of a novel HLA-DRB1*04 allele, DRB1*0461, in a Taiwanese volunteer marrow donor. Int. J. Immunogenet. 34: 269-272 (2007). *
Chen MJ, Chu CC, Shyr MH, Lin CL, Lin PY, Yang KL. Detection of a rare Caucasoid HLA-DRB1*0337 in a Taiwanese bone marrow donor using sequence-based typing method. Int. J. Immunogenet. Sep 17 [Epub ahead of print] (2009).
Chen QY, Huang W, She JX, Baxter F, Volpe R, Maclaren NK. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. J. Clin. Endocrinol. Metab. 84: 3182-3186 (1999). *
Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J. Clin. Endocrinol. Metab. 85: 1545-1549 (2000). *
Chen S, Ren X, Liu Y, Hu Q, Hong W, Xu A. Human leukocyte antigen class I polymorphism in Miao, Bouyei, and Shui ethnic minorities of Guizhou, China. Hum. Immunol. 68: 928-933 (2007).
Chen SS, Barankiewicz TJ, Yang YM, Goebel P, Liu FT. IgE peptide-specific CTL inhibit IgE production: a transient IgE suppression model in wild-type and HLA-A2.1 transgenic mice. Cell. Immunol. 254: 28-38 (2008). *
Chen SU, Su YN, Fang MY, Chang LJ, Tsai YY, Lin LT, Lee CN, Yang YS. PGD of beta-thalassaemia and HLA haplotypes using OmniPlex whole genome amplification. Reprod. Biomed. Online 17: 699-705 (2008).
Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 181: 5396-5404 (2008). *
Chen X, Jensen PE. The expression of HLA-DO (H2-O) in B lymphocytes. Immunol. Res. 29: 19-28 (2004). *
Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 72: 335-341 (2008). *
Chen XZ, Mao XH, Zhu KJ, Jin N, Ye J, Cen JP, Zhou Q, Cheng H. Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells. Arch. Dermatol. Res. Jul 4 [Epub ahead of print] (2009). *
Chen Y, Cicciarelli J, Pravica V, Hutchinson IV. Long-range linkage on chromosome 6p of VEGF, FKBP5, HLA and TNF alleles associated with transplant rejection. Mol. Immunol. 47: 96-100 (2009). *
Chen Y, Stankovic R, Cullen KM, Meininger V, Garner B, Coggan S, Grant R, Brew BJ, Guillemin GJ. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotox. Res. Nov 18 [Epub ahead of print] (2009). *
Chen YS, Chou PH, Li SN, Tsai WC, Lin KH, Tsai KB, Yen JH, Liu HW. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan. J. Rheumatol. 33: 887-891 (2006).
Chen YW, Shi R, Geraci N, Shrestha S, Gordish-Dressman H, Pachman LM. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. BMC Immunol. 9: 43 (2008). *
Chen Z, de Kauwe AL, Keech C, Wijburg O, Simpfendorfer K, Alexander WS, McCluskey J. Humanized transgenic mice expressing HLA DR4-DQ3 haplotype: reconstitution of phenotype and HLA-restricted T-cell responses. Tissue Antigens 68: 210-219 (2006). *
Chen Z, Takahashi M, Naruse T, Nakajima T, Chen YW, Inoue Y, Ishikawa I, Iwai T, Kimura A. Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. Hum. Genet. 122: 367-372 (2007). *
Cheng LH, Zou HY, Li Z, Jin SZ, Wang DM, Gao SQ. Application value of allele frequencies in direct identification of ambiguous HLA genotypes. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17: 487-492 (2009).
Cheng SH, Kwan P, Ng HK, Ng MH. New testing approach in HLA genotyping helps overcome barriers in effective clinical practice. Clin. Chem. 55: 1568-1572 (2009). *
Cheong KY, Allcock RJ, Eerligh P, Witt CS, Christiansen FT, McCann V, Price P. Localization of central MHC genes influencing type I diabetes. Hum. Immunol. 62: 1363-1370 (2001).
Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, Kjer-Nielsen L, Mifsud NA, Tait BD, Holdsworth R, Almeida CA, Nolan D, Macdonald WA, Archbold JK, Kellerher AD, Marriott D, Mallal S, Bharadwaj M, Rossjohn J, McCluskey J. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28: 822-832 (2008). *
Cheuk E, D'Souza C, Hu N, Liu Y, Lang H, Chamberlain JW. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes. J. Immunol. 169: 5571-5580 (2002). *
Cheung WH, Chan VS, Pang HW, Wong MK, Guo ZH, Tam PK, Che CM, Lin CL, Yu WY. Conjugation of latent membrane protein (LMP)-2 epitope to gold nanoparticles as highly immunogenic multiple antigenic peptides for induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses in vitro. Bioconjug. Chem. 20: 24-31 (2009). *
Cheung YK, Cheng SC, Sin FW, Chan KT, Xie Y. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope. Vaccine 25: 6070-6077 (2007).
Cheunsuk S, Hsu T, Gershwin ME, Bowlus CL. Analysis of the IDDM candidate gene Prss16 in NOD and NON mice. Dev. Immunol. 9: 183-186 (2002). *
Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J. Immunol. 179: 854-868 (2007). *
Chiba M, Iizuka M, Horie Y, Igarashi K, Masamune O. HLA-DR antigen expression in macroscopically uninvolved areas of intestinal epithelia in Crohn's disease. Gastroenterol. Jpn. 24: 365-372 (1989).
Chiba M, Iizuka M, Horie Y, Ishii N, Suzuki T, Masamune O. Further studies of HLA-DR antigens on colonic epithelium in ulcerative colitis. Tohoku J. Exp. Med. 177: 161-170 (1995).
Chinoy H, Lamb JA, Ollier WE, Cooper RG. An update on the immunogenetics of idiopathic inflammatory myopathies: major histocompatibility complex and beyond. Curr. Opin. Rheumatol. 21: 588-593 (2009).
Chinoy H, Payne D, Poulton KV, Fertig N, Betteridge Z, Gunawardena H, Davidson JE, Oddis CV, McHugh NJ, Wedderburn LR, Ollier WE, Cooper RG; on behalf of the UK Adult Onset Myositis Immunogenetic Collaboration & UK Juvenile Dermatomyositis Research Group. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology (Oxford) 48: 1213-1217 (2009).
Chinoy H, Platt H, Lamb JA, Betteridge Z, Gunawardena H, Fertig N, Varsani H, Davidson J, Oddis CV, McHugh NJ, Wedderburn LR, Ollier WE, Cooper RG. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheum. 58: 3247-3254 (2008). *
Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, Ollier WE, Cooper RG; for the UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC). Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology (Oxford) 46: 1411-1416 (2007). *
Chitta S, Santambrogio L, Stern LJ. GMCSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells. Immunol. Lett. 116: 41-54 (2008).
Chiu YF, Kao HY, Chen YS, Hsu FC, Yang HC. Assessment of gene-covariate interactions by incorporating covariates into association mapping. BMC Proc. 3 Suppl. 7: S85 (2009). *
Cho BY, Chung JH, Shong YK, Chang YB, Han H, Lee JB, Lee HK, Koh CS. A strong association between thyrotropin receptor-blocking antibody-positive atrophic autoimmune thyroiditis and HLA-DR8 and HLA-DQB1*0302 in Koreans. J. Clin. Endocrinol. Metab. 77: 611-615 (1993). *
Cho CS, Dayton MT, Thompson JS, Koltun WA, Heise CP, Harms BA. Proctocolectomy-ileal pouch-anal anastomosis for ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a multi-institutional analysis. J. Gastrointest. Surg. 12: 1221-1226 (2008). *
Cho J. Update on inflammatory bowel disease genetics. Curr. Gastroenterol. Rep. 2: 434-439 (2000).
Cho JH. Update on the genetics of inflammatory bowel disease. Curr. Gastroenterol. Rep. 3: 458-463 (2001).
Cho SW, Cheong JY, Ju YS, Oh do H, Suh YJ, Lee KW. Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype level. J. Korean Med. Sci. 23: 838-844 (2008).
Choi HB, Roh SY, Choi EJ, Yoon HY, Kim SY, Hong YS, Kim DW, Kim TG. Association of HLA alleles with non-Hodgkin's lymphoma in Korean population. Int. J. Hematol. 87: 203-209 (2008).
Choi JH, Lee KW, Kim CW, Park CS, Lee HY, Hur GY, Kim SH, Hong CS, Jang AS, Park HS. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma. Int. Arch. Allergy Immunol. 150: 156-163 (2009).
Cholongitas E, Papatheodoridis GV, Zappoli P, Giannakopoulos A, Patch D, Marelli L, Shusang V, Kalambokis G, Shirling G, Rolando N, Burroughs AK. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis. Liver Transpl. 13: 552-557 (2007). *
Choonhakarn C, Romphruk A, Puapairoj C, Jirarattanapochai K, Romphruk A, Leelayuwat C. Haplotype associations of the major histocompatibility complex with psoriasis in Northeastern Thais. Int. J. Dermatol. 41: 330-334 (2002).
Chou HT, Chen CH, Chen JY, Chang KC. Association of HLA DRB1-DQA1-DQB1 haplotypes with rheumatic heart disease in Taiwan. Int. J. Cardiol. 128: 434-435 (2008).
Choy MY, Walker-Smith JA, Williams CB, MacDonald TT. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut 31: 1365-1370 (1990). *
Christadoss P. Immunogenetics of experimental autoimmune myasthenia gravis. Crit. Rev. Immunol. 9: 247-278 (1989).
Christensen O, Lupu A, Schmidt S, Condomines M, Belle S, Maier A, Hose D, Neuber B, Moos M, Kleist C, Terness P, Ho AD, Goldschmidt H, Klein B, Hundemer M. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24. J. Immunother. 32: 613-621 (2009).
Christensen T, Petersen T, Thiel S, Brudek T, Ellermann-Eriksen S, Moller-Larsen A. Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway. J. Neuroimmunol. 183: 175-188 (2007).
Christiansen FT, Kim SJ, Silver DM, Dupont B. Cytotoxic effector cells against HLA antigens in strong linkage disequilibrium: identification of a strong, new CML determinant. Hum. Immunol. 2: 15-29 (1981).
Christiansen FT, Saueracker GC, Leaver AL, Tokunaga K, Cameron PU, Dawkins RL. Characterization of MHC ancestral haplotypes associated with insulin-dependent diabetes mellitus: evidence for involvement of non-HLA genes. J. Immunogenet. 17: 379-386 (1990).
Christiansen FT, Zhang WJ, Griffiths M, Mallal SA, Dawkins RL. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J. Rheumatol. 18: 1350-1358 (1991).
Chu CC, Ho HT, Lee HL, Chan YS, Chang FJ, Wang CL, Lin M. Anti-"Mi" immunization is associated with HLA-DRB1*0901. Transfusion 49: 472-478 (2009).
Chu CC, Lee HL, Lin M. A novel HLA-DRB1 allele, DRB*090202, is identified in a Taiwanese family. Tissue Antigens 74: 262-263 (2009). *
Chu CC, Lin CY, Trejaut JA, Wu MM, Lin M. HLA-DQB1*0317 is a novel allele with an unusual DR-DQ haplotype. Tissue Antigens 69: 370-372 (2007). *
Chui CK, Brumme ZL, Brumme CJ, Yip B, Phillips EJ, Montaner JS, Harrigan PR. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. Clin. Infect. Dis. 44: 1503-1508 (2007). *
Chung WH, Hung SI, Chen YT. Human leukocyte antigens and drug hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 7: 317-323 (2007).
Chung WH, Hung SI, Chen YT. Genetic predisposition of life-threatening antiepileptic-induced skin reactions. Expert Opin. Drug Saf. 9: 15-21 (2010).
Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428: 486 (2004). *
Ciacci C, Maiuri L, Russo I, Tortora R, Bucci C, Cappello C, Santonicola A, Luciani A, Passananti V, Iovino P. Efficacy of budesonide therapy in the early phase of treatment of adult celiac disease patients with malabsorption: an in vivo/in vitro pilot study. Clin. Exp. Pharmacol. Physiol. 36: 1170-1176 (2009). *
Ciardelli L, Meroni V, Avanzini MA, Bollani L, Tinelli C, Garofoli F, Gasparoni A, Stronati M. Early and accurate diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 27: 125-129 (2008).
Ciccocioppo R, Rossi M, Pesce I, Ricci G, Millimaggi D, Maurano F, Corazza GR. Effects of gliadin stimulation on bone marrow-derived dendritic cells from HLA-DQ8 transgenic mice. Dig. Liver Dis. 40: 927-935 (2008).
Ciesek S, Steinmann E, Wedemeyer H, Manns MP, Neyts J, Tautz N, Madan V, Bartenschlager R, von Hahn T, Pietschmann T. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A. Hepatology 50: 1638-1645 (2009).
Cigrovski-Berkovic M, Solter D, Solter M. Why does the patient with Graves' disease remain euthyroid/mildly hyperthyroid following total thyroidectomy - the role of thyrotropin receptor antibodies (TRAb) and vestigial remnants of the thyroglossal tract. Acta Clin. Croat. 47: 171-174 (2008).
Cinek O, Drevinek P, Sumnik Z, Bendlova B, Vavrinec J. Association of insulin gene variants with type 1 diabetes mellitus in Czech population. Cas. Lek. Cesk. 143: 318-322 (2004).
Cinova J, Palova-Jelinkova L, Smythies LE, Cerna M, Pecharova B, Dvorak M, Fruhauf P, Tlaskalova-Hogenova H, Smith PD, Tuckova L. Gliadin peptides activate blood monocytes from patients with celiac disease. J. Clin. Immunol. 27: 201-209 (2007). *
Ciprandi G, Contini P, Murdaca G, Deamici M, Gallina AM, Puppo F. Soluble serum HLA-G and HLA-A,-B,-C molecules in patients with seasonal allergic rhinitis exposed to pollens. Int. Immunopharmacol. 9: 1058-1062 (2009).
Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, Torbett BE, Meda P, Crisa L. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 55: 1214-1222 (2006). *
Ciurea SO, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ, Wang X, Thall PF, Champlin RE, Fernandez-Vina M. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 88: 1019-1024 (2009).
Clark DW. Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs 29: 342-375 (1985).
Clifton IJ, Kastelik JA, Peckham DG, Hale A, Denton M, Etherington C, Conway SP. Ten years of viral and non-bacterial serology in adults with cystic fibrosis. Epidemiol. Infect. 136: 128-134 (2008).
Clot F, Babron MC. Genetics of celiac disease. Mol. Genet. Metab. 71: 76-80 (2000). *
Coakley G, Brooks D, Iqbal M, Kondeatis E, Vaughan R, Loughran TP Jr, Panayi GS, Lanchbury JS. Major histocompatility complex haplotypic associations in Felty's syndrome and large granular lymphocyte syndrome are secondary to allelic association with HLA-DRB1 *0401. Rheumatology (Oxford) 39: 393-398 (2000). *
Coates LC, Cawkwell LS, Ng NW, Bennett AN, Bryer DJ, Fraser AD, Emery P, Marzo-Ortega H. Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis. Rheumatology (Oxford) 47: 897-900 (2008). *
Coban M, Erdem T, Ozdemir S, Pirim I, Atasoy M, Ikbal M. HLA class I and class II genotyping in patients with chronic urticaria. Int. Arch. Allergy Immunol. 147: 135-139 (2008).
Cobb BA, Kasper DL. Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. Glycobiology 18: 707-718 (2008). *
Cocco E, Murru MR, Melis C, Schirru L, Solla E, Lai M, Rolesu M, Marrosu MG. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients. J. Neurol. 251: 1085-1088 (2004). *
Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B, Mantero F, Betterle C. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J. Clin. Endocrinol. Metab. 91: 1637-1645 (2006). *
Coelho FM, Pradella-Hallinan M, Alves GR, Bittencourt LR, Pedrazzoli Neto M, Moreira F, Tufik S. A study of T CD4, CD8 and B lymphocytes in narcoleptic patients. Arq. Neuropsiquiatr. 65: 423-427 (2007).
Coelho FM, Pradella-Hallinan M, Predazzoli Neto M, Bittencourt LR, Tufik S. Prevalence of the HLA-DQB1*0602 allele in narcolepsy and idiopathic hypersomnia patients seen at a sleep disorders outpatient unit in Sao Paulo. Rev. Bras. Psiquiatr. 31: 10-14 (2009).
Cofie MD DQ, Rogers MD R, Draelos MD FACE MT, Olansky MD FACE L, Scofield MD RH. Syndrome of type II polyglandular autoimmunity associated with HLA-DR4 in a large kindred, including HLA-DR3/DR4 heterozygosity in the probands, identical twins with identical manifestations. Endocr. Pract. 1: 395-398 (1995).
Cohen D, Cohen O, Marcadet A, Massart C, Lathrop M, Deschamps I, Hors J, Schuller E, Dausset J. Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 81: 1774-1778 (1984). *
Cohen N, Brautbar C, Font MP, Dausset J, Cohen D. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics 23: 84-89 (1986).
Cojocariu C, Trifan A, Stanciu C. Hereditary hemochromatosis. Rev. Med. Chir. Soc. Med. Nat. Iasi. 111: 584-592 (2007).
Colaco CB, Awad J, Festenstein H, Fielder A, Batchelor JR, Alonso A, McCloskey D, Shipley M, Corbett M, Roitt IM. HLA frequency and haplotype analysis in a family study of adult onset rheumatoid arthritis. Dis. Markers 4: 99-102 (1986).
Colbert RA, Delay ML, Layh-Schmitt G, Sowders DP. HLA-B27 misfolding and spondyloarthropathies. Prion 3: 15-26 (2009).
Colina M, Govoni M, Orzincolo C, Trotta F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum. 61: 813-821 (2009). *
Collier PM, Wojnarowska F, Welsh K, McGuire W, Black MM. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br. J. Dermatol. 141: 867-875 (1999).
Collin P, Kaukinen K, Vogelsang H, Korponay-Szabo I, Sommer R, Schreier E, Volta U, Granito A, Veronesi L, Mascart F, Ocmant A, Ivarsson A, Lagerqvist C, Burgin-Wolff A, Hadziselimovic F, Furlano RI, Sidler MA, Mulder CJ, Goerres MS, Mearin ML, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur. J. Gastroenterol. Hepatol. 17: 85-91 (2005).
Colombe BW, Lou CD, Price VH. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J. Investig. Dermatol. Symp. Proc. 4: 216-219 (1999). *
Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD. HLA class II antigen associations help to define two types of alopecia areata. J. Am. Acad. Dermatol. 33: 757-764 (1995).
Colombel JF. IBD: genotypes - phenotypes. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 19 (2005). *
Colombel JF, Gower-Rousseau C. Etiology of Crohn disease. Current data. Presse. Med. 23: 558-560 (1994).
Colombel JF, Guillemot F, Van Gossum A, Dufosse F, Cortot A, Dupont E, Paris JC. Familial Crohn's disease in multiple siblings: no linkage to the HLA system. Gastroenterol. Clin. Biol. 13: 676-678 (1989).
Colucci G, Schaffner F, Paronetto F. In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis. Clin. Immunol. Immunopathol. 41: 35-42 (1986).
Comabella M, Craig DW, Camina-Tato M, Morcillo C, Lopez C, Navarro A, Rio J; BiomarkerMS Study Group, Montalban X, Martin R. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 3: e3490 (2008). *
Comabella M, Fernandez-Arquero M, R�o J, Guinea A, Fernandez M, Cenit MC, de la Concha EG, Montalban X. HLA class I and II alleles and response to treatment with interferon-beta in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 210: 116-119 (2009).
Combe B, Sany J, Le Quellec A, Clot J, Eliaou JF. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population. J. Rheumatol. 25: 94-98 (1998).
Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters MG, Di Bisceglie AM, Benner KG, Kowdley KV, Carithers Jr RL, Rosoff Jr L, Garcia-Tsao G, Boyer JL, Boyer TD, Martinez EJ, Bass NM, Lake JR, et al. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology 42: 1184-1193 (2005). *
Confer D, Robinett P. The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation. Bone Marrow Transplant. 42 Suppl. 1: S3-S5 (2008).
Confer DL, Abress LK, Navarro W, Madrigal A. Selection of adult unrelated hematopoietic stem cell donors: beyond HLA. Biol. Blood Marrow Transplant. Nov 2 [Epub ahead of print] (2009).
Congia M, Frau F, Lampis R, Frau R, Mele R, Cucca F, Muntoni F, Porcu S, Boi F, Contu L, et al. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201. Tissue Antigens 39: 78-83 (1992).
Connerotte T, Van Pel A, Godelaine D, Tartour E, Schuler-Thurner B, Lucas S, Thielemans K, Schuler G, Coulie PG. Functions of anti-MAGE T-cells induced in melanoma patients under different vaccination modalities. Cancer Res. 68: 3931-3940 (2008). *
Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B, Cambon-Thomsen A, Cantagrel A. Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheum. 46: 1754-1762 (2002). *
Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B, Cambon-Thomsen A, Cantagrel A. Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. J. Rheumatol. 29: 15-20 (2002). *
Conti F, Borrelli O, Anania C, Marocchi E, Romeo EF, Paganelli M, Valesini G, Cucchiara S. Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Dig. Liver Dis. 37: 761-767 (2005).
Contreas G, Valletta E, Ulmi D, Cantoni S, Pinelli L. Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing. Acta Paediatr. 93: 628-632 (2004).
Cook AD, Stockman A, Brand CA, Tait BD, Mackay IR, Muirden KD, Bernard CC, Rowley MJ. Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. Arthritis Rheum. 42: 2569-2576 (1999). *
Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, Donaldson PT. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 30: 851-856 (1999). *
Cooray HC, Janvilisri T, van Veen HW, Hladky SB, Barrand MA. Interaction of the breast cancer resistance protein with plant polyphenols. Biochem. Biophys. Res. Commun. 317: 269-275 (2004). *
Coote KJ, Atherton H, Young A, Sugar R, Burrows R, Smith NJ, Schlaeppi JM, Groot-Kormelink PJ, Gosling M, Danahay H. The guinea-pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways. Br. J. Pharmacol. 155: 1025-1033 (2008). *
Cope AP, Schulze-Koops H, Aringer M. The central role of T cells in rheumatoid arthritis. Clin. Exp. Rheumatol. 25: S4-S11 (2007).
Coppin H, Ribouchon MT, Bausero P, Pessac B, Fontaine B, Semana G, Clanet M, Roth MP; French Multiple Sclerosis Genetics Group. No evidence for transmission disequilibrium between a new marker at the myelin basic protein locus and multiple sclerosis in French patients. Genes Immun. 1: 478-482 (2000). *
Coppin H, Ribouchon MT, Fontaine B, Edan G, Clanet M, Roth MP; French Multiple Sclerosis Genetics Group. A vulnerability locus to multiple sclerosis maps to 7p15 in a region syntenic to an EAE locus in the rat. Genes Immun. 5: 72-75 (2004). *
Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW. High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404. Tissue Antigens 65: 448-458 (2005). *
Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, Hancock LN, Cleary PA, Mueller PW. Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes 57: 518-522 (2008). *
Cornelis MC, Bae SC, Kim I, El-Sohemy A. CYP1A2 genotype and rheumatoid arthritis in Koreans. Rheumatol. Int. Jul 5 [Epub ahead of print] (2009). *
Cornelis P. Shielding, a new pathogen defense mechanism against PMNs. Microbiology 155: 3474-3475 (2009).
Correa MC, Memije EV, Vargas-Alarcon G, Guzman RA, Rosetti F, Acuna-Alonzo V, Martinez-Rodriguez N, Granados J. HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients. J. Am. Acad. Dermatol. 56: 617-620 (2007).
Correa PA, Tobon GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1. Biomedica 24: 140-152 (2004).
Correale J, Farez M. Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infection. J. Neuroimmunol. 190: 177-189 (2007).
Corrigall VM, Vittecoq O, Panayi GS. Binding immunoglobulin protein-treated peripheral blood monocyte-derived dendritic cells are refractory to maturation and induce regulatory T-cell development. Immunology 128: 218-226 (2009). *
Cortes LM, Baltazar LM, Lopez-Cardona MG, Olivares N, Ramos C, Salazar M, Sandoval L, Lorenz MG, Chakraborty R, Paterson AD, Rivas F. HLA class II haplotypes in Mexican systemic lupus erythematosus patients. Hum. Immunol. 65: 1469-1476 (2004).
Corzo D, Yunis JJ, Salazar M, Lieberman JA, Howard A, Awdeh Z, Alper CA, Yunis EJ. The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups. Blood 86: 3835-3840 (1995). *
Cosentino A, Gambelunghe G, Tortoioli C, Falorni A. CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann. N. Y. Acad. Sci. 958: 337-340 (2002). *
Costa AI, Rao X, Lechenadec E, van Baarle D, Kesmir C. HLA-B molecules target more conserved regions of the HIV-1 proteome. AIDS 24: 211-215 (2010).
Costantino CM, Ploegh HL, Hafler DA. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells. J. Immunol. 183: 945-952 (2009).
Costello P, FitzGerald O. Disease mechanisms in psoriasis and psoriatic arthritis. Curr. Rheumatol. Rep. 3: 419-427 (2001).
Cottone M, Bunce M, Taylor CJ, Ting A, Jewell DP. Ulcerative colitis and HLA phenotype. Gut 26: 952-954 (1985). *
Cournu-Rebeix I, Genin E, Leray E, Babron MC, Cohen J, Gout C, Alizadeh M, Perdry H, Semana G, Brassat D, Clerget-Darpoux F, Yaouanq J, Edan G, Rosenheim M, Fontaine B. HLA-DRB1(*)15 allele influences the later course of relapsing remitting multiple sclerosis. Genes Immun. 9: 570-574 (2008). *
Couturier N, Gourraud PA, Cournu-Rebeix I, Gout C, Bucciarelli F, Edan G, Babron MC, Clerget-Darpoux F, Clanet M, Fontaine B, Brassat D. IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients. Eur. J. Hum. Genet. 17: 844-847 (2009).
Cox ST, Marsh SG, Scott I, Clayton J, Arguello JR, McWhinnie AJ, Prokupek B, Holman R, Madrigal JA, Little AM. HLA-A, -B, -C polymorphism in a UK Ashkenazi Jewish potential bone marrow donor population. Tissue Antigens 53: 41-50 (1999). *
Cragnolini JJ, Garcia-Medel N, Lopez de Castro JA. Endogenous processing and presentation of T-cell epitopes from Chlamydia trachomatis with relevance in HLA-B27-associated reactive arthritis. Mol. Cell. Proteomics 8: 1850-1859 (2009). *
Cragnolini JJ, Lopez de Castro JA. Identification of endogenously presented peptides from Chlamydia trachomatis with high homology to human proteins and to a natural self-ligand of HLA-B27. Mol. Cell. Proteomics 7: 170-180 (2008). *
Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr. Opin. Gastroenterol. 23: 142-148 (2007).
Creary LE, Girdlestone J, Zamora J, Brown J, Navarrete CV. Molecular typing of HLA genes using whole genome amplified DNA. Transfusion 49: 57-63 (2009).
Cree BA, Reich DE, Khan O, De Jager PL, Nakashima I, Takahashi T, Bar-Or A, Tong C, Hauser SL, Oksenberg JR. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch. Neurol. 66: 226-233 (2009).
Cresswell P. Cell biology. Cutting and pasting antigenic peptides. Science 304: 525-527 (2004). *
Criswell LA, Lum RF, Turner KN, Woehl B, Zhu Y, Wang J, Tiwari HK, Edberg JC, Kimberly RP, Moreland LW, Seldin MF, Bridges SL Jr. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept. Arthritis Rheum. 50: 2750-2756 (2004). *
Criswell LA, Mu H, Such CL, King MC. Inheritance of the shared epitope and long-term outcomes of rheumatoid arthritis among community-based Caucasian females. Genet. Epidemiol. 15: 61-72 (1998).
Criswell LA, Saag KG, Mikuls TR, Cerhan JR, Merlino LA, Lum RF, Pfeiffer KA, Woehl B, Seldin MF. Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women. Ann. Rheum. Dis. 65: 1163-1167 (2006). *
Crocchiolo R, Ciceri F, Fleischhauer K, Oneto R, Bruno B, Pollichieni S, Sacchi N, Sormani MP, Fanin R, Bandini G, Bonifazi F, Bosi A, Rambaldi A, Alessandrino PE, Falda M, Bacigalupo A. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. Bone Marrow Transplant. 44: 571-577 (2009).
Crompton L, Khan N, Khanna R, Nayak L, Moss PA. CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T cell receptor usage between different individuals. Blood 111: 2053-2061 (2008). *
Cruickshank SM, Southgate J, Wyatt JI, Selby PJ, Trejdosiewicz LK. Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis. J. Clin. Pathol. 52: 730-734 (1999). *
Csak T, Folhoffer A, Horvath A, Halasz J, Diczhazi C, Schaff Z, Szalay F. Holmes-Adie syndrome, autoimmune hepatitis and celiac disease: a case report. World J. Gastroenterol. 12: 1485-1487 (2006). *
Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, Lindner B, Lamprecht P, Holle JU, Hellmich B. Wegener's autoantigen induces maturation of dendritic cells and licences them for TH1 priming via the protease-activated receptor-2 pathway. Blood 107: 4440-4448 (2006). *
Csillag A, Boldogh I, Pazmandi K, Magyarics Z, Gogolak P, Sur S, Rajnavolgyi E, Bacsi A. Pollen-induced oxidative stress influences both innate and adaptive immune responses via altering dendritic cell functions. J. Immunol. Jan 29 [Epub ahead of print] (2010).
Cucca F, Congia M, Trowsdale J, Powis SH. Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence. Tissue Antigens 44: 234-240 (1994).
Cucca F, Contu D, Zavattari P, Murru D. Correlation between major histocompatibility complex (MHC)-class II and type 1 diabetes. Minerva Endocrinol. 28: 111-122 (2003).
Cucca F, Dudbridge F, Loddo M, Mulargia AP, Lampis R, Angius E, De Virgiliis S, Koeleman BP, Bain SC, Barnett AH, Gilchrist F, Cordell H, Welsh K, Todd JA. The HLA-DPB1-associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1. Diabetes 50: 1200-1205 (2001). *
Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum. Mol. Genet. 10: 2025-2037 (2001). *
Cucca F, Zhu ZB, Khanna A, Cossu F, Congia M, Badiali M, Lampis R, Frau F, De Virgiliis S, Cao A, Arnone M, Piras P, Campbell RD, Cooper MD, Volanakis JE, Powis SH. Evaluation of IgA deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III region. Clin. Exp. Immunol. 111: 76-80 (1998). *
Cuddihy RM, Bahn RS. Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population. J. Clin. Endocrinol. Metab. 81: 4476-4478 (1996). *
Cuddihy RM, Schaid DS, Bahn RS. Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease. Thyroid 6: 261-265 (1996).
Cui J, Taylor K, Destefano A, Criswell L, Izmailova E, Alex P, Roubenoff R, Plenge R, Weinblatt M, Shadick N, Karlson E. Genome wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis. Mol. Med. 15: 136-143 (2009). *
Cusick MF, Wang S, Eckels DD. In vitro responses to avian influenza H5 by human CD4 T cells. J. Immunol. 183: 6432-6441 (2009).
Cuvelier C, Mielants H, De Vos M, Quatacker J, Veys E. Idiopathic inflammatory bowel diseases: immunological hypothesis. Acta Gastroenterol. Belg. 57: 292-299 (1994).
Cuvelier C, Mielants H, De Vos M, Veys E, Roels H. Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy. Gut 31: 545-549 (1990). *
Czaja AJ. Autoimmune hepatitis. Part B: diagnosis. Expert Rev. Gastroenterol. Hepatol. 1: 129-143 (2007).
Czaja AJ. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J. Hepatol. 51: 161-167 (2009).
Czaja AJ. Variant forms of autoimmune hepatitis. Curr. Gastroenterol. Rep. 1: 63-70 (1999).
Czaja AJ. The autoimmune hepatitis/hepatitis C overlap syndrome: does it exist? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 42-43. October 15-16 (2003). *
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 20: 231-240 (2004).
Czaja AJ. Current concepts in autoimmune hepatitis. Ann. Hepatol. 4: 6-24 (2005). *
Czaja AJ. Extrahepatic immunologic features of chronic viral hepatitis. Dig. Dis. 15: 125-144 (1997).
Czaja AJ. Autoimmune hepatitis: clinical and laboratory diagnosis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 52-54 (2004). *
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 17: 268-275 (2001).
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 15: 240-248 (1999).
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 16: 262-270 (2000).
Czaja AJ. Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly. Drugs Aging 25: 219-239 (2008).
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 23: 255-262 (2007).
Czaja AJ. Autoimmune hepatitis - approach to diagnosis. MedGenMed. 8: 55 (2006). *
Czaja AJ. Autoimmune liver disease and rheumatic manifestations. Curr. Opin. Rheumatol. 19: 74-80 (2007).
Czaja AJ, Carpenter H, Santrach PJ, Moore SB. DR human leukocyte antigens and disease severity in chronic hepatitis C. J. Hepatol. 24: 666-673 (1996). *
Czaja AJ, Carpenter HA. Histological findings in chronic hepatitis C with autoimmune features. Hepatology 26: 459-466 (1997). *
Czaja AJ, Carpenter HA. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 39: 1631-1638 (2004). *
Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology 43: 532-538 (2006). *
Czaja AJ, Carpenter HA, Moore SB. Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4. Liver Int. 26: 552-558 (2006). *
Czaja AJ, Carpenter HA, Moore SB. HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients. Dig. Dis. Sci. 53: 522-528 (2008). *
Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J. Hepatol. 24: 52-59 (1996). *
Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108: 157-164 (1995). *
Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 105: 1502-1507 (1993).
Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 104: 1755-1761 (1993).
Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF, Homburger HA. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J. Hepatol. 18: 342-352 (1993).
Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24: 1068-1073 (1996). *
Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig. Dis. Sci. 42: 1688-1696 (1997). *
Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 117: 645-652 (1999). *
Czaja AJ, Doherty DG, Donaldson PT. Genetic bases of autoimmune hepatitis. Dig. Dis. Sci. 47: 2139-2150 (2002). *
Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am. J. Gastroenterol. 97: 2051-2057 (2002). *
Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol. Rev. 174: 250-259 (2000). *
Czaja AJ, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am. J. Gastroenterol. 97: 413-419 (2002). *
Czaja AJ, dos Santos RM, Porto A, Santrach PJ, Moore SB. Immune phenotype of chronic liver disease. Dig. Dis. Sci. 43: 2149-2155 (1998). *
Czaja AJ, Morshed SA, Parveen S, Nishioka M. Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis. Hepatology 26: 567-572 (1997). *
Czaja AJ, Rakela J, Hay JE, Moore SB. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 98: 1587-1593 (1990).
Czaja AJ, Santrach PJ, Moore SB. HLA-DQ associations in type 1 autoimmune hepatitis. Mayo Clin. Proc. 70: 1154-1160 (1995). *
Czaja AJ, Shums Z, Norman GL. Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis. Autoimmunity 35: 475-483 (2002).
Czaja AJ, Souto EO, Bittencourt PL, Cancado EL, Porta G, Goldberg AC, Donaldson PT. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J. Hepatol. 37: 302-308 (2002). *
Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, Mick R, Nisenbaum H, Pasha T, Xu M, Fox KR, Weinstein S, Orel SG, Vonderheide R, Coukos G, Demichele A, Araujo L, Spitz FR, Rosen M, Levine BL, June C, Zhang PJ. Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res. 67: 1842-1852 (2007). *
Czyzewska-Buczynska A, Majkowska-Skrobek G, Jankowski A. Association of HLA-B*08:DRB1*03 with immunoglobulin A-deficiency. Indian J. Pediatr. 74: 1021-1024 (2007). *
D'Alessandro LP, Forster DJ, Rao NA. Anterior uveitis and hypopyon. Am. J. Ophthalmol. 112: 317-321 (1991).
D'Alfonso S, Bolognesi E, Guerini FR, Barizzone N, Bocca S, Ferrante D, Castelli L, Bergamaschi L, Agliardi C, Ferrante P, Naldi P, Leone M, Caputo D, Ballerini C, Salvetti M, Galimberti D, Massacesi L, Trojano M, Momigliano-Richiardi P. A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun. 9: 7-15 (2008). *
D'Alfonso S, Rampi M, Bocchio D, Colombo G, Scorza-Smeraldi R, Momigliano-Richardi P. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum. 43: 120-128 (2000). *
D'Arienzo R, Maurano F, Lavermicocca P, Ricca E, Rossi M. Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity. Cytokine 48: 254-259 (2009).
D'Haens G, Hiele M, Rutgeerts P, Geboes K, Ceuppens JL. Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection. Gut 35: 1728-1733 (1994). *
D'Haens G, Hlavaty T. Advances in medical therapy for Crohn's disease. Curr. Gastroenterol. Rep. 6: 496-505 (2004).
Da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H, Miethke T. Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur. J. Immunol. 34: 2874 (2004). *
da Silva SA, Mazini PS, Reis PG, Sell AM, Tsuneto LT, Peixoto PR, Visentainer JE. HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistance. BMC Infect. Dis. 9: 134 (2009). *
Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J. Rheumatol. 25: 2140-2145 (1998).
Dabrowski A, Osada J, Dabrowska MI, Wereszczynska-Siemiatkowska U. Monocyte subsets and natural killer cells in acute pancreatitis. Pancreatology 8: 126-134 (2008).
Dagfinrud H, Heiberg MS, Bakland G, Skomsvoll J, Kvien TK. Ankylosing spondylitis - a consensus on diagnosis and treatment. Tidsskr. Nor. Laegeforen. 127: 3209-3212 (2007).
Dahl D, Hahn A, Koenecke C, Heuft HG, Dammann E, Stadler M, Buchholz S, Krauter J, Eder M, Sykora KW, Klein C, Ganser A, Sauer M. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk. Transfusion Nov 19 [Epub ahead of print] (2009).
Dahlan Y, Smith L, Simmonds D, Jewell LD, Wanless I, Heathcote EJ, Bain VG. Pediatric-onset primary biliary cirrhosis. Gastroenterology 125: 1476-1479 (2003). *
Dahmen N, Manderscheid N, Helfrich J, Musholt PB, Forst T, Pfutzner A, Engel A. Elevated peripheral visfatin levels in narcoleptic patients. PLoS ONE 3: e2980 (2008). *
Dai CY, Chuang WL, Hsieh MY, Huang JF, Lin YY, Chu PY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML. Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients. Antiviral Res. Nov 18 [Epub ahead of print] (2009).
Dai S, Crawford F, Marrack P, Kappler JW. The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles. Proc. Natl. Acad. Sci. U.S.A. 105: 11893-11897 (2008). *
Dalekos GN, Zachou K, Liaskos C, Gatselis N. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur. J. Intern. Med. 13: 293-303 (2002).
Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Semin. Liver Dis. 29: 400-411 (2009).
Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP; for the DILIGEN study; International SAE Consortium. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat. Genet. 41: 816-819 (2009). *
Dam-Tuxen R, Riise E. Antibodies against a class II HLA-peptide complex raised by active immunization of mice with antigen mimicking peptides. Scand. J. Immunol. 70: 93-100 (2009). *
Damico FM, Bezerra FT, da Silva GC, Gasparin F, Yamamoto JH. New insights into Vogt-Koyanagi-Harada disease. Arq. Bras. Oftalmol. 72: 413-420 (2009). *
Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest. Ophthalmol. Vis. Sci. 46: 2465-2471 (2005). *
Dang CW, Chu CC, Liu TY, Lin M, Lee YJ. A novel HLA-DRB1 allele, DRB1*0832, identified by sequence-based typing method. Tissue Antigens 70: 527-529 (2007). *
Daniel C, Schlauch T, Zugel U, Steinmeyer A, Radeke HH, Steinhilber D, Stein J. 22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities. Eur. J. Clin. Invest. 35: 343-349 (2005).
Danila MI, Hughes LB, Bridges SL. Pharmacogenetics of etanercept in rheumatoid arthritis. Pharmacogenomics 9: 1011-1015 (2008).
Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis. Markers. 12: 127-133 (1995).
Dankof A, Morawietz L, Feist E. Labial salivary gland biopsy in Sjogren's syndrome. Pathologe 27: 416-421 (2006).
Danze PM, Colombel JF, Jacquot S, Loste MN, Heresbach D, Ategbo S, Khamassi S, Perichon B, Semana G, Charron D, Cezard JP. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 39: 69-72 (1996). *
Danzer M, Polin H, Hofer K, Proll J, Gabriel C. Characterisation of two novel HLA alleles, HLA-Cw*0429 and HLA-DRB3*0223. Tissue Antigens 72: 498-499 (2008). *
Danzer M, Polin H, Proll J, Hofer K, Fae I, Fischer GF, Gabriel C. High-throughput sequence-based typing strategy for HLA-DRB1 based on real-time polymerase chain reaction. Hum. Immunol. 68: 915-917 (2007).
Dao T, Korontsvit T, Zakhaleva V, Haro K, Packin J, Scheinberg DA. Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cells. PLoS One 4: e6730 (2009). *
Das KM. Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen. J. Gastroenterol. Hepatol. 19: S290-S294 (2004). *
Das P, Abraham R, David C. HLA transgenic mice as models of human autoimmune diseases. Rev. Immunogenet. 2: 105-114 (2000).
Das P, Bradley DS, Geluk A, Griffiths MM, Luthra HS, David CS. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Hum. Immunol. 60: 575-582 (1999).
Das UN. Insulin in the critically ill with focus on cytokines, reactive oxygen species, HLA-DR expression. J. Assoc. Physicians India 55: S56-S65 (2007).
Dass J FP, Deepika V. Implications from predictions of HLA-DRB1 binding peptides in the membrane proteins of Corynebacterium diphtheriae. Bioinformation 3: 111-113 (2008). *
Dastis SN, Latinne D, Sempoux C, Geubel AP. Ulcerative colitis associated with IgG4 cholangitis: similar features in two HLA identical siblings. J. Hepatol. 51: 601-605 (2009).
Date Y, Seki N, Kamizono S, Higuchi T, Hirata T, Miyata K, Ohkuni M, Tatsuzawa O, Yokota S, Joo K, Ueda K, Sasazuki T, Kimura A, Itoh K, Kato H. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum. 42: 2577-2582 (1999). *
Daum F, Gould HB, Gold D, Dinari G, Friedman AH, Zucker P, Cohen MI. Asymptomatic transient uveitis in children with inflammatory bowel disease. Am. J. Dis. Child. 133: 170-171 (1979).
Daum S, Moos V, Loddenkemper C, Schurmann C, Marker-Hermann E, Stein H, Zeitz M, Schneider T. Immune reconstitution inflammatory syndrome (IRIS) of the small bowel in an immunocompromised patient suffering from systemic lupus erythematosus and non-tuberculous mycobacteriosis. Z. Rheumatol. 67: 277-283 (2008).
Dauvilliers Y, Arnulf I. Narcolepsy with cataplexy. Rev. Neurol. (Paris) 164: 634-645 (2008).
Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, Grattan DR. STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology 142: 3836-3841 (2001). *
David CS, Taneja V. Role of major histocompatibility complex genes in murine collagen-induced arthritis: a model for human rheumatoid arthritis. Am. J. Med. Sci. 327: 180-187 (2004).
Davidson H, McLachlan G, Wilson A, Boyd AC, Doherty A, Macgregor G, Davies L, Painter HA, Coles R, Hyde SC, Gill DR, Amaral MD, Collie DD, Porteous DJ, Penque D. Human specific cystic fibrosis transmembrane conductance regulator antibodies detect in vivo gene transfer to ovine airways. Am. J. Respir. Cell. Mol. Biol. 35: 72-83 (2006). *
Davies MN, Lamikanra A, Sansom CE, Flower DR, Moss DS, Travers PJ. Identification of the HLA-DM/HLA-DR interface. Mol. Immunol. 45: 1063-1070 (2008). *
Davis A, Mandal R, Johnson M, Makar R, Stowell C, Dzik S. A touch of TRALI. Transfusion 48: 541-545 (2008).
Dawkins RL, Kay PH, Christiansen FT. Immunogenetics of rheumatoid arthritis. Ann. Acad. Med. Singapore 12: 155-163 (1983).
Dawkins RL, Leaver A, Cameron PU, Martin E, Kay PH, Christiansen FT. Some disease-associated ancestral haplotypes carry a polymorphism of TNF. Hum. Immunol. 26: 91-97 (1989).
Dawkins RL, Martin E, Saueracker G, Kay PH, Leaver A, Christiansen FT. Supratypes and ancestral haplotypes in IDDM: potential importance of central non-HLA MHC genes. J. Autoimmun. 3 Suppl. 1: 63-68 (1990).
de Andrade M, Jackow CM, Dahm N, Hordinsky M, Reveille JD, Duvic M. Alopecia areata in families: association with the HLA locus. J. Investig. Dermatol. Symp. Proc. 4: 220-223 (1999). *
De Block CE, De Leeuw IH, Van Gaal LF. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J. Clin. Endocrinol. Metab. 84: 4062-4067 (1999).
de Bruin EC, van de Pas S, van de Velde CJ, van Krieken JH, Peltenburg LT, Marijnen CA, Medema JP. Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo. Apoptosis 12: 1671-1680 (2007). *
De Carlo E, Tamagno G, Martini C, Maffei P, Rubello D, Luca M, Sicolo N. Autoimmune diabetes mellitus, Hodgkin's disease and Graves' ophthalmopathy in a patient with 8.1 ancestral haplotype. Horm. Metab. Res. 36: 97-100 (2004).
De Gassart A, Camosseto V, Thibodeau J, Ceppi M, Catalan N, Pierre P, Gatti E. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl. Acad. Sci. U.S.A. 105: 3491-3496 (2008). *
De Hertogh G, Geboes K. Crohn's disease and infections: a complex relationship. MedGenMed. 6: 14 (2004). *
De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors. HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 70: 1113-1118 (2008).
de Jong BA, Huizinga TW, Zanelli E, Giphart MJ, Bollen EL, Uitdehaag BM, Polman CH, Westendorp RG. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 59: 549-555 (2002).
de Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Lee A, Sander B, Thorns C, Campo E, Molina T, Hagenbeek A, Horning S, Lister A, Raemaekers J, Salles G, Gascoyne R, Weller E. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications. A study from the Lunenburg Lymphoma Biomarker Consortium (LLBC). J. Clin. Pathol. 62: 128-138 (2009).
de Jong MA, de Witte L, Geijtenbeek TB. Isolation of immature primary Langerhans cells from human epidermal skin. Methods Mol. Biol. 595: 55-65 (2010).
de Jongh BM, Bruining GJ, Schreuder GM, Schuurman RK, Radder JK, van Loghem E, Meera Khan P, Hauptmann G, van Rood JJ. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study. Hum. Immunol. 10: 5-21 (1984).
de Jongh BM, Westedt ML, de Vries RR, Valkenburg HA, Cats A. Genetic heterogeneity of rheumatoid arthritis. Dis. Markers 4: 29-33 (1986).
De Juan D, Mart�n-Villa JM, Gomez-Reino JJ, Vicario JL, Corell A, Martinez-Laso J, Benmammar D, Arnaiz-Villena A. Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility. Hum. Genet. 91: 579-584 (1993).
de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O, Jackson DC, Ladhams J, Allison J, McCluskey J. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J. Immunol. 182: 7440-7450 (2009).
de la Concha EG, Arroyo R, Crusius JB, Campillo JA, Martin C, Varela de Seijas E, Pena AS, Claveria LE, Fernandez-Arquero M. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J. Neuroimmunol. 80: 172-178 (1997).
de la Concha EG, Fernandez-Arquero M, Conejero L, Lazaro F, Mendoza JL, Sevilla MC, Diaz-Rubio M, Ruiz de Leon A. Presence of a protective allele for achalasia on the central region of the major histocompatibility complex. Tissue Antigens 56: 149-153 (2000). *
De la Concha EG, Fernandez-Arquero M, Gual L, Vigil P, Martinez A, Urcelay E, Ferreira A, Garcia-Rodriguez MC, Fontan G. MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. J. Immunol. 169: 4637-4643 (2002). *
de la Concha EG, Fernandez-Arquero M, Lopez-Nava G, Martin E, Allcock RJ, Conejero L, Paredes JG, Diaz-Rubio M. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 119: 1491-1495 (2000). *
De La Concha EG, Fernandez-Arquero M, Martinez A, Vidal F, Vigil P, Conejero L, Garcia-Rodriguez MC, Fontan G. HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clin. Exp. Immunol. 116: 516-520 (1999). *
de la Concha EG, Fernandez-Arquero M, Martinez A, Vigil P, Vidal F, Lopez-Nava G, Diaz-Rubio M, Garcia-Paredes J. Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis. Dig. Dis. Sci. 44: 2324-2329 (1999). *
De La Concha EG, Fernandez-Arquero M, Santa-Cruz S, Lopez-Nava G, Figueredo MA, Diaz-Rubio M, Garcia-Paredes J. Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC). Clin. Exp. Immunol. 108: 392-395 (1997). *
de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, Polanco I, Fernandez C, Figueredo MA. Celiac disease and TNF promoter polymorphisms. Hum. Immunol. 61: 513-517 (2000).
de la Paz Bettinotti M, Kolek A, Brunnler G, Haas P, Paul C, Hochberger M, Bartova A, Kimura A, Sasazuki T, Albert ED. Polymorphism of the 5' flanking region of the HLA-DQA1 gene in coeliac disease. Eur. J. Immunogenet. 20: 399-407 (1993).
De Lerma Barbaro A, De Ambrosis A, Banelli B, Pira GL, Aresu O, Romani M, Ferrini S, Accolla RS. Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells. Int. Immunol. 20: 1457-1466 (2008). *
de Lira Freire A, Conde RA, Bertolo MB, Costallat LT, Levy-Neto M, Fernandes SR. HLA-DR in Brazilian patients with polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA). Dis. Markers 26: 105-109 (2009).
de Miranda NF, Nielsen M, Pereira D, van Puijenbroek M, Vasen HF, Hes FJ, van Wezel T, Morreau H. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers. J. Pathol. 219: 69-76 (2009). *
De Palma G, Capilla A, Nadal I, Nova E, Pozo T, Varea V, Polanco I, Castillejo G, Ribes-Koninckx C, Garrote JA, Calvo C, Garcia-Novo MD, Cilleruelo ML, Lopez A, Palau F, Sanz Y. Interplay between human leukocyte antigen genes and the microbial colonization process of the newborn intestine. Curr. Issues Mol. Biol. 12: 1-10 (2009).
De Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. Pivotal advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J. Leukoc. Biol. Dec 14 [Epub ahead of print] (2009). *
De Re V, Caggiari L, De Vita S, Mazzaro C, Lenzi M, Galli M, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Cannizzaro R, Guidoboni M, Dolcetti R. Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig. Liver Dis. 39 Suppl. 1: S65-S71 (2007).
de Rijke B, van Horssen-Zoetbrood A, Veenbergen S, Fredrix H, de Witte T, van de Wiel-van Kemenade E, Dolstra H. Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens. J. Immunol. Methods 329: 125-137 (2008). *
de Rooij AM, Florencia Gosso M, Haasnoot GW, Marinus J, Verduijn W, Claas FH, van den Maagdenberg AM, van Hilten JJ. HLA-B62 and HLA-DQ8 are associated with complex regional pain syndrome with fixed dystonia. Pain 145: 82-85 (2009).
de Rosbo NK, Kaye JF, Eisenstein M, Mendel I, Hoeftberger R, Lassmann H, Milo R, Ben-Nun A. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J. Immunol. 173: 1426-1435 (2004). *
de Silva HJ, Gatter KC, Millard PR, Kettlewell M, Mortensen NJ, Jewell DP. Crypt cell proliferation and HLA-DR expression in pelvic ileal pouches. J. Clin. Pathol. 43: 824-828 (1990). *
de Vijlder HC, Westerhof W, Schreuder GM, de Lange P, Claas FH. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res. 17: 270-274 (2004). *
de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J. Rheumatol. 27: 2860-2865 (2000).
de Vries AC, Bredius RG, Lankester AC, Bierings M, Trebo M, Sedlacek P, Niemeyer CM, Zecca M, Locatelli F, van den Heuvel-Eibrink MM. HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia. Haematologica 94: 302-304 (2009). *
de Vries DD, Dekker-Saeys AJ, Gyodi E, Bohm U, Ivanyi P. Absence of autoantibodies to peptides shared by HLA-B27.5 and Klebsiella pneumoniae nitrogenase in serum samples from HLA-B27 positive patients with ankylosing spondylitis and Reiter's syndrome. Ann. Rheum. Dis. 51: 783-789 (1992). *
de Vries N, Prinsen CF, Mensink EB, van Riel PL, van't Hof MA, van de Putte LB. A T cell receptor beta chain variable region polymorphism associated with radiographic progression in rheumatoid arthritis. Ann. Rheum. Dis. 52: 327-331 (1993). *
de Vries N, Ronningen KS, Tilanus MG, Bouwens-Rombouts A, Segal R, Egeland T, Thorsby E, van de Putte LB, Brautbar C. HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens 41: 26-30 (1993).
de Vries N, Tijssen H, van Riel PL, van de Putte LB. Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule. Arthritis Rheum. 46: 921-928 (2002). *
de Vries RR, Huizinga TW, Toes RE. Redefining the HLA and RA association: to be or not to be anti-CCP positive. J. Autoimmun. 25: S21-S25 (2005).
de Vries RR, Huizinga TW, Toes RE. HLA and RA revisited: citrullinated food for the SE hypothesis, the DR6 effect, and NIMA. Hum. Immunol. 67: 454-459 (2006).
de Vries RR, Nijenhuis LE, Khan MA, Mehra NK. Paradoxical inheritance of HLA-linked susceptibility to rheumatoid arthritis. Tissue Antigens 26: 286-292 (1985).
Dean G, Yeo TW, Goris A, Taylor CJ, Goodman RS, Elian M, Galea-Debono A, Aquilina A, Felice A, Vella M, Sawcer S, Compston DA. HLA-DRB1 and multiple sclerosis in Malta. Neurology 70: 101-105 (2008).
Decker JM, Zammit KP, Easlick JL, Santiago ML, Bonenberger D, Hahn BH, Kutsch O, Bibollet-Ruche F. Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes. Virology 394: 109-118 (2009).
Decker P, Briand JP, de Murcia G, Pero RW, Isenberg DA, Muller S. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases. Arthritis Rheum. 41: 918-926 (1998). *
Degli-Esposti MA, Abraham LJ, McCann V, Spies T, Christiansen FT, Dawkins RL. Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics 36: 345-356 (1992).
Degli-Esposti MA, Andreas A, Christiansen FT, Schalke B, Albert E, Dawkins RL. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics 35: 355-364 (1992).
Degli-Esposti MA, Leelayuwat C, Dawkins RL. Ancestral haplotypes carry haplotypic and haplospecific polymorphisms of BAT1: possible relevance to autoimmune disease. Eur. J. Immunogenet. 19: 121-127 (1992).
Deighton C, Criswell LA. Recent advances in the genetics of rheumatoid arthritis. Curr. Rheumatol. Rep. 8: 394-400 (2006).
Deighton CM, Cavanagh G, Rigby AS, Lloyd HL, Walker DJ. Both inherited HLA-haplotypes are important in the predisposition to rheumatoid arthritis. Br. J. Rheumatol. 32: 893-898 (1993).
Deighton CM, Fay A, Walker DJ. Rheumatoid arthritis in thyroid disease positive and negative same-sexed sibships. Br. J. Rheumatol. 31: 13-17 (1992).
Deisenhammer F. Neutralizing antibodies to interferon-beta and other immunological treatments for multiple sclerosis: prevalence and impact on outcomes. CNS Drugs 23: 379-396 (2009).
Dekker JW, Easteal S, Jakobsen IB, Gao X, Stewart GJ, Buhler MM, Hawkins BR, Higgins DA, Yu YL, Serjeantson SW. HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1*0602 allele. Tissue Antigens 41: 31-36 (1993).
Dekker-Saeys BJ, Meuwissen SG, Van Den Berg-Loonen EM, De Haas WH, Meijers KA, Tytgat GN. Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease. Ann. Rheum. Dis. 37: 36-41 (1978). *
del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A. Heterogeneity between men and women in the influence of the HLA-DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis Rheum. 46: 1480-1488 (2002). *
del Rincon I, Escalante A. HLA-DRB1 alleles associated with susceptibility or resistance to rheumatoid arthritis, articular deformities, and disability in Mexican Americans. Arthritis Rheum. 42: 1329-1338 (1999). *
Delaguillaumie A, Marin-Esteban V, Setterblad N, Leh LJ, Assier E, Gelin C, Charron D, Galy A, Mooney N. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells. Eur. J. Immunol. 38: 1096-1105 (2008). *
Delay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 60: 2633-2643 (2009). *
Delgado-Vega AM, Anaya JM. Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis. Autoimmun. Rev. 6: 402-408 (2007).
Delgado-Vega AM, Castiblanco J, Gomez LM, Diaz-Gallo LM, Rojas-Villarraga A, Anaya JM. BCL2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Ann. Rheum. Dis. Mar 11 [Epub ahead of print] (2009).
Delgado-Vega AM, Martin J, Granados J, Anaya JM. Genetic epidemiology of rheumatoid arthritis: what to expect from Latin America? Biomedica 26: 562-584 (2006).
Delicou S, Kitra-Roussou V, Peristeri J, Goussetis E, Vessalas G, Rigatou E, Psychou F, Salavoura K, Grafakos S. Successful HLA-identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency. Pediatr. Transplant. 11: 799-803 (2007).
Deluca DS, Beisswanger E, Wermter J, Horn PA, Hahn U, Blasczyk R. MaHCO: an ontology of the major histocompatibility complex for immunoinformatic applications and text mining. Bioinformatics 25: 2064-2070 (2009).
DeLuca GC, Ramagopalan SV, Herrera BM, Dyment DA, Lincoln MR, Montpetit A, Pugliatti M, Barnardo MC, Risch NJ, Sadovnick AD, Chao M, Sotgiu S, Hudson TJ, Ebers GC. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc. Natl. Acad. Sci. U.S.A. 104: 20896-20901 (2007). *
Demoly P, Guglielmi P, Guglielmi L. Drug allergy and hypersensitivity. Risk factors. Bull. Acad. Natl. Med. 190: 1733-1742 (2006).
Demotz S, Lanzavecchia A, Eisel U, Niemann H, Widmann C, Corradin G. Delineation of several DR-restricted tetanus toxin T cell epitopes. J. Immunol. 142: 394-402 (1989).
Demoulins-Giacco N, Gagey V, Teillac-Hamel D, Fraitag S, Caillat-Zucman S, Schmitz J, de Prost Y. Dermatitis herpetiformis occuring in patients with celiac disease in childhood. Arch. Pediatr. 3: 541-548 (1996).
Denardo GL, Mirick GR, Hok S, Denardo SJ, Beckett LA, Adamson GN, Balhorn RL. Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia. Int. J. Oncol. 34: 511-516 (2009).
Denardo GL, Natarajan A, Hok S, Perkins J, Cosman M, Denardo SJ, Lightstone FC, Mirick GR, Miers LA, Balhorn RL. Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma. J. Nucl. Med. 48: 1338-1347 (2007).
Deng CT, Cai J, Tarsitani C, El-Awar N, Lachmann N, Ozawa M. HLA class II DQ epitopes. Clin. Transpl. 2006: 115-122 (2006).
Deng Q, Mancini-Bourgine M, Zhang X, Cumont MC, Zhu R, Lone YC, Michel ML. Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models. Hepatology 50: 1380-1391 (2009).
Deng Z, Xu Y, Wang D, Jin S. Description of two novel alleles HLA-Cw*0766 and Cw*0767 identified in a Chinese Han individual by sequence-based typing. Hum. Immunol. 71: 93-95 (2010).
Denk GU, Hohenester S, Wimmer R, Bohland C, Rust C, Beuers U. Role of mitogen-activated protein kinases in tauroursodeoxycholic acid-induced bile formation in cholestatic rat liver. Hepatol. Res. 38: 717-726 (2008). *
Denzin LK, Fallas JL, Prendes M, Yi W. Right place, right time, right peptide: DO keeps DM focused. Immunol. Rev. 207: 279-292 (2005).
Depil S, Morales O, Castelli FA, Delhem N, Francois V, Georges B, Dufosse F, Morschhauser F, Hammer J, Maillere B, Auriault C, Pancre V. Determination of a HLA II promiscuous peptide cocktail as potential vaccine against EBV latency II malignancies. J. Immunother. 30: 215-226 (2007).
Depla E, Van der Aa A, Livingston BD, Crimi C, Allosery K, De Brabandere V, Krakover J, Murthy S, Huang M, Power S, Babe L, Dahlberg C, McKinney D, Sette A, Southwood S, Philip R, Newman MJ, Meheus L. Rational design of a multi-epitope vaccine encoding T-lymphocyte epitopes for treatment of chronic HBV infections. J. Virol. 82: 435-450 (2008). *
Depontieu FR, Qian J, Zarling AL, McMiller TL, Salay TM, Norris A, English AM, Shabanowitz J, Engelhard VH, Hunt DF, Topalian SL. Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proc. Natl. Acad. Sci. U.S.A. 106: 12073-12078 (2009). *
Dequeker J, Decock T, Walravens M, Van de Putte I. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases. J. Rheumatol. 5: 452-459 (1978).
Derre L, Ferber M, Touvrey C, Devevre E, Zoete V, Leimgruber A, Romero P, Michielin O, Levy F, Speiser DE. A novel population of human melanoma-specific CD8 T cells recognizes melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide. J. Immunol. 179: 7635-7645 (2007). *
Desai M, Zeggini E, Horton VA, Owen KR, Hattersley AT, Levy JC, Walker M, Gillespie KM, Bingley PJ, Hitman GA, Holman RR, McCarthy MI, Clark A. An association analysis of the HLA gene region in latent autoimmune diabetes in adults. Diabetologia 50: 68-73 (2007). *
Desai SN, White DM, O'Shea KM, Brown ML, Cywin CL, Spero DM, Panzenbeck MJ. An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity. Eur. J. Pharmacol. 538: 168-174 (2006). *
Desaules C, Villard J, Tiercy JM. A new HLA-DR4 allele, DRB1*0474, with an unusual residue at position 77. Tissue Antigens 72: 500-501 (2008). *
Deschamps I, Hors J, Clerget-Darpoux F, Marcelli-Barge A, Lestradet H, Dausset J. Increased risk of insulin-dependent diabetes for siblings of diabetic children with the DR 3 haplotype of the mother. C. R. Acad. Sci. III. 308: 501-506 (1989).
Deschamps I, Khalil I. The role of the HLA system in the genetics of type I diabetes mellitus. Diabete. Metab. 18: 253-263 (1992).
Deschamps I, Marcelli-Barge A, Lallemand N, Poirier JC, Bochu V, Prevost P, Busson A, Masset M, Lestradet H, Hors J. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes. Tissue Antigens 31: 259-269 (1988).
Deshaies F, Brunet A, Diallo DA, Denzin LK, Samaan A, Thibodeau J. A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM. Proc. Natl. Acad. Sci. U.S.A. 102: 6443-6448 (2005). *
Deshaies F, Diallo DA, Fortin JS, O'Rourke HM, Pezeshki AM, Bellemare-Pelletier A, Raby N, Bedard N, Brunet A, Denzin LK, Thibodeau J. Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DObeta. Immunology 127: 408-417 (2009). *
Desombere I, Hauser P, Rossau R, Paradijs J, Leroux-Roels G. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes. J. Immunol. 154: 520-529 (1995).
Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 51: 593-604 (1998).
Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J. Gastroenterol. 13: 4755-4760 (2007). *
Deuter CM, Kotter I, Wallace GR, Murray PI, Stubiger N, Zierhut M. Behcet's disease: ocular effects and treatment. Prog. Retin. Eye Res. 27: 111-136 (2008).
Dew A, Collins D, Artz A, Rich E, Stock W, Swanson K, van Besien K. Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options. Biol. Blood Marrow Transplant. 14: 938-941 (2008).
Dezsofi A, Szebeni B, Hermann CS, Kapitany A, Veres G, Sipka S, Korner A, Madacsy L, Korponay-Szabo I, Rajczy K, Arato A. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both. J. Pediatr. Gastroenterol. Nutr. 47: 283-287 (2008). *
D�az-Pena R, Blanco-Gelaz MA, Njobvu P, Lopez-Vazquez A, Suarez-Alvarez B, Lopez-Larrea C. Influence of HLA-B*5703 and HLA-B*1403 on susceptibility to spondyloarthropathies in the Zambian population. J. Rheumatol. 35: 2236-2240 (2008). *
Dick T, Mierau R, Sternfeld R, Weiner EM, Genth E. Clinical relevance and HLA association of autoantibodies against the nucleolus organizer region (NOR-90). J. Rheumatol. 22: 67-72 (1995).
Dickhaut K, Hoepner S, Eckhard J, Wiesmueller KH, Schindler L, Jung G, Falk K, Roetzschke O. Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE). PLoS One 4: e6811 (2009). *
Dickinson AM. Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics. Best Pract. Res. Clin. Haematol. 20: 189-207 (2007).
Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert Rev. Mol. Med. 9: 1-19 (2007).
Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E; Eurobank members. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br. J. Haematol. 127: 479-490 (2004). *
Diedrichs-Mohring M, Wildner G. Immunostimulatory and immunomodulatory peptides derived from the alpha1 domain of HLA-B27 in experimental autoimmune diseases in Lewis rats. Immunobiology 209: 711-717 (2005).
Diehl AM. Role of the immune system in the pathogenesis of nonalcoholic steatohepatitis. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 78 (2005). *
Diermayr S, Himmelreich H, Durovic B, Mathys-Schneeberger A, Siegler U, Langenkamp U, Hofsteenge J, Gratwohl A, Tichelli A, Paluszewska M, Wiktor-Jedrzejczak W, Kalberer CP, Wodnar-Filipowicz A. NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK cell lines with single KIR-HLA-class I specificities. Blood 111: 1428-1436 (2008). *
Dieterich W, Esslinger B, Schuppan D. Pathomechanisms in celiac disease. Int. Arch. Allergy Immunol. 132: 98-108 (2003).
Dieude P, Cornelis F. Genetic basis of rheumatoid arthritis. Joint Bone Spine 72: 520-526 (2005). *
Dijkstra G, Zandvoort AJ, Kobold AC, de Jager-Krikken A, Heeringa P, van Goor H, van Dullemen HM, Tervaert JW, van de Loosdrecht A, Moshage H, Jansen PL. Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel disease. Scand. J. Gastroenterol. 37: 546-554 (2002). *
Dimitrov I, Garnev P, Flower DR, Doytchinova I. Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis. Eur. J. Med. Chem. Oct 13 [Epub ahead of print] (2009).
Ding B, Padyukov L, Lundstrom E, Seielstad M, Plenge RM, Oksenberg JR, Gregersen PK, Alfredsson L, Klareskog L. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum. 60: 30-38 (2009). *
Ding D, Mehta H, McCune WJ, Kaplan MJ. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J. Immunol. 177: 5878-5889 (2006). *
Ding Y, Shen H, Wang X, Fan X, Wu X, Yang X. The polymorphism of HLA-DR and -DQ allelic genes associated with intrahepatic cholestasis of pregnancy. Genet. Test. 12: 215-220 (2008).
Dinges WL, Richardt J, Friedrich D, Jalbert E, Liu Y, Stevens CE, Maenza J, Collier AC, Geraghty DE, Smith J, Moodie Z, Mullins JI, McElrath MJ, Horton H. Virus specific CD8+ T cell responses better define HIV disease progression than HLA genotype. J. Virol. Feb 10 [Epub ahead of print] (2010).
Dite P, Novotny I, Trna J, Sevcikova A. Autoimmune pancreatitis. Best Pract. Res. Clin. Gastroenterol. 22: 131-143 (2008).
Dittmar M, Ide M, Wurm M, Kahaly GJ. Early onset of polyglandular failure is associated with HLA-DRB1*03. Eur. J. Endocrinol. 159: 55-60 (2008).
Dittmar M, Kaczmarczyk A, Bischofs C, Kahaly GJ. The proinflammatory cytokine TNF-alpha -308 AA genotype is associated with polyglandular autoimmunity. Immunol. Invest. 38: 255-267 (2009).
Dizier MH, Deschamps I, Hors J, Blanc M, Rivat-Peran L, Feingold N, Clerget-Darpoux F. Interaction between HLA and Gm for susceptibility to insulin-dependent diabetes. Rev. Epidemiol. Sante Publique 33: 337-340 (1985).
Dizier MH, Eliaou JF, Babron MC, Combe B, Sany J, Clot J, Clerget-Darpoux F. Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epitope hypothesis. Am. J. Hum. Genet. 53: 715-721 (1993). *
Djilali-Saiah I, Benini V, Daniel S, Assan R, Bach JF, Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 48: 87-92 (1996).
Djilali-Saiah I, Benini V, Schmitz J, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Absence of primary association between DM gene polymorphism and insulin-dependent diabetes mellitus or celiac disease. Hum. Immunol. 49: 22-27 (1996).
Djilali-Saiah I, Bertin E, Larger E, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Major histocompatibility class II genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity. Hum. Immunol. 59: 176-182 (1998).
Djilali-Saiah I, Caillat-Zucman S, Schmitz J, Chaves-Vieira ML, Bach JF. Polymorphism of antigen processing (TAP, LMP) and HLA class II genes in celiac disease. Hum. Immunol. 40: 8-16 (1994).
Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J. Hepatol. 45: 844-850 (2006). *
Djilali-Saiah I, Ouellette P, Caillat-Zucman S, Debray D, Kohn JI, Alvarez F. CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis. Hum. Immunol. 62: 1356-1362 (2001).
Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alvarez F. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J. Hepatol. 40: 904-909 (2004).
Dobrovolna M, Vrana M, Brdicka R, Loudova M. Significance of confirmatory testing of HLA system in unrelated haematopoietic stem cell donors. Cas. Lek. Cesk. 145: 32-35 (2006).
Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, McFarlane IG, Johnson PJ, Eddleston AL, Mowat AP, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19: 609-615 (1994).
Doherty DG, Underhill JA, Donaldson PT, Manabe K, Mieli-Vergani G, Eddleston AL, Vergani D, Demaine AG, Williams R. Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis. Autoimmunity 18: 243-249 (1994).
Doisne JM, Castaigne JG, Deruyffelaere C, Dieu-Nosjean MC, Chamot C, Alcaide-Loridan C, Charron D, Al-Daccak R. The context of HLA-DR/CD18 complex in the plasma membrane governs HLA-DR-derived signals in activated monocytes. Mol. Immunol. 45: 709-718 (2008). *
Donaldson P. HLA system and other genetic markers in PSC. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 71-72. October 15-16 (2003). *
Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 48: 397-402 (2001). *
Donaldson PT. Chapter 17. Immunogenetics of autoimmune liver disease: risk factors for susceptibility and progression. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 221-234 (2007). *
Donaldson PT. The role of genetics in immunopathogenesis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 47-48 (2004). *
Donaldson PT. Immunogenetics in liver diseases. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 23-24. September 12 - 13 (2003). *
Donaldson PT. Immunogenetics in liver disease. Baillieres Clin. Gastroenterol. 10: 533-549 (1996).
Donaldson PT. Basic concepts in PSC. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 73-75 (2005). *
Donaldson PT, Baragiotta A, Heneghan MA, Floreani A, Venturi C, Underhill JA, Jones DE, James OF, Bassendine MF. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 44: 667-674 (2006). *
Donaldson PT, Clare M, Constantini PK, Hadzic N, Mieli-Vergani G, Howard E, Kelley D. HLA and cytokine gene polymorphisms in biliary atresia. Liver 22: 213-219 (2002). *
Donaldson PT, Czaja AJ. Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis. Clin. Liver Dis. 6: 419-437 (2002).
Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 13: 129-133 (1991).
Donaldson PT, Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 35: 555-564 (2002).
Donaldson PT, Norris S, Constantini PK, Bernal W, Harrison P, Williams R. The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance. J. Hepatol. 32: 882-886 (2000). *
Donat E, Planelles D, Capilla-Villanueva A, Montoro JA, Palau F, Ribes-Koninckx C. Allelic distribution and the effect of haplotype combination for HLA type II loci in the celiac disease population of the Valencian community (Spain). Tissue Antigens 73: 255-261 (2009).
Dong Y, Denny TN. HLA-A2-restricted human CD8+ cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses. J. Infect. Dis. 194: 168-175 (2006). *
Donmez B, Ozakbas S, Oktem MA, Gedizlioglu M, Coker I, Genc A, Idiman E. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features. Hum. Immunol. 65: 752-757 (2004).
Donn RP, Thomson W, Pepper L, Carthy D, Farhan A, Ryder C, Southwood T, Holt L, Ollier W. Antinuclear antibodies in early onset pauciarticular juvenile chronic arthritis (JCA) are associated with HLA-DQB1*0603: a possible JCA-associated human leucocyte antigen haplotype. Br. J. Rheumatol. 34: 461-465 (1995).
Donner H, Tonjes RR, Van der Auwera B, Siegmund T, Braun J, Weets I, Herwig J, Kurth R, Usadel KH, Badenhoop K. The presence or absence of a retroviral long terminal repeat influences the genetic risk for type 1 diabetes conferred by human leukocyte antigen DQ haplotypes. Belgian Diabetes Registry. J. Clin. Endocrinol. Metab. 84: 1404-1408 (1999). *
Donvito B, Monnet D, Tabary T, Delair E, Vittier M, Reveil B, Chiquet C, Brezin AP, Cohen JH. A new HLA extended haplotype containing the A*2910 allele is also associated with birdshot retinochoroidopathy and narrows susceptibility to the disease to the HLA molecule itself. Invest. Ophthalmol. Vis. Sci. Dec 3 [Epub ahead of print] (2009).
Doolan A, Donaghue K, Fairchild J, Wong M, Williams AJ. Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care 28: 806-809 (2005). *
Dorak MT, Shao W, Machulla HK, Lobashevsky ES, Tang J, Park MH, Kaslow RA. Conserved extended haplotypes of the major histocompatibility complex: further characterization. Genes Immun. 7: 450-467 (2006). *
Dorak MT, Yee LJ, Tang J, Shao W, Lobashevsky ES, Jacobson LP, Kaslow RA. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma. J. Med. Virol. 76: 302-310 (2005). *
Dorner T, Haas J, Loddenkemper C, von Baehr V, Salama A. Implant-related inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 2: 53-56 (2006). *
Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res. Ther. 6: R199-R207 (2004). *
Dotan I, Allez M, Nakazawa A, Brimnes J, Schulder-Katz M, Mayer LF. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1630-G1640 (2007). *
Douroudis K, Tarassi K, Athanassiades T, Giannakopoulos F, Kominakis A, Thalassinos N, Papasteriades Ch. HLA alleles as predisposal factors for postmenopausal osteoporosis in a Greek population. Tissue Antigens 69: 592-596 (2007). *
Doxiadis GG, de Groot N, Claas FH, Doxiadis II, van Rood JJ, Bontrop RE. A highly divergent microsatellite facilitating fast and accurate DRB haplotyping in humans and rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 104: 8907-8912 (2007). *
Doxiadis GG, de Groot N, Dauber EM, van Eede PH, Fae I, Faner R, Fischer G, Grubic Z, Lardy NM, Mayr W, Palou E, Swelsen W, Stingl K, Doxiadis II, Bontrop RE. High resolution definition of HLA-DRB haplotypes by a simplified microsatellite typing technique. Tissue Antigens 74: 486-493 (2009). *
Doxiadis GG, de Groot N, de Groot NG, Doxiadis II, Bontrop RE. Reshuffling of ancient peptide binding motifs between HLA-DRB multigene family members: old wine served in new skins. Mol. Immunol. 45: 2743-2751 (2008). *
Doxiadis II, de Fijter JW, Mallat MJ, Haasnoot GW, Ringers J, Persijn GG, Claas FH. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation 83: 1207-1213 (2007).
Doytchinova IA, Flower DR. In silico identification of supertypes for class II MHCs. J. Immunol. 174: 7085-7095 (2005). *
Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J. Hepatol. 52: 252-257 (2010). *
Dragun D, Hegner B. Non-HLA antibodies post-transplantation: clinical relevance and treatment in solid organ transplantation. Contrib. Nephrol. 162: 129-139 (2009).
Droemann D, Rupp J, Goldmann T, Uhlig U, Branscheid D, Vollmer E, Kujath P, Zabel P, Dalhoff K. Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 175: 791-797 (2007). *
Drosos AA, Moutsopoulos HM. Rheumatoid arthritis in Greece: clinical, serological and genetic considerations. Clin. Exp. Rheumatol. 13 Suppl. 12: S7-S12 (1995).
Drouet M, Delpuget-Bertin N, Vaillant L, Chauchaix S, Boulanger MD, Bonnetblanc JM, Bernard P. HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians. Eur. J. Dermatol. 8: 330-333 (1998).
Drouin EE, Glickstein L, Kwok WW, Nepom GT, Steere AC. Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis. Mol. Immunol. 45: 180-189 (2008). *
Drouin EE, Glickstein L, Kwok WW, Nepom GT, Steere AC. Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis. Mol. Immunol. 45: 2323-2332 (2008). *
Drover S, Marshall WH, Kwok WW, Nepom GT, Karr RW. Amino acids in the peptide-binding groove influence an antibody-defined, disease-associated HLA-DR epitope. Scand. J. Immunol. 39: 539-550 (1994).
Du JW, Gu JY, Liu J, Cen XN, Zhang Y, Ou Y, Chu B, Zhu P. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Leuk. Lymphoma 48: 1618-1627 (2007).
Du KM, Ji Y, Xie JH, Fu M, Sun Y, Jin Y, Sun JL, Yang JH, Zhang Z, Mao Z, Liu DZ, Qian KC, Zhao TM. HLA-A, -B, -DR haplotype frequencies from DNA typing data of 26,266 Chinese bone marrow donors. Hum. Immunol. 68: 854-866 (2007).
Du L, Kijlstra A, Yang P. Immune response genes in uveitis. Ocul. Immunol. Inflamm. 17: 249-256 (2009).
du Montcel ST, Michou L, Petit-Teixeira E, Osorio J, Lemaire I, Lasbleiz S, Pierlot C, Quillet P, Bardin T, Prum B, Cornelis F, Clerget-Darpoux F. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum. 52: 1063-1068 (2005). *
Du QS, Wei YT, Pang ZW, Chou KC, Huang RB. Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction. Protein Eng. Des. Sel. 20: 417-423 (2007). *
Duah NO, Weiss HA, Jepson A, Tetteh KK, Whittle HC, Conway DJ. Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigens. PLoS One 4: e7381 (2009). *
Duarte-Rey C, Pardo AL, Rodr�guez-Velosa Y, Mantilla RD, Anaya JM, Rojas-Villarraga A. HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis. Autoimmun. Rev. 8: 325-331 (2009).
Dubois-Laforgue D, Timsit J, Djilali-Saiah I, Boitard C, Caillat-Zucman S. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects. Hum. Immunol. 57: 104-109 (1997).
Duchatelet S, Caillat-Zucman S, Dubois-Laforgue D, Blanc H, Timsit J, Julier C. FCRL3 -169CT functional polymorphism in type 1 diabetes and autoimmunity traits. Biomed. Pharmacother. 62: 153-157 (2008).
Duchini A, McHutchison JG, Pockros PJ. LKM-positive autoimmune hepatitis in the western United States: a case series. Am. J. Gastroenterol. 95: 3238-3241 (2000). *
Duchmann R, May E, Ackermann B, Goergen B, Meyer zum Buschenfelde KH, Marker-Hermann E. HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis. Scand. J. Immunol. 43: 101-108 (1996).
Duclos B, Reimund JM, Lang JM, Coumaros G, Chamouard P, Lehr L, Baumann R, Koehl C, Weill JP. Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors. Gastroenterol. Clin. Biol. 14: 22-27 (1990).
Dudek NL, Maier S, Chen ZJ, Mudd PA, Mannering SI, Jackson DC, Zeng W, Keech CL, Hamlin K, Pan ZJ, Davis-Schwarz K, Workman-Azbill J, Bachmann M, McCluskey J, Farris AD. T cell epitopes of the La/SSB autoantigen in humanized transgenic mice expressing the HLA class II haplotype DRB1*0301/DQB1*0201. Arthritis Rheum. 56: 3387-3398 (2007). *
Duerr RH. Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology 132: 2045-2049 (2007). *
Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 108: 423-427 (1995). *
Dugoujon JM, Cambon-Thomsen A. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity 22: 245-260 (1995).
Dultz G, Matheis N, Dittmar M, Rohrig B, Bender K, Kahaly GJ. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 19: 143-148 (2009).
Dumolard A, Gaudin P, Juvin R, Bost M, Peoc'h M, Phelip X. SAPHO syndrome or psoriatic arthritis? A familial case study. Rheumatology (Oxford) 38: 463-467 (1999). *
Dunckley H, Jazwinska EC, Gatenby PA, Serjeantson SW. DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma. Tissue Antigens 33: 418-420 (1989).
Dunne C, Crowley J, Hagan R, Rooney G, Lawlor E. HLA-A, B, Cw, DRB1, DQB1 and DPB1 alleles and haplotypes in the genetically homogenous Irish population. Int. J. Immunogenet. 35: 295-302 (2008). *
Dunne C, McGuigan C, Crowley J, Hagan R, Rooney G, Kelleher J, Hutchinson M, Lawlor E. Human leucocyte antigen class II polymorphism in Irish patients with multiple sclerosis. Tissue Antigens 68: 257-262 (2006). *
Dunstan SJ, Stephens HA, Blackwell JM, Duc CM, Lanh MN, Dudbridge F, Phuong CX, Luxemburger C, Wain J, Ho VA, Hien TT, Farrar J, Dougan G. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J. Infect. Dis. 183: 261-268 (2001). *
Dupuis J, Albers K, Allen-Brady K, Cho K, Elston RC, Kappen HJ, Tang H, Thomas A, Thomson G, Tsung E, Yang Q, Zhang W, Zhao K, Zheng G, Ziegler JT. Effect of linkage disequilibrium between markers in linkage and association analyses. Genet. Epidemiol. 31 Suppl. 1: S139-S148 (2007).
Dupuis J; on behalf of Group 17. Effect of linkage disequilibrium between markers in linkage and association analyses. Genet. Epidemiol. 31: S139-S148 (2007).
Duquesnoy RJ, Awadalla Y, Lomago J, Jelinek L, Howe J, Zern D, Hunter B, Martell J, Girnita A, Zeevi A. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes. Transpl. Immunol. 18: 352-360 (2008).
Durai M, Krueger C, Ye Z, Cheng L, Mackensen A, Oelke M, Schneck JP. In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC). Cancer Immunol. Immunother. 58: 209-220 (2009).
Durantez M, Lopez-Vazquez AB, de Cerio AL, Huarte E, Casares N, Prieto J, Borras-Cuesta F, Lasarte JJ, Sarobe P. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes. Scand. J. Immunol. 69: 80-89 (2009). *
Durazzo M, Premoli A, Morello E. Autoimmune hepatitis: present knowledges. Minerva Med. 95: 1-9 (2004).
Durinovic-Bello I, Jelinek E, Schlosser M, Eiermann T, Boehm BO, Karges W, Marchand L, Polychronakos C. Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals. Diabetes 54: S18-S24 (2005). *
Durinovic-Bello I, Rosinger S, Olson JA, Congia M, Ahmad RC, Rickert M, Hampl J, Kalbacher H, Drijfhout JW, Mellins ED, Al Dahouk S, Kamradt T, Maeurer MJ, Nhan C, Roep BO, Boehm BO, Polychronakos C, Nepom GT, Karges W, McDevitt HO, Sonderstrup G. DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype. Proc. Natl. Acad. Sci. U.S.A. 103: 11683-11688 (2006). *
Durrani K, Foster CS. Psoriatic uveitis: a distinct clinical entity? Am. J. Ophthalmol. 139: 106-111 (2005). *
Durupinar B, Okten G. HLA tissue types in nonresponders to hepatitis B vaccine. Indian J. Pediatr. 63: 369-373 (1996).
Duvefelt K, Anderson M, Fogdell-Hahn A, Hillert J. A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501. Tissue Antigens 63: 13-20 (2004). *
Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille JD. HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Arch. Dermatol. 127: 64-68 (1991).
Duyar H, Dengjel J, de Graaf KL, Wiesmuller KH, Stevanovic S, Weissert R. Peptide motif for the rat MHC class II molecule RT1.D(a): similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule. Immunogenetics 57: 69-76 (2005). *
Dyment DA, Cader MZ, Datta A, Broxholme SJ, Cherny SS, Willer CJ, Ramagopalan S, Herrera BM, Orton S, Chao M, Sadovnick AD, Hader M, Hader W, Ebers GC. A first stage genome-wide screen for regions shared identical-by-descent in Hutterite families with multiple sclerosis. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B: 467-472 (2008).
Dyment DA, Cader MZ, Herrera BM, Ramagopalan SV, Orton SM, Chao M, Willer CJ, Sadovnick AD, Risch N, Ebers GC. A genome-scan in a single pedigree with a high prevalence of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 79: 158-162 (2008).
Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum. Mol. Genet. 14: 2019-2026 (2005). *
Dyment DA, Steckley JL, Morrison K, Willer CJ, Cader MZ, DeLuca GC, Sadovnick AD, Risch N, Ebers GC; Canadian Collaborative Study Group. TCR beta polymorphisms and multiple sclerosis. Genes Immun. 5: 337-342 (2004). *
Dyment DA, Steckley JL, Willer CJ, Armstrong H, Sadovnick AD, Risch N, Ebers GC. No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study. J. Neuroimmunol. 123: 193-198 (2002).
Dyment DA, Willer CJ, Scott B, Armstrong H, Ligers A, Hillert J, Paty DW, Hashimoto S, Devonshire V, Hooge J, Kastrukoff L, Oger J, Metz L, Warren S, Hader W, Power C, Auty A, Nath A, Nelson R, Freedman M, Brunet D, et al. Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics 3: 145-151 (2001). *
Eade OE, Moulton C, MacPherson BR, Andre-Ukena SS, Albertini RJ, Beeken WL. Discordant HLA haplotype segregation in familial Crohn's disease. Gastroenterology 79: 271-275 (1980).
Earle KE, Tang Q, Zhou X, Liu W, Zhu S, Bonyhadi ML, Bluestone JA. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin. Immunol. 115: 3-9 (2005). *
Eberhardt K, Fex E, Johnson U, Wollheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann. Rheum. Dis. 55: 34-39 (1996). *
Eberle M, Baxter-Lowe LA. Molecular analysis of HLA-DRB1*08/12 alleles: identification of two additional alleles. Hum. Immunol. 34: 24-30 (1992).
Ebihara T, Sakai N, Koyama S. CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis. Tohoku J. Exp. Med. 162: 213-224 (1990).
Ebringer A, Ahmadi K, Fielder M, Rashid T, Tiwana H, Wilson C, Collado A, Tani Y. Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy. Clin. Rheumatol. 15 Suppl. 1: 57-61 (1996).
Ebringer A, Rashid T. Rheumatoid arthritis is caused by Proteus: the molecular mimicry theory and Karl Popper. Front. Biosci. (Elite Ed.) 1: 577-586 (2009).
Ebringer A, Rashid T, Wilson C. Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper. Autoimmun. Rev. Nov 3 [Epub ahead of print] (2009).
Edinur HA, Zafarina Z, Sp�nola H, Nurhaslindawaty AR, Panneerchelvam S, Norazmi MN. HLA polymorphism in six Malay sub-ethnic groups in Malaysia. Hum. Immunol. 70: 518-526 (2009).
Eerligh P, Koeleman BP, Dudbridge F, Jan Bruining G, Roep BO, Giphart MJ. Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes. Genes Immun. 5: 36-40 (2004). *
Efron PA, Matsumoto T, McAuliffe PF, Scumpia P, Ungaro R, Fujita S, Moldawer LL, Foley D, Hemming AW. Major hepatectomy induces phenotypic changes in circulating dendritic cells and monocytes. J. Clin. Immunol. 29: 568-581 (2009). *
Egan JE, Quadrini KJ, Santiago-Schwarz F, Hadden JW, Brandwein HJ, Signorelli KL. IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro. J. Immunother. 30: 624-633 (2007).
Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun. Rev. Dec 16 [Epub ahead of print] (2009).
Ehrenpreis ED. Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis. Aliment. Pharmacol. Ther. 29: 1202-1211 (2009). *
Eichenfield LF, Nighland M, Rossi AB, Cook-Bolden F, Grimes P, Fried R, Levy S; PUMP Study Group. Phase 4 study to assess tretinoin pump for the treatment of facial acne. J. Drugs Dermatol. 7: 1129-1136 (2008).
Eichler H, Nguyen XD, Roelen D, Celluzzi CM, McKenna D, Pamphilon D, Blair A, Read EJ, Takahashi TA, Szczepiorkowski ZM; Biomedical Excellence for Safer Transfusion Collaborative. Multicenter study on in vitro characterization of dendritic cells. Cytotherapy 10: 21-19 (2008).
Eiermann TH, Bettens F, Tiberghien P, Schmitz K, Beurton I, Bresson-Hadni S, Ammann RW, Goldmann SF, Vuitton DA, Gottstein B, Kern P. HLA and alveolar echinococcosis. Tissue Antigens 52: 124-129 (1998).
Eike MC, Becker T, Humphreys K, Olsson M, Lie BA. Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B. Genes Immun. 10: 56-67 (2009). *
Eike MC, Humphreys K, Becker T, Olsson M, Lie BA; Diabetes Genetics Consortium. Three microsatellites from the T1DGC MHC data set show highly significant association with type 1 diabetes, independent of the HLA-DRB1, -DQA1 and -DQB1 genes. Diabetes Obes. Metab. 11 Suppl. 1: 17-24 (2009). *
Eike MC, Olsson M, Undlien DE, Dahl-Jorgensen K, Joner G, Ronningen KS, Thorsby E, Lie BA. Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families. Genes Immun. 10: 141-150 (2009). *
Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, Lind L, Holmgren G, Holmberg M, Asplund K, Holmberg D. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur. J. Hum. Genet. 11: 81-84 (2003). *
Eiz-Vesper B, Deluca DS, Blasczyk R, Horn PA. The nature of recombination in HLA-B*4207. Tissue Antigens 70: 164-168 (2007). *
Eken C, Gasser O, Zenhaeusern G, Oehri I, Hess C, Schifferli JA. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. J. Immunol. 180: 817-824 (2008). *
El Neanaey WA, Barakat SS, Ahmed MA, El Nabie WM, Ahmed ME. The relation between HLA-DRB1 alleles and the outcome of therapy in children with idiopathic thrombocytopenic purpura. Egypt. J. Immunol. 12: 29-38 (2005).
El-Awar N, Terasaki PI, Cai J, Deng CT, Ozawa M, Nguyen A. Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens. Clin. Transpl. 2007: 175-194 (2007).
El-Chennawi FA, Auf FA, Metwally SS, Mosaad YM, El-Wahab MA, Tawhid ZE. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol. Invest. 37: 661-674 (2008). *
El-Chennawi FA, Kamel HA, Mosaad YM, El-Sherbini SM, El-Billey NA. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling. Hematology 11: 227-234 (2006).
El-Gabalawy H. The preclinical stages of RA: lessons from human studies and animal models. Best Pract. Res. Clin. Rheumatol. 23: 49-58 (2009).
El-Gabalawy HS, Goldbach-Mansky R, Smith D 2nd, Arayssi T, Bale S, Gulko P, Yarboro C, Wilder RL, Klippel JH, Schumacher HR Jr. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum. 42: 1696-1705 (1999). *
El-Gabalawy HS, Robinson DB, Hart D, Elias B, Markland J, Peschken CA, Smolik I, Montes-Aldana G, Schroeder M, Fritzler MJ, Cheang M, Oen K. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American native population with rheumatoid arthritis and their first-degree relatives. J. Rheumatol. 36: 1130-1135 (2009).
El-Hagrassy N, El-Chennawi F, Zaki ME, Fawzy H, Zaki A, Joseph N. HLA class I and class II HLA DRB profiles in Egyptian children with rheumatic valvular disease. Pediatr. Cardiol. Feb 10 [Epub ahead of print] (2010).
El-Shabrawi Y, Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, Ardjomand N, Hermann J. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations. Ophthalmology 113: 695-700 (2006).
Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim. Biophys. Acta 1792: 163-172 (2009).
Elahi MM, Asotra K, Matata BM, Mastana SS. Tumour necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim. Biophys. Acta Jan 26 [Epub ahead of print] (2009). *
Elias E. Hepatology highlights. Hepatology 39: 1467-1468 (2004). *
Elkord E, Burt DJ, Drijfhout JW, Hawkins RE, Stern PL. CD4(+) T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25(+) T cells. Cancer Immunol. Immunother. 57: 833-847 (2008). *
Eller E, Vardi P, Babu SR, Bugawan TL, Erlich HA, Yu L, Fain PR. Celiac disease and HLA in a Bedouin kindred. Hum. Immunol. 67: 940-950 (2006).
Eller E, Vardi P, McFann KK, Babu SR, Yu L, Bugawan TL, Erlich HA, Eisenbarth GS, Fain PR. Differential effects of DRB1(*)0301 and DQA1(*)0501-DQB1(*)0201 on the activation and progression of islet cell autoimmunity. Genes Immun. 8: 628-633 (2007). *
Elliott SL, Suhrbier A, Miles JJ, Lawrence G, Pye SJ, Le TT, Rosenstengel A, Nguyen T, Allworth A, Burrows SR, Cox J, Pye D, Moss DJ, Bharadwaj M. A phase I trial of a CD8+ T cell peptide epitope-based vaccine for infectious mononucleosis. J. Virol. 82: 1448-1457 (2008). *
Ellmerich S, Mycko M, Takacs K, Waldner H, Wahid FN, Boyton RJ, King RH, Smith PA, Amor S, Herlihy AH, Hewitt RE, Jutton M, Price DA, Hafler DA, Kuchroo VK, Altmann DM. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. J. Immunol. 174: 1938-1946 (2005). *
Elta GH, Sepersky RA, Goldberg MJ, Connors CM, Miller KB, Kaplan MM. Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig. Dis. Sci. 28: 971-975 (1983).
Endres RO, Redman H, Baumbach A, Capper J. A novel HLA-Cw*05 allele, Cw*0517. Tissue Antigens 70: 525-527 (2007). *
Endres RO, Redman H, Baumbach A, Capper J. A novel HLA-C locus allele with codon 54 deletion, Cw*0346. Tissue Antigens 70: 524-525 (2007). *
Endres RO, Redman H, Marcus N. Identification of the HLA-Cw*0774 and DQB1*060105 alleles. Tissue Antigens Oct 21 [Epub ahead of print] (2009). *
Endres RO, Redman H, Scavello GS. A novel HLA-B*51 allele, HLA-B*5149. Tissue Antigens 70: 259-260 (2007). *
Eoli M, Pandolfo M, Amoroso A, Salmaggi A, Zaffaroni M, Gasparini P, DiDonato S, Milanese C, Zeviani M. Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families. Eur. J. Hum. Genet. 3: 303-311 (1995).
Ercilla G, Pares A, Arriaga F, Bruguera M, Castillo R, Rodes J, Vives J. Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens 14: 449-452 (1979).
Erichsen MM, Lovas K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J. Clin. Endocrinol. Metab. 94: 4882-4890 (2009).
Erikstrup C, Kronborg G, Lohse N, Rye Ostrowski S, Gerstoft J, Ullum H. T-cell dysfunction in HIV-1-infected patients with impaired recovery of CD4 cells despite suppression of viral replication. J. Acquir. Immune Defic. Syndr. Dec 31 [Epub ahead of print] (2009).
Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippila C, Ahonen S, Nevalainen J, Veijola R, Pekkanen J, Ilonen J, Simell O, Knip M, Virtanen SM. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin. Exp. Allergy 39: 875-882 (2009). *
Erlich H, Bugawan T, Begovich A, Scharf S. Analysis of HLA class II polymorphism using polymerase chain reaction. Arch. Pathol. Lab. Med. 117: 482-485 (1993).
Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P; for the TIDGC. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium Families. Diabetes 57: 1084-1092 (2008). *
Erlich HA. HLA class II sequences and genetic susceptibility to insulin dependent diabetes mellitus. Baillieres Clin. Endocrinol. Metab. 5: 395-411 (1991).
Erlich HA, Bugawan TL, Scharf S, Nepom GT, Tait B, Griffith RL. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes 39: 96-103 (1990).
Erlich HA, Griffith RL, Bugawan TL, Ziegler R, Alper C, Eisenbarth G. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes 40: 478-481 (1991).
Erlich HA, Lohman K, Mack SJ, Valdes AM, Julier C, Mirel D, Noble JA, Morahan GE, Rich SS; for the Type I Diabetes Genetics Consortium. Association analysis of SNPs in the IL4R locus with type I diabetes. Genes Immun. 10: S33-S41 (2009).
Erlich HA, Valdes AM, Julier C, Mirel D, Noble JA. Evidence for association of the TCF7 locus with type I diabetes. Genes Immun. 10: S54-S59 (2009).
Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W, Beshkov Y, Costin G, Pressman S, Bugawan T, et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat. Genet. 3: 358-364 (1993). *
Ertem D, Gonen I, Tanidir C, Ugras M, Yildiz A, Pehlivanoglu E, Eksioglu-Demiralp E. The response to hepatitis B vaccine: does it differ in celiac disease? Eur. J. Gastroenterol. Hepatol. Jul 4 [Epub ahead of print] (2009).
Esdaile JM, Dwosh IL, Urowitz MB, Smythe HA, Falk J. HLA B27 in rheumatoid factor-negative polyarthritis. Ann. Intern. Med. 86: 699-702 (1977).
Ettinger RA, James EA, Kwok WW, Thompson AR, Pratt KP. Lineages of human T-cell clones, including TH17/TH1 cells, isolated at different stages of anti-factor VIII immune responses. Blood 114: 1423-1428 (2009). *
Ettinger RA, Liu AW, Nepom GT, Kwok WW. Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus. J. Immunol. 165: 3232-3238 (2000). *
Etxagibel A, Julia MR, Brotons A, Company MM, Dolz C. Drug-induced hepatitis superimposed on the presence of anti-SLA antibody: a case report. J. Med. Case Reports 2: 25 (2008). *
Etzensperger R, McMahon RM, Jones EY, Fugger L. Dissection of the multiple sclerosis associated DR2 haplotype. J. Autoimmun. 31: 201-207 (2008).
Ewing C, Ebringer R, Tribbick G, Geysen HM. Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199). J. Exp. Med. 171: 1635-1647 (1990). *
Fabris A, Catamo E, Segat L, Morgutti M, Claudio Arraes L, de Lima-Filho JL, Crovella S. Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children. AIDS 23: 177-182 (2009).
Fae KC, Oshiro SE, Toubert A, Charron D, Kalil J, Guilherme L. How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J. Autoimmun. 24: 101-109 (2005).
Fain PR, Babu SR, Bennett DC, Spritz RA. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res. 19: 51-57 (2006). *
Fais S, Pallone F, Squarcia O, Biancone L, Ricci F, Paoluzi P, Boirivant M. HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers. Clin. Exp. Immunol. 68: 605-612 (1987). *
Fajardy I, Vambergue A, Stuckens C, Weill J, Danze PM, Fontaine P. CTLA-4 49 A/G dimorphism and type 1 diabetes susceptibility: a French case-control study and segregation analysis. Evidence of a maternal effect. Eur. J. Immunogenet. 29: 251-257 (2002).
Fakler JW, Schmitt-Egenolf M, Vejbaesya S, Boehncke WH, Sterry W, Eiermann TH. Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis. Hum. Immunol. 40: 299-302 (1994).
Fallang LE, Bergseng E, Hotta K, Berg-Larsen A, Kim CY, Sollid LM. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat. Immunol. 10: 1096-1101 (2009). *
Fallang LE, Roh S, Holm A, Bergseng E, Yoon T, Fleckenstein B, Bandyopadhyay A, Mellins ED, Sollid LM. Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM. J. Immunol. 181: 5451-5461 (2008). *
Falorni A. Immunologic and genetic aspects of latent autoimmune diabetes in the adult. Minerva Endocrinol. 28: 297-312 (2003).
Fan LY, Wang WJ, Wang Q, Zong M, Yang L, Zhang H, Sun LS, Lu TB, Han J. A functional haplotype and expression of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Chinese. Tissue Antigens 72: 469-473 (2008). *
Fan XY, Li JZ, Yao SQ, Yan JD, Li CL, Ma QK. Relationship between pneumoconiosis and the polymorphisms of HLA-DRB1*, DQB1* genes. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 23: 278-281 (2005).
Faner R, James E, Huston L, Pujol-Borrel R, Kwok WW, Juan M. Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation. Eur. J. Immunol. Oct 14 [Epub ahead of print] (2009). *
Farias AQ, Goncalves LL, Bittencourt PL, De Melo ES, Abrantes-Lemos CP, Porta G, Nakhle MC, Carrilho FJ, Cancado EL. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis. J. Gastroenterol. Hepatol. 21: 887-893 (2006). *
Farid NR, Moens H, Larsen B, Payne R, Saltman K, Fifield F, Ingram DW. HLA haplotypes in familial Graves' disease. Tissue Antigens 15: 492-500 (1980).
Farid NR, Thompson C. HLA and autoimmune endocrine disease 1985. Mol. Biol. Med. 3: 85-97 (1986).
Farjadian S, Ghaderi A. HLA class II similarities in Iranian Kurds and Azeris. Int. J. Immunogenet. 34: 457-463 (2007). *
Farjadian S, Ghaderi A. HLA class II genetic diversity in Arabs and Jews of Iran. Iran J. Immunol. 4: 85-93 (2007).
Farjadian S, Kiyanimanesh N, Abbaszadegan A, Lotfazar M. HLA class I gene polymorphism in Iranian patients with Papillon-Lefevre syndrome. Iran. J. Immunol. 4: 241-245 (2007).
Farjadian S, Lotfazar M, Ghaderi A. Analysis of human leukocyte antigen class II gene polymorphism in Iranian patients with Papillon-Lefevre syndrome: a family study. Iran. J. Immunol. 5: 171-176 (2008).
Farouk HM, Mansour HE, Rahman SA, Mostafa AA, Shamy HA, Zarouk WA. Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients. Braz. J. Med. Biol. Res. 42: 831-838 (2009). *
Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W, Symmons D, Barton A. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum. 58: 359-369 (2008). *
Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, Eddleston AL, Williams R. Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 16: 390-395 (1992).
Farrell AM, Dean D, Millard PR, Charnock FM, Wojnarowska F. Cytokine alterations in lichen sclerosus: an immunohistochemical study. Br. J. Dermatol. 155: 931-940 (2006). *
Fasano A. Surprises from celiac disease. Sci. Am. 301: 54-61 (2009).
Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 128: S68-S73 (2005). *
Fathi NA, Ezz-Eldin AM, Mosad E, Bakry RM, Hamed HB, Ahmed S, Mahmoud M, Rashed HA, Abdullah F. Diagnostic performance and predictive value of rheumatoid factor, anti- cyclic -citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis. Int. Arch. Med. 1: 20 (2008). *
Fatma OS, Sarper DA, Dilek E, Emel OA, Semra A, Dilek KS, Mahmut C. HLA-DRB1 association in Turkish psoriasis vulgaris patients. Swiss Med. Wkly. 133: 541-543 (2003). *
Fauchais AL, Boumediene A, Lalloue F, Gondran G, Loustaud-Ratti V, Vidal E, Jauberteau MO. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome. Scand. J. Rheumatol. 38: 50-57 (2009).
Fausther-Bovendo H, Wauquier N, Cherfils-Vicini J, Cremer I, Debre P, Vieillard V. NKG2C is a major triggering receptor involved in the Vdelta1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells. AIDS 22: 217-226 (2008). *
Faustini F, Zoli A, Ferraccioli GF. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases. Eur. Rev. Med. Pharmacol. Sci. 13 Suppl. 1: 1-9 (2009).
Faux JA, Moffatt MF, Lalvani A, Dekker J, Warrell DA, Cookson WO. Sensitivity to bee and wasp venoms: association with specific IgE responses to the bee and wasp venom and HLA DRB1 and DPB1. Clin. Exp. Allergy 27: 578-583 (1997).
Favier B, Lemaoult J, Rouas-Freiss N, Moreau P, Menier C, Carosella ED. Research on HLA-G: an update. Tissue Antigens 69: 207-211 (2007). *
Favorova OO, Andreewski TV, Boiko AN, Sudomoina MA, Alekseenkov AD, Kulakova OG, Slanova AV, Gusev EI. The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology 59: 1652-1655 (2002).
Fdez-Morera JL, Rodrigo L, Lopez-Vazquez A, Rodero SR, Martinez-Borra J, Nino P, Gonzalez S, Lopez-Larrea C. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Hum. Immunol. 64: 816-822 (2003).
Fdez-Morera JL, Tunon A, Rodriguez-Rodero S, Rodrigo L, Martinez-Borra J, Gonzalez S, Lopez-Vazquez A, Lahoz CH, Lopez-Larrea C. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A. Tissue Antigens 67: 409-414 (2006). *
Fei H, Scharf S, Erlich H, Peebles C, Tan E, Fox R. Relationship between HLA D region gene and primary Sjogren's syndrome. Zhonghua Yi Xue Za Zhi 71: 555-559 (1991).
Fei HM, Kang H, Scharf S, Erlich H, Peebles C, Fox R. Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjogren's syndrome and autoantibody production. J. Clin. Lab. Anal. 5: 382-391 (1991).
Feist E, Dorner T, Hansen A. Indications and options of new immune modulatory therapies for Sjogren's syndrome. Z. Rheumatol. 66: 679-685 (2007).
Feist E, Hansen A. Critical overview of outcome parameters for patients with primary Sjogren's syndrome. Z. Rheumatol. 69: 25-31 (2010).
Feist E, Hermann KG, Dankof A. Vasculopathy in Sjogren's syndrome. Z. Rheumatol. 68: 305-311 (2009).
Feitsma AL, Toes RE, Begovich AB, Chokkalingam AP, de Vries RR, Huizinga TW, van der Helm-van Mil AH. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients. Rheumatology (Oxford) 46: 1092-1095 (2007). *
Feitsma AL, van der Voort EI, Franken KL, El Bannoudi H, Elferink BG, Drijfhout JW, Huizinga TW, de Vries RR, Toes RE, Ioan-Facsinay A. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis. Arthritis Rheum. 62: 117-125 (2009). *
Feitsma AL, Worthington J, van der Helm-van Mil AH, Plant D, Thomson W, Ursum J, van Schaardenburg D, van der Horst-Bruinsma IE, van Rood JJ, Huizinga TW, Toes RE, de Vries RR. Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development. Proc. Natl. Acad. Sci. U.S.A. 104: 19966-19970 (2007). *
Feld J, Heathcote E. Epidemiology of autoimmune liver disease. J. Gastroenterol. Hepatol. 18: 1118-1128 (2003). *
Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371: 2201-2212 (2008). *
Feldman PA, Regev A, Barkin JS. Hepatobiliary disorders associated with inflammatory bowel disease. Practical Gastroenterology, August 2006: 52-74 (2006). *
Fenalti G, Hampe CS, Arafat Y, Law RH, Banga JP, Mackay IR, Whisstock JC, Buckle AM, Rowley MJ. COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes 57: 1293-1301 (2008). *
Fennessy M, Metcalfe K, Hitman GA, Niven M, Biro PA, Tuomilehto J, Tuomilehto-Wolf E. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 37: 937-944 (1994).
Ferguson LR, Shelling AN, Browning BL, Huebner C, Petermann I. Genes, diet and inflammatory bowel disease. Mutat. Res. 622: 70-83 (2007).
Ferkolj I, Ihan A, Markovic S, Veceric Z, Pohar M. Infliximab reduces the number of activated mucosal lymphocytes in patients with Crohn's disease. J. Gastrointestin. Liver Dis. 15: 231-235 (2006). *
Fernandes TA, Fukai R, Souza CA, Lorand-Metze I, Magna LA, Kraemer MH. Molecular identification of the HLA-DRB1-DQB1 for diagnosis and follow-up of acute leukemias. Blood Cells Mol. Dis. Jan 3 [Epub ahead of print] (2010).
Fernandez Arquero M, Lopez Nava G, De la Concha EG, Figueredo MA, Santa Cruz S, Dumitru CG, Diaz Rubio M, Garcia Paredes J. HLA-DR2 gene and Spanish patients with ulcerative colitis. Rev. Esp. Enferm. Dig. 90: 243-249 (1998).
Fernandez L, Fernandez-Arquero M, Gual L, Lazaro F, Maluenda C, Polanco I, Figueredo MA, Gomez de la Concha E. Triplet repeat polymorphism in the transmembrane region of the MICA gene in celiac disease. Tissue Antigens 59: 219-222 (2002). *
Fernandez L, Mendoza JL, Martinez A, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Pena AS, Diaz-Rubio M, de la Concha EG. IBD1 and IBD3 determine location of Crohn's disease in the Spanish population. Inflamm. Bowel Dis. 10: 715-722 (2004). *
Fernandez L, Nunez C, Mendoza JL, Urcelay E, Fernandez-Arquero M, Taxonera C, Diaz-Rubio M, de la Concha EG, Martinez A. A recombined haplotype in the major histocompatibility region contains a cluster of genes conferring high susceptibility to ulcerative colitis in the Spanish population. Inflamm. Bowel Dis. 11: 785-791 (2005). *
Fernandez MN. Improving the outcome of cord blood transplantation: use of mobilized HSC and other cells from third party donors. Br. J. Haematol. 147: 161-176 (2009). *
Fernandez N, Hitman GA, Festenstein H, Garde L, Labeta M, Walker-Smith JA, Sachs JA. Novel HLA class II-associated structural patterns in coeliac disease and type I diabetes. Clin. Exp. Immunol. 72: 362-366 (1988). *
Fernandez O, Fernandez V, Alonso A, Caballero A, Luque G, Bravo M, Leon A, Mayorga C, Leyva L, de Ramon E. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain. J. Neurol. 251: 440-444 (2004).
Fernandez O, Fernandez V, Martinez-Cabrera V, Mayorga C, Alonso A, Leon A, Arnal C, Hens M, Luque G, de Ramon E, Caballero A, Leyva L. Multiple sclerosis in Gypsies from southern Spain: prevalence, mitochondrial DNA haplogroups and HLA class II association. Tissue Antigens 71: 426-433 (2008). *
Fernandez O, R-Antiguedad A, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, Guerrero M, Papais-Alvarenga M, Fernandez-Sanchez V, Leyva L. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J. Neurol. Jul 8 [Epub ahead of print] (2009).
Fernandez-Arquero M, Arroyo R, Rubio A, Martin C, Vigil P, Conejero L, Figueredo MA, de la Concha EG. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 53: 1361-1363 (1999).
Fernandez-Arquero M, Caldes T, Casado E, Maluenda C, Figueredo MA, De La Concha EG. Polymorphism within the HLA-DQB1*02 promoter associated with susceptibility to coeliac disease. Eur. J. Immunogenet. 25: 1-3 (1998).
Fernandez-Arquero M, Figueredo MA, Maluenda C, de la Concha EG. HLA-linked genes acting as additive susceptibility factors in celiac disease. Hum. Immunol. 42: 295-300 (1995).
Fernandez-Arquero M, Lopez-Nava G, Garcia Paredes J, Martinez A, De la Concha EG, Figueredo MA, Conejero L, Vigil P, Diaz Rubio M. Pancolitis and genetic markers in the Spanish population. Rev. Esp. Enferm. Dig. 91: 269-276 (1999).
Fernandez-Banares F, Esteve M, Salas A, Alsina M, Farre C, Gonzalez C, Buxeda M, Forne M, Rosinach M, Espinos JC, Maria Viver J. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am. J. Gastroenterol. 102: 2520-2528 (2007). *
Fernandez-Mestre MT, Vargas V, Montagnani S, Cotua M, Ogando V, Layrisse Z. HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis. Hum. Immunol. 65: 54-59 (2004).
Fernandez-Morera JL, Rodriguez-Rodero S, Tunon A, Martinez-Borra J, Vidal-Castineira JR, Lopez-Vazquez A, Rodrigo L, Rodrigo P, Gonz�lez S, Lahoz CH, Lopez-Larrea C. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility. Tissue Antigens 72: 54-59 (2008). *
Fernandez-Vina M, Ramirez LC, Raskin P, Stastny P. Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans. Tissue Antigens 41: 57-64 (1993).
Fernando MM, Stevens CR, Sabeti PC, Walsh EC, McWhinnie AJ, Shah A, Green T, Rioux JD, Vyse TJ. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet. 3: e192 (2007). *
Ferran M, Gimenez-Arnau AM, Bellosillo B, Pujol RM, Santamaria-Babi LF. Effector function of CLA(+) T lymphocytes on autologous keratinocytes in psoriasis. Actas Dermosifiliogr. 99: 701-707 (2008).
Ferrante A, Gorski J. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond. J. Immunol. Dec 28 [Epub ahead of print] (2009).
Ferrara F, Quaglia S, Caputo I, Esposito C, Lepretti M, Pastore S, Giorgi R, Martelossi S, Dal Molin G, Di Toro N, Ventura A, Not T. Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. Clin. Exp. Immunol. 159: 217-223 (2010). *
Ferreira AC, Gomes KB, Sampaio IB, Oliveira VC, Pardini VC, Godard AL. Type 1 diabetes susceptibility determined by HLA alleles and CTLA-4 and insulin genes polymorphisms in Brazilians. Arq. Bras. Endocrinol. Metabol. 53: 368-373 (2009).
Ferrell PB, McLeod HL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 9: 1543-1546 (2008).
Ferrer A, Nazabal M, Companioni O, Fernandez de Cossio ME, Camacho H, Cintado A, Benitez J, Casalvilla R, Sautie M, Villareal A, Diaz T, Marrero A, Fernandez de Cossio J, Hodelin A, Leal L, Ballester L, Novoa LI, Middleton D, Duenas M. HLA class I polymorphism in the Cuban population. Hum. Immunol. 68: 918-927 (2007).
Ferstl B, Zacher T, Lauer B, Blagitko-Dorfs N, Carl A, Wassmuth R. Allele-specific quantification of HLA-DQB1 gene expression by real-time reverse transcriptase-polymerase chain reaction. Genes Immun. 5: 405-416 (2004). *
Fert I, Glatigny S, Poulain C, Satumtira N, Dorris ML, Taurog JD, Breban M. Correlation between dendritic cell functional defect and spondylarthritis phenotypes in HLA-B27/human beta(2)-microglobulin-transgenic rat lines. Arthritis Rheum. 58: 3425-3429 (2008). *
Ferucci ED, Templin DW, Lanier AP. Rheumatoid arthritis in American Indians and Alaska natives: a review of the literature. Semin. Arthritis Rheum. 34: 662-667 (2005). *
Festen EA, Stokkers PC, van Diemen CC, van Bodegraven AA, Boezen HM, Crusius BJ, Hommes DW, van der Woude JC, Balschun T, Verspaget HW, Schreiber S, de Jong DJ, Franke A, Dijkstra G, Wijmenga C, Weersma RK. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk. Am. J. Gastroenterol. Oct 27 [Epub ahead of print] (2009). *
Festenstein H, Awad J, Hitman GA, Cutbush S, Groves AV, Cassell P, Ollier W, Sachs JA. New HLA DNA polymorphisms associated with autoimmune diseases. Nature 322: 64-67 (1986). *
Feuchtenberger M, Kneitz C, Tony HP. Cytokines. Z. Rheumatol. 66: 297-298, 300-303 (2007).
Feuchtenberger M, Muller S, Roll P, Waschbisch A, Schafer A, Kneitz C, Wiendl H, Tony HP. Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Open Rheumatol. J. 2: 81-88 (2008). *
Fialho RN, Martins L, Pinheiro JP, Bettencourt BF, Couto AR, Santos MR, Peixoto MJ, Garrett F, Leal J, Tomas AM, Bruges-Armas J. Role of HLA, KIR and cytokine gene polymorphisms in leptospirosis. Hum. Immunol. 70: 915-920 (2009).
Fiehn C. Methotrexate in rheumatology. Z. Rheumatol. 68: 747-756 (2009).
Field LL, Anderson CE, Neiswanger K, Hodge SE, Spence MA, Rotter JI. Interaction of HLA and immunoglobulin antigens in type 1 (insulin-dependent) diabetes. Diabetologia 27: 504-508 (1984).
Field LL, Fothergill-Payne C, Bertrams J, Baur MP. HLA-DR effects in a large German IDDM dataset. Genet. Epidemiol. Suppl. 1: 323-328 (1986).
Field LL, McArthur RG. The genetics of susceptibility to insulin-dependent diabetes mellitus - possible new markers. Clin. Invest. Med. 10: 437-443 (1987).
Field LL, Tobias R, Thomson G, Plon S. Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31. Genomics 33: 1-8 (1996). *
Field SF, Nejentsev S, Walker NM, Howson JM, Godfrey LM, Jolley JD, Hardy MP, Todd JA. Sequencing-based genotyping and association analysis of the MICA and MICB genes in type 1 diabetes. Diabetes 57: 1753-1756 (2008). *
Fietta P, Manganelli P, Zanetti A, Neri TM. Familial giant cell arteritis and polymyalgia rheumatica: aggregation in 2 families. J. Rheumatol. 29: 1551-1555 (2002). *
Fife MS, Fisher SA, John S, Worthington J, Shah CJ, Ollier WE, Panayi GS, Lewis CM, Lanchbury JS. Multipoint linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region. Arthritis Rheum. 43: 1673-1678 (2000). *
Figueiredo C, Horn PA, Blasczyk R, Seltsam A. Regulating MHC expression for cellular therapeutics. Transfusion 47: 18-27 (2007).
Figueiredo JF, Rodrigues Mde L, Deghaide NH, Donadi EA. HLA profile in patients with AIDS and tuberculosis. Braz. J. Infect. Dis. 12: 278-280 (2008). *
Figueiredo Soares T, Aguiar Rocha G, Camargos Rocha AM, Correa-Oliveira R, Martins-Filho OA, Teles Carvalho AS, Souto Bittencourt PF, Afonso Oliveira C, Ferreira Nogueira AM, Alvares Cabral MM, Caetano Faria AM, Queiroz DM. Differences in peripheral blood lymphocyte phenotypes between Helicobacter pylori-positive children and adults with duodenal ulcer. Clin. Microbiol. Infect. 13: 1083-1088 (2007). *
Figueroa-Vega N, Galindo-Rodriguez G, Bajana S, Portales-Perez D, Abud-Mendoza C, Sanchez-Torres C, Gonzalez-Amaro R. Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus. Scand. J. Immunol. 64: 668-676 (2006). *
Fijal B, Ricci D, Vercammen E, Palmer PA, Fotiou F, Fife D, Lindholm A, Broderick E, Francke S, Wu X, Colaianne J, Cohen N. Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia. Pharmacogenomics 9: 157-167 (2008).
Filipovich A. Hematopoietic cell transplantation for correction of primary immunodeficiencies. Bone Marrow Transplant. 42 Suppl. 1: S49-S52 (2008). *
Fimmers R, Neugebauer M, Dennert J, Wienker T, Baur MP. Association and sibpair analysis for the HLA, Gm, Km, and insulin polymorphisms in multiplex IDDM families. Genet. Epidemiol. 6: 107-112 (1989).
Fine KD, Do K, Schulte K, Ogunji F, Guerra R, Osowski L, McCormack J. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am. J. Gastroenterol. 95: 1974-1982 (2000). *
Finn TP, Jones RE, Rich C, Dahan R, Link J, David CS, Chou YK, Offner H, Vandenbark AA. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes. J. Neurosci. Res. 78: 100-114 (2004).
Fiocco U, Sfriso P, Oliviero F, Pagnin E, Scagliori E, Campana C, Cozzi L, Punzi L. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun. Rev. 8: 76-82 (2008).
Fiore M, Pera C, Delfino L, Scotese I, Ferrara GB, Pignata C. DNA typing of DQ and DR alleles in IgA-deficient subjects. Eur. J. Immunogenet. 22: 403-411 (1995).
Fiorillo MT, Ruckert C, Hulsmeyer M, Sorrentino R, Saenger W, Ziegler A, Uchanska-Ziegler B. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J. Biol. Chem. 280: 2962-2971 (2005). *
Fishback N, Koss M. Update on lymphoid interstitial pneumonitis. Curr. Opin. Pulm. Med. 2: 429-433 (1996).
Fisher M, Pusey CD, Vaughan RW, Rees AJ. Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. Kidney Int. 51: 222-229 (1997).
Fissolo N, Haag S, de Graaf KL, Drews O, Stevanovic S, Rammensee HG, Weissert R. Naturally presented peptides on MHC I and II molecules eluted from central nervous system of multiple sclerosis patients. Mol. Cell. Proteomics 8: 2090-2101 (2009). *
Fiten P, Vandenbroeck K, Dubois B, Van Coillie E, Nelissen I, Van Damme J, Ligers A, Hillert J, Andersson M, Olsson T, Opdenakker G. Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development. J. Neuroimmunol. 95: 195-201 (1999).
Fitzgerald O, McInnes I. Spondyloarthropathy: disease at the crossroads of immunity. Best Pract. Res. Clin. Rheumatol. 20: 949-967 (2006).
Fitzgerald O, Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res. Ther. 11: 214 (2009). *
Flato B, Hoffmann-Vold AM, Reiff A, Forre O, Lien G, Vinje O. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study. Arthritis Rheum. 54: 3573-3582 (2006). *
Flato B, Lien G, Smerdel-Ramoya A, Vinje O. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. J. Rheumatol. 36: 642-650 (2009).
Fletcher J, Mijovic C, Odugbesan O, Jenkins D, Bradwell AR, Barnett AH. Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes. Diabetologia 31: 864-870 (1988).
Flohe S, Scholz M. HLA-DR monitoring in the intensive care unit - more than a tool for the scientist in the laboratory? Crit. Care Med. 37: 2849-2850 (2009).
Flynn JC, Gardas A, Wan Q, Gora M, Alsharabi G, Wei WZ, Giraldo AA, David CS, Kong YM, Banga JP. Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. Clin. Exp. Immunol. 137: 503-512 (2004). *
Flynn JC, Gilbert JA, Meroueh C, Snower DP, David CS, Kong YC, Paul Banga J. Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice. Immunology 122: 261-267 (2007). *
Flynn JC, Meroueh C, Snower DP, David CS, Kong YM. Depletion of CD4CD25 regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin. Exp. Immunol. 147: 547-554 (2007). *
Foeldvari I, Kummerle-Deschner J. Autoinflammatory diseases in childhood. Z. Rheumatol. 68: 726-732 (2009).
Fofi C, Barberi S, Stoppacciaro A, Punzo G, Mene P. Focal segmental glomerulosclerosis as a complication of graft-versus-host disease. Nat. Rev. Nephrol. 5: 236-240 (2009).
Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55: 140-148 (2000). *
Foley PJ, McGrath DS, Puscinska E, Petrek M, Kolek V, Drabek J, Lympany PA, Pantelidis P, Welsh KI, Zielinski J, du Bois RM. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J. Respir. Cell. Mol. Biol. 25: 272-277 (2001). *
Folwaczny C, Zahn R, Brunnler G, Albert E, Koenig A, Noehl N, Loeschke K, Fricke H. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis. Z. Gastroenterol. 37: 133-140 (1999).
Fontaine B, Barcellos LF. Evidence for a complex interaction between HLA-DRB1 and environmental factors in MS. Neurology 70: 97-98 (2008).
Fontana S, Moratto D, Mangal S, De Francesco M, Vermi W, Ferrari S, Facchetti F, Kutukculer N, Fiorini C, Duse M, Das PK, Notarangelo LD, Plebani A, Badolato R. Functional defects of dendritic cells in patients with CD40 deficiency. Blood 102: 4099-4106 (2003). *
Fontecchio G, Fioroni MA, Azzarone R, Battistoni C, Cervelli C, Ventura L, Mercurio C, Fornaciari G, Papola F. Genetic predisposition to rheumatoid arthritis in a Tuscan (Italy) ancient human remain. Int. J. Immunopathol. Pharmacol. 20: 103-109 (2007).
Fontecchio G, Ventura L, Azzarone R, Fioroni MA, Fornaciari G, Papola F. HLA-DRB genotyping of an Italian mummy from the 16th century with signs of rheumatoid arthritis. Ann. Rheum. Dis. 65: 1676-1677 (2006). *
Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl. Acad. Sci. U.S.A. 97: 12717-12722 (2000). *
Forcione DG, Sands B, Isselbacher KJ, Rustgi A, Podolsky DK, Pillai S. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc. Natl. Acad. Sci. U.S.A. 93: 5094-5098 (1996). *
Forsberg G, Fahlgren A, Horstedt P, Hammarstrom S, Hernell O, Hammarstrom ML. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am. J. Gastroenterol. 99: 894-904 (2004). *
Forsthuber TG, Shive CL, Wienhold W, de Graaf K, Spack EG, Sublett R, Melms A, Kort J, Racke MK, Weissert R. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J. Immunol. 167: 7119-7125 (2001). *
Fortes MD, Machado IV, Gil G, Fernandez-Mestre M, Dagher L, Leon RV, Bianco NE, Tassinari P. Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela. Liver Int. 27: 1409-1416 (2007). *
Fountoulakis S, Vartholomatos G, Kolaitis N, Frillingos S, Philippou G, Tsatsoulis A. HLA-DR expressing peripheral T regulatory cells in newly diagnosed patients with different forms of autoimmune thyroid disease. Thyroid 18: 1195-1200 (2008).
Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, Harrison LC. The rising incidence of type 1 diabetes is accounted for by cases with lower risk HLA genotypes. Diabetes Care 31: 1546-1549 (2008). *
Fourmentraux-Neves E, Jalil A, Da Rocha S, Pichon C, Chouaib S, Bismuth G, Caignard A. Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells. Blood 112: 2381-2389 (2008). *
Fox RI. Epidemiology, pathogenesis, animal models, and treatment of Sjogren's syndrome. Curr. Opin. Rheumatol. 6: 501-508 (1994).
Fox RI, Liu AY. Sjogren's syndrome in dermatology. Clin. Dermatol. 24: 393-413 (2006).
Fox RI, Luppi M, Kang HI, Pisa P. Reactivation of Epstein-Barr virus in Sjogren's syndrome. Springer Semin. Immunopathol. 13: 217-231 (1991).
Fox RI, Saito I, Chan EK, Josephs S, Salahuddin SZ, Ahlashi DV, Staal FW, Gallo R, Pei-Ping H, Le CS. Viral genomes in lymphomas of patients with Sjogren's syndrome. J. Autoimmun. 2: 449-455 (1989).
Fracchia M, Galatola G, Corradi F, Dall'Omo AM, Rovera L, Pera A, Vitale C, Bertero MT. Coeliac disease associated with Sjogren's syndrome, renal tubular acidosis, primary biliary cirrhosis and autoimmune hyperthyroidism. Dig. Liver Dis. 36: 489-491 (2004).
Fracchia M, Manganaro M, Poccardi G, Pera A, Galatola G. Minimal change nephropathy presenting in a patient with primary sclerosing cholangitis. Ital. J. Gastroenterol. Hepatol. 29: 267-269 (1997).
Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J, Hraber P, Hewitt HS, Linde CH, Kavanagh DG, Woodberry T, Henry LM, Faircloth K, Listgarten J, Kadie C, Jojic N, Sango K, Brown NV, Pae E, Zaman MT, Bihl F, Khatri A, John M, Mallal S, Marincola FM, et al. Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur. J. Immunol. 37: 2419-2433 (2007). *
Franciotta D, Kwan P, Perucca E. Genetic basis for idiosyncratic reactions to antiepileptic drugs. Curr. Opin. Neurol. 22: 144-149 (2009).
Francis DA, Batchelor JR, McDonald WI, Dodi IA, Hing SN, Hern JE, Downie AW. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland. Tissue Antigens 29: 7-12 (1987).
Franck H; Kommission Osteologie der Deutschen Gesellschaft fur Rheumatologie, Braun J, Buttgereit F, Demary W, Hein G, Kekow J, Schett G, Kern PM. Bone densitometry in inflammatory rheumatic diseases: characteristics of the measurement site and disease-specific factors. Z. Rheumatol. 68: 845-850 (2009).
Franco J, Saeian K. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr. Gastroenterol. Rep. 1: 95-101 (1999).
Franke A, Lante W, Kollig E, Markewitz A. A comparison of monocyte counts and ex vivo and in vitro monocyte cytokine production after major surgical trauma. J. Surg. Res. 154: 91-98 (2009). *
Frauendorf E, von Goessel H, May E, Marker-Hermann E. HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides. Clin. Exp. Immunol. 134: 351-359 (2003). *
Frazier WJ, Hall MW. Immunoparalysis and adverse outcomes from critical illness. Pediatr. Clin. North Am. 55: 647-668 (2008).
Freeman M, Weetman AP. T and B cell reactivity to adrenal antigens in autoimmune Addison's disease. Clin. Exp. Immunol. 88: 275-279 (1992). *
Freiberger T, Litzman J, Vondruskova E. Role of aspartic acid at position 57 of the HLA-DQ beta chain in sporadic and familial forms of selective IgA deficiency. Cas. Lek. Cesk. 140: 770-773 (2001).
Frezza D, Giambra V, Tolusso B, De Santis M, Bosello S, Vettori S, Triolo G, Valentini G, Ferraccioli G. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann. Rheum. Dis. 66: 1210-1215 (2007). *
Friedrich W, Honig M. HLA-haploidentical donor transplantation in severe combined immunodeficiency. Immunol. Allergy Clin. North Am. 30: 31-44 (2010).
Friedrich W, Schutz C, Schulz A, Benninghoff U, Honig M. Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors. Immunol. Res. 44: 18-24 (2009). *
Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, Bruce B. HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum. 46: 2320-2329 (2002). *
Friesecke S, Lotze C, Kohler J, Heinrich A, Felix SB, Abel P. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med. 34: 1411-1420 (2008). *
Frigoul A, Lefranc MP. MICA: standardized IMGT allele nomenclature, polymorphisms and diseases. Recent Res. Devel. Human Genet. 3: 95-145 (2005). *
Friman S, Persson H, Schersten T, Svanvik J, Karlberg I. Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation. Transpl. Int. 5 Suppl. 1: S187-S189 (1992).
Frison S, Longhi E, Andreini E, Poli F, Scalamogna M. Characterization of two novel HLA class I alleles: HLA-A*310103 and HLA-B*9531. Int. J. Immunogenet. 35: 193-195 (2008). *
Frison S, Rinaldini C, Pagoda M, Brambilla C, Poli F. Characterization of a novel HLA-DRB1*04 allele (DRB1*0460) in the Italian population. Int. J. Immunogenet. 34: 1-2 (2007). *
Fronek Z, Cheung MM, Hanbury AM, Kagnoff MF. Molecular analysis of HLA DP and DQ genes associated with dermatitis herpetiformis. J. Invest. Dermatol. 97: 799-802 (1991).
Fruhauf P, Lojda Z, Fabianova J, Sedlackova M. Changing clinical image of celiac sprue in childhood. Cas. Lek. Cesk. 145: 470-474 (2006).
Fu Q, Cui NQ, Yu WL. Relationship between immune imbalance and sthenia-asthenia syndromes in patients suffering from severe intra-abdominal infection. Zhongguo Zhong Xi Yi Jie He Za Zhi 29: 120-125 (2009).
Fu QY, Gao YQ. Screening of AMP-activated protein kinase alpha2 subunit interacting proteins by bacterial two-hybrid system. Mol. Biol. Rep. 36: 337-344 (2009). *
Fugger L, Michie SA, Rulifson I, Lock CB, McDevitt GS. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc. Natl. Acad. Sci. U.S.A. 91: 6151-6155 (1994). *
Fugger L, Morling N, Ryder LP, Jakobsen BK, Andersen V, Oxholm P, Dalhoff K, Heilmann C, Karup Pedersen F, Friis J, et al. Restriction fragment length polymorphism of two HLA-B-associated transcripts genes in five autoimmune diseases. Hum. Immunol. 30: 27-31 (1991).
Fugger L, Morling N, Ryder LP, Jakobsen BK, Svejgaard A, Spies T, Strominger JL. Restriction fragment length polymorphism (RFLP) of two HLA-B-associated transcripts (BATs) genes in healthy Danes. Tissue Antigens 36: 57-61 (1990).
Fugger L, Morling N, Ryder LP, Platz P, Georgsen J, Jakobsen BK, Svejgaard A, Dalhoff K, Ranek L. NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNF alpha) region in primary biliary cirrhosis and in healthy Danes. Scand. J. Immunol. 30: 185-189 (1989).
Fugger L, Svejgaard A. The HLA-DQ7 and -DQ8 associations in DR4-positive rheumatoid arthritis patients. A combined analysis of data available in the literature. Tissue Antigens 50: 494-500 (1997).
Fujimaki K, Sakai R, Fujisawa S, Fujita H, Tanaka M, Hagihara M, Koharazawa H, Miyazaki T, Tomita N, Kanamori H, Maruta A, Ishigatsubo Y. Usefulness of hematopoietic cell transplantation-specific comorbidity index after allogeneic hematopoietic stem cell transplantation. Gan To Kagaku Ryoho 35: 87-91 (2008).
Fujisawa T, Sogo T, Komatsu H, Inui A. Autoimmune hepatitis in childhood. Hepatol. Res. 37 Suppl. 3: S496-S500 (2007). *
Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc. Natl. Acad. Sci. U.S.A. Dec 8 [Epub ahead of print] (2009). *
Fujita K, Naito S, Okabe N, Yao T. Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese. J. Clin. Lab. Immunol. 14: 99-102 (1984).
Fukazawa T, Kikuchi S, Niino M, Yabe I, Miyagishi R, Fukaura H, Hamada T, Tashiro K. Susceptibility genes for multiple sclerosis. Nippon Rinsho 61: 1311-1316 (2003).
Fukazawa T, Yamasaki K, Ito H, Kikuchi S, Minohara M, Horiuchi I, Tsukishima E, Sasaki H, Hamada T, Nishimura Y, Tashiro K, Kira J. Both the HLA-DPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens 55: 199-205 (2000). *
Fuleihan RL. The hyper IgM syndrome. Curr. Allergy Asthma Rep. 1: 445-450 (2001).
Funakoshi K, Sugimura K, Sasakawa T, Bannai H, Anezaki K, Ishizuka K, Yoshida K, Narisawa R, Asakura H. Study of cytokines in ulcerative colitis. J. Gastroenterol. 30 Suppl. 8: 61-63 (1995).
Funkhouser SW, Concannon P, Charmley P, Vredevoe DL, Hood L. Differences in T cell receptor restriction fragment length polymorphisms in patients with rheumatoid arthritis. Arthritis Rheum. 35: 465-471 (1992).
Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, Davies SE, Berelowitz M, Forbes A, Wakefield AJ, Walker-Smith JA, Murch SH. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J. Pediatr. 138: 366-372 (2001). *
Furukawa F, Yamamoto Y, Kanazawa N, Muto M. Race differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus from the aspect of Japanese studies. Ann. N. Y. Acad. Sci. 1173: 552-556 (2009). *
Furukawa N, Miyamura N, Nishida K, Motoshima H, Taketa K, Araki E. Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome. Diabetes Res. Clin. Pract. 75: 366-367 (2007).
Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T, Kamatani N, Kotake S. Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis. Clin. Rheumatol. 26: 2137-2141 (2007). *
Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T, Kobashigawa T, Tokunaga K, Tsuchiya N, Kamatani N, Kotake S. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide. Clin. Exp. Rheumatol. 25: 219-224 (2007).
Furuya T, Matsumoto I, Tsuchiya N, Hakoda M, Ichikawa N, Yago T, Higami K, Nanke Y, Sumida T, Kamatani N, Kotake S. Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis. Clin. Exp. Rheumatol. 26: 918-921 (2008).
Futagawa Y, Terasaki PI. An analysis of the OPTN/UNOS liver transplant registry. Clin. Transpl. 2004: 315-329 (2004).
Futagawa Y, Waki K, Cai J. The association of HLA-DR13 with lower graft survival rates in hepatitis B and primary sclerosing cholangitis Caucasian patients receiving a liver transplant. Liver Transpl. 12: 600-604 (2006). *
Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, Ohmoto A, Okano H, Miyamoto M, Inaba H. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig. Dis. Sci. 40: 814-818 (1995).
Futami S, Aoyama N, Uchihashi T, Tamura T, Motosako Y, Morimoto S, Omoto A, Nakajima T, Okano H, Miyamoto M, et al. HLA-DR2 DNA typing in Japanese ulcerative colitis. Nippon Shokakibyo Gakkai Zasshi 90: 1620 (1993).
Gaber SA, Mazzola G, Berrino M, Canale L, Cornaglia M, Ghali I, Sergio Curtoni E, Amoroso A. Human leukocyte antigen class II polymorphisms and genetic susceptibility of IDDM in Egyptian children. Diabetes Care 17: 1341-1344 (1994).
Gagnon F, Hajage D, Plancoulaine S, Tezenas du Montcel S. Modeling of PTPN22 and HLA-DRB1 susceptibility to rheumatoid arthritis. BMC Proc. 1 Suppl. 1: S14 (2007). *
Gagnon SJ, Borbulevych OY, Davis-Harrison RL, Baxter TK, Clemens JR, Armstrong KM, Turner RV, Damirjian M, Biddison WE, Baker BM. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants. J. Mol. Biol. 353: 556-573 (2005). *
Gagnon SJ, Borbulevych OY, Davis-Harrison RL, Turner RV, Damirjian M, Wojnarowicz A, Biddison WE, Baker BM. T cell receptor recognition via cooperative conformational plasticity. J. Mol. Biol. 363: 228-243 (2006). *
Gajinov Z, Prcic S, Matic M, Duran V, Ivkov-Simic M. Papular-purpuric gloves and socks syndrome - a case report. Med. Pregl. 59: 380-383 (2006).
Gakamsky DM, Lewitzki E, Grell E, Saulquin X, Malissen B, Montero-Julian F, Bonneville M, Pecht I. Kinetic evidence for a ligand-binding-induced conformational transition in the T cell receptor. Proc. Natl. Acad. Sci. U.S.A. 104: 16639-16644 (2007). *
Galgani A, Petrone A, Spoletini M, Hodge A, Del Buono ML, Locatelli M, Buzzetti R; Diabfin Study Group. HLA class II typing in newborns reveals a low frequency of the DRB1*04 allele and a high frequency of DRB1*11 allele in three regions of continental Italy. Hum. Immunol. 65: 366-372 (2004).
Galhenage SP, Viiala CH, Olynyk JK. Screening for hemochromatosis: patients with liver disease, families, and populations. Curr. Gastroenterol. Rep. 6: 44-51 (2004).
Galletti J, Canones C, Morande P, Borge M, Oppezzo P, Geffner J, Bezares R, Gamberale R, Giordano M. Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: possible role as initiators of autoimmune hemolytic anemia. J. Immunol. 181: 3674-3683 (2008). *
Galligan CL, Baig E, Bykerk V, Keystone EC, Fish EN. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes Immun. 8: 480-491 (2007). *
Galocha B, de Castro JA. Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis. Arthritis Rheum. 58: 401-412 (2008). *
Gambelunghe G, Brozzetti A, Ghaderi M, Candeloro P, Tortoioli C, Falorni A. MICA gene polymorphism in the pathogenesis of type 1 diabetes. Ann. N. Y. Acad. Sci. 1110: 92-98 (2007). *
Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 84: 3701-3707 (1999). *
Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin. Endocrinol. (Oxf.) 52: 565-573 (2000). *
Gambelunghe G, Gerli R, Bartoloni Bocci E, Del Sindaco P, Ghaderi M, Sanjeevi CB, Bistoni O, Bini V, Falorni A. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology (Oxford) 44: 287-292 (2005). *
Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Falorni A, Sanjeevi CB. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 43: 507-514 (2000). *
Gandjbakhch F, Fajardy I, Ferre B, Dubucquoi S, Flipo RM, Roger N, Solau-Gervais E. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population. J. Rheumatol. 36: 881-886 (2009).
Ganesh R Dr, Arvindkumar R, Vasanthi T. Infantile-onset diabetes mellitus: a 1-year follow-up study. Clin. Pediatr. (Phila.) 48: 271-274 (2009).
Gao C, Li Z, Ding J, Wang J, Hu X, Liu T, Xu T, Li H. Study on the relations between HLA-DRB 1 alleles and Helicobacter pylori infection. Zhonghua Liu Xing Bing Xue Za Zhi 21: 417-419 (2000).
Gao J, Lin Y, Qiu C, Liu Y, Ma Y, Liu Y. Association between HLA-DQA1, -DQB1 gene polymorphisms and susceptibility to asthma in northern Chinese subjects. Chin. Med. J. (Engl.) 116: 1078-1082 (2003).
Gao S, Deng Z, Xu Y. Identification of a novel allele HLA-DRB1*1218. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 26: 272-276 (2009).
Gao SQ, Cheng X, Li Q, Li YZ, Deng ZH. A total of 362 HLA different haplotypes and HLA recombination haplotypes based on analysis of their family pedigree in Chinese partial Han populations. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17: 782-786 (2009).
Gao SQ, Deng ZH, Xu YP. Identification of a novel HLA-DRB1*12 allele, DRB1*1218, in Chinese population. Tissue Antigens 74: 265-267 (2009). *
Gao X, Gazit E, Livneh A, Stastny P. Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility. J. Rheumatol. 18: 801-803 (1991).
Gao XH, Barnardo MC, Winsey S, Ahmad T, Cook J, Agudelo JD, Zhai N, Powell JJ, Fuggle SV, Wojnarowska F. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated � J. Invest. Dermatol. 125: 895-899 (2005). *
Gao XJ, Ball EJ, Dombrausky L, Olsen NJ, Pincus T, Khan MA, Wolfe F, Stastny P. Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am. J. Med. 85: 14-16 (1988).
Gao XJ, Brautbar C, Gazit E, Segal R, Naparstek Y, Livneh A, Stastny P. A variant of HLA-DR4 determines susceptibility to rheumatoid arthritis in a subset of Israeli Jews. Arthritis Rheum. 34: 547-551 (1991).
Garcia Borras S, Diez C, Cotorruelo C, Pellizon O, Biondi C, Beloscar J, Bottasso O, Racca A. HLA class II DRB1 polymorphism in Argentinians undergoing chronic Trypanosoma cruzi infection. Ann. Clin. Biochem. 43: 214-216 (2006).
Garcia Borras S, Racca L, Cotorruelo C, Biondi C, Beloscar J, Racca A. Distribution of HLA-DRB1 alleles in Argentinean patients with Chagas' disease cardiomyopathy. Immunol. Invest. 38: 268-275 (2009).
Garcia D, Angel B, Carrasco E, Albala C, Santos JL, Perez-Bravo F. VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile. Diabetes Res. Clin. Pract. 77: 134-140 (2007).
Garcia Herola A, Nos P, Hinijosa J, Hoyos M, Moles J, Carmona E, Puig N, Sanchez-Cuenca J, Ponce J, Berenguer J. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease. Rev. Esp. Enferm. Dig. 95: 755-759 (2003).
Garcia-Gonzalez E, Castro-Llamas J, Karchmer S, Zuniga J, de Oca DM, Ambaz M, Bolanos R, Granados J. Class II major histocompatibility complex typing across the ethnic barrier in pemphigoid gestationis. A study in Mexicans. Int. J. Dermatol. 38: 46-51 (1999). *
Garcia-Lozano JR, Gonzalez-Escribano MF, Valenzuela A, Garcia A, Nunez-Roldan A. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur. J. Immunogenet. 28: 89-93 (2001). *
Garcia-Ramos G, Tellez-Zenteno JF, Zapata-Zuniga M, Yamamoto-Furusho JK, Ruiz-Morales JA, Villarreal-Garza C, Vargas-Alarcon G, Estanol B, Llorente L, Granados J. HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis. Eur. J. Neurol. 10: 707-710 (2003). *
Gardiner KR, Crockard AD, Halliday MI, Rowlands BJ. Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease. Gut 35: 511-516 (1994). *
Garritsen HS, Fae I, Legath N, Hannig H, Fischer GF. Identification of a novel HLA-DRB3*01 variant, HLA-DRB3*0114, containing a DRB1 sequence motif by micro-temperature gradient gel electrophoresis confirmed by sequence-based typing. Tissue Antigens Dec 18 [Epub ahead of print] (2009). *
Garrity-Park MM, Loftus Jr EV, Sandborn WJ, Bryant S, Smyrk TC. MHC class II alleles in ulcerative colitis-associated colorectal cancer. Gut 58: 1226-1233 (2009). *
Gaseitsiwe S, Maeurer MJ. Identification of MHC class II binding peptides: microarray and soluble MHC class II molecules. Methods Mol. Biol. 524: 417-426 (2009).
Gaseitsiwe S, Valentini D, Mahdavifar S, Reilly M, Ehrnst A, Maeurer M. Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501 and DRB1*0401. Clin. Vaccine Immunol. Oct 28 [Epub ahead of print] (2009). *
Gaspar FT, Da Silva C, Damico FM, Marin ML, Goldberg AC, Hirata CE, Takiuti PH, Olivalves E, Yamamoto JH. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: considerations on the different disease categories. Am. J. Ophthalmol. 147: 339-345.e5 (2009). *
Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J, Brouns G, Schmidt M, Von Kalle C, Barington T, Jakobsen MA, Christensen HO, Al Ghonaium A, White HN, Smith JL, Levinsky RJ, Ali RR, Kinnon C, Thrasher AJ. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364: 2181-2187 (2004). *
Gaston H. Mechanisms of disease: the immunopathogenesis of spondyloarthropathies. Nat. Clin. Pract. Rheumatol. 2: 383-392 (2006). *
Gatanaga H, Honda H, Oka S. Pharmacogenetic information derived from analysis of HLA alleles. Pharmacogenomics 9: 207-214 (2008).
Gattorno M, Chicha L, Gregorio A, Ferlito F, Rossi F, Jarrossay D, Lanzavecchia A, Martini A, Manz MG. Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue. Rheumatology (Oxford) 46: 657-665 (2007). *
Gaudieri S, Rauch A, Pfafferott K, Barnes E, Cheng W, McCaughan G, Shackel N, Jeffrey GP, Mollison L, Baker R, Furrer H, Gunthard HF, Freitas E, Humphreys I, Klenerman P, Mallal S, James I, Roberts S, Nolan D, Lucas M. Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. Hepatology 49: 1069-1082 (2009).
Gazic M. A familial study of seronegative spondyloarthritis. Reumatizam 36: 35-40 (1989).
Gebe JA, Unrath KA, Yue BB, Miyake T, Falk BA, Nepom GT. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice. J. Autoimmun. 30: 197-206 (2008).
Gebe JA, Yue BB, Unrath KA, Falk BA, Nepom GT. Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms. J. Immunol. 183: 59-65 (2009).
Geboes K, Rutgeerts P, Penninckx F, Desmet V, Vantrappen G. Changes in small intestinal epithelial expression of MHC class II antigen after terminal ileal resection for Crohn's disease. Int. J. Colorectal Dis. 3: 102-108 (1988).
Gebreselassie D, Spiegel H, Vukmanovic S. Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides. Hum. Immunol. 67: 894-906 (2006).
Gelder CM, Williams OM, Hart KW, Wall S, Williams G, Ingrams D, Bull P, Bunce M, Welsh K, Marshall SE, Borysiewicz L. HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J. Virol. 77: 1927-1939 (2003). *
Geldmacher C, Metzler IS, Tovanabutra S, Asher TE, Gostick E, Ambrozak DR, Petrovas C, Schuetz A, Ngwenyama N, Kijak G, Maboko L, Hoelscher M, McCutchan F, Price DA, Douek DC, Koup RA. Minor viral and host genetic polymorphisms can dramatically impact the biological outcome of an epitope-specific CD8 T cell response. Blood 114: 1553-1562 (2009). *
Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA. HLA class II alleles are not a general susceptibility factor in Guillain-Barre syndrome. Neurology 64: 44-49 (2005).
Gelsthorpe AR, Wells RS, Lowe AP, Tonks S, Bodmer JG, Bodmer WF. High-throughput class I HLA genotyping using fluorescence resonance energy transfer (FRET) probes and sequence-specific primer-polymerase chain reaction (SSP-PCR). Tissue Antigens 54: 603-614 (1999).
Geluk A, van Meijgaarden KE, Franken KL, Drijfhout JW, D'Souza S, Necker A, Huygen K, Ottenhoff TH. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J. Immunol. 165: 6463-6471 (2000). *
Geluk A, van Meijgaarden KE, Schloot NC, Drijfhout JW, Ottenhoff TH, Roep BO. HLA-DR binding analysis of peptides from islet antigens in IDDM. Diabetes 47: 1594-1601 (1998). *
Genc S, Genc K, Sercan O, Kizildag S, Gulay Z, Atay T, Dundar B, Sakizli M, Buyukgebiz A. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism in patients with type 1 diabetes mellitus in a Turkish population. J. Pediatr. Endocrinol. Metab. 17: 731-735 (2004).
Gencik M, Borgmann S, Zahn R, Albert E, Sitter T, Epplen JT, Fricke H. Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin. Exp. Immunol. 117: 412-417 (1999). *
Gendzekhadze K, Norman PJ, Abi-Rached L, Graef T, Moesta AK, Layrisse Z, Parham P. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc. Natl. Acad. Sci. U.S.A. 106: 18692-18697 (2009). *
Genel F, Atlihan F, Ozsu E, Ozbek E. Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis. J. Infect. Dec 15 [Epub ahead of print] (2009).
Genin E, Babron MC, McDermott MF, Mulcahy B, Waldron-Lynch F, Adams C, Clegg DO, Ward RH, Shanahan F, Molloy MG, O'Gara F, Clerget-Darpoux F. Modelling the major histocompatibility complex susceptibility to RA using the MASC method. Genet. Epidemiol. 15: 419-430 (1998).
Gerbase-Delima M, Pinto LC, Grumach A, Carneiro-Sampaio MM. HLA antigens and haplotypes in IgA-deficient Brazilian paediatric patients. Eur. J. Immunogenet. 25: 281-285 (1998).
Gerber BO, Pichler WJ. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions. AAPS J. 8: E160-E165 (2006). *
Gerl V, Lischka A, Panne D, GroBmann P, Berthold R, Hoyer BF, Biesen R, Bruns A, Alexander T, Jacobi A, Dorner T, Burmester GR, Radbruch A, Hiepe F. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function. Ann. Rheum. Dis. Oct 22 [Epub ahead of print] (2009).
Gern JE, Busse WW. Relationship of viral infections to wheezing illnesses and asthma. Nat. Rev. Immunol. 2: 132-138 (2002). *
Geubel AP, Sempoux C, Rahier J. Bile duct disorders. Clin. Liver Dis. 7: 295-309 (2003).
Geurts JJ, Bo L, Roosendaal SD, Hazes T, Daniels R, Barkhof F, Witter MP, Huitinga I, van der Valk P. Extensive hippocampal demyelination in multiple sclerosis. J. Neuropathol. Exp. Neurol. 66: 819-827 (2007).
Ghabaee M, Bayati A, Amri Saroukolaei S, Sahraian MA, Sanaati MH, Karimi P, Houshmand M, Sadeghian H, Hashemi Chelavi L. Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cell. Mol. Neurobiol. 29: 109-114 (2009).
Ghabanbasani MZ, Gu XX, Spaepen M, Vandevyver C, Raus J, Marynen P, Carton H, Cassiman JJ. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis. J. Neuroimmunol. 59: 77-82 (1995).
Ghaderi M, Gambelunghe G, Tortoioli C, Brozzetti A, Jatta K, Gharizadeh B, De Bellis A, Pecori Giraldi F, Terzolo M, Betterle C, Falorni A. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J. Clin. Endocrinol. Metab. 91: 4107-4111 (2006). *
Ghandil P, Chelala C, Dubois-Laforgue D, Senee V, Caillat-Zucman S, Kockum I, Luthman H, Nerup J, Pociot F, Timsit J, Julier C. Crohn's disease associated CARD15 (NOD2) variants are not involved in the susceptibility to type 1 diabetes. Mol. Genet. Metab. 86: 379-383 (2005). *
Ghio M, Contini P, Negrini S, Proietti M, Gonella R, Ubezio G, Ottonello L, Indiveri F. sHLA-I contaminating molecules as novel mechanism of ex vivo/in vitro transcriptional and posttranscriptional modulation of transforming growth factor-beta in CD8+ T lymphocytes and neutrophils after intravenous immunoglobulin treatment. Transfusion Nov 9 [Epub ahead of print] (2009).
Ghoneim MA, Refaie AF. Is matching for human leukocyte antigen-DR beneficial in pediatric kidney transplantation? Nat. Clin. Pract. Nephrol. 5: 70-71 (2009).
Ghosh M, Wang H, Ai Y, Romeo E, Luyendyk JP, Peters JM, Mackman N, Dey SK, Hla T. COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation. J. Exp. Med. 204: 2053-2061 (2007). *
Giagounidis AA, Haase S, Germing U, Heinsch M, Aul C. Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion. Acta Haematol. 113: 146-149 (2005).
Giannitti C, Morozzi G, D'Alfonso S, Bellisai F, Galeazzi M. Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection. Reumatismo 60: 192-198 (2008).
Gianotti L, Morelli L, Galbiati F, Rocchetti S, Coppola S, Beneduce A, Gilardini C, Zonenschain D, Nespoli A, Braga M. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J. Gastroenterol. 16: 167-175 (2010). *
Giardiello FM, Lazenby AJ, Yardley JH, Bias WB, Johnson J, Alianiello RG, Bedine MS, Bayless TM. Increased HLA A1 and diminished HLA A3 in lymphocytic colitis compared to controls and patients with collagenous colitis. Dig. Dis. Sci. 37: 496-499 (1992).
Gibert M, Balandraud N, Touinssi M, Mercier P, Roudier J, Reviron D. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Hum. Immunol. 64: 930-935 (2003).
Giebel S, Labopin M, Holowiecki J, Labar B, Komarnicki M, Koza V, Masszi T, Mistrik M, Lange A, Hellmann A, Vitek A, Pretnar J, Mayer J, Rzepecki P, Indrak K, Wiktor-Jedrzejczak W, Wojnar J, Krawczyk-Kulis M, Kyrcz-Krzemien S, Rocha V. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years. Ann. Hematol. 88: 1005-1013 (2009).
Giest S, Grace S, Senegaglia AC, Pasquini R, Gonzalo-Daganzo RM, Fern�ndez MN, Mackinnon S, Madrigal JA, Travers PJ. Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequencies. Br. J. Haematol. Nov 4 [Epub ahead of print] (2009). *
Gil-Carrasco F, Vargas-Alarcon G, Zuniga J, Tinajero-Castaneda O, Hernandez-Martinez B, Hernandez-Pacheco G, Rodr�guez-Reyna TS, Hesiquio R, Gamboa R, Granados J. HLA-DRB and HLA-DQB loci in the genetic susceptibility to develop glaucoma in Mexicans. Am. J. Ophthalmol. 128: 297-300 (1999). *
Gilchrist FC, Bunn C, Foley PJ, Lympany PA, Black CM, Welsh KI, du Bois RM. Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun. 2: 76-81 (2001). *
Giles JT, Allison M, Bingham CO 3rd, Scott WM Jr, Bathon JM. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum. 61: 1248-1256 (2009). *
Gilhar A, Shalaginov R, Assy B, Serafimovich S, Kalish RS. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J. Investig. Dermatol. Symp. Proc. 4: 207-210 (1999). *
Gilhar A, Yaniv R, Assy B, Serafimovich S, Ullmann Y, Kalish RS. Fas pulls the trigger on psoriasis. Am. J. Pathol. 168: 170-175 (2006). *
Gillespie KM, Dix RJ, Williams AJ, Newton R, Robinson ZF, Bingley PJ, Gale EA, Shield JP. Islet autoimmunity in children with Down's syndrome. Diabetes 55: 3185-3188 (2006). *
Gionanlis L, Alexopoulos E, Papagianni A, Leontsini M, Memmos D. Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9. Ren. Fail. 30: 239-246 (2008).
Giquel B, Carmouse S, Denais C, Cherfa A, Chimenti MS, Fert I, Hacquard-Bouder C, Breban M, Andre C. Two HLA-B27 alleles differently associated with spondylarthritis, B*2709 and B*2705, display similar intracellular trafficking and oligomer formation. Arthritis Rheum. 56: 2232-2242 (2007). *
Girnita A, Mazariegos GV, Castellaneta A, Reyes J, Bentlejewski C, Thomson AW, Zeevi A. Liver transplant recipients weaned off immunosuppression lack circulating donor-specific antibodies. Hum. Immunol. Dec 14 [Epub ahead of print] (2009).
Girnita AL, McCurry KR, Zeevi A. Increased lung allograft failure in patients with HLA-specific antibody. Clin. Transpl. 2007: 231-239 (2007).
Gironi M, Guerini FR, Beghi E, Antonini G, Martinelli-Boneschi F, Ceresa L, Morino S, Agliardi C, Ferrante P, Nemni R. HLA-DRB1 polymorphisms distribution in chronic dysimmune polyneuropathy. Neuromuscul. Disord. 18: 967-969 (2008).
Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A. Bacterial triggers and autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 26: S12-S17 (2008).
Giscombe R, Wang XB, Kakoulidou M, Lefvert AK. Characterization of the expanded T-cell populations in patients with Wegener's granulomatosis. J. Intern. Med. 260: 224-230 (2006). *
Giuliani L, Mele R, Di Giovine M, Altieri L, Crino A, Rava L, Fierabracci A. Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients. J. Biomed. Biotechnol. 2009: 576219 (2009). *
Giza S. HLADQB105 association with Hashimotos thyroiditis in children of Northern Greek origin. Indian Pediatr. 45: 493-496 (2008). *
Gjertsen HA, Sollid LM, Ek J, Thorsby E, Lundin KE. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand. J. Immunol. 39: 567-574 (1994).
Gladman DD, Farewell VT, Pellett F, Schentag C, Rahman P. HLA is a candidate region for psoriatic arthritis. Evidence for excessive HLA sharing in sibling pairs. Hum. Immunol. 64: 887-889 (2003).
Glisic S, Klinker M, Waukau J, Jailwala P, Jana S, Basken J, Wang T, Alemzadeh R, Hagopian W, Ghosh S. Genetic association of HLA DQB1 with CD4+CD25+(high) T-cell apoptosis in type 1 diabetes. Genes Immun. 10: 334-340 (2009).
Glotz D. Post-transplantation anti-HLA antibodies: which relevance? Nephrol. Ther. 4 Suppl. 1: S8-S12 (2008).
Go RC, Alarcon GS, Acton RT, Koopman WJ, Vittor VJ, Barger BO. Analyses of HLA linkage in white families with multiple cases of seropositive rheumatoid arthritis. Arthritis Rheum. 30: 1115-1123 (1987).
Godde R, Rohde K, Becker C, Toliat MR, Entz P, Suk A, Muller N, Sindern E, Haupts M, Schimrigk S, Nurnberg P, Epplen JT. Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips. J. Mol. Med. 83: 486-494 (2005). *
Godet Y, Moreau-Aubry A, Mompelat D, Vignard V, Khammari A, Dreno B, Lang F, Jotereau F, Labarriere N. An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context. Cancer Immunol. Immunother. Sep 4 [Epub ahead of print] (2009).
Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 41: 1383-1390 (2005). *
Godkin A, Friede T, Davenport M, Stevanovic S, Willis A, Jewell D, Hill A, Rammensee HG. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int. Immunol. 9: 905-911 (1997). *
Gold MC, Robinson TL, Cook MS, Byrd LK, Ehlinger HD, Lewinsohn DM, Lewinsohn DA. Human neonatal dendritic cells are competent in MHC class I antigen processing and presentation. PLoS ONE 2: e957 (2007). *
Goldberg AC, Bittencourt PL, Mougin B, Cancado EL, Porta G, Carrilho F, Kalil J. Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus. Hum. Immunol. 62: 165-169 (2001).
Goldberg AC, Bittencourt PL, Oliveira LC, Ramasawmy R, Marin ML, Palacios SA, Kalil J, Porta G. Autoimmune hepatitis in Brazil: an overview. Scand. J. Immunol. 66: 208-216 (2007). *
Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J. Clin. Endocrinol. Metab. 90: 4904-4911 (2005). *
Goldstein E, Hermann R, Renfors TJ, Nanto-Salonen KM, Korhonen T, Karkkainen M, Veijola RK, Knip M, Simell TT, Simell OG. From genetic risk awareness to overt type 1 diabetes: parental stress in a placebo-controlled prevention trial. Diabetes Care 32: 2181-2183 (2009).
Goldstein R, Moulds JM, Smith CD, Sengar DP. MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus. J. Rheumatol. 23: 1173-1179 (1996).
Goldstein R, Sengar DP. Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. Arthritis Rheum. 36: 1121-1127 (1993).
Gombos Z, Hermann R, Kiviniemi M, Nejentsev S, Reimand K, Fadeyev V, Peterson P, Uibo R, Ilonen J. Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations. Eur. J. Endocrinol. 157: 757-761 (2007). *
Gomez de la Concha E. Inflammatory bowel disease: genotype-fenotype relationship. An. R. Acad. Nac. Med. (Madr.) 123: 307-317 (2006).
Gomez LM, Ruiz-Narvaez EA, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM. TNF microsatellites polymorphism is associated with rheumatoid arthritis. Confirming evidence in north-western Colombians. Clin. Exp. Rheumatol. 25: 443-448 (2007).
Gomez P, Mavian C, Galocha B, Garcia-Medel N, Lopez de Castro JA. Presentation of cytosolically stable peptides by HLA-B27 is not dependent on the canonic interactions of N-terminal basic residues in the A pocket. J. Immunol. 182: 446-455 (2009). *
Gomez-Garcia M, Oliver J, Marquez A, Mendoza JL, Lopez-Nevot MA, Fernandez-Arquero M, Gonzalez-Escribano MF, Diaz-Rubio M, Concha EG, Urcelay E, Martin J, Martinez A. Strong protective effect of DR3 against ulcerative colitis in the Spanish population. Am. J. Gastroenterol. 102: 2762-2766 (2007). *
Gomez-Lozano N, Trompeter HI, de Pablo R, Estefania E, Uhrberg M, Vilches C. Epigenetic silencing of potentially functional KIR2DL5 alleles: implications for the acquisition of KIR repertoires by NK cells. Eur. J. Immunol. 37: 1954-1965 (2007). *
Gong YL, Xie DW, Deng ZL, Bostick RM, Miao XJ, Zhang JH, Gong ZH. Vitamin D receptor gene Tru9I polymorphism and risk for incidental sporadic colorectal adenomas. World J. Gastroenterol. 11: 4794-4799 (2005). *
Gony J, Vexiau P, Lhomme C, Marcelli A, Poirier JC, Bochu V, Cathelineau G, Assan R, Deschamps I, Hors J. MHC classes I, II, III antigens study in 70 insulin-dependent diabetics with associated auto-immune diseases. Tissue Antigens 31: 229-234 (1988).
Gonzalez A, Nicovani S, Massardo L, Aguirre V, Cervilla V, Lanchbury JS, Jacobelli S. Influence of the HLA-DR beta shared epitope on susceptibility to and clinical expression of rheumatoid arthritis in Chilean patients. Ann. Rheum. Dis. 56: 191-193 (1997). *
Gonzalez S, Brautbar C, Martinez-Borra J, Lopez-Vazquez A, Segal R, Blanco-Gelaz MA, Enk CD, Safriman C, Lopez-Larrea C. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum. Immunol. 62: 632-638 (2001).
Gonzalez S, Martinez-Borra J, Lopez-Vazquez A, Garcia-Fernandez S, Torre-Alonso JC, Lopez-Larrea C. MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. J. Rheumatol. 29: 973-978 (2002). *
Gonzalez S, Rodrigo L, Lopez-Vazquez A, Fuentes D, Agudo-Ibanez L, Rodriguez-Rodero S, Fdez-Morera JL, Martinez-Borra J, Lopez-Larrea C. Association of MHC class I related gene B (MICB) to celiac disease. Am. J. Gastroenterol. 99: 676-680 (2004). *
Gonzalez-Diaz JP, Gonzalez T, Gonzalez-Espinosa C, Gantes M, Santisteban M, Bustad S. HLA haplotypes in congenital adrenal hyperplasia (21-hydroxylase deficiency. An. Esp. Pediatr. 21: 583-586 (1984).
Gonzalez-Escribano MF, Rodriguez MR, Walter K, Sanchez-Roman J, Garcia-Lozano JR, Nunez-Roldan A. Association of HLA-B51 subtypes and Behcet's disease in Spain. Tissue Antigens 52: 78-80 (1998).
Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin. Arthritis Rheum. 33: 38-48 (2003). *
Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin. Arthritis Rheum. 31: 355-360 (2002). *
Gonzalez-Gay MA, Gonzalez-Juanatey C, Llorca J, Ollier WE, Martin J. Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: comment on the article by Farragher et al. Arthritis Rheum. 58: 2584 (2008). *
Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 57: 125-132 (2007). *
Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Garcia-Porrua C, Llorca J, Martin J. Cardiovascular disease in rheumatoid arthritis. Biomed. Pharmacother. 60: 673-677 (2006).
Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Mattey DL, Amoli MM, Thomson W, Ollier WE. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin. Exp. Rheumatol. 20: 179-184 (2002).
Gonzalez-Gay MA, Hajeer AH, Dababneh A, Makki R, Garcia-Porrua C, Thomson W, Ollier W. Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association. J. Rheumatol. 28: 122-125 (2001).
Gonzalez-Gay MA, Hajeer AH, Garcia-Porrua C, Dababneh A, Thomson W, Ollier WE, Mattey DL. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset. J. Rheumatol. 29: 271-275 (2002).
Gonzalez-Gay MA, Rueda B, Vilchez JR, Lopez-Nevot MA, Robledo G, Ruiz MP, Fernandez O, Garcia-Porrua C, Gonzalez-Escribano MF, Martin J. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis. Rheumatology (Oxford) 46: 431-434 (2007). *
Gonzalez-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, Rosen CB, Wiesner RH. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl. 7: 302-310 (2001). *
Gonzalez-Roldan N, Ferat-Osorio E, Aduna-Vicente R, Wong-Baeza I, Esquivel-Callejas N, Astudillo-de la Vega H, Sanchez-Fernandez P, Arriaga-Pizano L, Villasis-Keever MA, Lopez-Macias C, Isibasi A. Expression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgery. World J. Gastroenterol. 11: 7473-7479 (2005). *
Goodin DS. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS ONE 4: e4565 (2009). *
Gopalakrishnan S, Marwaha RK. Juvenile autoimmune thyroiditis. J. Pediatr. Endocrinol. Metab. 20: 961-970 (2007).
Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J. Hepatol. 31: 242-247 (1999). *
Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER. Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology 7: 889-892 (1987).
Goris A, Walton A, Ban M, Dubois B, Compston A, Sawcer S. A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLA-DRB1*1501 allele. Tissue Antigens 72: 401-403 (2008). *
Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA. Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum. 50: 3476-3484 (2004). *
Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA. Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: an individual patient data meta-analysis of 3,272 Caucasian patients with rheumatoid arthritis. Arthritis Rheum. 50: 753-762 (2004). *
Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum. 50: 400-412 (2004). *
Gorodezky C, Alaez C, Murguia A, Rodriguez A, Balladares S, Vazquez M, Flores H, Robles C. HLA and autoimmune diseases: type 1 diabetes (T1D) as an example. Autoimmun. Rev. 5: 187-194 (2006).
Gorski J, Niven MJ, Sachs JA, Mach B, Cassell PG, Festenstein H, Awad J, Hitman GA. HLA-DR alpha, -DX alpha, and DR beta III gene association studies in DR3 individuals. Hum. Immunol. 20: 273-278 (1987).
Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli RL 2nd, McGovern RM, Sloan JA, Cha SS, Persing DH. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol. Oncol. 88: 326-332 (2003).
Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, Sibilia J, Mariette X. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 48: 2240-2245 (2003). *
Gottenberg JE, Busson M, Loiseau P, Dourche M, Cohen-Solal J, Lepage V, Charron D, Miceli C, Sibilia J, Mariette X. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjogren's syndrome. Arthritis Rheum. 50: 570-580 (2004). *
Gottlieb AB. Immunologic mechanisms in psoriasis. J. Invest. Dermatol. 95: 18S-19S (1990). *
Gourraud PA, Boyer JF, Barnetche T, Abbal M, Cambon-Thomsen A, Cantagrel A, Constantin A. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity. Arthritis Rheum. 54: 593-599 (2006). *
Gourraud PA, Dieude P, Boyer JF, Nogueira L, Cambon-Thomsen A, Cornelis F, Mazieres B, Serre G, Cantagrel A, Constantin A. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis. Arthritis Res. Ther. 9: R27 (2007). *
Goussetis E, Konialis CP, Peristeri I, Kitra V, Dimopoulou M, Petropoulou T, Vessalas G, Papassavas A, Tzanoudaki M, Kokkali G, Petrakou E, Spiropoulos A, Pangalos CG, Pantos K, Graphakos S. Successful hematopoietic stem cell transplantation in two children with X-linked chronic granulomatous disease from their unaffected HLA-identical siblings selected using pre-implantation genetic diagnosis combined with HLA-typing. Biol. Blood Marrow Transplant. Oct 13 [Epub ahead of print] (2009).
Gow PJ, Fleming KA, Chapman RW. Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease? J. Hepatol. 34: 631-635 (2001). *
Gowthaman U, Agrewala JN. In silico methods for predicting T-cell epitopes: Dr Jekyll or Mr Hyde? Expert Rev. Proteomics 6: 527-537 (2009).
Gowthaman U, Agrewala JN. In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion. J. Proteome Res. 7: 154-163 (2008). *
Grabczynska SA, Carey BS, McGregor JM, Hawk JL, Vaughan RW. Tumour necrosis factor alpha promoter polymorphism at position -308 is not associated with actinic prurigo. Clin. Exp. Dermatol. 26: 700-704 (2001). *
Graham RR, Ortmann W, Rodine P, Espe K, Langefeld C, Lange E, Williams A, Beck S, Kyogoku C, Moser K, Gaffney P, Gregersen PK, Criswell LA, Harley JB, Behrens TW. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur. J. Hum. Genet. 15: 823-830 (2007). *
Grammatikos AP. The genetic and environmental basis of atopic diseases. Ann. Med. 40: 482-495 (2008).
Granito A, Muratori L, Pappas G, Muratori P, Ferri S, Cassani F, Lenzi M, Bianchi FB. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients. Aliment. Pharmacol. Ther. 21: 1273-1277 (2005). *
Grassegger A, Pohla-Gubo G, Frauscher M, Hintner H. Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis. Wien. Med. Wochenschr. 158: 19-28 (2008). *
Grattagliano I, Bonfrate L, Diogo CV, Wang HH, Wang DQ, Portincasa P. Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J. Gastroenterol. 15: 4865-4876 (2009). *
Grau R, Lang KS, Wernet D, Lang P, Niethammer D, Pusch CM, Handgretinger R. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals. Exp. Mol. Pathol. 76: 90-98 (2004). *
Graudal N. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins. Scand. J. Rheumatol. Suppl. 118: 1-38 (2004).
Gray E, Thomas TL, Betmouni S, Scolding N, Love S. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol. 18: 86-95 (2008).
Graziadei IW, Obermoser GE, Sepp NT, Erhart KH, Vogel W. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus 12: 409-412 (2003). *
Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, Paparo F, Gasperi V, Limongelli MG, Cotichini R, D'Agate C, Tinto N, Sacchetti L, Tosi R, Stazi MA. The first large population based twin study of coeliac disease. Gut 50: 624-628 (2002). *
Green AJ, Barcellos LF, Rimmler JB, Garcia ME, Caillier S, Lincoln RR, Bucher P, Pericak-Vance MA, Haines JL, Hauser SL, Oksenberg JR; Multiple Sclerosis Genetics Group. Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility. J. Neuroimmunol. 116: 116-124 (2001).
Greenberg DA, Hodge SE, Rotter JI. Evidence for recessive and against dominant inheritance at the HLA-"linked" locus in coeliac disease. Am. J. Hum. Genet. 34: 263-277 (1982). *
Greenberg DA, Rotter JI. Two locus models for gluten sensitive enteropathy: population genetic considerations. Am. J. Med. Genet. 8: 205-214 (1981).
Greene MT, Ercolini AM, Degutes M, Miller SD. Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor. J. Autoimmun. 31: 399-407 (2008).
Greer JM, Csurhes PA, Muller DM, Pender MP. Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis. J. Immunol. 180: 6402-6410 (2008). *
Gregersen JW, Kranc KR, Ke X, Svendsen P, Madsen LS, Thomsen AR, Cardon LR, Bell JI, Fugger L. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 443: 574-577 (2006). *
Gregori S, Magnani CF, Roncarolo MG. Role of HLA-G in the induction of adaptive type 1 regulatory T cells. Hum. Immunol. 70: 966-969 (2009).
Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33: 544-553 (2001). *
Gregory WL, Daly AK, Dunn AN, Cavanagh G, Idle JR, James OF, Bassendine MF. Analysis of HLA-class-II-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis. Q. J. Med. 87: 237-244 (1994).
Gregory WL, Mehal W, Dunn AN, Cavanagh G, Chapman R, Fleming KA, Daly AK, Idle JR, James OF, Bassendine MF. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q. J. Med. 86: 393-399 (1993).
Greidinger EL, Zang Y, Jaimes K, Hogenmiller S, Nassiri M, Bejarano P, Barber GN, Hoffman RW. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum. 54: 661-669 (2006). *
Greidinger EL, Zang YJ, Jaimes K, Martinez L, Nassiri M, Hoffman RW. CD4+ T cells target epitopes residing within the RNA-binding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease. J. Immunol. 180: 8444-8454 (2008). *
Grennan DM, Dyer P, Dodds W, Read A, Haeney M, Clague R, Harris R. Clinical and immunogenetic studies in multicase rheumatoid families. Q. J. Med. 53: 479-485 (1984).
Grennan DM, Dyer PA, Clague R, Dodds W, Smeaton I, Harris R. Family studies in RA - the importance of HLA-DR4 and of genes for autoimmune thyroid disease. J. Rheumatol. 10: 584-589 (1983).
Grennan DM, Sanders PA. Rheumatoid arthritis. Baillieres Clin. Rheumatol. 2: 585-601 (1988).
Grennan DM, Sanders PA, Dyer PA, Harris R. HLA haplotype sharing by siblings with rheumatoid arthritis: evidence for genetic heterogeneity. Ann. Rheum. Dis. 45: 126-129 (1986). *
Grennan DM, Sanders PA, Thomson W, Dyer PA. Rheumatoid arthritis: inheritance and association with other autoimmune diseases. Dis. Markers 4: 157-162 (1986).
Grienay M, Lukaszewicz AC, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction* Crit. Care Med. 37: 2746-2752 (2009).
Griffith ME, Pusey CD. HLA genes in ANCA-associated vasculitides. Exp. Clin. Immunogenet. 14: 196-205 (1997).
Groeneweg M, Hartwig NG, Poerink-Stockschl�der AB, Schweizer JJ, Bijleveld CM, Bredius RG. Two children with severe recurrent infections and the X-linked hyper-IgM syndrome. Ned. Tijdschr. Geneeskd. 147: 1024-1028 (2003).
Gros F, Cabillic F, Toutirais O, Maux AL, Sebti Y, Amiot L. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells. Eur. J. Immunol. 38: 742-749 (2008). *
Gross K, Combe C, Kruger K, Schattenkirchner M. Arthritis after hepatitis B vaccination. Report of three cases. Scand. J. Rheumatol. 24: 50-52 (1995).
Grosskreutz C, Gudzowaty O, Shi P, Rodriguez-Laiz G, Malone A, Isola L. Partial HLA matching and RH incompatibility resulting in graft versus host reaction and Evans syndrome after liver transplantation. Am. J. Hematol. 83: 599-601 (2008). *
Grotzke JE, Harriff MJ, Siler AC, Nolt D, Delepine J, Lewinsohn DA, Lewinsohn DM. The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle. PLoS Pathog. 5: e1000374 (2009). *
Grubic Z, Peric P, Cecuk-Jelicic E, Zunec R, Curkovic B, Kerhin-Brkljacic V. The distribution of HLA alleles class I and class II among patientes with psoriatic arthritis in Croatia. Reumatizam 51: 5-11 (2004).
Grubic Z, Peric P, Eeeuk-Jelicic E, Zunec R, Stingl K, Curkovic B, Kerhin-Brkljacic V. The MICA-A4 triplet repeats polymorphism in the transmembrane region confers additional risk for development of psoriatic arthritis in the Croatian population. Eur. J. Immunogenet. 31: 93-98 (2004). *
Grubic Z, Stingl K, Kerhin-Brkljacic V, Zunec R. The study of the extended haplotypes of rare HLA-B*2730 allele using microsatellite loci. Tissue Antigens 71: 514-519 (2008). *
Grubic Z, Zunec R, Cecuk-Jelicic E, Kastelan D, Kerhin-Brkljacic V, Kastelan A. High resolution molecular typing of HLA class II region in the population of the island of Krk, Croatia. Coll. Antropol. 23: 577-588 (1999).
Grubic Z, Zunec R, Cecuk-Jelicic E, Kerhin-Brkljacic V, Kastelan A. Polymorphism of HLA-A, -B, -DRB1, -DQA1 and -DQB1 haplotypes in a Croatian population. Eur. J. Immunogenet. 27: 47-51 (2000). *
Grubic Z, Zunec R, Kastelan M, Cecuk-Jelicic E, Gruber F, Kastelan A. HLA class II haplotypic association and DQCAR microsatellite polymorphisms in Croatian patients with psoriasis. Coll. Antropol. 26: 61-67 (2002).
Grubic Z, Zunec R, Naipal A, Kastelan A, Giphart MJ. Molecular analysis of HLA class II polymorphism in Croatians. Tissue Antigens 46: 293-298 (1995).
Grubic Z, Zunec R, Peros-Golubicic T, Tekavec-Trkanjec J, Martinez N, Alilovic M, Smojver-Jezek S, Kerhin-Brkljacic V. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease. Tissue Antigens 70: 301-306 (2007). *
Grubic Z, Zunec R, Stingl K, Svilicic D, Kerhin-Brkljacic V. Haplotipic associations of the two most common HLA-B*27 alleles in the Croatian population. Reumatizam 55: 5-9 (2008).
Gruenbacher G, Gander H, Rahm A, Nussbaumer W, Romani N, Thurnher M. CD56+ human blood dendritic cells effectively promote TH1-type gammadelta T cell responses. Blood 114: 4422-4431 (2009). *
Gruener M, Bravo IG, Momburg F, Alonso A, Tomakidi P. The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells. Virol. J. 4: 116 (2007). *
Gruhn B, Intek J, Pfaffendorf N, Zell R, Corbacioglu S, Zintl F, Beck JF, Debatin KM, Steinbach D. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children. Biol. Blood Marrow Transplant. 15: 1571-1577 (2009).
Grundschober C, Sanchez-Mazas A, Excoffier L, Langaney A, Jeannet M, Tiercy JM. HLA-DPB1 DNA polymorphism in the Swiss population: linkage disequilibrium with other HLA loci and population genetic affinities. Eur. J. Immunogenet. 21: 143-157 (1994).
Grunebaum E, Roifman CM. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency. Immunol. Allergy Clin. North Am. 30: 63-73 (2010).
Grunewald J, Eklund A. Lofgren's syndrome: human leukocyte antigen strongly influence the disease course. Am. J. Respir. Crit. Care Med. 179: 307-312 (2009). *
Grunewald J, Eklund A. State of the art. Role of CD4+ T cells in sarcoidosis. Proc. Am. Thorac. Soc. 4: 461-464 (2007). *
Grunewald J, Eklund A. Gender specific manifestations of Lofgren's syndrome. Am. J. Respir. Crit. Care Med. 175: 40-44 (2007). *
Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am. J. Respir. Crit. Care Med. 169: 696-702 (2004). *
Grunewald J, Olerup O, Persson U, Ohrn MB, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc. Natl. Acad. Sci. U.S.A. 91: 4965-4969 (1994). *
Grunnet N, Rasmussen HH, Tage-Jensen U, Norby Rasmussen S. Association of primary sclerosing cholangitis with HLA-DRw52a? Tissue Antigens 38: 133-136 (1991).
Gu X, Nei M. Locus specificity of polymorphic alleles and evolution by a birth-and-death process in mammalian MHC genes. Mol. Biol. Evol. 16: 147-156 (1999). *
Guan P, Doytchinova IA, Flower DR. The classification of HLA supertypes by GRID/CPCA and hierarchical clustering methods. Methods Mol. Biol. 409: 143-154 (2007).
Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J. Cell. Mol. Med. 9: 741-744 (2005). *
Guarnizo-Zuccardi P, Lopez Y, Giraldo M, Garcia N, Rodriguez L, Ramirez L, Uribe O, Garcia L, Vasquez G. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70: 376-382 (2007). *
Gueant JL, Gueant-Rodriguez RM, Gastin IA, Cornejo-Garcia JA, Viola M, Barbaud A, Mertes PM, Blanca M, Romano A. Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity. Curr. Pharm. Des. 14: 2770-2777 (2008).
Gueant-Rodriguez RM, Gueant JL, Viola M, Tramoy D, Gaeta F, Romano A. Association of tumor necrosis factor-alpha -308G>A polymorphism with IgE-mediated allergy to betalactams in an Italian population. Pharmacogenomics J. 8: 162-168 (2008). *
Guerin V, Leniaud L, Pedron B, Guilmin-Crepon S, Tubiana-Rufi N, Sterkers G. HLA-associated genetic resistance and susceptibility to type I diabetes in French North Africans and French natives. Tissue Antigens 70: 214-218 (2007). *
Guerini FR, Bolognesi E, Manca S, Sotgiu S, Zanzottera M, Agliardi C, Usai S, Clerici M. Family-based transmission analysis of HLA genetic markers in Sardinian children with autistic spectrum disorders. Hum. Immunol. 70: 184-190 (2009).
Guerini FR, Ferrante P, Losciale L, Caputo D, Lombardi ML, Pirozzi G, Luongo V, Sudomoina MA, Andreewski TV, Alekseenkov AD, Boiko AN, Gusev EI, Favorova OO. Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians. Neurology 61: 520-526 (2003).
Guerne PA, Salvi M, Seitz M, Bruhlmann P, Rivier G, Frey D, Mermillod B, Vischer TL, Tiercy JM. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica. J. Rheumatol. 24: 671-676 (1997).
Guggenbuhl P, Jean S, Jego P, Grosbois B, Chales G, Semana G, Lancien G, Veillard E, Pawlotsky Y, Perdriger A. Primary Sjogren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes. J. Rheumatol. 25: 900-905 (1998).
Guglielmi L, Guglielmi P, Demoly P. Drug hypersensitivity: epidemiology and risk factors. Curr. Pharm. Des. 12: 3309-3312 (2006).
Guidry PA, Stroynowski I. The murine family of gut-restricted class Ib MHC includes alternatively spliced isoforms of the proposed HLA-G homolog, "blastocyst MHC". J. Immunol. 175: 5248-5259 (2005). *
Guilherme L, Fae KC, Oshiro SE, Tanaka AC, Pomerantzeff PM, Kalil J. Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions. Ann. N. Y. Acad. Sci. 1051: 132-140 (2005). *
Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand. J. Immunol. 66: 199-207 (2007). *
Guja C, Guja L, Nutland S, Rance H, Sebastien M, Todd JA, Ionescu-Tirgoviste C. Type 1 diabetes genetic susceptibility encoded by HLA DQB1 genes in Romania. J. Cell. Mol. Med. 8: 249-256 (2004). *
Guja C, Guja L, Nutland S, Rance H, Todd JA, Ionescu-Tirgoviste C. Strong association of insulin gene INS-VNTR polymorphisms with type 1 diabetes in the Romanian population. Rom. J. Intern. Med. 42: 313-323 (2004).
Gullstrand C, Wahlberg J, Ilonen J, Vaarala O, Ludvigsson J. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study. Pediatr. Diabetes 9: 182-190 (2008).
Gulubova M, Manolova I, Cirovski G, Sivrev D. Recruitment of dendritic cells in human liver with metastases. Clin. Exp. Metastasis 25: 777-785 (2008).
Gulwani-Akolkar B, Akolkar PN, Lin XY, Heresbach D, Manji R, Katz S, Yang SY, Silver J. HLA class II alleles associated with susceptibility and resistance to Crohn's disease in the Jewish population. Inflamm. Bowel Dis. 6: 71-76 (2000). *
Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181: 1133-1144 (1995). *
Gunal EK, Sarvan FO, Kamali S, Gul A, Inanc M, Carin M, Konice M, Aral O, Ocal L. Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey. Joint Bone Spine 75: 299-302 (2008). *
Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE, Cooper RG, Oddis CV, Ramanan AV, Davidson JE, McHugh NJ; Juvenile Dermatomyositis Research Group, UK and Ireland. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum. 60: 1807-1814 (2009). *
Gunnarsson I, Kanerud L, Pettersson E, Lundberg I, Lindblad S, Ringertz B. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Br. J. Rheumatol. 36: 1089-1094 (1997).
Gunther C, Hertl M, Meurer M. Diagnostic use of autoantibodies. Hautarzt. 58: 1063-1075 (2007).
Guo X, Barroso L, Becker SM, Lyerly DM, Vedvick TS, Reed SG, Petri WA Jr, Houpt ER. Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by IFN-gamma. Infect. Immun. 77: 3909-3918 (2009). *
Gupta D, Mirza N. Systemic lupus erythematosus, celiac disease and antiphospholipid antibody syndrome: a rare association. Rheumatol. Int. 28: 1179-1180 (2008). *
Gupta M, Ludvigsson J, Sanjeevi CB. Frequency of MICA in all babies in Southeast Sweden (ABIS) positive for high-risk HLA-DQ associated with type 1 diabetes. Ann. N. Y. Acad. Sci. 1037: 138-144 (2004). *
Gupta M, Nikitina-Zake L, Zarghami M, Landin-Olsson M, Kockum I, Lernmark A, Sanjeevi CB. Association between the transmembrane region polymorphism of MHC class I chain related gene-A and type 1 diabetes mellitus in Sweden. Hum. Immunol. 64: 553-561 (2003).
Gupta S, Kuhnisch J, Mustafa A, Lhotak S, Schlachterman A, Slifker MJ, Klein-Szanto A, High KA, Austin RC, Kruger WD. Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J. 23: 883-893 (2009). *
Gurgel R, Bohland A, Vieira S, Oliveira D, Fontes P, Barros V, Ramos M, Dove W, Nakagomi T, Nakagomi O, Correia J, Cunliffe N, Cuevas L. Incidence of rotavirus and all-cause siarrhea in Northeast Brazil following the introduction of a national vaccination program. Gastroenterology 137: 1970-1975 (2009). *
Gusev EI, Sudomoina MA, Boiko AN, Turetskaia RL, Demina TL, Alekseev LP, Boldyreva MN, Trofimov DIu, Undritsov IM, Favorova OO. Genetic predisposition factors for multiple sclerosis (based on the data from genotyping patients of the Russian ethnic group). Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 97: 39-46 (1997).
Guseva IA, Nasonov EL. State-of-the-art immune genetic and immune biological aspects of rheumatoid arthritis. Vestn. Ross. Akad. Med. Nauk. 6: 7-13 (2008).
Gwosdz M, Korber A, Hillen U, Dissemond J. Vasculitic leg ulcers in primary Sjogren syndrome. Hautarzt. 59: 404-408 (2008).
Gyetvai A, Szekanecz Z, Soos L, Szabo Z, Fekete A, Kapitany A, Teodorescu M, Sipka S, Szegedi G, Lakos G. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies. Rheumatology (Oxford) 49: 25-33 (2010). *
Gylling H, Hallikainen M, Pihlajamaki J, Agren J, Laakso M, Rajaratnam RA, Rauramaa R, Miettinen TA. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J. Lipid Res. 45: 1660-1665 (2004). *
Haas JP, Kimura A, Andreas A, Hochberger M, Keller E, Brunnler G, Bettinotti MP, Nevinny-Stickel C, Hildebrandt B, Sierp G, et al. Polymorphism in the upstream regulatory region of DQA1 genes and DRB1, QAP, DQA1, and DQB1 haplotypes in the German population. Hum. Immunol. 39: 31-40 (1994).
Haas JP, Metzler M, Frank C, Haefner R, Wassmuth R. HLA-DQA1 gene expression profiling in oligoarticular JIA. Autoimmunity 42: 389-391 (2009).
Habbe N, Langer P, Bartsch DK. Hereditary pancreatic cancer. Chirurg. 79: 1029-1037 (2008).
Haberhauer G. Induction of anticentromere antibody in patients receiving treatment with D-penicillamine. Klin. Wochenschr. 67: 535-537 (1989).
Habior A, Rawa T, Orlowska J, Sankowska M, Lewartowska A, Tilszer A, Pawlak J, Krawczyk M, Butruk E. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings. Eur. J. Gastroenterol. Hepatol. 14: 787-791 (2002).
Hacquard-Bouder C, Chimenti MS, Giquel B, Donnadieu E, Fert I, Schmitt A, Andre C, Breban M. Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27. Arthritis Rheum. 56: 1478-1489 (2007). *
Hacsek G, Arato A, Savilahti E, Paszti I. Characteristics of HLA II antigen expression in the rectal mucosa of children suffering from ulcerative colitis and Crohn disease. Orv. Hetil. 136: 2279-2282 (1995).
Hadj Kacem H, Kaddour N, Adyel FZ, Bahloul Z, Ayadi H. HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome. Rheumatology (Oxford) 40: 1370-1374 (2001). *
Haegert DG, Marrosu MG. Genetic susceptibility to multiple sclerosis. Ann. Neurol. 36 Suppl. 2: S204-S210 (1994).
Haegert DG, Swift FV, Benedikz J. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology 46: 1107-1111 (1996).
Hafer A, Kramer S, Duncker S, Kruger M, Manns MP, Bischoff SC. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol. 7: 36 (2007). *
Hagglof B, Holmgren G, Holmlund G, Lindblom B, Olaisen B, Teisberg P. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden. Hum. Hered. 36: 201-212 (1986).
Haghi Ashtiani MT, Rabbani A, Mostafavi F, Monajemzadeh M, Ranjbar Kermani F, Soltaninia J. HLA typing of patients with 21-hydroxylase deficiency in Iranian children with congenital adrenal hyperplasia. Biochem. Genet. 46: 712-719 (2008). *
Haghighi S, Andersen O, Nilsson S, Rydberg L, Wahlstrom J. A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy. Mult. Scler. 12: 723-730 (2006). *
Hagopian WA, Lernmark A, Rewers MJ, Simell OG, She JX, Ziegler AG, Krischer JP, Akolkar B. TEDDY-The Environmental Determinants of Diabetes in the Young: an observational clinical trial. Ann. N. Y. Acad. Sci. 1079: 320-326 (2006). *
Hagymasi K, Tulassay Z. Genetics of primary biliary cirrhosis. Orv. Hetil. 146: 2151-2155 (2005).
Haile LA, Wasielewski RV, Gamrekelashvili J, Kruger C, Bachmann O, Westendorf AM, Buer J, Liblau R, Manns MP, Korangy F, Greten TF. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135: 871-881.e5 (2008). *
Haines JL, Bradford Y, Garcia ME, Reed AD, Neumeister E, Pericak-Vance MA, Rimmler JB, Menold MM, Martin ER, Oksenberg JR, Barcellos LF, Lincoln R, Hauser SL; Multiple Sclerosis Genetics Group. Multiple susceptibility loci for multiple sclerosis. Hum. Mol. Genet. 11: 2251-2256 (2002). *
Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, Oksenberg JR, Lincoln R, Zhang DY, Banatao DR, Gatto N, Goodkin DE, Hauser SL. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum. Mol. Genet. 7: 1229-1234 (1998). *
Hajeer AH, Dababneh A, Makki RF, Thomson W, Poulton K, Gonzalez-Gay MA, Garcia-Porrua C, Mattey DL, Ollier WE. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 55: 319-325 (2000). *
Hajeer AH, Sawidan FA, Bohlega S, Saleh S, Sutton P, Shubaili A, Tahan AA, Al Jumah M. HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis. Int. J. Immunogenet. 36: 169-172 (2009). *
Hajeer AH, Worthington J, Silman AJ, Ollier WE. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04-bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum. 39: 1109-1114 (1996).
Hakala M, Ilonen J, Reijonen H, Knip M, Koivisto O, Isomaki H. No association between rheumatoid arthritis and insulin dependent diabetes mellitus: an epidemiologic and immunogenetic study. J. Rheumatol. 19: 856-858 (1992).
Hall MA, Lanchbury JS, Bolsover WJ, Welsh KI, Ciclitira PJ. HLA association with dermatitis herpetiformis is accounted for by a cis or transassociated DQ heterodimer. Gut 32: 487-490 (1991). *
Hall MA, Lanchbury JS, Bolsover WJ, Welsh KI, Ciclitira PJ. Celiac disease is associated with an extended HLA-DR3 haplotype which includes HLA-DPw1. Hum. Immunol. 27: 220-228 (1990).
Hall MA, Lanchbury JS, Lee JS, Welsh KI, Ciclitira PJ. HLA-DQ2 second-domain polymorphisms may explain increased trans-associated risk in celiac disease and dermatitis herpetiformis. Hum. Immunol. 38: 284-292 (1993).
Hall RP, Ward FE, Wenstrup RJ. An HLA class II region restriction fragment length polymorphism (RFLP) in patients with dermatitis herpetiformis: association with HLA-DP phenotype. J. Invest. Dermatol. 95: 172-177 (1990).
Hall SM, Brogan P, Haworth SG, Klein N. Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children. Thorax 64: 778-783 (2009).
Hallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M, Mayer G, Plazzi G, Nevsimalova S, Bourgin P, Hong SS, Honda Y, Honda M, Hogl B, Longstreth WT Jr, Montplaisir J, Kemlink D, Einen M, Chen J, Musone SL, Akana M, Miyagawa T, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 41: 708-711 (2009). *
Halme L, Turunen U, Paavola-Sakki P, Helio T, Lappalainen M, Farkkila M, Kontula K, Repo H. CARD15 frameshift mutation in patients with CROHN disease is associated with immune dysregulation. Scand. J. Gastroenterol. 39: 1243-1249 (2004). *
Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kampe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J. Clin. Endocrinol. Metab. 87: 2568-2574 (2002). *
Halvorsen EH, Pollmann S, Gilboe IM, van der Heijde D, Landewe R, Odegard S, Kvien TK, Molberg O. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann. Rheum. Dis. 67: 414-417 (2008).
Hamaguchi K, Kimura A, Seki N, Higuchi T, Yasunaga S, Takahashi M, Sasazuki T, Kusuda Y, Okeda T, Itoh K, Sakata T. Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens 55: 10-16 (2000). *
Hameed K, Bowman S, Kondeatis E, Vaughan R, Gibson T. The association of HLA-DRB genes and the shared epitope with rheumatoid arthritis in Pakistan. Br. J. Rheumatol. 36: 1184-1188 (1997). *
Hamilton ML, Gladman DD, Shore A, Laxer RM, Silverman ED. Juvenile psoriatic arthritis and HLA antigens. Ann. Rheum. Dis. 49: 694-697 (1990). *
Hammarstrom L, Axelsson U, Bjorkander J, Hanson LA, Moller E, Smith CI. HLA antigens in selective IgA deficiency: distribution in healthy donors and patients with recurrent respiratory tract infections. Tissue Antigens 24: 35-39 (1984).
Hammarstrom L, Grubb R, Smith CI. Gm allotypes in IgA deficiency. J. Immunogenet. 12: 125-130 (1985).
Hammarstrom L, Lonnqvist B, Ringden O, Smith CI, Wiebe T. Transfer of IgA deficiency to a bone-marrow-grafted patient with aplastic anaemia. Lancet 1: 778-781 (1985).
Hammarstrom L, Persson MA, Smith CI. Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA. Scand. J. Immunol. 18: 509-513 (1983).
Hammarstrom L, Smith CI. HLA-A, B, C and DR antigens in immunoglobulin A deficiency. Tissue Antigens 21: 75-79 (1983).
Han SH, Jung SM, Park SR, Chung SY, Han H. Identification of a new HLA-DRB1*14 variant, HLA-DRB1*1478, in a Korean individual. Tissue Antigens 73: 81-83 (2009). *
Han YN, Yang JL, Zheng SG, Tang Q, Zhu W. Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients. World J. Gastroenterol. 11: 5721-5724 (2005). *
Hanauer SB. Update on the etiology, pathogenesis and diagnosis of ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 26-31 (2004). *
Hancock L, Beckly J, Geremia A, Cooney R, Cummings F, Pathan S, Guo C, Warren BF, Mortensen N, Ahmad T, Jewell D. Clinical and molecular characteristics of isolated colonic Crohn's disease. Inflamm. Bowel Dis. 14: 1667-1677 (2008). *
Handa R. Spondylo-arthropathies. J. Indian Med. Assoc. 101: 514, 516, 518 (2003).
Hanprasertpong T, Hanprasertpong J, Riabroi K. Cerebral venous sinus thrombosis in early pregnancy: an unusual presentation of primary antiphospholipid syndrome. J. Obstet. Gynaecol. Res. 35: 1125-1128 (2009).
Hansen BE, Rasmussen AH, Jakobsen BK, Ryder LP, Svejgaard A. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules. Tissue Antigens 70: 42-52 (2007). *
Hansen J, Jensen KT, Follmann F, Agger EM, Theisen M, Andersen P. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital Chlamydial infection in a mouse model. J. Infect. Dis. 198: 758-767 (2008). *
Hansen K, Ruttekolk IR, Glauner H, Becker F, Brock R, Hannus S. The in vitro biological activity of the HLA-DR-binding clinical IgG4 antibody 1D09C3 is a consequence of the disruption of cell aggregates and can be abrogated by Fab arm exchange. Mol. Immunol. 46: 3269-3277 (2009). *
Hanyecz A, Bardos T, Berlo SE, Buzas E, Nesterovitch AB, Mikecz K, Glant TT. Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan. Arthritis Rheum. 48: 2959-2973 (2003). *
Haque A, Hajiaghamohseni LM, Li P, Toomy K, Blum JS. Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells. Cell. Immunol. 249: 20-29 (2007). *
Hara J, Ohtani H, Matsumoto T, Nakamura S, Kitano A, Arakawa T, Nagura H, Kobayashi K. Expression of costimulatory molecules B7-1 and B7-2 in macrophages and granulomas of Crohn's disease: demonstration of cell-to-cell contact with T lymphocytes. Lab. Invest. 77: 175-184 (1997).
Haraldsen G, Sollid LM, Bakke O, Farstad IN, Kvale D, Molberg, Norstein J, Stang E, Brandtzaeg P. Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells. Gastroenterology 114: 649-656 (1998). *
Harari A, Cellerai C, Bellutti Enders F, Kostler J, Codarri L, Tapia G, Boyman O, Castro E, Gaudieri S, James I, John M, Wagner R, Mallal S, Pantaleo G. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc. Natl. Acad. Sci. U.S.A. 104: 16233-16238 (2007). *
Harbo HF, Celius EG, Vartdal F, Spurkland A. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 53: 106-110 (1999). *
Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sorensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63: 237-247 (2004). *
Harbo HF, Riccio ME, Lorentzen AR, Utsi E, Myhr KM, Mellgren SI, Fl�m ST, Thorsby E, Sanchez-Mazas A, Lie BA. Norwegian Sami differs significantly from other Norwegians according to their HLA profile. Tissue Antigens Dec 30 [Epub ahead of print] (2009). *
Harbo HF, Utsi E, Lorentzen AR, Kampman MT, Celius EG, Myhr KM, Lie BA, Mellgren SI, Thorsby E. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami. Tissue Antigens 69: 299-304 (2007). *
Harding A. Fine-tuning our defenses. The Scientist May, 2007 (http://www.the-scientist.com/2007/05/01/s56/1/) (2007).
Harfouch-Hammoud E, Walk T, Otto H, Jung G, Bach JF, van Endert PM, Caillat-Zucman S. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes. Diabetes 48: 1937-1947 (1999). *
Harfouch-Hammoud EI, Daher NA. Susceptibility to and severity of tuberculosis is genetically controlled by human leukocyte antigens. Saudi Med. J. 29: 1625-1629 (2008).
Harjacek M, Margetic T, Kerhin-Brkljacic V, Martinez N, Grubic Z. HLA-B*27/HLA-B*07 in combination with D6S273-134 allele is associated with increased susceptibility to juvenile spondyloarthropathies. Clin. Exp. Rheumatol. 26: 498-504 (2008).
Harney S, Newton J, Milicic A, Brown MA, Wordsworth BP. Non-inherited maternal HLA alleles are associated with rheumatoid arthritis. Rheumatology (Oxford) 42: 171-174 (2003). *
Harney SM, Vilarino-Guell C, Adamopoulos IE, Sims AM, Lawrence RW, Cardon LR, Newton JL, Meisel C, Pointon JJ, Darke C, Athanasou N, Wordsworth BP, Brown MA. Fine mapping of the MHC class III region demonstrates association of AIF1 and rheumatoid arthritis. Rheumatology (Oxford) 47: 1761-1767 (2008). *
Harp CT, Lovett-Racke AE, Racke MK, Frohman EM, Monson NL. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis. Clin. Immunol. 128: 382-391 (2008). *
Harrison B, Thomson W, Symmons D, Ollier B, Wiles N, Payton T, Barrett E, Silman A. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis Rheum. 42: 2174-2183 (1999). *
Harrison P, Pointon JJ, Chapman K, Roddam A, Wordsworth BP. Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis. Rheumatology (Oxford) 47: 1768-1770 (2008). *
Harrison P, Pointon JJ, Farrar C, Brown MA, Wordsworth BP. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford) 45: 1009-1011 (2006). *
Harscher S, Rummler S, Oelzner P, Mentzel HJ, Brodhun M, Witte OW, Terborg C, Isenmann S. Selective immunoadsorption in neurologic complications of systemic lupus erythematosus. Nervenarzt. 78: 441-444 (2007).
Hartmann U, Schmitt S, Reuss-Borst M. Elevated liver enzymes in rheumatoid arthritis: differential diagnostic considerations based on a case report. Z. Rheumatol. 67: 440-444 (2008).
Hartung K, Seelig HP. Laboratory diagnostics of systemic autoimmune diseases: part II. Rheumatoid arthritis and vasculopathies. Z. Rheumatol. 66: 225-238 (2007).
Hartung K, Seelig HP. Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses. Z. Rheumatol. 65: 709-724 (2006).
Haruta I, Hashimoto E, Shibata N, Kato Y, Kobayashi M, Shiratori K. Lipoteichoic acid may affect the pathogenesis of PBC-like bile duct damage and might be involved in systemic multifocal epithelial inflammations in chronic colitis-harboring TCRalpha-/-xAIM-/- mice. Autoimmunity 40: 372-379 (2007). *
Haruta J, Kusugami K, Kuroiwa A, Ina K, Shinoda M, Morise K, Iokawa H, Morita M, Ishihara A, Sarai S. Phenotypic and functional analysis of lamina propria mononuclear cells from colonoscopic biopsy specimens in patients with ulcerative colitis. Am. J. Gastroenterol. 87: 448-454 (1992).
Harvald B. Genetic epidemiology of Greenland. Clin. Genet. 36: 364-367 (1989).
Hashigucci K, Yokoyama M, Niizeki H, Yamasaki Y, Akiya K, Tojo T, Urushibara T, Yamazaki Y, Shimizu H, Nishikawa T. Polymorphism in the tumor necrosis factor B gene is associated with palmoplantar pustulosis. Tissue Antigens 54: 288-290 (1999).
Hashimoto E, Shimada M, Noguchi S, Taniai M, Tokushige K, Hayashi N, Takasaki K, Fuchinoue S, Ludwig J. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study. Liver Transpl. 7: 588-595 (2001). *
Hashimoto K, Maruyama H, Nishiyama M, Asaba K, Ikeda Y, Takao T, Iwasaki Y, Kumon Y, Suehiro T, Tanimoto N, Mizobuchi M, Nakamura T. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population. Horm. Res. 64: 253-260 (2005).
Hassan AB, Nikitina-Zake L, Padyukov L, Karlsson G, Gupta M, Lundberg IE, Sanjeevi CB. MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients. Hum. Immunol. 64: 290-296 (2003).
Hassan AS, Simon D, Simon HU, Braathen LR, Yawalkar N. Efalizumab-associated papular psoriasis. Arch. Dermatol. 143: 900-906 (2007). *
Hatake K, Yokoyama M, Terui Y. Recent progress in rituximab therapy and its resistance - how do we overcome? Gan To Kagaku Ryoho 34: 1177-1182 (2007).
Hattotuwagama CK, Doytchinova IA, Flower DR. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships. Methods Mol. Biol. 409: 227-245 (2007).
Hatzioannou A, Liakata E, Karras E, Thrasyvoulides A, Alevizaki M, Lymberi P. Pathogenicity of a human thyroglobulin peptide (2340-2359) in mice with high or low genetic susceptibility to thyroiditis. Immunology 122: 343-349 (2007). *
Hauache OM, Reis AF, Oliveira CS, Vieira JG, Sjoroos M, Ilonen J. Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes. Dis. Markers 21: 139-145 (2005).
Haug M, Schepp CP, Kalbacher H, Dannecker GE, Holzer U. 70-kDa heat shock proteins: specific interactions with HLA-DR molecules and their peptide fragments. Eur. J. Immunol. 37: 1053-1063 (2007). *
Hautekeete ML, Horsmans Y, Van Waeyenberge C, Demanet C, Henrion J, Verbist L, Brenard R, Sempoux C, Michielsen PP, Yap PS, Rahier J, Geubel AP. HLA association of amoxicillin-clavulanate-induced hepatitis. Gastroenterology 117: 1181-1186 (1999). *
Hawkins BR, Lam KS, Ma JT, Low LC, Cheung PT, Serjeantson SW, Yeung RT. Strong association of HLA-DR3/DRw9 heterozygosity with early-onset insulin-dependent diabetes mellitus in Chinese. Diabetes 36: 1297-1300 (1987).
Hayase Y, Iwasaki S, Akisawa N, Saibara T, Kadokawa Y, Omagari K, Maeda T, Onishi S. Similar anti-mitochondrial antibody reactivity profiles in familial primary biliary cirrhosis. Hepatol. Res. 33: 33-38 (2005).
Haydardedeoglu FE, Tutkak H, Kose K, Duzgun N. Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR alleles. Tissue Antigens 68: 293-296 (2006). *
Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, Kahn MF, Meyer O. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin. Arthritis Rheum. 29: 159-171 (1999). *
Hayman MW, van Beijnen MT, Stamp LK, Spellerberg MB, O'Donnell JL. Soluble human leukocyte antigen: a diagnostic indicator of rheumatoid arthritis? J. Immunol. Methods 315: 19-26 (2006). *
He B, Giedraitis V, Ligers A, Binzer M, Andersen PM, Forsgren L, Sandkuijl LA, Hillert J. Sharing of a conserved haplotype suggests a susceptibility gene for multiple sclerosis at chromosome 17p11. Eur. J. Hum. Genet. 10: 271-275 (2002). *
He F, Guo R, Du X, Lu ZS, Weng JY, Lin W. Inhibitory effects of anti-CII TA M1-RNA on IFN-gamma induced major histocompatibility complex class II antigens expression on cultured human chondrocytes. Transpl. Immunol. 17: 231-236 (2007).
Heard RN, Cullen C, Middleton D, Hawkins SA, Francis DA, Hern JE, McDonald WI, Batchelor JR, Lechler RI. An allelic cluster of DQ alpha restriction fragments is associated with multiple sclerosis: evidence that a second haplotype may influence disease susceptibility. Hum. Immunol. 25: 111-123 (1989).
Heathcote J. Overlap syndromes - outlier syndromes and changing diagnoses. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 39-41. October 15-16 (2003). *
Heckerman D, Kadie C, Listgarten J. Leveraging information across HLA alleles/supertypes improves epitope prediction. J. Comput. Biol. 14: 736-746 (2007).
Hedger SC, Macardle P, Bond MJ, Ahern MJ, Smith MD, Roberts-Thomson PJ. Shared rheumatoid epitope as a risk factor in determining outcome in rheumatoid arthritis. Aust. N. Z. J. Med. 29: 234-238 (1999).
Heeg MH, Ulsenheimer A, Gruner NH, Jung MC, Gerlach JT, Raziorrouh B, Schraut W, Horster S, Kauke T, Spannagl M, Diepolder HM. FOXP3+ expression in hepatitis C virus specific CD4+ T cells during acute hepatitis C. Gastroenterology 137: 1280-1288.e1-e6 (2009). *
Heemskerk MB, Haase-Kromwijk BJ, Claas FH, Doxiadis II, Haasnoot GW, Homan van der Heide JJ, Weimar WW, Hoitsma AJ. Regional kidney allocation based only on full HLA-DR compatibility is not feasible. Transplantation 88: 600-601 (2009).
Heemskerk MH, de Paus RA, Lurvink EG, Koning F, Mulder A, Willemze R, van Rood JJ, Falkenburg JH. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc. Natl. Acad. Sci. U.S.A. 98: 6806-6811 (2001). *
Hegde GV, Meyers-Clark E, Joshi SS, Sanderson SD. A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells. Int. Immunopharmacol. 8: 819-827 (2008).
Heiligenhaus A, Rebmann V, Neubert A, Plewa S, Ferencik S, Vogeler U, Steuhl KP, Grosse-Wilde H. Soluble HLA class I and HLA-DR plasma levels in patients with anterior uveitis. Tissue Antigens 63: 369-375 (2004). *
Heinold A, Bauer M, Opelz G, Scherer S, Schmidt AH, Tran TH. Identification and characterization of three novel HLA alleles, HLA-A*240214, HLA-A*3215 and HLA-DQB1*060302. Tissue Antigens 70: 511-514 (2007). *
Heinrich A, Ahrens N, Schmidt S, Khaw AV. Immunophenotypic patterns of T-cell activation in neuroinflammatory diseases. Acta Neurol. Scand. 113: 248-255 (2006).
Heise CP, Kennedy G, Foley EF, Harms BA. Laparoscopic restorative proctocolectomy with ileal S-pouch. Dis. Colon Rectum 51: 1790-1794 (2008). *
Helbig KJ, Heatley SL, Harris RJ, Mullighan CG, Bardy PG, Marmion BP. Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post-Q fever fatigue syndrome. Genes Immun. 4: 82-85 (2003). *
Heldt C, Listing J, Sozeri O, Blasing F, Frischbutter S, Muller B. Differential expression of HLA class II genes associated with disease susceptibility and progression in rheumatoid arthritis. Arthritis Rheum. 48: 2779-2787 (2003). *
Helenius LM, Hallikainen D, Helenius I, Meurman JH, Koskimies S, Tervahartiala P, Kivisaari L, Hietanen J, Suuronen R, Lindqvist C, Leirisalo-Repo M. HLA-DRB1* alleles and temporomandibular joint erosion in patients with various rheumatic diseases. Scand. J. Rheumatol. 33: 24-29 (2004).
Helgadottir H, Andersson E, Villabona L, Kanter L, van der Zanden H, Haasnoot GW, Seliger B, Bergfeldt K, Hansson J, Ragnarsson-Olding B, Kiessling R, Masucci GV. The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma. Cancer Immunol. Immunother. 58: 1599-1608 (2009). *
Hellier JP, Eliaou JF, Daures JP, Sany J, Combe B. HLA-DRB1 genes and patients with late onset rheumatoid arthritis. Ann. Rheum. Dis. 60: 531-533 (2001). *
Henseler T. The genetics of psoriasis. J. Am. Acad. Dermatol. 37: S1-S11 (1997).
Heo WB, Kim CD, Won DI. HLA class II-specific antibodies can react with T cells in flow cytometry crossmatch: a case report. Transplant. Proc. 39: 3485-3487 (2007). *
Herait P, Tursz T, Guillard MY, Hanna K, Lipinski M, Micheau C, Sancho-Garnier H, Schwaab G, Cachin Y, Degos L, et al. HLA-A, -B, and -DR antigens in North African patients with nasopharyngeal carcinoma. Tissue Antigens 22: 335-341 (1983).
Herbst F, Ciclitira PJ, Talbot IC, Nicholls RJ. Early changes of ileoanal pouch mucosa in patients with ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 12: 899-905 (2000).
Heresbach D, Alizadeh M, Bretagne JF, Dabadie A, Colombel JF, Pagenault M, Heresbach-Le Berre N, Genetet B, Gosselin M, Semana G. TAP gene transporter polymorphism in inflammatory bowel diseases. Scand. J. Gastroenterol. 32: 1022-1027 (1997).
Heresbach D, Alizadeh M, Bretagne JF, Gautier A, Quillivic F, Lemarchand B, Gosselin M, Genetet B, Semana G. Investigation of the association of major histocompatibility complex genes, including HLA class I, class II and TAP genes, with clinical forms of Crohn's disease. Eur. J. Immunogenet. 23: 141-151 (1996).
Heresbach D, Alizadeh M, Reumaux D, Colombel JF, Delamaire M, Danze PM, Gosselin M, Genetet B, Bretagne JF, Semana G. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis? J. Autoimmun. 9: 777-784 (1996).
Hermann E, Fleischer B, Meyer zum Buschenfelde KH. Bacteria-specific cytotoxic CD8+ T cells: a missing link in the pathogenesis of the HLA-B27-associated spondylarthropathies. Ann. Med. 26: 365-369 (1994).
Hermann E, Mayet WJ, Poralla T, Meyer zum Buschenfelde KH. Rheumatologic syndrome in gastrointestinal diseases. Clinical and pathogenetic aspects. Z. Gastroenterol. 26: 137-144 (1988).
Hermann E, Yu DT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342: 646-650 (1993).
Hermann R, Bartsocas CS, Soltesz G, Vazeou A, Paschou P, Bozas E, Malamitsi-Puchner A, Simell O, Knip M, Ilonen J. Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence. Diabetes Metab. Res. Rev. 20: 322-329 (2004). *
Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O, Knip M, Ilonen J. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 49: 1198-1208 (2006). *
Hermann R, Soltesz G. Predictive genetic screening for type-1 diabetes in the Hungarian population. Orv. Hetil. 145: 337-342 (2004).
Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, Sipil� I, Akerblom HK, Ilonen J. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 62: 162-169 (2003). *
Hernandez A, Burger M, Blomberg BB, Ross WA, Gaynor JJ, Lindner I, Cirocco R, Mathew JM, Carreno M, Jin Y, Lee KP, Esquenazi V, Miller J. Inhibition of NF-kappaB during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches. Hum. Immunol. 68: 715-729 (2007).
Hernandez-Charro B, Donat E, Miner I, Aranburu E, Sanchez-Valverde F, Ramos-Arroyo MA. Modifying effect of HLA haplotypes located trans to DQB1*02-DRB1*03 in celiac patients of Southern Europe. Tissue Antigens 71: 213-218 (2008). *
Herrera B, Cader M, Dyment D, Bell J, Deluca G, Willer C, Lincoln M, Ramagopalan S, Chao M, Orton SM, Sadovnick A, Ebers G. Multiple sclerosis susceptibility and the X chromosome. Mult. Scler. 13: 856-864 (2007). *
Herrera BM, Cader MZ, Dyment DA, Bell JT, Ramagopalan SV, Lincoln MR, Orton S, Chao MJ, Sadovnick AD, Ebers GC. Follow-up investigation of 12 proposed linkage regions in multiple sclerosis. Genes Immun. 7: 366-371 (2006). *
Herrera M, Chertkoff L, Palavecino E, Mota A, Guala MC, Fainboim L, Satz ML. Restriction fragment length polymorphism in HLA class II genes of Latin-American Caucasian celiac disease patients. Hum. Immunol. 26: 272-280 (1989).
Herst PM, Davis JE, Neeson P, Berridge MV, Ritchie DS. The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells. Haematologica 94: 928-934 (2009). *
Herting E. Asthma in children - is it different? Internist (Berl.) 49: 1326-1334 (2008).
Hestvik A, Skorstad G, Price D, Vartdal F, Holmoy T. Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid. Mult. Scler. 14: 749-758 (2008). *
Hestvik AL, Vartdal F, Fredriksen AB, Thompson KM, Kvale EO, Skorstad G, Bogen B, Holmoy T. T cells from multiple sclerosis patients recognize multiple epitopes on self-IgG. Scand. J. Immunol. 66: 393-401 (2007). *
Hetherington S, Hughes AR, Mosteller M, Shortino D, Baker KL, Spreen W, Lai E, Davies K, Handley A, Dow DJ, Fling ME, Stocum M, Bowman C, Thurmond LM, Roses AD. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 359: 1121-1122 (2002). *
Hetland ML, Ejbjerg BJ, Horslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Skjodt H, Pedersen JK, Majgaard O, Svendsen AJ, Ellingsen T, Lindegaard HM, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2 year randomized controlled trial (CIMESTRA). Ann. Rheum. Dis. 68: 384-390 (2009).
Heufelder AE. Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev. Endocr. Metab. Disord. 1: 87-95 (2000).
Heward JM, Allahabadia A, Sheppard MC, Barnett AH, Franklyn JA, Gough SC. Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501. Clin. Endocrinol. (Oxf.) 51: 115-118 (1999). *
Heward JM, Mijovic CH, Kelly MA, Morrison E, Barnett AH. HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica. Eur. J. Immunogenet. 29: 47-52 (2002). *
Hiasa Y, Akbar SM, Abe M, Michitaka K, Horiike N, Onji M. Dendritic cell subtypes in autoimmune liver diseases; decreased expression of HLA DR and CD123 on type 2 dendritic cells. Hepatol. Res. 22: 241-249 (2002).
Hibbs AM, Bznik-Cizman B, Guttenberg M, Goldberg B, Meyers K. Ulcerative colitis in a renal transplant patient with previous Goodpasture disease. Pediatr. Nephrol. 16: 543-546 (2001). *
Hietarinta M, Koskimies S, Lassila O, Soppi E, Toivanen A. Familial scleroderma: HLA antigens and autoantibodies. Br. J. Rheumatol. 32: 336-368 (1993).
Higashide T, Kawamura T, Nagata M, Kotani R, Kimura K, Hirose M, Inada H, Niihira S, Yamano T. T cell epitope mapping study with insulin overlapping peptides using ELISPOT assay in Japanese children and adolescents with type 1 diabetes. Pediatr. Res. 59: 445-450 (2006). *
Higgins R, Lowe D, Hathaway M, Lam F, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Zehnder D, Briggs D. Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation. Transplantation 87: 882-888 (2009).
Hill CM, Liu A, Marshall KW, Mayer J, Jorgensen B, Yuan B, Cubbon RM, Nichols EA, Wicker LS, Rothbard JB. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 152: 2890-2898 (1994).
Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 40: 1-19 (2005). *
Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM, Lee DM, Hueber W, Robinson WH, Cairns E. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J. Exp. Med. 205: 967-979 (2008). *
Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J. Immunol. 171: 538-541 (2003). *
Hillemand B, Allard S, Reumont G, Joly JP, Dero M. Intestinal malabsorption with a dissociated deficiency of immunoglobulins. Ann. Med. Interne (Paris) 132: 322-327 (1981).
Hillen N, Mester G, Lemmel C, Weinzierl AO, Muller M, Wernet D, Hennenlotter J, Stenzl A, Rammensee HG, Stevanovic S. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype. Eur. J. Immunol. 38: 2993-3003 (2008). *
Hillert J. The genetics of multiple sclerosis. Results Probl. Cell Differ. Jul 7 [Epub ahead of print] (2009). *
Hilzenrat N, Zilberman D, Klein T, Zur B, Sikuler E. Autoimmune hepatitis in a genetically susceptible patient: is it triggered by acute viral hepatitis A? Dig. Dis. Sci. 44: 1950-1952 (1999). *
Himoto T, Nakai S, Kinekawa F, Yoneyama H, Deguchi A, Kurokochi K, Masaki T, Senda S, Haba R, Watanabe S, Nishioka M, Kuriyama S. Clinical characteristics of patients with hepatitis C virus-related chronic liver disease seropositive for anticentromere antibody. Dig. Dis. Sci. 54: 360-368 (2009). *
Hiraide A, Imazeki F, Yokosuka O, Kanda T, Kojima, H, Fukai K, Suzuki Y, Hata A, Saisho H. Fas polymorphisms influence susceptibility to autoimmune hepatitis. Am. J. Gastroenterol. 100: 1322-1329 (2005). *
Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, Song YW, Mimori T, Targoff IN. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 56: 1295-1303 (2007). *
Hirankarn N, Nakkuntod J, Duangchalermwong P, Deesomchok U, Charoenwongse P. The association of DRB1*04 share epitope alleles and tumor necrosis factor-alpha gene polymorphism (-863) with susceptibility to rheumatoid arthritis in Thai. Rheumatol. Int. 28: 161-165 (2007). *
Hirata I, Austin LL, Blackwell WH, Weber JR, Dobbins WO 3rd. Immunoelectron microscopic localization of HLA-DR antigen in control small intestine and colon and in inflammatory bowel disease. Dig. Dis. Sci. 31: 1317-1330 (1986).
Hirata I, Berrebi G, Austin LL, Keren DF, Dobbins WO 3rd. Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and in inflammatory bowel disease. Dig. Dis. Sci. 31: 593-603 (1986).
Hirata I, Murano M, Ishiguro T, Toshina K, Wang FY, Katsu K. HLA genotype and development of gastric cancer in patients with Helicobacter pylori infection. Hepatogastroenterology 54: 990-994 (2007).
Hirayama K, Ishizu T, Shimohata H, Miyamoto Y, Kakita T, Nagai M, Ogawa Y, Fujita S, Hirayama A, Yamagata K, Kobayashi M, Koyama A. Analysis of T-cell receptor usage in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis. Clin. Exp. Nephrol. Oct 7 [Epub ahead of print] (2009).
Hirschfield GM, Al-Harthi N, Heathcote EJ. Review: current status of therapy in autoimmune liver disease. Ther. Adv. Gastroenterol. 2: 11-28 (2009). *
Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, Gu X, Walker EJ, Jing K, Juran BD, Mason AL, Myers RP, Peltekian KM, Ghent CN, Coltescu C, Atkinson EJ, Heathcote EJ, Lazaridis KN, Amos CI, Siminovitch KA. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 360: 2544-2555 (2009). *
Hirv K, Bloch K, Fischer M, Einsiedler B, Schrezenmeier H, Mytilineos J. Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies. Bone Marrow Transplant. 44: 433-440 (2009).
Hirv K, Seyfarth M, Uibo R, Kull K, Salupere R, Latza U, Rink L. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers. Scand. J. Gastroenterol. 34: 1025-1032 (1999). *
Hitman GA, Niven MJ, Festenstein H, Cassell PG, Awad J, Walker-Smith J, Leonard JN, Fry L, Ciclitira P, Kumar P, et al. HLA class II alpha chain gene polymorphisms in patients with insulin-dependent diabetes mellitus, dermatitis herpetiformis, and celiac disease. J. Clin. Invest. 79: 609-615 (1987). *
Hiwatashi N, Kikuchi T, Masamune O, Ouchi E, Watanabe H, Goto Y. HLA antigens in inflammatory bowel disease. Tohoku J. Exp. Med. 131: 381-385 (1980).
Hlavaty P, Kunelova M, Gojova M, Tvrzicka E, Vecka M, Roubal P, Hill M, Hlavata K, Kalouskova P, Hainer V, Zak A, Drbohlav J. Change in fatty acid composition of serum lipids in obese females after short-term weight reducing regimen with the addition of n-3 long chain polyunsaturated fatty acids in comparison to controls. Physiol. Res. 57 Suppl. 1: S57-S65 (2008). *
Ho HH, Yu KH, Chen JY, Lin JL, Wu YJ, Luo SF, Liou LB. Coexisting ankylosing spondylitis and gouty arthritis. Clin. Rheumatol. 26: 1655-1661 (2007). *
Ho PY, Barton A, Worthington J, Plant D, Griffiths CE, Young HS, Bradburn P, Thomson W, Silman AJ, Bruce IN. Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann. Rheum. Dis. 67: 677-682 (2008). *
Ho PY, Barton A, Worthington J, Thomson W, Silman AJ, Bruce IN. HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann. Rheum. Dis. 66: 807-811 (2007). *
Ho YP, Sheen IS, Chiu CT, Wu CS, Lin CY. A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am. J. Gastroenterol. 101: 1117-1124 (2006). *
Hoa BK, Hang NT, Kashiwase K, Ohashi J, Lien LT, Horie T, Shojima J, Hijikata M, Sakurada S, Satake M, Tokunaga K, Sasazuki T, Keicho N. HLA-A, -B, -C, -DRB1 and -DQB1 alleles and haplotypes in the Kinh population in Vietnam. Tissue Antigens 71: 127-134 (2008). *
Hoang P, Crotty B, Dalton HR, Jewell DP. Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes. Gut 33: 1089-1093 (1992). *
Hoang P, Senju M, Lowes JR, Jewell DP. Phenotypic characterization of isolated intraepithelial lymphocytes in patients with ulcerative colitis and normal controls. Dig. Dis. Sci. 37: 1725-1728 (1993).
Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J. Allergy Clin. Immunol. 117: 696-702 (2006). *
Hochrein H, Schlatter B, O'Keeffe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Suter M, Wagner H. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. U.S.A. 101: 11416-11421 (2004). *
Hodak E, Lapidoth M, Kohn K, David D, Brautbar B, Kfir K, Narinski N, Safirman S, Maron M, Klein K. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients. Br. J. Dermatol. 145: 974-980 (2001). *
Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, Manns MP, Greten TF, Korangy F. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135: 234-243 (2008). *
Hoffmann HJ, Malling TM, Topcu A, Ryder LP, Nielsen KR, Varming K, Dahl R, Omland O, Sigsgaard T. CD4(dim)CD25(bright) Treg cell frequencies above a standardized gating threshold are similar in asthmatics and controls. Cytometry A. 71: 371-378 (2007).
Hoffmann S, Cepok S, Grummel V, Lehmann-Horn K, Hackermueller J, Stadler PF, Hartung HP, Berthele A, Deisenhammer F, Wasmuth R, Hemmer B. HLA-DRB1(*)0401 and HLA-DRB1(*)0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis. Am. J. Hum. Genet. 83: 219-227 (2008). *
Hoffmann V, Pohlau D, Przuntek H, Epplen JT, Hardt C. A null mutation within the ciliary neurotrophic factor (CNTF)-gene: implications for susceptibility and disease severity in patients with multiple sclerosis. Genes Immun. 3: 53-55 (2002). *
Hoffmeister A, Wittenburg H, Teich N, Bachmann A, Borte G, Mossner J, Achenbach H. A 32-year-old patient with diarrhoe and acute kidney failure. Internist (Berl.) 47: 1063-1067 (2006).
Hogen Esch CE, Csizmadia GD, van Hoogstraten IM, Schreurs MW, Mearin ML, VON Blomberg BM. Childhood coeliac disease: towards an improved serological mass screening strategy. Aliment. Pharmacol. Ther. Dec 25 [Epub ahead of print] (2009). *
Hohjoh H, Nakayama T, Ohashi J, Miyagawa T, Tanaka H, Akaza T, Honda Y, Juji T, Tokunaga K. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 54: 138-145 (1999). *
Hohler T, Grossmann S, Stradmann-Bellinghausen B, Kaluza W, Reuss E, de Vlam K, Veys E, Marker-Hermann E. Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis. Ann. Rheum. Dis. 61: 213-218 (2002). *
Hohler T, Schneider PM, Rittner C, Hasenclever P, Meyer zum Buschenfelde KH, Marker-Hermann E. LMP polymorphisms do not influence disease expression in psoriatic arthritis. Clin. Exp. Rheumatol. 14: 661-664 (1996).
Holderbaum D, Malvitz T, Ciesielski CJ, Carson D, Corr MP, Moskowitz RW. A newly described hereditary cartilage debonding syndrome. Arthritis Rheum. 52: 3300-3304 (2005). *
Holdstock G, Chastenay BF, Krawitt EL. Increased suppressor cell activity in inflammatory bowel disease. Gut 22: 1025-1030 (1981). *
Holdsworth R, Hurley CK, Marsh SG, Lau M, Noreen HJ, Kempenich JH, Setterholm M, Maiers M. The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens 73: 95-170 (2009). *
Holle JU, Schinke S, Gross WL. Risk of infection by biologics. Z. Rheumatol. 67: 295-304 (2008).
Hollenbach JA, Ladner MB, Saeteurn K, Taylor KD, Mei L, Haritunians T, McGovern DP, Erlich HA, Rotter JI, Trachtenberg EA. Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand. Immunogenetics Sep 30 [Epub ahead of print] (2009). *
Hollenbach M, Hintersdorf A, Huse K, Sack U, Bigl M, Groth M, Santel T, Buchold M, Lindner I, Otto A, Sicker D, Schellenberger W, Almendinger J, Pustowoit B, Birkemeyer C, Platzer M, Oerlecke I, Hemdan N, Birkenmeier G. Ethyl pyruvate and ethyl lactate down-regulate the production of pro-inflammatory cytokines and modulate expression of immune receptors. Biochem. Pharmacol. 76: 631-644 (2008). *
Holler E, Rogler G, Brenmoehl J, Hahn J, Herfarth H, Greinix H, Dickinson AM, Socie G, Wolff D, Fischer G, Jackson G, Rocha V, Steiner B, Eissner G, Marienhagen J, Schoelmerich J, Andreesen R. Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 107: 4189-4193 (2006). *
Holm K, Maki M, Vuolteenaho N, Mustalahti K, Ashorn M, Ruuska T, Kaukinen K. Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment. Pharmacol. Ther. 23: 1463-1472 (2006). *
Holm K, Savilahti E, Koskimies S, Lipsanen V, Maki M. Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells. Gut 35: 55-60 (1994). *
Holmberg H, Vaarala O, Sadauskaite-Kuehne V, Ilonen J, Padaiga Z, Ludvigsson J. Higher prevalence of autoantibodies to insulin and GAD(65) in Swedish compared to Lithuanian children with type 1 diabetes. Diabetes Res. Clin. Pract. 72: 308-314 (2006).
Holmes S, Siebold C, Jones EY, Friese MA, Fugger L, Bell J. Multiple sclerosis: MHC associations and therapeutic implications. Expert Rev. Mol. Med. 7: 1-17 (2005).
Holmoy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F. Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells. Eur. J. Immunol. 35: 1786-1794 (2005). *
Holmoy T, Harbo H, Vartdal F, Spurkland A. Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update. Curr. Mol. Med. 9: 591-611 (2009).
Holmoy T, Vartdal F. The immunological basis for treatment of multiple sclerosis. Scand. J. Immunol. 66: 374-382 (2007). *
Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr. Opin. Rheumatol. Jan 7 [Epub ahead of print] (2010).
Holtmeier W, Rowell DL, Nyberg A, Kagnoff MF. Distinct delta T cell receptor repertoires in monozygotic twins concordant for coeliac disease. Clin. Exp. Immunol. 107: 148-157 (1997). *
Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, Ballinger DG, Kosoy R, Demirci FY, Kamboh MI, Kao AH, Tian C, Gunnarsson I, Bengtsson AA, Rantapaa-Dahlqvist S, Petri M, Manzi S, Seldin MF, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358: 900-909 (2008). *
Homeff G, Burgos-Vargas R. TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides. Clin. Exp. Rheumatol. 20: S137-S142 (2002).
Honda M, Eriksson KS, Zhang S, Tanaka S, Lin L, Salehi A, Hesla PE, Maehlen J, Gaus SE, Yanagisawa M, Sakurai T, Taheri S, Tsuchiya K, Honda Y, Mignot E. IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS ONE 4: e4254 (2009). *
Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1: 576-582 (1995). *
Hong GH, Park MH, Takeuchi F, Oh MD, Song YW, Nabeta H, Nakano K, Ito K, Park KS. Association of specific amino acid sequence of HLA-DR with rheumatoid arthritis in Koreans and its diagnostic value. J. Rheumatol. 23: 1699-1703 (1996).
Hong SH, Wang KC, Kim SK, Cho BK, Park MH. Association of HLA-DR and -DQ genes with familial Moyamoya disease in Koreans. J. Korean Neurosurg. Soc. 46: 558-563 (2009).
Honma J, Mitomi H, Murakami K, Igarashi M, Saigenji K, Toyama K. Nodular duodenitis involving CD8+ cell infiltration in patients with ulcerative colitis. Hepatogastroenterology 48: 1604-1610 (2001).
Hoover ML, Marta RT. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type 1 diabetes. Scand. J. Immunol. 45: 193-202 (1997).
Hopf U, Riecken EO, Zeitz M, Eckhardt R, Lobeck H, Malchus R, Moller B. Immunologic parameters in pericholangitis and primary sclerosing cholangitis with and without ulcerative colitis. Dtsch. Med. Wochenschr. 108: 1515-1521 (1983).
Hopner S, Dickhaut K, Hofstatter M, Kramer H, Ruckerl D, Soderhall JA, Gupta S, Marin-Esteban V, Kuhne R, Freund C, Jung G, Falk K, Rotzschke O. Small organic compounds enhance antigen-loading of class II MHC proteins by targeting the polymorphic P1 pocket. J. Biol. Chem. 281: 38535-38542 (2006). *
Hoppe B, Haupl T, Egerer K, Gruber R, Kiesewetter H, Salama A, Burmester GR, Dorner T. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. Ann. Rheum. Dis. 68: 898-903 (2009).
Hoppe B, Haupl T, Gruber R, Kiesewetter H, Burmester GR, Salama A, Dorner T. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res. Ther. 8: R34 (2006). *
Hoppe C, Klitz W, Vichinsky E, Styles L. HLA type and risk of alloimmunization in sickle cell disease. Am. J. Hematol. 84: 462-464 (2009).
Hoppenbrouwers IA, Aulchenko YS, Ebers GC, Ramagopalan SV, Oostra BA, van Duijn CM, Hintzen RQ. EVI5 is a risk gene for multiple sclerosis. Genes Immun. 9: 334-337 (2008).
Hoppenbrouwers IA, Aulchenko YS, Janssens AC, Ramagopalan SV, Broer L, Kayser M, Ebers GC, Oostra BA, van Duijn CM, Hintzen RQ. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. J. Hum. Genet. 54: 676-680 (2009).
Hoppenbrouwers IA, Cortes LM, Aulchenko YS, Sintnicolaas K, Njajou O, Snijders PJ, Oostra BA, van Duijn CM, Hintzen RQ. Familial clustering of multiple sclerosis in a Dutch genetic isolate. Mult. Scler. 13: 17-24 (2007). *
Horan JT, Alonzo TA, Lyman GH, Gerbing RB, Lange BJ, Ravindranath Y, Becton D, Smith FO, Woods WG. Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group. J. Clin. Oncol. 26: 5797-5801 (2008).
Horie Y, Chiba M, Iizuka M, Masamune O. Class II (HLA-DR, HLA-DP, and HLA-DQ) antigens on colonic epithelia in ulcerative colitis: a comparison between uneventful and intractable cases. Tohoku J. Exp. Med. 165: 87-97 (1991).
Horie Y, Chiba M, Iizuka M, Masamune O. Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine. Gastroenterol. Jpn. 25: 575-584 (1990).
Horiki T, Inoko H, Moriuchi J, Ichikawa Y, Arimori S. Combinations of HLA-DPB1 and HLA-DQB1 alleles determine susceptibility to early-onset myasthenia gravis in Japan. Autoimmunity 19: 49-54 (1994).
Horlock C, Stott B, Dyson J, Ogg G, McPherson T, Jones L, Sewell A, Wooldridge L, Cole D, Stebbing J, Savage P. ELISPOT and functional T cell analyses using HLA mono-specific target cells. J. Immunol. Methods 350: 150-160 (2009). *
Horn GT, Bugawan TL, Long CM, Manos MM, Erlich HA. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. Hum. Immunol. 21: 249-263 (1988).
Horn M, Collingro A, Schmitz-Esser S, Beier CL, Purkhold U, Fartmann B, Brandt P, Nyakatura GJ, Droege M, Frishman D, Rattei T, Mewes HW, Wagner M. Illuminating the evolutionary history of chlamydiae. Science 304: 728-730 (2004). *
Horn PA, Albis-Camps M, Verboom M, Bunce M, Yousaf K, Williams S, Blasczyk R. The nature of diversity of HLA-DRB1 exon 3. Tissue Antigens 70: 335-337 (2007). *
Hornum L, Markholst H. New autoimmune genes and the pathogenesis of type 1 diabetes. Curr. Diab. Rep. 4: 135-142 (2004).
Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S. Gene map of the extended human MHC. Nat. Rev. Genet. 5: 889-899 (2004). *
Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group. Diabetologia 42: 608-616 (1999). *
Hosszufalusi N, Karcagi V, Horvath R, Palik E, Varkonyi J, Rajczy K, Prohaszka Z, Szentirmai C, Karadi I, Romics L, Panczel P. A detailed investigation of maternally inherited diabetes and deafness (MIDD) including clinical characteristics, C-peptide secretion, HLA-DR and -DQ status and autoantibody pattern. Diabetes Metab. Res. Rev. 25: 127-135 (2009). *
Hou HA, Tang JL, Hsu SC, Yu CL, Chen YC, Yao M. Acquisition and cure of autoimmune disease following allogeneic hematopoietic stem cell transplantation. J. Formos. Med. Assoc. 106: 779-783 (2007).
Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, Kijlstra A. Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population. Mol. Vis. 14: 2597-2603 (2008). *
Hovhannisyan Z, Weiss A, Martin A, Wiesner M, Tollefsen S, Yoshida K, Ciszewski C, Curran SA, Murray JA, David CS, Sollid LM, Koning F, Teyton L, Jabri B. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 456: 534-538 (2008). *
Howe R, Dillon S, Rogers L, McCarter M, Kelly C, Gonzalez R, Madinger N, Wilson CC. Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria. Clin. Immunol. 131: 317-332 (2009). *
Howell MD, Smith JR, Austin RK, Kelleher D, Nepom GT, Volk B, Kagnoff MF. An extended HLA-D region haplotype associated with celiac disease. Proc. Natl. Acad. Sci. U.S.A. 85: 222-226 (1988). *
Howell WM, Calder PC, Grimble RF. Gene polymorphisms, inflammatory diseases and cancer. Proc. Nutr. Soc. 61: 447-456 (2002). *
Howell WM, Evans PR, Wilson PJ, Cawley MI, Smith JL. HLA class II DR, DQ, and DP restriction fragment length polymorphisms in rheumatoid arthritis. Ann. Rheum. Dis. 48: 295-301 (1989). *
Howell WM, Leung ST, Jones DB, Nakshabendi I, Hall MA, Lanchbury JS, Ciclitira PJ, Wright DH. HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum. Immunol. 43: 29-37 (1995).
Howell WM, Standring P, Warner JA, Warner JO. HLA class II genotype, HLA-DR B cell surface expression and allergen specific IgE production in atopic and non-atopic members of asthmatic family pedigrees. Clin. Exp. Allergy 29 Suppl. 4: 35-38 (1999).
Howson JM, Dunger DB, Nutland S, Stevens H, Wicker LS, Todd JA. A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 50: 741-746 (2007). *
Howson JM, Walker NM, Clayton D, Todd JA; Diabetes Genetics Consortium. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes. Metab. 11 Suppl. 1: 31-45 (2009). *
Hrycek A, Siekiera U, Cieslik P, Szkrobka W. HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumatol. Int. 26: 1-6 (2005). *
Hsieh HJ, Palmer CG, Harney S, Chen HW, Bauman L, Brown MA, Sinsheimer JS. Using the maternal-fetal genotype incompatibility test to assess non-inherited maternal HLA-DRB1 antigen coding alleles as rheumatoid arthritis risk factors. BMC Proc. 1 Suppl. 1: S124 (2007). *
Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, Childs RW, Rodgers GP, Powell JD, Tisdale JF. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N. Engl. J. Med. 361: 2309-2317 (2009). *
Hsu HY, Chang MH, Ho HN, Hsieh RP, Lee SD, Chen DS, Lee CY, Hsieh KH. Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. Vaccine 11: 1437-1440 (1993).
Hu CY, Allen M, Chuang LM, Lin BJ, Gyllensten U. Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles. Hum. Immunol. 38: 105-114 (1993).
Hu W, Tang L, Wang J, Wang B, Li S, Yu H, Tang W, Li H, Tan S, Shou W, Xiao C. Polymorphism of HLA-DRB1, -DQB1 and -DPB1 genes in Bai ethnic group in southwestern China. Tissue Antigens 72: 474-477 (2008). *
Huang BB, Bonish BK, Chaturvedi V, Qin JZ, Nickoloff BJ. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis. J. Invest. Dermatol. 116: 305-312 (2001). *
Huang CH, Cong L, Xie J, Qiao B, Lo SH, Zheng T. Rheumatoid arthritis-associated gene-gene interaction network for rheumatoid arthritis candidate genes. BMC Proc. 3 Suppl. 7: S75 (2009). *
Huang F, Cai XH, Shi GY. Role of enteric Klebsiella pneumonia infection and HLA-B27 in ankylosing spondylitis. Zhonghua Nei Ke Za Zhi 31: 398-400, 443 (1992).
Huang HC, Wu JC, Huang YS, Teh-Ia H, Lo JC, Li CP, Chang FY, Lee SD. Genetic distinctions and clinical characteristics of type 1 autoimmune hepatitis in Taiwan. Hepatogastroenterology 55: 605-608 (2008).
Huang HS, Peng JT, She JY, Zhang LP, Chao CC, Liu KH, She JX. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Hum. Immunol. 44: 210-219 (1995).
Huang J, Goedert JJ, Sundberg EJ, Cung TD, Burke PS, Martin MP, Preiss L, Lifson J, Lichterfeld M, Carrington M, Yu XG. HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J. Exp. Med. 206: 2959-2966 (2009). *
Huang JL, Yeh CC, Shaw CK, Yao TC, Chen LC, Lee TD, Kuo ML. HLA-DRB1 genotyping in patients with juvenile idiopathic arthritis in Taiwan. Eur. J. Immunogenet. 31: 185-188 (2004).
Huang SM, Wu TJ, Lee TD, Yang EK, Shaw CK, Yeh CC. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people. Tissue Antigens 61: 154-158 (2003). *
Huang W, Connor E, Rosa TD, Muir A, Schatz D, Silverstein J, Crockett S, She JX, Maclaren NK. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. J. Clin. Endocrinol. Metab. 81: 2559-2563 (1996). *
Huang X, Shen N, Bao C, Gu Y, Wu L, Chen S. Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into DC-like cells. Arthritis Res. Ther. 10: R91 (2008). *
Huang Y, Bartlett CW, Segre AM, O'Connell JR, Mangin L, Vieland VJ. Exploiting gene x gene interaction in linkage analysis. BMC Proc. 1 Suppl. 1: S64 (2007). *
Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Bruck W, Wiendl H. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Ann. Neurol. 66: 171-183 (2009).
Huang YK, Wen GS, Li HL, Hao P, Qi Q, Zhou LF. Possible association between HLA-HRB1 and DQB1 genes frequency and susceptibility or resistance to Helicobacter pylori infection in Kunming Yi ethnic group children. Zhonghua Er Ke Za Zhi 43: 137-140 (2005).
Huang YW, Hu CY, Chen CL, Liao YT, Liu CJ, Lai MY, Chen PJ, Yang SS, Hu JT, Chen DS, Kao JH. Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus. J. Med. Virol. 81: 588-593 (2009). *
Huang YY, Lin FJ, Fu LS, Lan JL. HLA-DR, -DQB typing of steroid-sensitive idiopathic nephrotic syndrome children in Taiwan. Nephron. Clin. Pract. 112: c57-c64 (2009).
Huber CE, Judex AG, Freyschmidt J, Feuerbach S, Scholmerich J, Muller-Ladner U. Sequential combination therapy leading to sustained remission in a patient with SAPHO syndrome. Open Rheumatol. J. 3: 18-21 (2009). *
Hughes AR, Mosteller M, Bansal AT, Davies K, Haneline SA, Lai EH, Nangle K, Scott T, Spreen WR, Warren LL, Roses AD; CNA30027 Study Team; CNA30032 Study Team. Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics 5: 203-211 (2004).
Hughes LB, Morrison D, Kelley JM, Padilla MA, Vaughan LK, Westfall AO, Dwivedi H, Mikuls TR, Holers VM, Parrish LA, Alarcon GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Gilkeson GS, Howard G, Moreland LW, Patterson N, Reich D, Bridges SL Jr. The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum. 58: 349-358 (2008). *
Hughes S, Hughes A, Brothers C, Spreen W, Thorborn D; on behalf of the CNA106030 Study Team. PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events. Pharm. Stat. 7: 121-129 (2007).
Hughes SM, Amadi B, Mwiya M, Nkamba H, Tomkins A, Goldblatt D. Dendritic cell anergy results from endotoxemia in severe malnutrition. J. Immunol. 183: 2818-2826 (2009).
Hugot JP, Laurent-Puig P, Gower-Rousseau C, Caillat-Zucman S, Beaugerie L, Dupas JL, Van Gossum A, Bonait-Pellie C, Cortot A, Thomas G. Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. Am. J. Med. Genet. 52: 207-213 (1994).
Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RR, Gregersen PK, Toes RE, Criswell LA. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 52: 3433-3438 (2005). *
Hulsmeyer M, Fiorillo MT, Bettosini F, Sorrentino R, Saenger W, Ziegler A, Uchanska-Ziegler B. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J. Exp. Med. 199: 271-281 (2004). *
Humbert P, Dupond JL. Multiple autoimmune syndromes. Ann. Med. Interne. (Paris) 139: 159-168 (1988).
Hume DA, Allan W, Hogan PG, Doe WF. Immunohistochemical characterisation of macrophages in human liver and gastrointestinal tract: expression of CD4, HLA-DR, OKM1, and the mature macrophage marker 25F9 in normal and diseased tissue. J. Leukoc. Biol. 42: 474-484 (1987). *
Hummel S, Hummel M, Banholzer J, Hanak D, Mollenhauer U, Bonifacio E, Ziegler AG. Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding. Diabetologia 50: 390-394 (2007). *
Hundemer M, Schmidt S, Condomines M, Lupu A, Hose D, Moos M, Cremer F, Kleist C, Terness P, Belle S, Ho AD, Goldschmidt H, Klein B, Christensen O. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma. Exp. Hematol. 34: 486-496 (2006). *
Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet. Genomics 16: 297-306 (2006).
Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl. Acad. Sci. U.S.A. 102: 4134-4139 (2005). *
Hunt PJ, Marshall SE, Weetman AP, Bunce M, Bell JI, Wass JA, Welsh KI. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin. Endocrinol. (Oxf.) 55: 491-499 (2001). *
Hunt S. Increased dietary intake of omega-3-PUFA reduces pathological retinal angiogenesis. Ophthalmologe 104: 727-729 (2007).
Hurgin V, Novick D, Werman A, Dinarello CA, Rubinstein M. Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha. Proc. Natl. Acad. Sci. U.S.A. 104: 5044-5049 (2007). *
Hurley CK, Schreuder GM, Marsh SG, Lau M, Middleton D, Noreen H. The search for HLA-matched donors: a summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens. Tissue Antigens 50: 401-418 (1997).
Hurtado-Nedelec M, Chollet-Martin S, Chapeton D, Hugot JP, Hayem G, Gerard B. Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes. J. Rheumatol. Dec 23 [Epub ahead of print] (2009).
Husain S, Yildirim-Toruner C, Rubio JP, Field J; The Southern MS Genetics Consortium, Schwalb M, Cook S, Devoto M, Vitale E. Variants of ST8SIA1 are associated with risk of developing multiple sclerosis. PLoS ONE 3: e2653 (2008). *
Husain Z, Kelly MA, Eisenbarth GS, Pugliese A, Awdeh ZL, Larsen CE, Alper CA. The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1. J. Autoimmun. 30: 266-272 (2008).
Hussein A. HLA-B27 associated spondyloarthritis in childhood. Monatsschr. Kinderheilkd. 135: 185-194 (1987).
Hviid TV, Christiansen OB. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G - possible implications for human reproduction and autoimmune disease. Hum. Immunol. 66: 688-699 (2005).
Iannuzzi MC. Genetics of sarcoidosis. Semin. Respir. Crit. Care Med. 28: 15-21 (2007).
Ibberson M, Peclat V, Guerne PA, Tiercy JM, Wordsworth P, Lanchbury J, Camilleri J, So AK. Analysis of T cell receptor V alpha polymorphisms in rheumatoid arthritis. Ann. Rheum. Dis. 57: 49-51 (1998). *
Ichikawa N, Kotake S, Hakoda M, Higami K, Kawasaki A, Furuya T, Nanke Y, Tsuchiya N, Tokunaga K, Kamatani N. Combining effects of polymorphism of tumor necrosis factor alpha 5'-flanking region and HLA-DRB1 on radiological progression in patients with rheumatoid arthritis. Mod. Rheumatol. 19: 134-139 (2009). *
Ichiki Y, Bowlus CL, Shimoda S, Ishibashi H, Vierling JM, Gershwin ME. T cell immunity and graft-versus-host disease (GVHD). Autoimmun. Rev. 5: 1-9 (2006).
Ichiki Y, Shimoda S, Hara H, Shigematsu H, Nakamura M, Hayashida K, Ishibashi H, Niho Y. Analysis of T-cell receptor beta of the T-cell clones reactive to the human PDC-E2 163-176 peptide in the context of HLA-DR53 in patients with primary biliary cirrhosis. Hepatology 26: 728-733 (1997).
Ide A, Babu SR, Robles DT, Wang T, Erlich HA, Bugawan TL, Rewers M, Fain PR, Eisenbarth GS. "Extended" A1, B8, DR3 haplotype shows remarkable linkage disequilibrium but is similar to nonextended haplotypes in terms of diabetes risk. Diabetes 54: 1879-1883 (2005). *
Ide A, Kawasaki E, Abiru N, Sun F, Kobayashi M, Fukushima T, Takahashi R, Kuwahara H, Kita A, Oshima K, Uotani S, Yamasaki H, Yamaguchi Y, Eguchi K. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J. Autoimmun. 22: 73-78 (2004).
Igo RP Jr, Londono D, Miller K, Parrado AR, Quade SR, Sinha M, Kim S, Won S, Li J, Goddard KA. Density-based clustering in haplotype analysis for association mapping. BMC Proc. 1 Suppl. 1: S27 (2007). *
Ihan Hren N, Ihan A. T lymphocyte activation and cytokine expression in periapical granulomas and radicular cysts. Arch. Oral Biol. 54: 156-161 (2009).
Ihrler S, Adam P, Guntinas-Lichius O, Harrison JD, Weiler C. Pattern recognition in the differential diagnosis of salivary lymphoepithelial lesions. Pathologe Oct 8 [Epub ahead of print] (2009).
Iizuka B, Yamagishi N, Honma N, Hayashi N. Cardio vascular disease associated with ulcerative colitis. Nippon Rinsho 57: 2540-2555 (1999).
Iizuka M, Chiba M, Horie Y, Masamune O, Ohta H. Lymphoid cell subsets in colonic mucosa and HLA-DR antigens on colonic epithelia in colitis excluding ulcerative colitis and Crohn's disease. Gastroenterol. Jpn. 25: 700-707 (1990).
Iizuka M, Chiba M, Ohta H, Kodama K, Igarashi K, Arakawa H, Masamune O. Expression of HLA-DR antigens on colonic epithelium in ulcerative colitis. Gastroenterol. Jpn. 22: 571-577 (1987).
Ikaheimo I, Silvennoinen-Kassinen S, Karvonen J, Jarvinen T, Tiilikainen A. Immunogenetic profile of psoriasis vulgaris: association with haplotypes A2,B13,Cw6,DR7,DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201. Arch. Dermatol. Res. 288: 63-67 (1996). *
Ikeda S, Kudsk KA, Fukatsu K, Johnson CD, Le T, Reese S, Zarzaur BL. Enteral feeding preserves mucosal immunity despite in vivo MAdCAM-1 blockade of lymphocyte homing. Ann. Surg. 237: 677-685 (2003). *
Ikegami H, Awata T, Kawasaki E, Kobayashi T, Maruyama T, Nakanishi K, Shimada A, Amemiya S, Kawabata Y, Kurihara S, Tanaka S, Kanazawa Y, Mochizuki M, Ogihara T. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multi-center collaborative study in Japan. J. Clin. Endocrinol. Metab. 91: 1087-1092 (2006). *
Ikuta Y, Hayashida Y, Hirata S, Irie A, Senju S, Kubo T, Nakatsura T, Monji M, Sasaki Y, Baba H, Nishimura Y. Identification of the H2-Kd-restricted cytotoxic T lymphocyte epitopes of a tumor-associated antigen, SPARC, which can stimulate antitumor immunity without causing autoimmune disease in mice. Cancer Sci. 100: 132-137 (2009). *
Ilinskaya A, Oliferuk N, Livov V, Khaitov RM. Functional changes of macrophages induced by dimeric glycosaminylmuramyl pentapeptide. Adv. Exp. Med. Biol. 601: 205-210 (2007).
Iliopoulou BP, Alroy J, Huber BT. Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment. Arthritis Rheum. 58: 3892-3901 (2008). *
Iliopoulou BP, Guerau-De-Arellano M, Huber BT. HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis. Arthritis Rheum. 60: 3831-3840 (2009). *
Ilonen J, Kocova M, Lipponen K, Sukarova-Angelovska E, Jovanovska A, Knip M. HLA-DR-DQ haplotypes and type 1 diabetes in Macedonia. Hum. Immunol. 70: 461-463 (2009).
Im CH, Kang EH, Ryu HJ, Lee JH, Lee EY, Lee YJ, Lee EB, Song YW. Anti-cyclic citrullinated peptide antibody is associated with radiographic erosion in rheumatoid arthritis independently of shared epitope status. Rheumatol. Int. 29: 251-256 (2009). *
Imabayashi K, Yamamoto Y, Inagaki S, Doi Y, Yositome K, Miyaishi S, Ishizu H. A new HLA-DRB1 genotyping method using single nucleotide polymorphism (SNP) analysis with multiplex primer extension reactions and its application to mixed samples. Acta Med. Okayama. 59: 179-194 (2005).
Imagawa A, Hanafusa T, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes. Diabetes Res. Clin. Pract. 82: 233-237 (2008).
Imboden JB. The immunopathogenesis of rheumatoid arthritis. Annu. Rev. Pathol. 4: 417-434 (2009).
Imrell K, Greiner E, Hillert J, Masterman T. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis. J. Neuroimmunol. 210: 128-130 (2009).
Inada H, Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Umemura T, Tanaka E, Kiyosawa K. T cell repertoire in the liver of patients with primary biliary cirrhosis. Hum. Immunol. 61: 675-683 (2000).
Infante AJ, Baillargeon J, Kraig E, Lott L, Jackson C, Hammerling GJ, Raju R, David C. Evidence of a diverse T cell receptor repertoire for acetylcholine receptor, the autoantigen of myasthenia gravis. J. Autoimmun. 21: 167-174 (2003).
Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J. Rheumatol. 35: 1002-1008 (2008).
International MHC and Autoimmunity Genetics Network (IMAGEN), Rioux JD, Goyette P, Vyse TJ, Hammarstrom L, Fernando MM, Green T, De Jager PL, Foisy S, Wang J, de Bakker PI, Leslie S, McVean G, Padyukov L, Alfredsson L, Annese V, Hafler DA, et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc. Natl. Acad. Sci. U.S.A. 106: 18680-18685 (2009). *
Invernizzi P, Battezzati PM, Crosignani A, Perego F, Poli F, Morabito A, De Arias AE, Scalamogna M, Zuin M, Podda M. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J. Hepatol. 38: 401-406 (2003). *
Invernizzi P, Gershwin ME. The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology 135: 1044-1047 (2008). *
Invernizzi P, Selmi C, Mackay IR, Podda M, Gershwin ME. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin. Gastroenterol. Hepatol. 3: 401-410 (2005). *
Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, Almasio P, Rosina F, Marzioni M, Fabris L, Muratori L, Qi L, Seldin MF, Gershwin ME, Podda M; Italian PBC Genetic Study Group. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 48: 1906-1912 (2008). *
Ioachim E, Michael M, Katsanos C, Demou A, Tsianos EV. The immunohistochemical expression of metallothionein in inflammatory bowel disease. Correlation with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices. Histol. Histopathol. 18: 75-82 (2003).
Ionescu-Tirgoviste C, Guja C, Herr M, Cucca E, Welsh K, Bunce M, Marshall S, Todd JA. Low frequency of HLA DRB1*03 - DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of type I diabetes. Diabetologia 44 Suppl. 3: B60-B66 (2001).
Iqniebi A, Gaafar A, Sheereen A, Al-Suliman A, Mohamed G, Al-Hussein K, Tabbara KF. HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia. Mol. Vis. 15: 1876-1880 (2009). *
Irie N, Muraji T, Hosaka N, Takada Y, Sakamoto S, Tanaka K. Maternal HLA class I compatibility in patients with biliary atresia. J. Pediatr. Gastroenterol. Nutr. Jul 8 [Epub ahead of print] (2009).
Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F, Lum RF, Massarotti E, Weisman M, Bombardier C, Remmers EF, Kastner DL, Seldin MF, Criswell LA, Gregersen PK. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum. 52: 3813-3818 (2005). *
Ishihara M, Ishida T, Inoko H, Ando H, Naruse T, Nose Y, Ohno S. HLA serological and class II genotyping in sarcoidosis patients in Japan. Jpn. J. Ophthalmol. 40: 86-94 (1996).
Ishihara M, Ohno S. Genetic influences on sarcoidosis. Eye 11: 155-161 (1997).
Ishihara M, Ohno S, Ishida T, Ando H, Naruse T, Nose Y, Inoko H. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 43: 238-241 (1994).
Ishihara M, Ohno S, Ishida T, Naruse T, Inoko H. Genetic polymorphism in intron 6 of the LMP7 gene in Japanese and its association with sarcoidosis. Tissue Antigens 50: 650-653 (1997).
Ishihara M, Ohno S, Mizuki N, Yamagata N, Ishida T, Naruse T, Kuwata S, Inoko H. Genetic polymorphisms of the major histocompatibility complex-encoded antigen-processing genes TAP and LMP in sarcoidosis. Hum. Immunol. 45: 105-110 (1996).
Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase. Immunol. Lett. 99: 180-185 (2005).
Ishii W, Matsuda M, Shimojima Y, Itoh S, Sumida T, Ikeda S. Flow cytometric analysis of lymphocyte subpopulations and TH1/TH2 balance in patients with polymyositis and dermatomyositis. Intern. Med. 47: 1593-1599 (2008). *
Ishikawa T, Aoyama H, Ohtake H, Ohnishi S, Aburatani H, Imawari M, Shiga J, Takaku F. Primary intrahepatic sclerosing cholangitis with inflammatory bowel disease. Acta Pathol. Jpn. 37: 1637-1643 (1987).
Ishizuka J, Stewart-Jones GB, van der Merwe A, Bell JI, McMichael AJ, Jones EY. The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity 28: 171-182 (2008). *
Isobe N, Matsushita T, Yamasaki R, Ramagopalan S, Kawano Y, Nishimura Y, Ebers G, Kira J. Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status. Mult. Scler. Dec 22 [Epub ahead of print] (2009).
Isobe Z, Suga T, Hamaguchi S, Yamaguchi S, Hara K, Aoki F, Aoki N, Aoyagi K, Ueno M, Maeno T, Kurabayashi M. A case of HLA-DR8 positive sarcoidosis following polymyositis and Sjogren's syndrome. Nihon Kokyuki Gakkai Zasshi 46: 96-100 (2008).
Isoyama K, Yamada K, Ishikawa K, Sanada Y. Coincidental cases of primary sclerosing cholangitis and biliary atresia in siblings? Acta Paediatr. 84: 1444-1446 (1995).
Israni N, Goswami R, Kumar A, Rani R. Interaction of vitamin D receptor with HLA DRB1*0301 in type 1 diabetes patients from North India. PLoS One 4: e8023 (2009). *
Ito M, Kojima T, Miyata M, Saka M, Kokubun M, Ohira H, Ishikawa H, Kuroda M, Sato Y, Takagi T, et al. Primary biliary cirrhosis (PBC)-CREST (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly and telangiectasia) overlap syndrome complicated by Sjogren's syndrome and arthritis. Intern. Med. 34: 451-454 (1995). *
Ivanov A, Beers SA, Walshe CA, Honeychurch J, Alduaij W, Cox KL, Potter KN, Murray S, Chan CH, Klymenko T, Erenpreisa J, Glennie MJ, Illidge TM, Cragg MS. Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J. Clin. Invest. 119: 2143-2159 (2009). *
Ivarsson SA, Eriksson S, Kockum I, Lernmark A, Lindgren S, Nilsson KO, Sundkvist G, Wassmuth R. HLA-DR3, DQ2 homozygosity in two patients with insulin-dependent diabetes mellitus superimposed with ulcerative colitis and primary sclerosing cholangitis. J. Intern. Med. 233: 281-286 (1993).
Iwaizumi M, Yamada M, Kitagawa M, Takehira Y, Hanajima K, Murohisa G, Kawamura M, Iwaoka Y, Wada T, Morita S, Kawata K. Ulcerative colitis in monozygotic twin sisters. Intern. Med. 41: 629-632 (2002). *
Iwama S, Ikezaki A, Kikuoka N, Kim HS, Matsuoka H, Yanagawa T, Sato H, Hoshi M, Sakamaki T, Sugihara S. Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children. Horm. Res. 63: 55-60 (2005).
Iwamoto S, Iwai S, Tsujiyama K, Kurahashi C, Takeshita K, Naoe M, Masunaga A, Ogawa Y, Oguchi K, Miyazaki A. TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses. J. Immunol. 179: 1449-1457 (2007). *
Izzedine H, Brocheriou I, Valantin MA, Camous L, Bourry E, Baumelou A, Deray G, Katlama C. A case of acute renal failure associated with diffuse infiltrative lymphocytosis syndrome. Nat. Clin. Pract. Nephrol. 4: 110-114 (2008). *
Jaakkola E, Herzberg I, Laiho K, Barnardo MC, Pointon JJ, Kauppi M, Kaarela K, Tuomilehto-Wolf E, Tuomilehto J, Wordsworth BP, Brown MA. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann. Rheum. Dis. 65: 775-780 (2006). *
Jackson AM, Connolly JE, Matsumoto S, Noguchi H, Onaca N, Levy MF, Naziruddin B. Evidence for induced expression of HLA class II on human islets: possible mechanism for HLA sensitization in transplant recipients. Transplantation 87: 500-506 (2009).
Jacob JB, Kong YC, Meroueh C, Snower DP, David CS, Ho YS, Wei WZ. Control of her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells. Cancer Res. 67: 7020-7027 (2007). *
Jacobsen S, Baslund B, Madsen HO, Tvede N, Svejgaard A, Garred P. Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis. J. Rheumatol. 29: 2148-2153 (2002). *
Jacobsen S, Madsen HO, Klarlund M, Jensen T, Skjodt H, Jensen KE, Svejgaard A, Garred P; TIRA Group. The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis. J. Rheumatol. 28: 935-942 (2001).
Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J. Autoimmun. 30: 58-62 (2008). *
Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid 17: 949-961 (2007).
Jacobson EM, Yang H, Menconi F, Wang R, Osman R, Skrabanek L, Li CW, Fadlalla M, Gandhi A, Chaturvedi V, Smith EP, Schwemberger S, Osterburg A, Babcock GF, Tomer Y. Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II- thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective. J. Biol. Chem. 284: 34231-34243 (2009). *
Jager E, Karbach J, Gnjatic S, Jager D, Maeurer M, Atmaca A, Arand M, Skipper J, Stockert E, Chen YT, Old LJ, Knuth A. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. Cancer Immun. 2: 12 (2002). *
Jagiello P, Wieczorek S, Yu P, Csernok E, Gross WL, Epplen JT. Association study with Wegener granulomatosis of the human phospholipase Cgamma2 gene. J. Negat. Results Biomed. 4: 1 (2005). *
Jahangier ZN, Jacobs JW, Bijlsma JW. SAPHO syndrome: common denominator for various bone and skin diseases. Ned. Tijdschr. Geneeskd. 141: 764-769 (1997).
Jahn-Schmid B, Sirven P, Leb V, Pickl WF, Fischer GF, Gadermaier G, Egger M, Ebner C, Ferreira F, Maillere B, Bohle B. Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen. J. Immunol. 181: 3636-3642 (2008). *
Jahromi MM, Eisenbarth GS. Cellular and molecular pathogenesis of type 1A diabetes. Cell. Mol. Life Sci. 64: 865-872 (2007). *
Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database. Liver Transpl. 13: 1405-1413 (2007). *
Jakob E, Reuland MS, Mackensen F, Harsch N, Fleckenstein M, Lorenz HM, Max R, Becker MD. Uveitis subtypes in a German Interdisciplinary Uveitis Center - analysis of 1916 patients. J. Rheumatol. 36: 127-136 (2009).
Jakob F. Metabolic bone diseases. Internist (Berl.) 48: 1101-1117 (2007).
Jalihal A, Telisinghe PU, Chong VH. Profiles of autoimmune hepatitis in Brunei Darussalam. Hepatobiliary Pancreat. Dis. Int. 8: 602-607 (2009). *
Jalleh RP, Gilbertson JA, Williamson RC, Slater SD, Foster CS. Expression of major histocompatibility antigens in human chronic pancreatitis. Gut 34: 1452-1457 (1993). *
James EA, Kwok WW, Ettinger RA, Thompson AR, Pratt KP. T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide. J. Thromb. Haemost. 5: 2399-2407 (2007). *
James EA, Moustakas AK, Berger D, Huston L, Papadopoulos GK, Kwok WW. Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling. Mol. Immunol. 45: 2651-2659 (2008). *
James EA, Moustakas AK, Bui J, Nouv R, Papadopoulos GK, Kwok WW. The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9. J. Immunol. 183: 3249-3258 (2009).
James I, McKinnon E, Gaudieri S, Morahan G; Diabetes Genetics Consortium. Missingness in the T1DGC MHC fine-mapping SNP data: association with HLA genotype and potential influence on genetic association studies. Diabetes Obes. Metab. 11 Suppl. 1: 101-107 (2009). *
James WH. Sex ratios and hormones in HLA related rheumatic diseases. Ann. Rheum. Dis. 50: 401-404 (1991). *
Jamshidi F, Bouzari N, Seirafi H, Farnaghi F, Firooz A. The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran. Arch. Iran. Med. 11: 162-165 (2008).
Jankowski J, Crombie I, Jankowski R. Behcet's syndrome in Scotland. Postgrad. Med. J. 68: 566-570 (1992). *
Janossy G, Montano L, Selby WS, Duke O, Panayi G, Lampert I, Thomas JA, Granger S, Bofill M, Tidman N, Thomas HC, Goldstein G. T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host disease. J. Clin. Immunol. 2: 42S-56S (1982).
Jansen PL, Sanders JB. Primary sclerosing cholangitis. An unresolved enigma. Scand. J. Gastroenterol. Suppl. 194: 76-81 (1992).
Janssens AC, Steyerberg EW, Jiang Y, Habbema JD, Van Duijn CM, Criswell LA. Value of the HLA-DRB1 shared epitope for predicting radiographic damage in rheumatoid arthritis depends on the individual patient risk profile. J. Rheumatol. 33: 2383-2389 (2006).
Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, Grote V, Diebold J, Jansson V, Schneider K, Belohradsky BH. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 46: 154-160 (2007). *
Jaraquemada D, Ollier W, Awad J, Young A, Festenstein H. HLA and rheumatoid arthritis: susceptibility or severity? Dis. Markers 4: 43-53 (1986).
Jaruskova M, Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur. J. Nucl. Med. Mol. Imaging 33: 913-918 (2006). *
Jarvinen TM, Harjutsalo V, Kinnunen L, Miettinen ME, Tuomilehto-Wolf E, Tuomilehto J. A population-specific diabetogenic haplotype HLA-A2,Cw1,B56,DR4,DQ8 is associated with high birthweight in Finnish diabetic families. Genes Immun. 9: 207-213 (2008). *
Jaspan JB, Sullivan K, Garry RF, Lopez M, Wolfe M, Clejan S, Yan C, Tenenbaum S, Sander DM, Ahmed B, Bryer-Ash M. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease. J. Clin. Endocrinol. Metab. 81: 2271-2279 (1996). *
Jawaheer D, Li W, Graham RR, Chen W, Damle A, Xiao X, Monteiro J, Khalili H, Lee A, Lundsten R, Begovich A, Bugawan T, Erlich H, Elder JT, Criswell LA, Seldin MF, Amos CI, Behrens TW, Gregersen PK. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am. J. Hum. Genet. 71: 585-594 (2002). *
Jawaheer D, Lum RF, Amos CI, Gregersen PK, Criswell LA. Clustering of disease features within 512 multicase rheumatoid arthritis families. Arthritis Rheum. 50: 736-741 (2004). *
Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Etzel C, Damle A, Xiao X, Chen D, Lum RF, Monteiro J, Kern M, Criswell LA, Albani S, Nelson JL, Clegg DO, Pope R, Schroeder HW Jr, Bridges SL Jr, Pisetsky DS, Ward R, Kastner DL, Wilder RL, et al. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48: 906-916 (2003). *
Jawaheer D, Thomson W, MacGregor AJ, Carthy D, Davidson J, Dyer PA, Silman AJ, Ollier WE. "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum. 37: 681-686 (1994).
Jean S, Quelvennec E, Alizadeh M, Guggenbuhl P, Birebent B, Perdriger A, Grosbois B, Pawlotsky PY, Semana G. DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjogren's syndrome genetic susceptibility. Clin. Exp. Rheumatol. 16: 725-728 (1998).
Jee SH, Tsai TF, Tsai WL, Liaw SH, Chang CH, Hu CY. HLA-DRB1*0701 and DRB1*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population. Br. J. Dermatol. 139: 978-983 (1998).
Jeldres C, Cardinal H, Duclos A, Shariat SF, Suardi N, Capitanio U, Hebert MJ, Karakiewicz PI. Prediction of delayed graft function after renal transplantation. Can. Urol. Assoc. J. 3: 377-382 (2009).
Jenisch S, Henseler T, Nair RP, Guo SW, Westphal E, Stuart P, Kronke M, Voorhees JJ, Christophers E, Elder JT. Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am. J. Hum. Genet. 63: 191-199 (1998). *
Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann. Allergy Asthma Immunol. 99: 13-21 (2007).
Jewell DP. Genotype-based classification of IBD phenotype. Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, p. 36 (2006). *
Ji JD, Lee WJ, Kong KA, Woo JH, Choi SJ, Lee YH, Song GG. Association of STAT4 polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol. Biol. Rep. May 29 [Epub ahead of print] (2009). *
Jia QT, Xu LH, Zha QB, Chi XY, Li FY, He XH. High level expression of HLA-A*0203-BSP fusion protein in Escherichia coli and construction of soluble HLA-A*0203 monomer and tetramer loaded with Epstein-Barr virus peptide. Cell. Mol. Immunol. 4: 301-308 (2007). *
Jiang C, Deshmukh US, Gaskin F, Bagavant H, Hanson J, David CS, Fu SM. Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J. Immunol. 184: 1085-1091 (2010).
Jiang R, Dong J, Dai Y. Genome-wide association study of rheumatoid arthritis by a score test based on wavelet transformation. BMC Proc. 3 Suppl. 7: S8 (2009). *
Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF. TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur. J. Immunol. 37: 2205-2213 (2007). *
Jiang X, Shen C, Yu H, Karunakaran KP, Brunham RC. Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection. Immunology Sep 11 [Epub ahead of print] (2009). *
Jiang XH, Zong RQ, Fang XY, An F, Hu Y, Kong XT. Relationship between alleles of HLA-DRB and HLA-DQB1 and Chinese patients with primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 12: 436 (2004).
Jiang Y, Chen G, Zhang Y, Lu L, Liu S, Cao X. Nerve growth factor promotes TLR4 signaling-induced maturation of human dendritic cells in vitro through inducible p75NTR1. J. Immunol. 179: 6297-6304 (2007). *
Jiang YG, Wang YM. Study on the polymorphisme of human leucocyte antigen-DRB1, -DQA1 and -DQB1 alleles in patients with hepatitis B. Zhonghua Liu Xing Bing Xue Za Zhi 25: 337-340 (2004).
Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J. Gastroenterol. 9: 2221-2225 (2003). *
Jin Y, Yang S, Zhang F, Kong Y, Xiao F, Hou Y, Fan X, Zhang X. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China. J. Eur. Acad. Dermatol. Venereol. 23: 132-137 (2009).
Jing L, McCaughey SM, Davies DH, Chong TM, Felgner PL, De Rosa SP, Wilson CB, Koelle DM. ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. J. Immunol. Methods 347: 36-45 (2009). *
Joergensen GH, Luov�ksson BR. The current concept of primary IgA deficiency and its prevalence in Iceland. Laeknabladid. 87: 873-879 (2001).
Johannesen J. Aspects of the molecular and functional genetics in T1DM - a study of selected candidate genes. Dan. Med. Bull. 53: 122-171 (2006).
Johansen BH, Gjertsen HA, Vartdal F, Buus S, Thorsby E, Lundin KE, Sollid LM. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. Clin. Immunol. Immunopathol. 79: 288-293 (1996).
Johansen BH, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM. Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential. Immunogenetics 45: 142-150 (1996).
Johansson A, Ingman M, Mack SJ, Erlich H, Gyllensten U. Genetic origin of the Swedish Sami inferred from HLA class I and class II allele frequencies. Eur. J. Hum. Genet. 16: 1341-1349 (2008). *
Johansson M, Arlestig L, Hallmans G, Rantapaa-Dahlqvist S. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res. Ther. 8: R19-R25 (2005). *
Johansson S, Lie BA, Cambon-Thomsen A, Pociot F, Nerup J, Kockum I, Thorsby E, Undlien DE. No evidence of type 1 diabetes susceptibility genes in the region centromeric of the HLA complex. Hum. Immunol. 64: 951-959 (2003).
Johansson S, Lie BA, Pociot F, Nerup J, Cambon-Thomsen A, Kockum I, Thorsby E, Undlien DE. HLA associations in type 1 diabetes: DPB1 alleles may act as markers of other HLA-complex susceptibility genes. Tissue Antigens 61: 344-351 (2003). *
Johansson S, Lie BA, Todd JA, Pociot F, Nerup J, Cambon-Thomsen A, Kockum I, Akselsen HE, Thorsby E, Undlien DE. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun. 4: 46-53 (2003). *
John S, Amos C, Shephard N, Chen W, Butterworth A, Etzel C, Jawaheer D, Seldin M, Silman A, Gregersen P, Worthington J. Linkage analysis of rheumatoid arthritis in US and UK families reveals interactions between HLA-DRB1 and loci on chromosomes 6q and 16p. Arthritis Rheum. 54: 1482-1490 (2006). *
John S, Shephard N, Liu G, Zeggini E, Cao M, Chen W, Vasavda N, Mills T, Barton A, Hinks A, Eyre S, Jones KW, Ollier W, Silman A, Gibson N, Worthington J, Kennedy GC. Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am. J. Hum. Genet. 75: 54-64 (2004). *
Johnson CM, Traherne JA, Jamieson SE, Tremelling M, Bingham S, Parkes M, Blackwell JM, Trowsdale J. Analysis of the BTNL2 truncating splice site mutation in tuberculosis, leprosy and Crohn's disease. Tissue Antigens 69: 236-241 (2007). *
Johnson ML, Keeton LG, Zhu ZB, Volanakis JE, Cooper MD, Schroeder HW Jr. Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin. Exp. Immunol. 108: 477-483 (1997). *
Johnson WG, Buyske S, Mars AE, Sreenath M, Stenroos ES, Williams TA, Stein R, Lambert GH. HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. Arch. Pediatr. Adolesc. Med. 163: 542-546 (2009).
Johnston DE, Kaplan MM, Miller KB, Connors CM, Milford EL. Histocompatibility antigens in primary biliary cirrhosis. Am. J. Gastroenterol. 82: 1127-1129 (1987).
Johnston DT, Schroeder HW Jr. B-cell numbers in the blood of patients with non-HLA*B8 or non-HLA*B44 common variable immunodeficiency. Ann. Allergy Asthma Immunol. 98: 163-167 (2007).
Jones DC, Edgar RS, Ahmad T, Cummings JR, Jewell DP, Trowsdale J, Young NT. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility. Genes Immun. 7: 576-582 (2006). *
Jones DE, Donaldson PT. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin. Liver Dis. 7: 841-864 (2003).
Jones DE, Watt FE, Grove J, Newton JL, Daly AK, Gregory WL, Day CP, James OF, Bassendine MF. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. J. Hepatol. 30: 232-236 (1999). *
Jones L, Black AP, Malavige GN, Ogg GS. Phenotypic analysis of human CD4(+) T cells specific for immediate early 63 protein of varicella-zoster virus. Eur. J. Immunol. 37: 3393-3403 (2007). *
Jonsen A, Bengtsson AA, Sturfelt G, Truedsson L. Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility. Arthritis Res. Ther. 6: R557-R562 (2004). *
Jonson CO, Hedman M, Karlsson Faresjo M, Casas R, Ilonen J, Ludvigsson J, Vaarala O; for the ABIS Study Group. The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children. Clin. Exp. Immunol. 145: 48-55 (2006). *
Jonson CO, Lernmark A, Ludvigsson J, Rutledge EA, Hinkkanen A, Faresjo M. The importance of CTLA-4 polymorphism and human leukocyte antigen genotype for the induction of diabetes-associated cytokine response in healthy school children. Pediatr. Diabetes 8: 185-192 (2007). *
Jores RD, Frau F, Cucca F, Clemente MG, Orru S, Rais M, De Virgiliis S, Congia M. HLA-DQB1*0201 homozygosis predisposes to severe intestinal damage in celiac disease. Scand. J. Gastroenterol. 42: 48-53 (2007). *
Ju LY, Sun YP, Semana G, Gu XF, Krishnamoorty R, Fauchet R, Charron D. Aspartic acid at position 57 of the HLA-DQ beta chain in insulin-dependent diabetes mellitus: an association with one DRw9-DQw9 subtype in the Chinese population. Tissue Antigens 37: 218-223 (1991).
Juan A, Ibanez M, Saez de Ibarra JI, Ros I, Cremer D, Rosell J. Dissection of the ascending aorta in a patient with HLA-B27 associated ankylosing spondylitis. J. Rheumatol. 35: 713-716 (2008).
Julier C, Hyer RN, Davies J, Merlin F, Soularue P, Briant L, Cathelineau G, Deschamps I, Rotter JI, Froguel P, et al. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 354: 155-159 (1991). *
Jun KR, Choi SE, Cha CH, Oh HB, Heo YS, Ahn HY, Lee KJ. Meta-analysis of the association between HLA-DRB1 allele and rheumatoid arthritis susceptibility in Asian populations. J. Korean Med. Sci. 22: 973-980 (2007). *
Jung C, Stoeckle C, Wiesmuller KH, Laub R, Emmrich F, Jung G, Melms A. Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis. J. Neuroimmunol. 201-202: 41-49 (2008).
Jung J, Song JJ, Kwon D. Allelic based gene-gene interactions in rheumatoid arthritis. BMC Proc. 3 Suppl. 7: S76 (2009). *
Jung MH, Yu J, Shin CH, Suh BK, Yang SW, Lee BC. Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms and HLA class II alleles with the development of type 1 diabetes in Korean children and adolescents. J. Korean Med. Sci. 24: 1004-1009 (2009).
Jung YJ, Woo SY, Jang MH, Miyasaka M, Ryu KH, Park HK, Seoh JY. Human eosinophils show chemotaxis to lymphoid chemokines and exhibit antigen-presenting-cell-like properties upon stimulation with IFN-gamma, IL-3 and GM-CSF. Int. Arch. Allergy Immunol. 146: 227-234 (2008).
Junta CM, Sandrin-Garcia P, Fachin-Saltoratto AL, Mello SS, Oliveira RD, Rassi DM, Giuliatti S, Sakamoto-Hojo ET, Louzada-Junior P, Donadi EA, Passos GA. Differential gene expression of peripheral blood mononuclear cells from rheumatoid arthritis patients may discriminate immunogenetic, pathogenic and treatment features. Immunology 127: 365-372 (2009). *
Juntunen R, Liukko A, Taivainen A, Narvanen A, Durand G, Kauppinen A, Nieminen A, Rytkonen-Nissinen M, Saarelainen S, Maillere B, Virtanen T, Kinnunen T. Suboptimal recognition of a T cell epitope of the major dog allergen Can f 1 by human T cells. Mol. Immunol. 46: 3320-3327 (2009). *
Jurado A, Cardaba B, Jara P, Cuadrado P, Hierro L, de Andres B, del Pozo V, Cortegano MI, Gallardo S, Camarena C, Barcena R, Castaner JL, Alvarez R, Lahoz C, Palomino P. Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. J. Hepatol. 26: 983-991 (1997). *
Jurcic Z, Brkljacic-Surkalovic L, Grubic Z, Zunec R, Vezmar V, Kastelan A. Gluten enteropathy in Croatian children is primarily associated with the HLA-DR3-DQ2 haplotype. Lijec. Vjesn. 122: 259-263 (2000).
Juse U, Fleckenstein B, Bergseng E, Sollid LM. Soluble HLA-DQ2 expressed in S2 cells copurifies with a high affinity insect cell derived protein. Immunogenetics 61: 81-89 (2009). *
Kabasakal C, Keskinoglu A, Mir S, Basdemir G. IgA nephropathy occurring in two siblings of three families. Turk. J. Pediatr. 39: 395-401 (1997).
Kader M, Bixler S, Roederer M, Veazey R, Mattapallil JJ. CD4 T cell subsets in the mucosa are CD28Ki-67HLA-DRCD69 but show differential infection based on alpha4beta7 receptor expression during acute SIV infection. J. Med. Primatol. 38 Suppl. 1: 24-31 (2009).
Kader M, Wang X, Piatak M, Lifson J, Roederer M, Veazey R, Mattapallil JJ. alpha4+beta7hiCD4+ memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol. 2: 439-449 (2009).
Kagatani S, Sasaki Y, Hirota M, Mizuashi M, Suzuki M, Ohtani T, Itagaki H, Aiba S. Oxidation of cell surface thiol groups by contact sensitizers triggers the maturation of dendritic cells. J. Invest. Dermatol. 130: 175-183 (2010). *
Kagnoff MF, Harwood JI, Bugawan TL, Erlich HA. Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype. Proc. Natl. Acad. Sci. U.S.A. 86: 6274-6278 (1989). *
Kahles H, Kordonouri O, Ramos Lopez E, Walter M, Rosinger S, Boehm BO, Badenhoop K, Seidl C, Ziegler A; Diabetes Genetics Consortium. Mating in parents of type 1 diabetes families as a function of the HLA DR-DQ haplotype. Diabetes Obes. Metab. 11 Suppl. 1: 84-87 (2009). *
Kahn MF, Bouchon JP, Chamot AM, Palazzo E. Chronic enterocolopathies and SAPHO syndrome. 8 cases. Rev. Rhum. Mal. Osteoartic. 59: 91-94 (1992).
Kahn MF, Khan MA. The SAPHO syndrome. Baillieres Clin. Rheumatol. 8: 333-362 (1994).
Kahraman A, Schlattjan M, Kocabayoglu P, Yildiz-Meziletoglu S, Schlensak M, Fingas CD, Wedemeyer I, Marquitan G, Gieseler RK, Baba HA, Gerken G, Canbay A. Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. Hepatology 51: 92-102 (2010). *
Kaibe M, Takakuwa K, Murakawa H, Ishii K, Tamura M, Tanaka K. Studies on the human leukocyte antigens in patients with polycystic ovary syndrome in a Japanese population - possible susceptibility of HLA-A11 and -DRB1*0403 to patient population with polycystic ovary syndrome. Am. J. Reprod. Immunol. 55: 301-306 (2006). *
Kaiser BK, Pizarro JC, Kerns J, Strong RK. Structural basis for NKG2A/CD94 recognition of HLA-E. Proc. Natl. Acad. Sci. U.S.A. 105: 6696-6701 (2008). *
Kaiser H. A dermatoligist and a rheumatologist define a syndrome: George Thibierge (1856-1926), Raymond J. Weissenbach (1885-1963). Z. Rheumatol. 68: 594-598, 600-601 (2009).
Kaistha A, Castells S. Celiac disease in African American children with type 1 diabetes mellitus in inner city Brooklyn. Pediatr. Endocrinol. Rev. 5 Suppl. 4: 994-998 (2008).
Kalish RS, Gilhar A. Alopecia areata: autoimmunity - the evidence is compelling. J. Investig. Dermatol. Symp. Proc. 8: 164-167 (2003). *
Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, van der Helm-van Mil AH, Toes RE, Huizinga TW, Klareskog L, Alfredsson L; Epidemiological Investigation of Rheumatoid Arthritis (EIRA) Study Group. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am. J. Hum. Genet. 80: 867-875 (2007). *
Kalli KR, Krco CJ, Hartmann LC, Goodman K, Maurer MJ, Yu C, Johnson EM, Erskine CL, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL. An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer. Cancer Res. 68: 4893-4901 (2008). *
Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK, Casciola-Rosen L, Hong G, Dellaripa PF, Highland KB. Clinical profile of anti-PL-12 autoantibody: cohort study and review of the literature. Chest 135: 1550-1556 (2009).
Kalman B, Lublin FD. The genetics of multiple sclerosis. A review. Biomed. Pharmacother. 53: 358-370 (1999).
Kalpaklioglu AF, Turan M. Possible association between cockroach allergy and HLA class II antigens. Ann. Allergy Asthma Immunol. 89: 155-158 (2002).
Kamata A, Chiba M, Ishii N, Kudo T, Horie Y, Iizuka M, Masamune O. Three cases of familial ulcerative colitis - in a mother and two of her sons. J. Gastroenterol. 32: 401-404 (1997).
Kamatani Y, Matsuda K, Ohishi T, Ohtsubo S, Yamazaki K, Iida A, Hosono N, Kubo M, Yumura W, Nitta K, Katagiri T, Kawaguchi Y, Kamatani N, Nakamura Y. Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population. J. Hum. Genet. 53: 64-73 (2008). *
Kammula US, Marincola FM. Cancer immunotherapy: is there real progress at last? BioDrugs 11: 249-260 (1999).
Kamphuis S, Kuis W, de Jager W, Teklenburg G, Massa M, Gordon G, Boerhof M, Rijkers GT, Uiterwaal CS, Otten HG, Sette A, Albani S, Prakken BJ. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 366: 50-56 (2005). *
Kanai T, Makita S, Kawamura T, Nemoto Y, Kubota D, Nagayama K, Totsuka T, Watanabe M. Extracorporeal elimination of TNF-alpha-producing CD14(dull)CD16(+) monocytes in leukocytapheresis therapy for ulcerative colitis. Inflamm. Bowel Dis. 13: 284-290 (2007). *
Kanazawa Y, Motohashi Y, Yamada S, Oikawa Y, Shigihara T, Okubo Y, Maruyama T, Shimada A. Frequency of CTLA-4 gene CT60 polymorphism may not be affected by vitamin D receptor gene Bsm I polymorphism or HLA DR9 in autoimmune-related type 1 diabetes in the Japanese. Ann. N. Y. Acad. Sci. 1079: 251-256 (2006). *
Kandler K, Shaykhiev R, Kleemann P, Klescz F, Lohoff M, Vogelmeier C, Bals R. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int. Immunol. 18: 1729-1736 (2006). *
Kane S, Kisiel J, Shih L, Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am. J. Gastroenterol. 99: 1523-1526 (2004). *
Kaneko T, Okiji T, Kaneko R, Nor JE, Suda H. Antigen-presenting cells in human radicular granulomas. J. Dent. Res. 87: 553-557 (2008). *
Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum. 54: 90-96 (2005). *
Kang MY, Hahm JR, Jung TS, Lee GW, Kim DR, Park MH. A 20-year-old woman with Hashimoto's thyroiditis and Evans' syndrome. Yonsei Med. J. 47: 432-436 (2006). *
Kanga U, Vaidyanathan B, Jaini R, Menon PS, Mehra NK. HLA haplotypes associated with type 1 diabetes mellitus in North Indian children. Hum. Immunol. 65: 47-53 (2004).
Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Sawada JI, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9: 1617-1622 (2008).
Kankonkar S, Jeyanti G, Singhal BS, Shankarkumar U. Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India. Hum. Immunol. 64: 478-482 (2003).
Kankonkar SR, Raikar SC, Joshi SV, Tijoriwala SJ. Association of HLA B27 antigen in Indian patients of ankylosing spondylitis and other autoimmune diseases. J. Assoc. Physicians India 46: 345-350 (1998).
Kannian P, Drouin EE, Glickstein L, Kwok WW, Nepom GT, Steere AC. Decline in the frequencies of Borrelia burgdorferi OspA161 175-specific T cells after antibiotic therapy in HLA-DRB1*0401-positive patients with antibiotic-responsive or antibiotic-refractory lyme arthritis. J. Immunol. 179: 6336-6342 (2007). *
Kano Y, Hirahara K, Asano Y, Shiohara T. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions. Acta Derm. Venereol. 88: 616-618 (2008).
Kantarci O, Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr. Opin. Neurol. 19: 248-254 (2006).
Kantarci OH. Genetics and natural history of multiple sclerosis. Semin. Neurol. 28: 7-16 (2008).
Kanterakis S, Magira E, Rosenman KD, Rossman M, Talsania K, Monos DS. SKDM human leukocyte antigen (HLA) tool: a comprehensive HLA and disease associations analysis software. Hum. Immunol. 69: 522-525 (2008).
Kanzler S, Bozkurt S, Herkel J, Galle PR, Dienes HP, Lohse AW. Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome). Dtsch. Med. Wochenschr. 126: 450-456 (2001).
Kanzler S, Weidemann C, Gerken G, Lohr HF, Galle PR, Meyer zum Buschenfelde KH, Lohse AW. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J. Hepatol. 31: 635-640 (1999). *
Kapitany A, Szabo Z, Lakos G, Aleksza M, Vegvari A, Soos L, Karanyi Z, Sipka S, Szegedi G, Szekanecz Z. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis. Isr. Med. Assoc. J. 10: 32-36 (2008). *
Kapitany A, Tarr T, Gyetvai A, Szodoray P, Tumpek J, Poor G, Szegedi G, Sipka S, Kiss E. Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome. Ann. N. Y. Acad. Sci. 1173: 545-551 (2009). *
Kapitany A, Zilahi E, Szanto S, Szucs G, Szabo Z, Vegvari A, Rass P, Sipka S, Szegedi G, Szekanecz Z. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary. Ann. N. Y. Acad. Sci. 1051: 263-270 (2005). *
Kaplan MM. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am. J. Gastroenterol. 99: 2147-2149 (2004). *
Kaplan MM, Bianchi DW. Primary biliary cirrhosis: for want of an X chromosome? Lancet 363: 505-506 (2004). *
Kapoerchan VV, Wiesner M, Hillaert U, Drijfhout JW, Overhand M, Alard P, van der Marel GA, Overkleeft HS, Koning F. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule. Mol. Immunol. Dec 2 [Epub ahead of print] (2009). *
Karahan GE, Seyhun Y, Oguz FS, Kekik C, Onal AE, Yazici H, Turkmen A, Aydin AE, Sever MS, Eldegez U, Carin MN. Impact of HLA on the underlying primary diseases in Turkish patients with end-stage renal disease. Ren. Fail. 31: 44-49 (2009).
Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD, Porter DL, Uberti JP, King RJ, Confer DL. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol. Blood Marrow Transplant. 14: S8-S15 (2008).
Karasneh J, Gul A, Ollier WE, Silman AJ, Worthington J. Whole-genome screening for susceptibility genes in multicase families with Behcet's disease. Arthritis Rheum. 52: 1836-1842 (2005). *
Karbach J, Gnjatic S, Bender A, Neumann A, Weidmann E, Yuan J, Ferrara CA, Hoffmann E, Old LJ, Altorki NK, Jager E. Tumor-reactive CD8(+) T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and montanide(R) ISA-51: association with survival. Int. J. Cancer 126: 909-918 (2009). *
Karban A, Waterman M, Panhuysen CI, Pollak RD, Nesher S, Datta L, Weiss B, Suissa A, Shamir R, Brant SR, Eliakim R. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic jews with Crohn's disease. Am. J. Gastroenterol. 99: 1134-1140 (2004). *
Karell K, Holopainen P, Mustalahti K, Collin P, Maki M, Partanen J. Not all HLA DR3 DQ2 haplotypes confer equal susceptibility to coeliac disease: transmission analysis in families. Scand. J. Gastroenterol. 37: 56-61 (2002). *
Karell K, Korponay-Szabo I, Szalai Z, Holopainen P, Mustalahti K, Collin P, Maki M, Partanen J. Genetic dissection between coeliac disease and dermatitis herpetiformis in sib pairs. Ann. Hum. Genet. 66: 387-392 (2002). *
Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, Ciclitira PJ, Sollid LM, Partanen J; European Genetics Cluster on Celiac Disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum. Immunol. 64: 469-477 (2003).
Karinen H, Karkkainen P, Pihlajamaki J, Janatuinen E, Heikkinen M, Julkunen R, Kosma VM, Naukkarinen A, Laakso M. HLA genotyping is useful in the evaluation of the risk for coeliac disease in the 1st-degree relatives of patients with coeliac disease. Scand. J. Gastroenterol. 41: 1299-1304 (2006). *
Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J. Hepatol. 46: 899-906 (2007). *
Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun. 8: 275-278 (2007). *
Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismuller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma R, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology Nov 25 [Epub ahead of print] (2009). *
Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, Devivo I, Costenbader KH. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident RA. Ann. Rheum. Dis. 69: 54-60 (2010). *
Karlson EW, Chibnik LB, Cui J, Plenge RM, Glass RJ, Maher NE, Parker A, Roubenoff R, Izmailova E, Coblyn JS, Weinblatt ME, Shadick NA. Associations between HLA, PTPN22, CTLA4 genotypes and RA phenotypes of autoantibody status, age at diagnosis, and erosions in a large cohort study. Ann. Rheum. Dis. 67: 358-363 (2008).
Karlsson-Parra A, Nyberg A, Totterman TH, Loof L, Forsum U. Primary biliary cirrhosis - phenotypic characterization of immunocompetent cells in peripheral blood and liver tissue. Ups. J. Med. Sci. 89: 254-265 (1984).
Karlsson-Parra A, Totterman TH, Nyberg A, Mendel-Hartvig I, Loof L, Forsum U. Immunological effects of ciclosporin in primary biliary cirrhosis: suppression of activated T cells and autoantibody levels. Int. Arch. Allergy Appl. Immunol. 83: 256-264 (1987).
Karni A, Kohn Y, Safirman C, Abramsky O, Barcellos L, Oksenberg JR, Kahana E, Karussis D, Chapman J, Brautbar C. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel. Mult. Scler. 5: 410-415 (1999). *
Karp DR, Marthandan N, Marsh SG, Ahn C, Arnett FC, Deluca DS, Diehl AD, Dunivin R, Eilbeck K, Feolo M, Guidry PA, Helmberg W, Lewis S, Mayes MD, Mungall C, Natale DA, Peters B, Petersdorf E, Reveille JD, Smith B, Thomson G, Waller MJ, Scheuermann RH. Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis. Hum. Mol. Genet. Nov 18 [Epub ahead of print] (2009).
Karvunidis T, Jindra P, Fischer G, Venigova P, Dorner A, Koza V. Identification of a novel HLA-DRB1*14 allele, HLA-DRB1*1458, by sequence-based typing. Tissue Antigens 70: 348-349 (2007). *
Karyampudi L, Formicola C, Erskine CL, Maurer MJ, Ingle JN, Krco CJ, Wettstein PJ, Kalli KR, Fikes JD, Beebe M, Hartmann LC, Disis ML, Ferrone S, Ishioka G, Knutson KL. A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102. Clin. Cancer Res. Jan 26 [Epub ahead of print] (2010). *
Karyampudi L, Krco CJ, Kalli KR, Erskine CL, Hartmann LC, Goodman K, Ingle JN, Maurer MJ, Nassar A, Yu C, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL. Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen. Cancer Immunol. Immunother. 59: 161-171 (2010).
Kashima A, Tajiri A, Yamashita A, Asada Y, Setoyama M. Two Japanese cases of lichen planus pigmentosus-inversus. Int. J. Dermatol. 46: 740-742 (2007). *
Kasten P, Beyen I, Egermann M, Suda AJ, Moghaddam AA, Zimmermann G, Luginbuhl R. Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro. Eur. Cell Mater. 16: 47-55 (2008).
Katahira M, Maeda H, Tosaki T, Segawa S. The human leukocyte antigen class II gene has different contributions to autoimmune type 1 diabetes with or without autoimmune thyroid disease in the Japanese population. Diabetes Res. Clin. Pract. 85: 293-297 (2009).
Katakura S. HLA-DR antigen expression on colonic epithelium of ulcerative colitis in comparison with infectious colitis and ischemic colitis. Nippon Shokakibyo Gakkai Zasshi 88: 1191-1199 (1991).
Katalin I, Koo E, Magdolna S, Vladimir B, Bitterova O. Genetics in patients with psoriatic arthritis. Orv. Hetil. 147: 2415-2419 (2006).
Kataria RK, Brent LH. Spondyloarthropathies. Am. Fam. Physician 69: 2853-2860 (2004). *
Katarina K, Daniela P, Peter N, Marianna R, Pavlina C, Stepanka P, Jan L, Ludmila T, Michal A, Marie C. HLA, NFKB1 and NFKBIA gene polymorphism profile in autoimmune diabetes mellitus patients. Exp. Clin. Endocrinol. Diabetes 115: 124-129 (2007).
Kato M, Kinukawa T, Hattori R, Tsuji Y, Hirano A, Horie K, Tsuyuki M, Mizutani K. Does MICA influence acute rejection in kidney transplantation? Clin. Transpl. 2006: 389-393 (2006).
Kato T, Itoh M, Hanashita J, Itoi T, Matsumoto T, Ono Y, Imamura S, Hayakawa N, Suzuki A, Mizutani Y, Uchigata Y, Oda N. Severe hypoglycaemia in a person with insulin autoimmune syndrome accompanied by insulin receptor anomaly type B. Diabet. Med. 24: 1279-1281 (2007). *
Kato T, Yazawa K, Madono K, Saito J, Hosomi M, Itoh K. Acute graft-versus-host-disease in kidney transplantation: case report and review of literature. Transplant. Proc. 41: 3949-3952 (2009). *
Kato Z, Stern JN, Nakamura HK, Kuwata K, Kondo N, Strominger JL. Positioning of autoimmune TCR-Ob.2F3 and TCR-Ob.3D1 on the MBP85-99/HLA-DR2 complex. Proc. Natl. Acad. Sci. U.S.A. 105: 15523-15528 (2008). *
Katsinelos P, Tsolkas P, Beltsis A, Chatzimavroudis G, Papaziogas B, Kapelidis P, Katsinelos T, Atmatzidis K, Paroutoglou G. Takayasu's arteritis and ulcerative colitis in a young non-Asian woman: a rare association. Vasa 34: 272-274 (2005).
Kaur G, Kumar N, Szilagyi A, Blasko B, Fust G, Rajczy K, Pozsonyi E, Hosso A, Petranyi G, Tandon N, Mehra N. Autoimmune-associated HLA-B8-DR3 haplotypes in Asian Indians are unique in C4 complement gene copy numbers and HSP-2 1267A/G. Hum. Immunol. 69: 580-587 (2008).
Kaur G, Sarkar N, Bhatnagar S, Kumar S, Rapthap CC, Bhan MK, Mehra NK. Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes. Hum. Immunol. 63: 677-682 (2002).
Kaur M, Schmeier S, Macpherson CR, Hofmann O, Hide WA, Taylor S, Willcox N, Bajic VB. Prioritizing genes of potential relevance to diseases affected by sex hormones: an example of myasthenia gravis. BMC Genomics 9: 481 (2008). *
Kaushansky N, Altmann DM, Ascough S, David CS, Lassmann H, Ben-Nun A. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. J. Immunol. 183: 3531-3541 (2009).
Kaushansky N, Eisenstein M, Zilkha-Falb R, Ben-Nun A. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Autoimmun. Rev. Aug 12 [Epub ahead of print] (2009).
Kavak A, Baykal C, Ozarmagan G, Akar U. HLA in alopecia areata. Int. J. Dermatol. 39: 589-592 (2000).
Kavanagh B, Ko A, Venook A, Margolin K, Zeh H, Lotze M, Schillinger B, Liu W, Lu Y, Mitsky P, Schilling M, Bercovici N, Loudovaris M, Guillermo R, Lee SM, Bender J, Mills B, Fong L. Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides. J. Immunother. 30: 762-772 (2007).
Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J. Gastroenterol. 42 Suppl. 18: 9-14 (2007). *
Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K, Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 122: 1264-1269 (2002). *
Kawabata K, Yamamoto K. Rheumatoid arthritis in the context of bone and cartilage. Recent advances in the pathogenesis of rheumatoid arthritis. Clin. Calcium 19: 303-309 (2009).
Kawabata Y, Ikegami H, Awata T, Imagawa A, Maruyama T, Kawasaki E, Tanaka S, Shimada A, Osawa H, Kobayashi T, Hanafusa T, Tokunaga K, Makino H; on behalf of the Committee on Type 1 Diabetes, Japan Diabetes Society. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia Oct 8 [Epub ahead of print] (2009). *
Kawabata Y, Ikegami H, Fujisawa T, Noso S, Asano K, Hiromine Y, Ogihara T. A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region. Ann. N. Y. Acad. Sci. 1079: 278-284 (2006). *
Kawabata Y, Ikegami H, Kawaguchi Y, Fujisawa T, Hotta M, Ueda H, Shintani M, Nojima K, Ono M, Nishino M, Taniguchi H, Noso S, Yamada K, Babaya N, Ogihara T. Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. Hum. Immunol. 61: 624-629 (2000).
Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DS, Hertl M, Goes NB, Wong W, Williams WW Jr, Colvin RB, Sykes M, Sachs DH. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358: 353-361 (2008). *
Kawamura K, McLaughlin KA, Weissert R, Forsthuber TG. Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice. J. Immunol. 181: 3202-3211 (2008). *
Kawamura K, Yao K, Shukaliak-Quandt JA, Huh J, Baig M, Quigley L, Ito N, Necker A, McFarland HF, Muraro PA, Martin R, Ito K. Different development of myelin basic protein agonist- and antagonist-specific human TCR transgenic T cells in the thymus and periphery. J. Immunol. 181: 5462-5472 (2008). *
Kawano A, Shimoda S, Kamihira T, Ishikawa F, Niiro H, Soejima Y, Taketomi A, Maehara Y, Nakamura M, Komori A, Migita K, Ishibashi H, Azuma M, Gershwin ME, Harada M. Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis. J. Immunol. 179: 3315-3324 (2007). *
Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K. Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun. 1: 351-357 (2000). *
Kawasaki E, Eguchi K. Genetics of fulminant type 1 diabetes. Ann. N. Y. Acad. Sci. 1079: 24-30 (2006). *
Kawasaki E, Imagawa A, Makino H, Uga M, Abiru N, Hanafusa T, Uchigata Y, Eguchi K. Differences in the contribution of CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care 31: 1608-1610 (2008). *
Kawase T, Akatsuka Y, Torikai H, Morishima S, Oka A, Tsujimura A, Miyazaki M, Tsujimura K, Miyamura K, Ogawa S, Inoko H, Morishima Y, Kodera Y, Kuzushima K, Takahashi T. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood 110: 1055-1063 (2007). *
Kayser K, Probst F, Gabius HJ, Muller KM. Are there characteristic alterations in lung tissue associated with Crohn's disease? Pathol. Res. Pract. 186: 485-490 (1990).
Kchir MM, Hamdi W, Laadhar L, Kochbati S, Kaffel D, Saadellaoui K, Lahmar H, Ghannouchi MM, Azzouz D, Daoud L, Ben Hamida A, Zouari B, Zitouni M, Makni S. HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study). Rheumatol. Int. Aug 5 [Epub ahead of print] (2009). *
Kedzierska A, Turowski G. HLA class I haplotypes in families of children with coeliac disease. Med. Sci. Monit. 6: 336-341 (2000).
Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes. J. Immunol. 172: 3955-3962 (2004). *
Keles B, Cora T, Acar H, Arbag H, Inan Z, Ozturk K, Ozer B. Evaluation of HLA-A, -B, -Cw, and -DRB1 alleles frequency in Turkish patients with nasal polyposis. Otolaryngol. Head Neck Surg. 139: 580-585 (2008).
Kelley JM, Hughes LB, Faggard JD, Danila MI, Crawford MH, Edberg Y, Padilla MA, Tiwari HK, Westfall AO, Alarcon GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD, Allison DB, Kimberly RP, Moreland LW, Edberg JC, Bridges SL. An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans. PLoS Genet. 5: e1000424 (2009). *
Kelly P, Patchett S, McCloskey D, Alstead E, Farthing M, Fairclough P. Sclerosing cholangitis, race and sex. Gut 41: 688-689 (1997). *
Kelsch R, Binder TM, Elsner HA, Eiermann TH, Sibrowski W. An HLA-DR11/DQ3 haplotype with a DRB1*0301 sequence motif in the third hypervariable region of the HLA-DR beta-1 chain: molecular and serological analysis of its generation in a European Caucasian family. Tissue Antigens 74: 330-335 (2009). *
Kempter W, Stein A, Bauer A, Wozel G. Therapy-resistant "psoriasis vulgaris". Hautarzt. 60: 332-335 (2009).
Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR, Oksenberg JR, Hauser SL, Clanet M, Brassat D, Edan G, Yaouanq J, Semana G, Cournu-Rebeix I, Lyon-Caen O, Fontaine B. A second-generation genomic screen for multiple sclerosis. Am. J. Hum. Genet. 75: 1070-1078 (2004). *
Kenealy SJ, Herrel LA, Bradford Y, Schnetz-Boutaud N, Oksenberg JR, Hauser SL, Barcellos LF, Schmidt S, Gregory SG, Pericak-Vance MA, Haines JL. Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44. Genes Immun. 7: 73-76 (2006). *
Kessler JH, Benckhuijsen WE, Mutis T, Melief CJ, van der Burg SH, Drijfhout JW. Competition-based cellular peptide binding assay for HLA class I. Curr. Protoc. Immunol. Chapter 18: Unit 18.12 (2004).
Kestelyn PG. An eye on inflammatory eye disease. Acta Clin. Belg. 60: 270-275 (2005).
Kettaneh A, Seng L, Tiev KP, Toledano C, Fabre B, Cabane J. Human leukocyte antigens and susceptibility to tuberculosis: a meta-analysis of case-control studies. Int. J. Tuberc. Lung Dis. 10: 717-725 (2006).
Key T, Taylor CJ, Bradley JA, Taylor AL. Recipients who receive a human leukocyte antigen-B compatible cadaveric liver allograft are at high risk of developing acute graft-versus-host disease. Transplantation 78: 1809-1811 (2004).
KeyBer G, Muller L, Schendel M, Schmoll HJ. Therapeutic application of mesenchymal stromal cells in autoimmune disease: rationale and initial clinical experience. Z. Rheumatol. 68: 220-227 (2009).
Keyeux G, Lefranc MP, Chevailler A, Lefranc G. Molecular analysis of the IGHA and MHC class III region genes in one family with IgA and C4 deficiencies. Exp. Clin. Immunogenet. 7: 170-180 (1990).
Khalil H, Brunet A, Thibodeau J. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35. J. Cell. Sci. 118: 4679-4687 (2005). *
Khalil I, Berrih-Aknin S, Lepage V, Loste MN, Gajdos P, Hors J, Charron D, Degos L. Trans-encoded DQ alpha beta heterodimers confer susceptibility to myasthenia gravis disease. C. R. Acad. Sci. III. 316: 652-660 (1993).
Khan MA. HLA-B27 and its pathogenic role. J. Clin. Rheumatol. 14: 50-52 (2008).
Khan MA, Khan MK. Analysis of genetic susceptibility to familial rheumatoid arthritis. Dis. Markers 4: 77-84 (1986).
Khan MA, Khan MK. HLA studies in familial and sporadic rheumatoid arthritis. Dis. Markers 4: 67-76 (1986).
Khan MA, Kushner I, Weitkamp LR. Genetics of HLA-associated disease; rheumatoid arthritis. Tissue Antigens 22: 182-185 (1983).
Khan MA, Mathieu A, Sorrentino R, Akkoc N. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun. Rev. 6: 183-189 (2007). *
Khani-Hanjani A, Lacaille D, Hoar D, Chalmers A, Horsman D, Anderson M, Balshaw R, Keown PA. Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 356: 820-825 (2000). *
Khani-Hanjani A, Lacaille D, Horne C, Chalmers A, Hoar DI, Balshaw R, Keown PA. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis. J. Rheumatol. 29: 1358-1365 (2002).
Khanna D, Wu H, Park G, Gersuk V, Gold RH, Nepom GT, Wong WK, Sharp JT, Reed EF, Paulus HE, Tsao BP. Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum. 54: 1105-1116 (2006). *
Khare M, Mangalam A, Rodriguez M, David CS. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice. J. Neuroimmunol. 169: 1-12 (2005).
Khare M, Rodriguez M, David CS. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. Int. Immunol. 15: 535-546 (2003). *
Khoshakhlagh P, Bahrololoumi-Shapourabadi M, Mohammadirad A, Ashtaral-Nakhai L, Minaie B, Abdollahi M. Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; molecular evidence for involvement of oxidative stress. Toxicol. Mech. Methods 17: 281-288 (2007).
Kiewe P, Mansmann V, Scheibenbogen C, Buhr HJ, Thiel E, Nagorsen D. HLA-A2 expression, stage, and survival in colorectal cancer. Int. J. Colorectal Dis. 23: 767-772 (2008). *
Kiewe P, Wojtke S, Thiel E, Nagorsen D. Antiviral cellular immunity in colorectal cancer patients. Hum. Immunol. 70: 85-88 (2009).
Kijlstra A, Luyendijk L, van der Gaag R, van Kregten E, Linssen A, Willers JM. IgG and IgA immune response against Klebsiella in HLA-B27-associated anterior uveitis. Br. J. Ophthalmol. 70: 85-88 (1986). *
Kikuchi S, Miyagishi R, Fukazawa T, Yabe I, Miyazaki Y, Sasaki H. TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis. J. Neuroimmunol. 167: 170-174 (2005).
Kikuoka N, Sugihara S, Yanagawa T, Ikezaki A, Kim HS, Matsuoka H, Kobayashi Y, Wataki K, Konda S, Sato H, Miyamoto S, Sasaki N, Sakamaki T, Niimi H, Murata M. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies. Clin. Endocrinol. (Oxf.) 55: 597-603 (2001). *
Kilby AE, Krawitt EL, Albertini RJ, Chastenay BF, John A. Suppressor T-cell deficiency in primary sclerosing cholangitis. Case and family study. Dig. Dis. Sci. 36: 1213-1216 (1991). *
Kilding R, Iles MM, Timms JM, Worthington J, Wilson AG. Additional genetic susceptibility for rheumatoid arthritis telomeric of the DRB1 locus. Arthritis Rheum. 50: 763-769 (2004). *
Kilic SS, Oral HB, Budak F, Aydogdu H, Yavascaoglu B, Goral G. Immunoglobulin subclasses and HLA alleles in immunoglobulin A deficiency. Indian J. Pediatr. 70: 389-392 (2003).
Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 93: 870-877 (2008). *
Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl. Acad. Sci. U.S.A. 101: 4175-4179 (2004). *
Kim DH, Jung HD, Kwack DH, Lee NY, Sohn SK, Baek JH, Kim JG, Suh JS, Lee KB, Shin IH. Predicting outcomes of HLA-identical allogeneic stem cell transplants from variable number of tandem repeat disparity between donors and recipients. Haematologica 91: 71-77 (2006). *
Kim EY, Shin CH, Yang SW. Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease. Autoimmunity 36: 177-181 (2003).
Kim HY, Kim TG, Park SH, Lee SH, Cho CS, Han H. Predominance of HLA-DRB1*0405 in Korean patients with rheumatoid arthritis. Ann. Rheum. Dis. 54: 988-990 (1995). *
Kim I, Kim YJ, Kim K, Kang C, Choi CB, Sung YK, Lee HS, Bae SC. Genetic studies of systemic lupus erythematosus in Asia: where are we now? Genes Immun. 10: 421-432 (2009).
Kim JJ, Hong SJ, Hong YM, Kim S, Kang MJ, Kim KJ, Seo EJ, Yoo HW, Cheong HS, Shin HD, Park IS, Lee JK. Genetic variants in the HLA-G region are associated with Kawasaki disease. Hum. Immunol. 69: 867-871 (2008).
Kim JU, Chang HK, Lee SS, Kim JW, Kim KT, Lee SW, Chung WT. Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis. Ann. Rheum. Dis. 62: 1083-1087 (2003). *
Kim K, Sung YK, Kang CP, Choi CB, Kang C, Bae SC. A regulatory SNP at position -899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis. Genes Immun. 10: 482-486 (2009).
Kim MH, Seong MC, Kwak NH, Yoo JS, Huh W, Kim TG, Han H. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am. J. Ophthalmol. 129: 173-177 (2000). *
Kim SH, Choi JH, Lee KW, Kim SH, Shin ES, Oh HB, Suh CH, Nahm DH, Park HS. The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clin. Exp. Allergy 35: 339-344 (2005). *
Kim TG, Choi HB, Park SH, Kim HY, Han H. DQCAR 113 and DQCAR 115 in combination with HLA-DRB1 alleles are significant markers of susceptibility to rheumatoid arthritis in the Korean population. Tissue Antigens 54: 552-559 (1999). *
Kim TH, Uhm WS, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr. Opin. Rheumatol. 17: 400-405 (2005).
Kim TJ, Na KS, Lee HJ, Lee B, Kim TH. HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin. Exp. Rheumatol. 27: 574-579 (2009).
Kimura H, Kato Y, Shimizu S, Takano K, Sato K. Association of polymorphism at position 49 in exon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction. Thyroid 19: 975-981 (2009).
Kimura M, Morise K. Immunohistochemical studies of ulcerative colitis - expression of HLA-DR antigen by colonic epithelium and the role of dendritic cells in the lamina propria. Nippon Shokakibyo Gakkai Zasshi 87: 187-194 (1990).
Kinikli G, Ates A, Turgay M, Akay G, Kinikli S, Tokgoz G. HLA-DRB1 genes and disease severity in rheumatoid arthritis in Turkey. Scand. J. Rheumatol. 32: 277-280 (2003).
Kiriyama K, Usui T, Takemura T, Ikeda K, Kishida H, Izumoto T, Kanayama Y, Hirota S. A case of rapid-onset antimitochondrial antibody-positive autoimmune hepatitis possibly triggered by a urinary tract infection. Nippon Shokakibyo Gakkai Zasshi 107: 270-277 (2010).
Kirsten H, Petit-Teixeira E, Scholz M, Hasenclever D, Hantmann H, Heider D, Wagner U, Sack U, Teixeira VH, Prum B, Burkhardt J, Pierlot C, Emmrich F, Cornelis F, Ahnert P. Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control study. Arthritis Res. Ther. 11: R60 (2009). *
Kishi A, Kawabata Y, Ugi S, Iwai T, Tanaka Y, Yoshizaki T, Uzu T, Nishio Y, Ikegami H, Kashiwagi A, Maegawa H. The onset of diabetes in three out of four sisters: a Japanese family with type 1 diabetes. A case report. Endocr. J. 56: 767-772 (2009). *
Kiszel P, Kovacs M, Szalai C, Yang Y, Pozsonyi E, Blasko B, Laki J, Prohaszka Z, Fazakas A, Panczel P, Hosszufalusi N, Rajczy K, Wu YL, Chung EK, Zhou B, Blanchong CA, Vatay A, Yu CY, Fust G. Frequency of carriers of 8.1 ancestral haplotype and its fragments in two Caucasian populations. Immunol. Invest. 36: 307-319 (2007). *
Kita H, Ansari AA, He XS, Lian ZX, Van de Water J, Coppel RL, Luketic V, Kaplan M, Inamori H, Isoda N, Sugano K, Imawari M, Gershwin ME. Proteasome is required for class I-restricted presentation by Fcgamma receptor-mediated endocytosis in primary biliary cirrhosis. J. Autoimmun. 21: 175-182 (2003). *
Kita H, Lian ZX, Van de Water J, He XS, Matsumura S, Kaplan M, Luketic V, Coppel RL, Ansari AA, Gershwin ME. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J. Exp. Med. 195: 113-123 (2002). *
Kita H, Matsumura S, He XS, Ansari AA, Lian ZX, Van de Water J, Coppel RL, Kaplan MM, Gershwin ME. Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis. Hepatology 36: 918-926 (2002). *
Kitagawa W, Imai H, Komatsuda A, Maki N, Wakui H, Hiki Y, Sugiyama S. The HLA-DRB1*1501 allele is prevalent among Japanese patients with anti-glomerular basement membrane antibody-mediated disease. Nephrol. Dial. Transplant. 23: 3126-3129 (2008). *
Kitumnuaypong T, Scalzi LV, Nalbant S, Von Feldt JM, Schumacher HR Jr. Is there a role for Chlamydia pneumoniae infection in systemic lupus erythematosus and in the associated atherosclerotic cardiovascular disease? Clin. Exp. Rheumatol. 22: 339-342 (2004).
Kivisakk P, Healy BC, Viglietta V, Quintana FJ, Hootstein MA, Weiner HL, Khoury SJ. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology 72: 1922-1930 (2009).
Klajman A, Drucker I, Mekori J. The importance of HLA-DR in autoimmune diseases. Isr. J. Med. Sci. 26: 691-692 (1990).
Klareskog L, Padyukov L, Lorentzen J, Alfredsson L. Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 2: 425-433 (2006). *
Klareskog L, Padyukov L, Ronnelid J, Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Curr. Opin. Immunol. 18: 650-655 (2006).
Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26: 651-675 (2008). *
Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Erlandsson Harris H, Ulfgren AK, Rantapaa-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 54: 38-46 (2005). *
Klausen T, Amris K, Helin P. Ulcerative colitis complicating seronegative HLA-A2-B27 rheumatoid arthritis with sacroiliitis. Ann. Rheum. Dis. 51: 1009-1011 (1992). *
Kleine G. A severe anemia in a young woman. Description of a rare coincidence. Dtsch. Med. Wochenschr. 132: 1571-1574 (2007).
Kleinschnitz C, Meuth SG, Kieseier BC, Wiendl H. Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis. Nervenarzt. 78: 883-911 (2007).
Klemola T, Savilahti E, Koskimies S, Pelkonen P. HLA antigens in IgA deficient paediatric patients. Tissue Antigens 32: 218-223 (1988).
Kling C, Steinmann J, Westphal E, Magez J, Kabelitz D. Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity. Hum. Reprod. 21: 429-435 (2006).
Klitz W, Bugawan TL, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P, Steiner L, Alejandrino M, Erlich HA. Association of CTLA-4 variation with type I diabetes in Filipinos. Immunogenetics 54: 310-313 (2002). *
Klitz W, Gragert L, Maiers M, Tu B, Lazaro A, Yang R, Xu Q, Masaberg C, Ng J, Hurley CK. Four-locus high-resolution HLA typing in a sample of Mexican Americans. Tissue Antigens Oct 21 [Epub ahead of print] (2009). *
Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM, Fernandez-Vina M. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 62: 296-307 (2003). *
Klouda PT, Harris R, Price DA. Linkage and association between HLA and 21-hydroxylase deficiency. J. Med. Genet. 17: 337-341 (1980). *
Klucar P, Barnes PF, Kong Y, Howard ST, Pang X, Huang FF, Tvinnereim AR, Samten B, Shams H. Vaccination strategies to enhance local immunity and protection against Mycobacteriun tuberculosis. Vaccine 27: 1816-1824 (2009).
Kluge F, Hoppe-Seyler P, Gerok W. Immunogenetic findings in Crohn disease, ulcerative colitis and gluten sensitive enteropathy. Z. Gastroenterol. 22: 277-284 (1984).
Klyushnenkova EN, Kouiavskaia DV, Berard CA, Alexander RB. Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection. J. Immunol. 182: 1242-1246 (2009).
Knapp B, Omasits U, Bohle B, Maillere B, Ebner C, Schreiner W, Jahn-Schmid B. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model. Mol. Immunol. 46: 1839-1844 (2009). *
Knapp S, Warshow U, Hegazy D, Brackenbury L, Guha IN, Fowell A, Little AM, Alexander GJ, Rosenberg WM, Cramp ME, Khakoo SI. Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology Nov 30 [Epub ahead of print] (2009). *
Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun. Rev. 7: 550-557 (2008).
Knopf PM, Rivera DS, Hai SH, McMurry J, Martin W, De Groot AS. Novel function of complement C3d as an autologous helper T-cell target. Immunol. Cell Biol. 86: 221-225 (2008). *
Knopfle G, Adam A, Fischer HP. Cholestasis-associated hepatopathies in neonates and infants. Pathologe 29: 61-72 (2008).
Koay LB, Sun CS, Tsai SL, Lin CY. Significant association of HLA-DQ5 with autoimmune hepatitis in Taiwan. J. Formos. Med. Assoc. 106: 1063-1068 (2007).
Kobayashi K, Atoh M, Konoeda Y, Yagita A, Inoko H, Sekiguchi S. HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis. Clin. Exp. Immunol. 80: 400-403 (1990). *
Kobayashi K, Atoh M, Yagita A, Konoeda Y, Inoko H, Ando A, Sekiguchi S. Crohn's disease in the Japanese is associated with the HLA-DRw53. Exp. Clin. Immunogenet. 7: 101-108 (1990).
Kobayashi M, Lee H, Nakayama J, Fukuda M. Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection. Curr. Drug Metab. 10: 29-40 (2009). *
Kochbati S, Ben Miled M, Boussema F, Ketari S, Ben Maatallah Kochbati A, Kraiem S, Ben Amor G, Ben Rhouma S, Cherif O, Rokbani L. Cardiac involvement in spondylarthropathies. Tunis. Med. 82: 1082-1090 (2004).
Kochi Y, Suzuki A, Yamada R, Yamamoto K. Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. J. Autoimmun. 32: 158-162 (2009).
Kochi Y, Yamada R, Kobayashi K, Takahashi A, Suzuki A, Sekine A, Mabuchi A, Akiyama F, Tsunoda T, Nakamura Y, Yamamoto K. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum. 50: 63-71 (2004). *
Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur. J. Immunogenet. 26: 361-372 (1999). *
Koehm S, Slavin RG, Hutcheson PS, Trejo T, David CS, Bellone CJ. HLA-DRB1 alleles control allergic bronchopulmonary aspergillosis-like pulmonary responses in humanized transgenic mice. J. Allergy Clin. Immunol. 120: 570-577 (2007).
Koeleman BP, Herr MH, Zavattari P, Dudbridge F, March R, Campbell D, Barnett AH, Bain SC, Mulargia AP, Loddo M, Amos W, Cucca F, Todd JA. Conditional ETDT analysis of the human leukocyte antigen region in type 1 diabetes. Ann. Hum. Genet. 64: 215-221 (2000).
Koeleman BP, Lie BA, Undlien DE, Dudbridge F, Thorsby E, de Vries RR, Cucca F, Roep BO, Giphart MJ, Todd JA. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun. 5: 381-388 (2004). *
Koesters SA, Matu L, Kiama P, Anzala O, Embree J, Plummer FA, Kimani J, Fowke KR. Elevation of immune activation in Kenyan women is associated with alterations in immune function: implications for vaccine development. J. Clin. Immunol. 24: 702-709 (2004). *
Kohler S, Thiel A, Rudwaleit M, Sieper J, Braun J. CD27+ memory and CD27- effector CD8+ T cells are responsible for a decreased production of proinflammatory cytokines in HLA B27-positive subjects. Clin. Exp. Rheumatol. 23: 840-846 (2005).
Kohonen-Corish MR, Serjeantson SW, Lee HK, Zimmet P. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups. Dis. Markers 5: 153-164 (1987).
Kokaraki G, Daniilidis M, Yiangou M, Arsenakis M, Karyotis N, Tsilipakou M, Fleva A, Gerofotis A, Karadani N, Yovos JG. Major histocompatibility complex class II (DRB1*, DQA1*, and DQB1*) and DRB1*04 subtypes' associations of Hashimoto's thyroiditis in a Greek population. Tissue Antigens 73: 199-205 (2009). *
Kokkonen H, Johansson M, Innala L, Eriksson C, Jidell E, Rantapaa Dahlqvist S. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody positive early rheumatoid arthritis in northern Sweden. Arthritis Res. Ther. 9: R56 (2007). *
Kollgaard T, Hadrup SR, Petersen SL, Masmas TN, Andersen MH, Spierings E, Vindelov L, Thor Straten P. Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: what are the requirements for a 'good' mHag? Leukemia 22: 1948-1951 (2008).
Kollman C, Maiers M, Gragert L, Muller C, Setterholm M, Oudshoorn M, Hurley CK. Estimation of HLA-A, -B, -DRB1 haplotype frequencies using mixed resolution data from a national registry with selective retyping of volunteers. Hum. Immunol. 68: 950-958 (2007).
Kolte AM, Steffensen R, Nielsen HS, Hviid TV, Christiansen OB. Study of the structure and impact of HLA-G-A, -B and -DRB1 haplotypes in families with recurrent miscarriage. Hum. Immunol. Feb 8 [Epub ahead of print] (2010).
Komata T, Tsuchiya N, Matsushita M, Hagiwara K, Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 53: 527-533 (1999). *
Komine M, Karakawa M, Takekoshi T, Sakurai N, Minatani Y, Mitsui H, Tada Y, Saeki H, Asahina A, Tamaki K. Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there Interaction between dendritic cells and keratinocytes? J. Invest. Dermatol. 127: 1915-1922 (2007). *
Kondrashova A, Mustalahti K, Kaukinen K, Viskari H, Volodicheva V, Haapala AM, Ilonen J, Knip M, Maki M, Hyoty H, Group TE. Lower economic status and inferior hygienic environment may protect against celiac disease. Ann. Med. 40: 223-231 (2008).
Kong KF, Yeap SS, Chow SK, Phipps ME. HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia. Autoimmunity 35: 235-239 (2002).
Kong SY, Kang S. Epstein-Barr virus-transformation of B-cell lines in ovarian cancer patients: feasibility of genomic storage for unlimited use. J. Gynecol. Oncol. 20: 243-245 (2009).
Kong YC, David CS. New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models. Int. Rev. Immunol. 19: 573-585 (2000).
Kong YC, Flynn JC, Banga JP, David CS. Application of HLA class II transgenic mice to study autoimmune regulation. Thyroid 17: 995-1003 (2007).
Kong YC, Flynn JC, Wan Q, David CS. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity 36: 397-404 (2003).
Kong YC, Jacob JB, Flynn JC, Elliott BE, Wei WZ. Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy. Autoimmun. Rev. 9: 28-33 (2009).
Kong YC, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, Hammerling GJ, David CS. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J. Exp. Med. 184: 1167-1172 (1996). *
Koning F, Schuppan D, Cerf-Bensussan N, Sollid LM. Pathomechanisms in celiac disease. Best Pract. Res. Clin. Gastroenterol. 19: 373-387 (2005).
Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GALEN task force consensus report: the autologous serum skin test in urticaria. Allergy 64: 1256-1268 (2009).
Kopacova M, Bures J, Vykouril L, Hladik P, Simkovic D, Jon B, Ferko A, Tacheci I, Rejchrt S. Intraoperative enteroscopy: ten years' experience at a single tertiary center. Surg. Endosc. 21: 1111-1116 (2007).
Korendowych E, Dixey J, Cox B, Jones S, McHugh N. The influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. J. Rheumatol. 30: 96-101 (2003).
Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology (Oxford) 44: 1056-1060 (2005). *
Koretz K, Momburg F, Otto HF, Moller P. Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease. Am. J. Pathol. 129: 493-502 (1987). *
Korniszewski L, Kurzyna M, Stolarski B, Torbicki A, Smerdel A, Ploski R. Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome. Eur. Respir. J. 22: 709-711 (2003). *
Korsten S, Purrmann J, Bertrams J, Reis HE, Miller B, Munch H, Korsten FW, Strohmeyer G. Genetics of Crohn disease: study of the HLA association in 169 patients. Klin. Wochenschr. 63: 747-751 (1985).
Kort JJ, Kawamura K, Fugger L, Weissert R, Forsthuber TG. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice. J. Neuroimmunol. 173: 23-34 (2006).
Korthals M, Safaian N, Kronenwett R, Maihofer D, Schott M, Papewalis C, Diaz Blanco E, Winter M, Czibere A, Haas R, Kobbe G, Fenk R. Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J. Transl. Med. 5: 46 (2007). *
Kosar Y, Kacar S, Sasmaz N, Oguz P, Turhan N, Parlak E, Heneghan MA, McFarlane IG. Type 1 autoimmune hepatitis in Turkish patients: absence of association with HLA B8. J. Clin. Gastroenterol. 35: 185-190 (2002).
Koskela RM, Karttunen TJ, Niemela SE, Lehtola JK, Ilonen J, Karttunen RA. Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis. Eur. J. Gastroenterol. Hepatol. 20: 276-282 (2008).
Kosmoliaptsis V, Chaudhry AN, Sharples LD, Halsall DJ, Dafforn TR, Bradley JA, Taylor CJ. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation 88: 791-798 (2009).
Kosmopoulou A, Vlassi M, Stavrakoudis A, Sakarellos C, Sakarellos-Daitsiotis M. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex. J. Comput. Chem. 27: 1033-1044 (2006). *
Kostic I, Toffoletto B, Fontanini E, Moretti M, Cesselli D, Beltrami CA, Ambesi Impiombato FS, Curcio F. Influence of iodide excess and interferon-gamma on human primary thyroid cell proliferation, thyroglobulin secretion, and intracellular adhesion molecule-1 and human leukocyte antigen-DR expression. Thyroid 19: 283-291 (2009).
Kostinov MP, Skochilova TV, Vorob'eva VA, Tarasova AA, Korovkina TI, Lukachev IV, Iushkova IIu, Vaneeva NP. Autoantibodies after vaccination against pneumococcal and influenza infections in children and adolescents with type I diabetes mellitus. Zh. Mikrobiol. Epidemiol. Immunobiol. 2: 53-57 (2009).
Kotake S, Kamatani N. Association of polymorphisms in genes of osteoclastogenesis-related cytokines with severity in patients with rheumatoid arthritis. Nippon Rinsho 63: 1574-1578 (2005).
Kotalova R, Vrana M, Dobrovolna M, Nevoral J, Loudova M. HLA-DRB1/DQA1/DQB1 alleles and haplotypes in Czech children with celiac sprue. Cas. Lek. Cesk. 141: 518-522 (2002).
Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin. Endocrinol. (Oxf.) 46: 551-554 (1997).
Kotter I, Schedel J, Kummerle-Deschner JB. Periodic fever syndrome/autoinflammatory syndrome. Z. Rheumatol. 68: 137-149 (2009).
Kotturi MF, Assarsson E, Peters B, Grey H, Oseroff C, Pasquetto V, Sette A. Of mice and humans: how good are HLA transgenic mice as a model of human immune responses? Immunome Res. 5: 3 (2009). *
Kovacs A, Endreffy E, Petri I, Kovacs L, Pokorny G. HLA class II allele polymorphism in Hungarian patients with primary Sjogren's syndrome. Scand. J. Rheumatol. 35: 75-76 (2006). *
Kralovicova J, Hammarstrom L, Plebani A, Webster AD, Vorechovsky I. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J. Immunol. 170: 2765-2775 (2003). *
Kramer W, Glombik H. Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs. Curr. Med. Chem. 13: 997-1016 (2006).
Krasowska D, Pietrzak A, Surdacka A, Tuszynska-Bogucka V, Janowski K, Rolinski J. Psychological stress, endocrine and immune response in patients with lichen planus. Int. J. Dermatol. 47: 1126-1134 (2008). *
Kratz LE, Boughman JA, Needleman BW. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5. Dis. Markers 7: 209-213 (1989).
Kredel M, Brederlau J, Roewer N, Wunder C. Cholestasis and liver dysfunction in critical care patients. Anaesthesist 57: 1172-1182 (2008).
Krenn V, Jakobs M, Kriegsmann J, Krukemeyer MG, Rieger A. Is bioptic assurance reasonable in patients with Sjogren's syndrome? From focus score to diagnosing vasculitides. Z. Rheumatol. 69: 11-18 (2010).
Kriegel MA, Adam-Klages S, Gabler C, Blank N, Schiller M, Scheidig C, Kalden JR, Lorenz HM. Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy. Int. Immunol. 20: 601-613 (2008).
Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 34: 391-399 (1997). *
Kroesen AJ, Grone J, Buhr HJ, Ritz JP. Therapy of refractory proctocolitis and Crohn's disease: incisionless laparoscopic proctocolectomy with a Brooke ileostomy. Chirurg. 80: 730-733 (2009).
Kroger N, Zabelina T, Binder T, Ayuk F, Bacher U, Amtsfeld G, Lellek H, Schrum J, Erttmann R, Eiermann T, Zander A. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen. Biol. Blood Marrow Transplant. 15: 454-462 (2009).
Krokowski M, Bodalski J, Bratek A, Boitard C, Caillat-Zucman S. HLA class II-associated predisposition to insulin-dependent diabetes mellitus in a Polish population. Hum. Immunol. 59: 451-455 (1998).
Kruger A, Adams P, Hammer J, Bocher WO, Schneider PM, Rittner C, Hoehler T. Hepatitis B surface antigen presentation and HLA-DRB1* - lessons from twins and peptide binding studies. Clin. Exp. Immunol. 140: 325-332 (2005). *
Kruger A, Quack P, Schneider PM, Rittner C, Hohler T. Sequence analysis of the DRB1 promoter reveals limited polymorphism with no influence on gene expression. Genes Immun. 2: 211-215 (2001). *
Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J. Exp. Med. 175: 495-502 (1992). *
Ksiaa L, Ayed-Jendoubi S, Sfar I, Gorgi Y, Najjar HA, Abdallah TB, Ayed K. Clearance and persistence of hepatitis C virus in a tunisian population: association with HLA classI and class II. Viral Immunol. 20: 312-319 (2007).
Kuang DM, Zhao Q, Peng C, Xu J, Zhang JP, Wu C, Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med. 206: 1327-1337 (2009). *
Kuang M, Wang S, Wu M, Ning G, Yao Z, Li L. Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid-stimulating hormone receptors in Graves' disease. Mol. Cell. Endocrinol. Dec 13 [Epub ahead of print] (2009).
Kubryn I, Mlynarski W, Trippenbach-Dulska H, Szalecki M, Lisowicz L, Surdej B, Pilecki O, Heinrich A, Wyka K, Perenc M, Bodalski J. Alleles of HLA-DQB1 and familial aggregation of type 1 diabetes. Med. Wieku. Rozwoj. 7: 157-164 (2003).
Kudela P, Janjic B, Fourcade J, Castelli F, Andrade P, Kirkwood JM, El-Hefnawy T, Amicosante M, Maillere B, Zarour HM. Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients. J. Immunol. 179: 7932-7940 (2007). *
Kuhne M, Erben U, Schulze-Tanzil G, Kohler D, Wu P, Richter FJ, John T, Radbruch A, Sieper J, Appel H. HLA-B27-restricted antigen presentation by human chondrocytes to CD8+ T cells: potential contribution to local immunopathologic processes in ankylosing spondylitis. Arthritis Rheum. 60: 1635-1646 (2009). *
Kuhnl P, Sibrowski W, Bohm BO, Bender SW, Kalmar G, Loliger C. HLA antigen frequencies in familial Crohn's disease (CD). Beitr. Infusionsther. 26: 283-286 (1990).
Kuipers JG, Bialowons A, Dollmann P, Jendro MC, Wagener N, Rebmann V, Ikeda M, Huang F, Grosse-Wilde H, Yu DT, Zeidler H, Marker-Hermann E. The genetically-engineered secretory B27/Q10 chimeric molecule inhibits HLA-B27 restricted alloreactive T-lymphocytes. Clin. Exp. Rheumatol. 20: 455-462 (2002).
Kula D, Bednarczuk T, Jurecka-Lubieniecka B, Polanska J, Hasse-Lazar K, Jarzab M, Steinhof-Radwanska K, Hejduk B, Zebracka J, Kurylowicz A, Bar-Andziak E, Stechly T, Pawlaczek A, Gubala E, Krawczyk A, Szpak-Ulczok S, Nauman J, Jarzab B. Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07. Thyroid 16: 447-453 (2006).
Kulkarni O, Anders HJ. CCL2/MCP1: a novel target in systemic lupus erythematosus and lupus nephritis. Z. Rheumatol. 67: 220-224 (2008).
Kulkarni S, Single RM, Martin MP, Rajalingam R, Badwe R, Joshi N, Carrington M. Comparison of the rapidly evolving KIR locus in Parsis and natives of India. Immunogenetics 60: 121-129 (2008). *
Kuloglu Z, Doganci T, Kansu A, Demirceken F, Duman M, Tutkak H, Ensari A, Girgin N. HLA types in Turkish children with celiac disease. Turk. J. Pediatr. 50: 515-520 (2008).
Kumagi T, Alswat K, Hirschfield GM, Heathcote J. New insights into autoimmune liver diseases. Hepatol. Res. 38: 745-761 (2008). *
Kumar M, Sundaramurthi JC, Mehra NK, Kaur G, Raja A. Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India. Med. Microbiol. Immunol. Nov 10 [Epub ahead of print] (2009). *
Kumar N, Kaur G, Tandon N, Mehra NK. Allotyping human complement factor B in Asian Indian type 1 diabetic patients. Tissue Antigens 72: 517-524 (2008). *
Kumar R, Goswami R, Agarwal S, Israni N, Singh SK, Rani R. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens 69: 557-567 (2007). *
Kumar R, Lumsden A, Ciclitira PJ, Ellis HJ, Laurie GW. Human genome search in celiac disease using gliadin cDNA as probe. J. Mol. Biol. 300: 1155-1167 (2000). *
Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J. Viral Hepat. 14: 841-848 (2007).
Kumpfel T, Hoffmann LA, Pellkofer H, Pollmann W, Feneberg W, Hohlfeld R, Lohse P. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases. Neurology 71: 1812-1820 (2008).
Kunishige JH, Hymes SR, Madkan V, Wyatt AJ, Uptmore D, Lazar AJ, Giralt S, Rady P, Tyring S. Epidermodysplasia verruciformis in the setting of graft-versus-host disease. J. Am. Acad. Dermatol. 57: S78-S80 (2007).
Kunstmann E, Hardt C, Crabtree JE, Suerbaum S, Epplen JT. Helicobacter pylori infection: CagA-specific antibodies are associated with clinical outcome, but not with HLA-class II polymorphisms of the host. Int. J. Med. Microbiol. 292: 537-540 (2003).
Kunstmann E, Hardt C, Treitz H, Suerbaum S, Faller G, Peitz U, Schmiegel W, Epplen JT. In the European population HLA-class II genes are not associated with Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 14: 49-53 (2002).
Kuokkanen S, Sundvall M, Terwilliger JD, Tienari PJ, Wikstrom J, Holmdahl R, Pettersson U, Peltonen L. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat. Genet. 13: 477-480 (1996). *
Kurdow R, Marks HG, Kraemer-Hansen H, Luttges J, Kremer B, Henne-Bruns D. Recurrence of primary biliary cirrhosis after orthotopic liver transplantation. Hepatogastroenterology 50: 322-325 (2003).
Kuroki K, Tsuchiya N, Shiroishi M, Rasubala L, Yamashita Y, Matsuta K, Fukazawa T, Kusaoi M, Murakami Y, Takiguchi M, Juji T, Hashimoto H, Kohda D, Maenaka K, Tokunaga K. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. Hum. Mol. Genet. 14: 2469-2480 (2005). *
Kurylowicz A, Kula D, Ploski R, Skorka A, Jurecka-Lubieniecka B, Zebracka J, Steinhof-Radwanska K, Hasse-Lazar K, Hiromatsu Y, Jarzab B, Bednarczuk T. Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease. Thyroid 15: 1119-1124 (2005).
Kurylowicz A, Miskiewicz P, Bar-Andziak E, Nauman J, Bednarczuk T. Association of polymorphism in genes encoding kappa B inhibitors (IkappaB) with susceptibility to and phenotype of Graves' disease: a case-control study. Thyroid Res. 2: 10 (2009).
Kurylowicz A, Ramos-Lopez E, Bednarczuk T, Badenhoop K. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. Exp. Clin. Endocrinol. Diabetes 114: 329-335 (2006).
Kurzwelly D, Muller CA, Korfel A, Thiel E, Linnebank M, Weller M, Herrlinger U. Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients. J. Neurooncol. 90: 53-55 (2008).
Kusaka I, Nagasaka S, Fujibayashi K, Hayashi H, Kawakami A, Nakamura T, Rokkaku K, Saito T, Higashiyama M, Honda K, Ishikawa S, Saito T. Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement. Endocr. J. 46: 747-754 (1999).
Kuwana M, Inoko H, Kameda H, Nojima T, Sato S, Nakamura K, Ogasawara T, Hirakata M, Ohosone Y, Kaburaki J, Okano Y, Mimori T. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. Intern. Med. 38: 336-344 (1999). *
Kuwana M, Kaburaki J, Pandey JP, Murata M, Kawakami Y, Inoko H, Ikeda Y. HLA class II alleles in Japanese patients with immune thrombocytopenic purpura. Associations with anti-platelet glycoprotein autoantibodies and responses to splenectomy. Tissue Antigens 56: 337-343 (2000).
Kuwana M, Kimura K, Hirakata M, Kawakami Y, Ikeda Y. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases. Ann. Rheum. Dis. 61: 842-846 (2002). *
Kuwana M, Matsuura E, Kobayashi K, Okazaki Y, Kaburaki J, Ikeda Y, Kawakami Y. Binding of beta2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. Blood 105: 1552-1557 (2005). *
Kuwana M, Okano Y, Kaburaki J, Inoko H. HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma). Ann. Rheum. Dis. 54: 983-987 (1995). *
Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, Kaneshige T, Tatsumi T, Ito A, Mochizuki K, Sasaki Y, Kasahara A, Hori M. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 27: 240-244 (1998). *
Kvien TK, Moller P, Dale K. Juvenile ankylosing spondylitis and HLA B27 homozygosity. Scand. J. Rheumatol. 14: 47-50 (1985).
Kvistborg P, Hadrup SR, Svane IM, Andersen MH, Straten PT. Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patients. Hum. Immunol. 69: 266-272 (2008).
Kwak JH, Kim SI, Kim JK, Choi ME. BAT3 interacts with transforming growth factor-beta (TGF-beta) receptors and enhances TGF-beta1-induced type I collagen expression in mesangial cells. J. Biol. Chem. 283: 19816-19825 (2008). *
Kwok WW, Lotshaw C, Milner EC, Knitter-Jack N, Nepom GT. Mutational analysis of the HLA-DQ3.2 insulin-dependent diabetes mellitus susceptibility gene. Proc. Natl. Acad. Sci. U.S.A. 86: 1027-1030 (1989). *
Kwon OJ, Brautbar C, Weintrob N, Sprecher E, Saphirman C, Bloch K, Pinhas-Hamiel O, Assah S, Vardi P, Israel S. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients. Hum. Immunol. 62: 85-91 (2001).
Kwon OJ, Karni A, Israel S, Brautbar C, Amar A, Meiner Z, Abramsky O, Karussis D. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch. Neurol. 56: 555-560 (1999). *
Kyogoku C, Tsuchiya N, Matsuta K, Tokunaga K. Studies on the association of Fc gamma receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A. Genes Immun. 3: 488-493 (2002). *
La Nasa G, Carcassi C, Cirillo R, Mulargia M, Leone AL, Vacca A, Pizzati A, Boero R, Arras M, Porcella R, et al. Serological and molecular studies of HLA in insulin-dependent diabetes mellitus in Sardinia. Dis. Markers 8: 333-340 (1990).
La Nasa G, Littera R, Locatelli F, Giardini C, Ventrella A, Mulargia M, Vacca A, Orru N, Orru S, Piras E, Giustolisi G, Lisini D, Nesci S, Caocci G, Carcassi C. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients. Biol. Blood Marrow Transplant. 13: 1358-1368 (2007).
Laadhar L, Toumi A, Kallel-Sellami M, Zitouni M, Bouraoui S, Maherzi A, Makni S, Ben Hariz M. HLA class II polymorphism in children with coeliac disease in Tunisia: is there any influence on clinical manifestation? Eur. J. Gastroenterol. Hepatol. 21: 1286-1290 (2009).
Laaksonen M, Pastinen T, Sjoroos M, Kuokkanen S, Ruutiainen J, Sumelahti ML, Reijonen H, Salonen R, Wikstrom J, Panelius M, Partanen J, Tienari PJ, Ilonen J. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study. J. Neuroimmunol. 122: 140-145 (2002).
Lachance DH, Lennon VA, Pittock SJ, Tracy JA, Krecke KN, Amrami KK, Poeschla EM, Orenstein R, Scheithauer BW, Sejvar JJ, Holzbauer S, Devries AS, Dyck PJ. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol. Nov 27 [Epub ahead of print] (2009).
Lachlan KL, Karen Temple I, Mumford AD. Clinical features and molecular analysis of seven British kindreds with hereditary hyperferritinaemia cataract syndrome. Eur. J. Hum. Genet. 12: 790-796 (2004). *
Lahteenoja H, Maki M, Viander M, Raiha I, Vilja P, Rantala I, Toivanen A, Syrjanen S. Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease. Am. J. Gastroenterol. 95: 2880-2887 (2000). *
Lahteenoja H, Maki M, Viander M, Toivanen A, Syrjanen S. Local challenge of oral mucosa with gliadin in patients with coeliac disease. Clin. Exp. Immunol. 120: 38-45 (2000). *
Lahteenoja H, Toivanen A, Viander M, Raiha I, Rantala I, Syrjanen S, Maki M. Increase in T-cell subsets of oral mucosa: a late immune response in patients with treated coeliac disease? Scand. J. Immunol. 52: 602-608 (2000). *
Lai HJ, Shoff SM. Classification of malnutrition in cystic fibrosis: implications for evaluating and benchmarking clinical practice performance. Am. J. Clin. Nutr. 88: 161-166 (2008). *
Lai HJ, Shoff SM, Farrell PM; with the Wisconsin Cystic Fibrosis Neonatal Screening Group. Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis. Pediatrics 123: 714-722 (2009). *
Laivoranta-Nyman S, Mottonen T, Hannonen P, Korpela M, Kautiainen H, Leirisalo-Repo M, Julkunen H, Luukkainen R, Hakala M, Vuori K, Laine AP, Toivanen A, Ilonen J. Association of tumour necrosis factor a, b and c microsatellite polymorphisms with clinical disease activity and induction of remission in early rheumatoid arthritis. Clin. Exp. Rheumatol. 24: 636-642 (2006).
Laivoranta-Nyman S, Mottonen T, Hermann R, Tuokko J, Luukkainen R, Hakala M, Hannonen P, Korpela M, Yli-Kerttula U, Toivanen A, Ilonen J; FIN-RACo Trial Group. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann. Rheum. Dis. 63: 1406-1412 (2004). *
Laivoranta-Nyman S, Mottonen T, Luukkainen R, Hakala M, Yli-Kerttula U, Hannonen P, Tuokko J, Toivanen A, Ilonen J. Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis. Ann. Rheum. Dis. 59: 173-177 (2000). *
Lakhanpal S, O'Duffy JD, Homburger HA, Moore SB. Evidence for linkage of IgA deficiency with the major histocompatibility complex. Mayo Clin. Proc. 63: 461-465 (1988).
Laki J, Kiszel P, Vatay A, Blasko B, Kovacs M, Korner A, Madacsy L, Blatniczky L, Almassy Z, Szalai C, Rajczy K, Pozsonyi E, Karadi I, Fazakas A, Hosszufalusi N, Panczel P, Arason GJ, Wu YL, Zhou B, Yang Y, Yu CY, Fust G. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation end product (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobin(A1C) levels � Mol. Immunol. 44: 648-655 (2007). *
Laki J, Laki I, Nemeth K, Ujhelyi R, Bede O, Endreffy E, Bolbas K, Gyurkovits K, Csiszer E, Solyom E, Dobra G, Halasz A, Pozsonyi E, Rajczy K, Prohaszka Z, Fekete G, Fust G. The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis. Int. Immunol. 18: 1585-1590 (2006). *
Lakos G, Soos L, Fekete A, Szabo Z, Zeher M, Horvath IF, Danko K, Kapitany A, Gyetvai A, Szegedi G, Szekanecz Z. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope. Clin. Exp. Rheumatol. 26: 253-260 (2008).
Lambert AP, Gillespie KM, Thomson G, Cordell HJ, Todd JA, Gale EA, Bingley PJ. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J. Clin. Endocrinol. Metab. 89: 4037-4043 (2004). *
Lambert N, Nelson JL. Microchimerism in autoimmune disease: more questions than answers? Autoimmun. Rev. 2: 133-139 (2003).
Lambert NC, Stevens AM, Tylee TS, Erickson TD, Furst DE, Nelson JL. From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis. Ann. N. Y. Acad. Sci. 945: 164-171 (2001). *
Lamoureux JL, Buckner JH, David CS, Bradley DS. Mice expressing HLA-DQ6ab8ab transgenes develop polychondritis spontaneously. Arthritis Res. Ther. 8: R134 (2006). *
Lamprecht P. New pathogenetic aspects in primary systemic vasculitides. Internist (Berl.) 50: 291-297 (2009).
Lamprecht P. Adult-onset Still's disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood. Z. Rheumatol. 68: 740-746 (2009).
Lamprecht P, Gross WL. Autoinflammatory syndromes. Internist (Berl.) 50: 676-684 (2009).
Lamprecht P, Gross WL. Current knowledge on cellular interactions in the WG-granuloma. Clin. Exp. Rheumatol. 25: S49-S51 (2007).
Lamprecht P, Till A, Kabelitz D. New aspects of the pathogenesis of gout: danger signals, autoinflammation and beyond. Z. Rheumatol. 67: 151-156 (2008).
Lan NT, Kikuchi M, Huong VT, Ha do Q, Thuy TT, Tham VD, Tuan HM, Tuong VV, Nga CT, Van Dat T, Oyama T, Morita K, Yasunami M, Hirayama K. Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl. Trop. Dis. 2: e304 (2008). *
Lan T, Zhang D, Wang G. Polymorphism of HLA-A,-B and DRB1 in Han population of Shanxi province. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22: 583-584 (2005).
Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 3: 940-943 (2002). *
Lang T, Haberl M, Jung D, Drescher A, Schlagenhaufer R, Keil A, Mornhinweg E, Stieger B, Kullak-Ublick G, Kerb R. Genetic variability, haplotype structures, and ethnical diversity of hepatic transporters MDR3 (ABCB4) and BSEP (ABCB11). Drug Metab. Dispos. 34: 1582-1599 (2006). *
Lange A. Genetic factors predicting IFN-gamma generation potential in patients with sarcoidosis and after haematopoietic stem cell transplantation. Int. J. Immunogenet. 35: 385-388 (2008). *
Lanino E, Sacchi N, Peters C, Giardino S, Rocha V, Dini G; EBMT Paediatric, Acute Leukemia Working Parties; Eurocord. Strategies of the donor search for children with second CR ALL lacking a matched sibling donor. Bone Marrow Transplant. 41 Suppl. 2: S75-S79 (2008).
Lapaque N, Hutchinson JL, Jones DC, Meresse S, Holden DW, Trowsdale J, Kelly AP. Salmonella regulates polyubiquitination and surface expression of MHC class II antigens. Proc. Natl. Acad. Sci. U.S.A. 106: 14052-14057 (2009). *
Lapaque N, Jahnke M, Trowsdale J, Kelly AP. The HLA-DRalpha chain is modified by poly-ubiquitination. J. Biol. Chem. 284: 7007-7016 (2009). *
Lapinski TW, Puzanowska B, Ziarko S. Prevalence of HLA class I and II antigens and extra-bowel manifestations in ulcerative colitis. Pol. Merkuriusz. Lek. 13: 133-136 (2002).
Lappalainen M, Halme L, Turunen U, Saavalainen P, Einarsdottir E, Farkkila M, Kontula K, Paavola-Sakki P. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflamm. Bowel Dis. 14: 1118-1124 (2008). *
Lara-Marquez ML, Yunis JJ, Layrisse Z, Ortega F, Carvallo-Gil E, Montagnani S, Makhatadze NJ, Pocino M, Granja C, Yunis E. Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population. Clin. Exp. Allergy 29: 60-71 (1999). *
Larche M. Determining MHC restriction of T-cell responses. Methods Mol. Med. 138: 57-72 (2008). *
Larizza D, Calcaterra V, Martinetti M, Negrini R, De Silvestri A, Cisternino M, Iannone AM, Solcia E. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J. Clin. Endocrinol. Metab. 91: 176-179 (2006). *
Laroni A, Calabrese M, Perini P, Albergoni MP, Ranzato F, Tiberio M, Battistin L, Gallo P. Multiple sclerosis and autoimmune diseases epidemiology and HLA-DR association in North-east Italy. J. Neurol. 253: 636-639 (2006). *
Larsen F, Oturai A, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Sawcer S, Fugger L, Sorensen PS, Svejgaard A. Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q. Genes Immun. 1: 456-459 (2000). *
Larsson HE, Hansson G, Carlsson A, Cederwall E, Jonsson B, Jonsson B, Larsson K, Lynch K, Neiderud J, Lernmark A, Ivarsson SA; for the DiPiS Study Group. Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes. Diabetologia 51: 1623-1630 (2008). *
Larsson K, Carlsson A, Cederwall E, Jonsson B, Neiderud J, Jonsson B, Lernmark A, Ivarsson SA; on behalf of the Skane Study Group. Annual screening detects celiac disease in children with type 1 diabetes. Pediatr. Diabetes 9: 354-359 (2008).
Latham KA, Whittington KB, Zhou R, Qian Z, Rosloniec EF. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints. J. Immunol. 174: 3978-3985 (2005). *
Latinne D, Vandeput Y, De Bruyere M, Bottazzo F, Sokal G, Crabbe J. Addison's disease: immunological aspects. Tissue Antigens 30: 23-24 (1987).
Laub R, Dorsch M, Meyer D, Ermann J, Hedrich HJ, Emmrich F. A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses. J. Immunol. Methods 246: 37-50 (2000). *
Lavant EH, Carlson JA. A new automated human leukocyte antigen genotyping strategy to identify DR-DQ risk alleles for celiac disease and type 1 diabetes mellitus. Clin. Chem. Lab. Med. 47: 1489-1495 (2009). *
Lawrence BP, Denison MS, Novak H, Vorderstrasse BA, Harrer N, Neruda W, Reichel C, Woisetschlager M. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low molecular weight compound. Blood 112: 1158-1165 (2008). *
Lawrence SP, Sherman KE, Lawson JM, Goodman ZD. A 39 year old man with chronic hepatitis. Semin. Liver Dis. 14: 97-105 (1994).
Layrisse Z, Matos M, Montagnani S, Herrera F. The novel HLA-DRB1*0807 allele is present in a Carib Amerindian population: the Yucpa. Tissue Antigens 49: 427-428 (1997).
Layrisse Z, White C, Gunczler P, Gafaro Valera L, Arias S, Yunis EJ, Alper CA, Awdeh ZL. Sharing of MHC haplotypes among apparently unrelated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Immunogenetics 25: 99-103 (1987).
Lazaro AM, Hwang WY, Yeoh AE, Ng J, Posch PE. Characterization of new HLA-B and -DRB1 alleles from Singapore. Tissue Antigens 73: 75-76 (2009). *
Lazaro AM, Xiao Y, Masaberg C, Lebeck L, Ng J, Hurley CK, Posch PE. Novel alleles at the HLA-DRB1 and -DQB1 loci. Tissue Antigens 72: 72-74 (2008). *
Lazaro AM, Xiao Y, Regenscheid A, Ng J, Hurley CK, Posch PE. Characterization of 104 novel alleles at the HLA-A, -B, and -DRB1 loci from National Marrow Donor Program volunteer donors. Tissue Antigens 73: 364-372 (2009). *
Le Poole IC, Luiten RM. Autoimmune etiology of generalized vitiligo. Curr. Dir. Autoimmun. 10: 227-243 (2008).
Leb VM, Jahn-Schmid B, Schmetterer KG, Kueng HJ, Haiderer D, Neunkirchner A, Fischer GF, Nissler K, Hartl A, Thalhamer J, Bohle B, Seed B, Pickl WF. Molecular and functional analysis of the antigen receptor of Art v 1-specific helper T lymphocytes. J. Allergy Clin. Immunol. 121: 64-71 (2008). *
Lebedeva T, Harrison K, Fresia B, Ohashi M, Yu N. DQB1 intron 3 sequences provide an insight into the evolution of DQB1 alleles and form the basis for intron-based sequencing. Tissue Antigens 74: 339-342 (2009). *
Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, Kapsenberg ML, de Jong EC. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127: 331-341 (2007). *
Lecendreux M, Bassetti C, Dauvilliers Y, Mayer G, Neidhart E, Tafti M. HLA and genetic susceptibility to sleepwalking. Mol. Psychiatry 8: 114-117 (2003). *
Leden I, Gotherstrom A, Drenzel L, Svensson B. HLA-B27 sequences identified in a mediaeval skeleton with ankylosing spondylitis. Ann. Rheum. Dis. 68: 757-758 (2009).
Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM, Kent J, Wolfe F, Begovich AB, Gregersen PK. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun. 6: 129-133 (2005). *
Lee HB, Kim JH, Yim CY, Kim DG, Ahn DS. Differences in immunophenotyping of mucosal lymphocytes between ulcerative colitis and Crohn's disease. Korean J. Intern. Med. 12: 7-15 (1997).
Lee HC, Ikegami H, Fujisawa T, Ogihara T, Park SW, Chung YS, Park JO, Lee EJ, Lim SK, Kim KR, Huh KB, Kim YS, Lee DS, Kim DH. Role of HLA class II alleles in Korean patients with IDDM. Diabetes Res. Clin. Pract. 31: 9-15 (1996).
Lee HL, Chu CC, Trejaut JA, Yang KL, Lin M. Identification of two novel HLA-DRB1 alleles, HLA-DRB1*1214 and HLA-DRB1*1215, in two Taiwanese individuals. Int. J. Immunogenet. 35: 423-426 (2008). *
Lee HS, Chung YH, Kim TG, Kim TH, Jun JB, Jung S, Bae SC, Yoo DH. Independent association of HLA-DR and FCgamma receptor polymorphisms in Korean patients with systemic lupus erythematosus. Rheumatology (Oxford) 42: 1501-1507 (2003). *
Lee HS, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H, Wolfe F, Lum RF, Massarotti E, Weisman M, Bombardier C, Karlson EW, Criswell LA, Vlietinck R, Gregersen PK. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum. 56: 1745-1753 (2007). *
Lee HS, Lee AT, Criswell LA, Seldin MF, Amos CI, Carulli JP, Navarrete C, Remmers EF, Kastner DL, Plenge RM, Li W, Gregersen PK. Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus. Mol. Med. 14: 293-300 (2008). *
Lee HS, Lee KW, Song GG, Kim HA, Kim SY, Bae SC. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. Arthritis Rheum. 50: 3468-3475 (2004). *
Lee HS, Li W, Lee A, Rodine P, Graham RR, Ortmann WA, Batliwalla F, Lee KW, Bae SC, Behrens TW, Gregersen PK. Microsatellite typing for DRB1 alleles: application to the analysis of HLA associations with rheumatoid arthritis. Genes Immun. 7: 533-543 (2006). *
Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC, Gregersen PK. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol. Med. 13: 455-460 (2007). *
Lee HW, Hahm KB, Lee JS, Ju YS, Lee KM, Lee KW. Association of the human leukocyte antigen class II alleles with chronic atrophic gastritis and gastric carcinoma in Koreans. J. Dig. Dis. 10: 265-271 (2009). *
Lee J, Kim H, Ahn JK, Hwang JW, Jang JH, Koh EM, Cha HS. Ankylosing spondylitis in a patient with myelodysplastic syndrome: an association with HLA-B27 or coincidence? Rheumatol. Int. 29: 689-692 (2009). *
Lee KR, Park E, Moon SH, Kim JM, Kwon OJ, Kim MH, Sohn YH, Ko SY, Oh HB. Development and clinical evaluation of a microarray for HLA-A and -DRB1 genotyping. Tissue Antigens 72: 568-577 (2008). *
Lee KW, Jung YA. Description of three novel HLA-DRB3 alleles: DRB3*010105, DRB3*0112 and DRB3*0113. Tissue Antigens 73: 83-84 (2009). *
Lee KW, Lee Y, Kim DS, Kwon HJ. Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression. Eur. J. Immunol. 36: 1254-1266 (2006). *
Lee KW, Oh DH, Lee C, Yang SY. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 65: 437-447 (2005). *
Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, Weisdorf D, Williams TM, Anasetti C. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110: 4576-4583 (2007). *
Lee SM, Morcos Y, Jang H, Stuart JM, Levin MC. HTLV-1 induced molecular mimicry in neurological disease. Curr. Top. Microbiol. Immunol. 296: 125-136 (2005).
Lee YT, Sung JJ, Poon P, Lai KN, Li PK. Association of HLA class-II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease. Scand. J. Gastroenterol. 33: 623-627 (1998). *
Lefaucheur C, Suberbielle-Boissel C, Hill GS, Nochy D, Andrade J, Antoine C, Gautreau C, Charron D, Glotz D. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib. Nephrol. 162: 1-12 (2009).
Lehe C, Ghebeh H, Al-Sulaiman A, Al Qudaihi G, Al-Hussein K, Almohareb F, Chaudhri N, Alsharif F, Al-Zahrani H, Tbakhi A, Aljurf M, Dermime S. The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. Cancer Res. 68: 6350-6359 (2008). *
Leidenius MH, Koskimies SA, Kellokumpu IH, Hockerstedt KA. HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 103: 519-524 (1995).
Lekka E, Gritzapis AD, Perez SA, Tsavaris N, Missitzis I, Mamalaki A, Papamichail M, Baxevanis CN. Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy. Cancer Immunol. Immunother. Nov 11 [Epub ahead of print] (2009). *
Lekpa FK, Farrenq V, Claudepierre P. Spondylarthropathies. Rev. Prat. 59: 519-532 (2009).
Lemire M. On the association between rheumatoid arthritis and classical HLA class I and class II alleles predicted from single-nucleotide polymorphism data. BMC Proc. 3 Suppl. 7: S33 (2009). *
Leonardi S, Rotolo N, Vitaliti G, Spicuzza L, La Rosa M. IgE values and T-lymphocyte subsets in children with atopic eczema/dermatitis syndrome. Allergy Asthma Proc. 28: 529-534 (2007).
Lernmark B, Lynch K, Lernmark AK. Cord blood islet autoantibodies are related to stress in the mother during pregnancy. Ann. N. Y. Acad. Sci. 1079: 345-349 (2006). *
Lesiak A, Narbutt J, Kobos J, Sysa-Jedrzejowska A, Wozniacka A. The influence of ultraviolet radiation on HLA-DR+ and CD1a+ cells' number in systemic lupus erythematosus patients. Przegl. Lek. 64: 563-567 (2007).
Leslie S, Donnelly P, McVean G. A statistical method for predicting classical HLA alleles from SNP data. Am. J. Hum. Genet. 82: 48-56 (2008). *
Lester SE, McLure C, Williamson J, Bardy P, Rischmueller M, Dawkins RL. Epistasis between MHC and the RCA alpha block in primary Sjogren's syndrome. Ann. Rheum. Dis. 67: 849-854 (2008). *
Leung PS, Park O, Matsumura S, Ansari AA, Coppel RL, Gershwin ME. Is there a relation between Chlamydia infection and primary biliary cirrhosis? Clin. Dev. Immunol. 10: 227-233 (2003). *
Leung W, Handgretinger R, Iyengar R, Turner V, Holladay MS, Hale GA. Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma. Br. J. Cancer 97: 539-542 (2007). *
Leuschner M, Dietrich CF, You T, Seidl C, Raedle J, Herrmann G, Ackermann H, Leuschner U. Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment. Gut 46: 121-126 (2000). *
Leuschner U. Combination therapy in primary biliary cirrhosis and overlap syndromes. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 52-53. October 15-16 (2003). *
Leuschner U. Autoimmune hepatitis/PSC-overlap syndrome. Falk Workshop "Primary Sclerosing Cholangitis: Complications and Consequences", Moscow (Russia), June 11, 2006, p. 10-11 (2006). *
Leuschner U, Guldutuna S, Bhatti S, Elze A, Imhof M, You T, Zimmer G. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects. Ital. J. Gastroenterol. 27: 376-377 (1995).
Levin L, Ban Y, Concepcion E, Davies TF, Greenberg DA, Tomer Y. Analysis of HLA genes in families with autoimmune diabetes and thyroiditis. Hum. Immunol. 65: 640-647 (2004).
Levinson RD, Du Z, Luo L, Holland GN, Rao NA, Reed EF, Rajalingam R. KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. Hum. Immunol. 69: 349-353 (2008).
Levitsky J, Miller J, Leventhal J, Huang X, Flaa C, Wang E, Tambur A, Burt RK, Gallon L, Mathew JM. The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. Transplantation 88: 1303-1311 (2009).
Levitsky J, Miller J, Rosen A, Flaa C, Abecassis M, Mathew J, Tambur A. Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents. Hum. Immunol. 70: 146-150 (2009).
Levy C, Lindor KD. Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis. Curr. Treat. Options Gastroenterol. 6: 93-103 (2003).
Levy O, Elsbach P. Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis. Curr. Infect. Dis. Rep. 3: 407-412 (2001).
Levy R, Shriker O, Porath A, Riesenberg K, Schlaeffer F. Vitamin C for the treatment of recurrent furunculosis in patients with imparied neutrophil functions. J. Infect. Dis. 173: 1502-1505 (1996).
Lewis C, Book L, Black J, Sawitzke A, Cannon-Albright L, Zone J, Neuhausen S. Celiac disease and human leukocyte antigen genotype: accuracy of diagnosis in self-diagnosed individuals, dosage effect, and sibling risk. J. Pediatr. Gastroenterol. Nutr. 31: 22-27 (2000). *
Leyden JJ, Grossman R, Nighland M. Cumulative irritation potential of topical retinoid formulations. J. Drugs Dermatol. 7: s14-s18 (2008).
Li CF, He XH, Teng Q, Jiang ZF. Association of HLA-A, B, and DR haplotypes with genotype in Chinese children with systemic lupus erythematosus. Zhonghua Er Ke Za Zhi 41: 422-425 (2003).
Li H, Dai Y, Huang H, Li L, Leng S, Cheng J, Niu Y, Duan H, Liu Q, Zhang X, Huang X, Xie J, Feng Z, Wang J, He J, Zheng Y. HLA-B*1301 as a biomarker for genetic susceptibility to hypersensitivity dermatitis induced by trichloroethylene among workers in China. Environ. Health Perspect. 115: 1553-1556 (2007). *
Li H, Zhao Y, Guo Y, Li Z, Eisele L, Mourad W. Zinc induces dimerization of the class II major histocompatibility complex molecule that leads to cooperative binding to a superantigen. J. Biol. Chem. 282: 5991-6000 (2007). *
Li J, Melenhorst J, Hensel N, Rezvani K, Sconocchia G, Kilical Y, Hou J, Curfman B, Major E, Barrett AJ. T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus. J. Gen. Virol. 87: 2951-2960 (2006). *
Li K, Yang P, Zhao M, Hou S, Du L, Zhou H, Kijlstra A. Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome. Mol. Vis. 15: 955-961 (2009). *
Li X, Li R, Li Z. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides. Tissue Antigens 67: 45-52 (2006). *
Li X, Li R, Li Z. Influenza virus haemagglutinin-derived peptides inhibit T-cell activation induced by HLA-DR4/1 specific peptides in rheumatoid arthritis. Clin. Exp. Rheumatol. 24: 148-154 (2006).
Li X, Yang A, Huang H, Zhang X, Town J, Davis B, Cockcroft DW, Gordon JR. Induction of Th2 cell allergen tolerance by IL-10-differentiated regulatory dendritic cells. Am. J. Respir. Cell. Mol. Biol. Apr 16 [Epub ahead of print] (2009). *
Li Y, Huang Y, Lue J, Quandt JA, Martin R, Mariuzza RA. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 24: 2968-2979 (2005). *
Li Y, Li H, Martin R, Mariuzza RA. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J. Mol. Biol. 304: 177-188 (2000). *
Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM, Tang J. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum. Genet. 126: 685-696 (2009). *
Li Z, Zhang LH, Zou HY, Jin SZ. A novel HLA-DRB1 allele, DRB1*112802, was identified in a Chinese individual. Tissue Antigens 74: 350-352 (2009). *
Liang G, Yang L, Chen Z, Mei H, Shu M, Li Z. A set of new amino acid descriptors applied in prediction of MHC class I binding peptides. Eur. J. Med. Chem. 44: 1144-1154 (2009). *
Liang HX, Yu ZJ, Jiang HQ. Study on the association between chronic hepatitis B cirrhosis and HLA-DRB1 * 1301,1302 allele. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23: 302-303 (2009).
Liang S, Ristich V, Arase H, Dausset J, Carosella ED, Horuzsko A. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 105: 8357-8362 (2008). *
Liang W, Karabekian Z, Xu Q, Viley AM, Scott DW. B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis. Clin. Immunol. 118: 35-41 (2006). *
Liang X, Gao Y, Lam TK, Li Q, Falk C, Yang XR, Goldstein AM, Goldin LR. Identifying rheumatoid arthritis susceptibility genes using high-dimensional methods. BMC Proc. 3 Suppl. 7: S79 (2009). *
Liao F, Li Z, Wang Y, Shi B, Gong Z, Cheng X. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis. Med. Hypotheses 72: 732-735 (2009).
Liao HT, Lin KC, Chang YT, Chen CH, Liang TH, Chen WS, Su KY, Tsai CY, Chou CT. Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients. J. Rheumatol. 35: 891-895 (2008). *
Liao HT, Lin KC, Chen CH, Liang TH, Lin MW, Tsai CY, Tak Yan Yu D, Chou CT. Human leukocyte antigens in undifferentiated spondyloarthritis. Semin. Arthritis Rheum. 37: 198-201 (2007). *
Liblau R, Gautam AM. HLA, molecular mimicry and multiple sclerosis. Rev. Immunogenet. 2: 95-104 (2000).
Lich JD, Jayne JA, Zhou D, Elliott JF, Blum JS. Editing of an immunodominant epitope of glutamate decarboxylase by HLA-DM. J. Immunol. 171: 853-859 (2003). *
Liden M, Kristjansson G, Valtysdottir S, Hallgren R. Gluten sensitivity in patients with primary Sjogren's syndrome. Scand. J. Gastroenterol. 42: 962-967 (2007). *
Lie BA, Sollid LM, Ascher H, Ek J, Akselsen HE, Ronningen KS, Thorsby E, Undlien DE. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens 54: 162-168 (1999). *
Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, Joner G, Dahl-Jorgensen K, Ronningen KS, Thorsby E, Undlien DE. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am. J. Hum. Genet. 64: 793-800 (1999). *
Lie HC, Simmons LW, Rhodes G. Does genetic diversity predict health in humans? PLoS One 4: e6391 (2009). *
Ligeiro DA, Fonseca JE, Abade O, Abreu I, Cruz M, Nero P, Cavaleiro J, Teles J, Trindade H, Caetano M, Branco J. Influence of human leukocyte antigen-DRB1 on the susceptibility to rheumatoid arthritis and on the production of anti-cyclic citrullinated peptide antibodies in a Portuguese population. Ann. Rheum. Dis. 66: 246-248 (2007). *
Ligers A, Dyment DA, Willer CJ, Sadovnick AD, Ebers G, Risch N, Hillert J; Canadian Collaborative Study Groups. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am. J. Hum. Genet. 69: 900-903 (2001). *
Likanonsakul S, Rattanatham T, Feangvad S, Uttayamakul S, Prasithsirikul W, Tunthanathip P, Nakayama EE, Shioda T. HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients. AIDS Res. Ther. 6: 22 (2009).
Lilienfeld BG, Crew MD, Forte P, Baumann BC, Seebach JD. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Xenotransplantation 14: 126-134 (2007).
Lim YS, Oh HB, Choi SE, Kwon OJ, Heo YS, Lee HC, Suh DJ. Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule. J. Hepatol. 48: 133-139 (2008). *
Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O, Labib T, Taing L, Sladek R; ANRS Genomic Group, Deveau C, Ratsimandresy R, Montes M, Spadoni JL, Lelievre JD, Levy Y, Therwath A, Schachter F, Matsuda F, Gut I, Froguel P, et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS genomewide association study 02). J. Infect. Dis. 199: 419-426 (2009). *
Lin A, Li M, Xu DP, Zhang WG, Yan WH. Ethnic variation of the HLA-G*0105N allele in two Chinese populations. Tissue Antigens 73: 270-274 (2009).
Lin A, Yan WH, Xu HH, Gan MF, Cai JF, Zhu M, Zhou MY. HLA-G expression in human ovarian carcinoma counteracts NK cell function. Ann. Oncol. 18: 1804-1809 (2007). *
Lin CH, Cho CL, Tsai WC, Ou TT, Wu CC, Yen JH, Liu HW. Inhibitors of kB-like gene polymorphisms in rheumatoid arthritis. Immunol. Lett. 105: 193-197 (2006).
Lin CH, Wang SC, Ou TT, Li RN, Tsai WC, Liu HW, Yen JH. IkappaBalpha promoter polymorphisms in patients with systemic lupus erythematosus. J. Clin. Immunol. 28: 207-213 (2008). *
Lin CY, Tsai IF, Ho YP, Huang CT, Lin YC, Lin CJ, Tseng SC, Lin WP, Chen WT, Sheen IS. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J. Hepatol. 46: 816-826 (2007). *
Lin HH, Liao HW, Lin SK, Wang LY. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. Vaccine 26: 3414-3420 (2008).
Lin HH, Zhang GL, Tongchusak S, Reinherz EL, Brusic V. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics 9 Suppl. 12: S22 (2008). *
Lin HJ, Rotter JI, Conte WJ. Use of HLA marker associations and HLA haplotype linkage to estimate disease risks in families with gluten-sensitive enteropathy. Clin. Genet. 28: 185-198 (1985).
Lin J, Cheng Y, Tian D, Liao J, Liu N, Xiong P, Liang K. Tumor necrosis factor alpha HLA-DRB(1) gene polymorphism and genetic susceptibility to cirrhosis. Zhonghua Nei Ke Za Zhi 41: 818-821 (2002).
Lin JH, Liu ZH, Lv FJ, Fu YG, Fan XL, Li SY, Lu JM, Liu XY, Xu AL. Molecular analyses of HLA-DRB1, -DPB1, and -DQB1 in Jing ethnic minority of Southwest China. Hum. Immunol. 64: 830-834 (2003).
Lin L, Chen Y, Xiao Z, Huang S, Yang Z. The association of HLA-DRB1 alleles with rheumatoid arthritis in the Chinese Shantou population: a follow-up study. Biochem. Cell. Biol. 85: 227-238 (2007).
Lin TH. Predicting the MHC-peptide affinity using some interactive-type molecular descriptors and QSAR models. Methods Mol. Biol. 409: 247-260 (2007).
Lin XP, Almqvist N, Telemo E. Human small intestinal epithelial cells constitutively express the key elements for antigen processing and the production of exosomes. Blood Cells Mol. Dis. 35: 122-128 (2005).
Lin YJ, Wan L, Wu JY, Sheu JJ, Lin CW, Lan YC, Lai CH, Hung CH, Tsai Y, Tsai CH, Lin TH, Lin JG, Hsueh KC, Huang YM, Chang JS, Tsai FJ. HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms. Arthritis Rheum. 60: 604-610 (2009). *
Lin YL, Liang YC, Chiang BL. Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells. J. Leukoc. Biol. 82: 1473-1480 (2007). *
Lin YL, Liang YC, Tseng YS, Huang HY, Chou SY, Hseu RS, Huang CT, Chiang BL. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-{kappa}B and MAPK pathways. J. Leukoc. Biol. 86: 877-889 (2009). *
Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, Tiislar M, Ferretti V, Tienari PJ, Sadovnick AD, Peltonen L, Ebers GC, Hudson TJ. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat. Genet. 37: 1108-1112 (2005). *
Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, Dyment DA, Sadovnick AD, Ebers GC. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc. Natl. Acad. Sci. U.S.A. 106: 7542-7547 (2009). *
Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 50: 808-814 (2009). *
Lindstedt R, Monk N, Lombardi G, Lechler R. Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation. J. Immunol. 166: 800-808 (2001). *
Ling S, Lai A, Borschukova O, Pumpens P, Holoshitz J. Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum. 54: 3423-3432 (2006). *
Ling S, Li Z, Borschukova O, Xiao L, Pumpens P, Holoshitz J. The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway. Arthritis Res. Ther. 9: R5 (2007). *
Ling S, Pi X, Holoshitz J. The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin. J. Immunol. 179: 6359-6367 (2007). *
Lingappa J, Kuffner T, Tappero J, Whitworth W, Mize A, Kaiser R, McNicholl J. HLA-DQ6 and ingestion of contaminated water: possible gene-environment interaction in an outbreak of Leptospirosis. Genes Immun. 5: 197-202 (2004). *
Link JM, Rich CM, Korat M, Burrows GG, Offner H, Vandenbark AA. Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice. Clin. Immunol. 123: 95-104 (2007). *
Linn-Rasker SP, van der Helm-van Mil AH, Van Gaalen FA, Kloppenburg M, de Vries R, le Cessie S, Breedveld FC, Toes RE, Huizinga TW. Smoking is a risk factor for anti-CCP antibodies only in RA patients that carry HLA-DRB1 shared epitope alleles. Ann. Rheum. Dis. 65: 366-371 (2006). *
Linssen A, Dekker-Saeys AJ, Dijkstra PF, Rothova A, Kruit PJ, Bakker M, Kijlstra A, Feltkamp TE. The use of HLA-B27 as a diagnostic and prognostic aid in acute anterior uveitis (AAU) in The Netherlands. Doc. Ophthalmol. 64: 217-223 (1986).
Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C. A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity. Hum. Immunol. 62: 705-713 (2001).
Lio D, D'Anna C, Gervasi F, Cigna D, Modica MA, Candore G, Caruso C. In vitro impairment of interleukin-5 production in HLA-B8, DR3-positive individuals implications for immunoglobulin A synthesis dysfunction. Hum. Immunol. 44: 170-174 (1995).
Lio D, D'Anna C, Leone F, Curro MF, Candore G, Caruso C. Hypothesis: interleukin-5 production impairment can be a key point in the pathogenesis of the MHC-linked selective IgA deficiency. Autoimmunity 27: 185-188 (1998).
Liphaus BL, Kiss MH, Goldberg AC. HLA-DRB1 alleles in juvenile-onset systemic lupus erythematosus: renal histologic class correlations. Braz. J. Med. Biol. Res. 40: 591-597 (2007). *
Lisheng W, Meng E, Guo Z. High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cells Dev. 17: 805-814 (2008). *
Listgarten J, Brumme Z, Kadie C, Xiaojiang G, Walker B, Carrington M, Goulder P, Heckerman D. Statistical resolution of ambiguous HLA typing data. PLoS Comput. Biol. 4: e1000016 (2008). *
Listrom C, Holt K. Inflammatory bowel disease. Emerg. Med. 36: 24-28 (2004).
Litjens NH, Rademaker M, Ravensbergen B, Thio HB, van Dissel JT, Nibbering PH. Effects of monomethylfumarate on dendritic cell differentiation. Br. J. Dermatol. 154: 211-217 (2006). *
Litjens NH, van de Wetering J, van Besouw NM, Betjes MG. The human alloreactive CD4+ T cell repertoire is biased to a Th-17 response and the frequency is inversely related with the number of HLA class II mismatches. Blood 114: 3947-3955 (2009). *
Litzman J, Vlkova M, Pikulova Z, Stikarovska D, Lokaj J. T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency. Clin. Exp. Immunol. 147: 249-254 (2007). *
Liu CP, Bach FH, Wu SK. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes. J. Immunol. 140: 3631-3639 (1988).
Liu D, Huang X, Liu K, Xu L, Chen H, Han W, Chen Y, Zhang X, Jiang Q. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children. Biol. Blood Marrow Transplant. 14: 469-477 (2008).
Liu E, Li M, Bao F, Miao D, Rewers MJ, Eisenbarth GS, Hoffenberg EJ. Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children. J. Pediatr. 146: 494-499 (2005). *
Liu H, Wang B, Liu D, Cheng Y, Yu W, Liang X, An W. Molecular genetic studies on relationships among longevity, diseases, and HLA-DRB1/DQB1 allelic polymorphism. Exp. Aging Res. 33: 123-125 (2007).
Liu HY, Deng AM, Zhang J, Zhou H, Yao DK, Shen F, Tu XQ, Fan LY, Zhong RQ. Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 13: 410-413 (2005).
Liu HY, Deng AM, Zhou Y, Yao DK, Xu DX, Zhong RQ. Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis. Hepatobiliary Pancreat. Dis. Int. 5: 129-132 (2006). *
Liu LY, Mathur SK, Sedgwick JB, Jarjour NN, Busse WW, Kelly EA. Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion. Allergy 61: 589-597 (2006). *
Liu Q, Bu DF, Li D, Zhu XJ. Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus. Br. J. Dermatol. 158: 587-591 (2008). *
Liu SC, Chang TY, Lee YJ, Chu CC, Lin M, Chen ZX, Liu HF, Dang CW, Chang SC, Lee CS, Chen TL, Huang CH. Influence of HLA-DRB1 genes and the shared epitope on genetic susceptibility to rheumatoid arthritis in Taiwanese. J. Rheumatol. 34: 674-680 (2007). *
Liu W, Li WM, Sun NL. HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of northern China. Ann. Hum. Genet. 69: 382-388 (2005).
Liu W, Li WM, Yang SS, Gao C, Li SJ, Li Y, Kong YH, Gan RT. Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality. Autoimmunity 39: 461-467 (2006).
Liu Y, Helms C, Liao W, Zaba LC, Duan S, Gardner J, Wise C, Miner A, Malloy MJ, Pullinger CR, Kane JP, Saccone S, Worthington J, Bruce I, Kwok PY, Menter A, Krueger J, Barton A, Saccone NL, Bowcock AM. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4: e1000041 (2008). *
Liu Y, Zhu Q, Zhu N. Rapid HLA-DR fluorotyping based on melting curve analysis. Immunol. Invest. 36: 507-521 (2007). *
Liu Z, Zheng X, Wang J, Wang E. Molecular analysis of thymopentin binding to HLA-DR molecules. PLoS ONE 2: e1348 (2007). *
Liu ZX, Hiwatashi N, Noguchi M, Toyota T. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease. Scand. J. Gastroenterol. 32: 1241-1246 (1997).
Llanes E, Quiralte J, Lopez E, Sastre B, Chacartegui M, Del Pozo V, Palomino P, Lahoz C, Cardaba B. Analysis of polymorphisms in olive pollen allergy: IL13, IL4RA, IL5 and ADRB2 genes. Int. Arch. Allergy Immunol. 148: 228-238 (2008).
Llorca J, Lopez-Diaz MJ, Gonzalez-Juanatey C, Ollier WE, Martin J, Gonzalez-Gay MA. Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of Northwestern Spain. Semin. Arthritis Rheum. 37: 31-38 (2007). *
Lo FS, Lee YJ, Huang CY, Lin CH, Chang SC, Dang CW, Liu HF. Polymorphism in the transmembrane region of the major histocompatibility complex class I chain-related gene A: association of five GCT repetitions with Graves' disease in children. Thyroid 13: 839-843 (2003).
Lo Monaco E, Sibilio L, Melucci E, Tremante E, Such�nek M, Horejsi V, Martayan A, Giacomini P. HLA-E: strong association with beta2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides. J. Immunol. 181: 5442-5450 (2008). *
Lobnig BM, Chantelau E, Vidgren G, Van Landeghem AA, Kinnunen L, Tuomilehto-Wolf E. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases. Diabetes Metab. 28: 217-221 (2002).
Locatelli F, Giorgiani G, Di-Cesare-Merlone A, Merli P, Sparta V, Moretta F. The changing role of stem cell transplantation in childhood. Bone Marrow Transplant. 41 Suppl. 2: S3-S7 (2008).
Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, Kangwanshiratada O, Hirankarn N, Suphapeetiporn K, Shotelersuk V. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 49: 2087-2091 (2008).
Loewenthal R, Slomov Y, Gonzalez-Escribano MF, Goldberg I, Korostishevsky M, Brenner S, Nunez-Roldan A, Conejo-Mir JS, Gazit E. Common ancestral origin of pemphigus vulgaris in Jews and Spaniards: a study using microsatellite markers. Tissue Antigens 63: 326-334 (2004). *
Lohmann T, Halder T, Engler J, Morgenthaler NG, Khoo-Morgenthaler UY, Schroder S, Seissler J, Scherbaum WA, Kalbacher H. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes. Exp. Clin. Endocrinol. Diabetes 107: 166-171 (2005).
Lohr H, Fleischer B, Gerken G, Meyer zum Buschenfelde KH, Manns M. Infiltrating T-cells in primary biliary cirrhosis recognize mitochondrial epitopes. Z. Gastroenterol. 31 Suppl. 2: 99-103 (1993).
Lohr HF. Autoimmune hepatitis and overlap syndrome: therapy. Schweiz. Rundsch. Med. Prax. 91: 1347-1351 (2002).
Lohse AW, Gerken G, Mohr H, Lohr HF, Treichel U, Dienes HP, Meyer zum Buschenfelde KH. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Z. Gastroenterol. 33: 527-533 (1995).
Lohse AW, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 29: 1078-1084 (1999). *
Loiseau P, Lepage V, Djelal F, Busson M, Tamouza R, Raffoux C, Menkes CJ, Meyer O, Charron D, Goldberg D. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum. Immunol. 62: 725-731 (2001).
Loisel DA, Rockman MV, Wray GA, Altmann J, Alberts SC. Ancient polymorphism and functional variation in the primate MHC-DQA1 5' cis-regulatory region. Proc. Natl. Acad. Sci. U.S.A. 103: 16331-16336 (2006). *
Lombard Z, Brune AE, Hoal EG, Babb C, Van Helden PD, Epplen JT, Bornman L. HLA class II disease associations in Southern Africa. Tissue Antigens 67: 97-110 (2006). *
Lombard Z, Dalton DL, Venter PA, Williams RC, Bornman L. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum. Immunol. 67: 643-654 (2006).
Lombardi ML, Pirozzi G, Luongo V, Mercuro O, Pace E, Blanco Del Vecchio G, Cozzolino A, Errico S, Fusco C, Castiglione F. Crohn disease: susceptibility and disease heterogeneity revealed by HLA genotyping. Hum. Immunol. 62: 701-704 (2001).
Lombardi ML, Terrazzano G, Cosentini E, Gargiulo L, Risitano A, Camerlingo R, Sica M, Aufiero D, Poggi A, Pirozzi G, Luzzatto L, Rotoli B, Notaro R, Alfinito F, Ruggiero G. Paroxysmal nocturnal hemoglobinuria: significant association with specific HLA-A, -B, -C, and -DR alleles in an Italian population. Hum. Immunol. 69: 202-206 (2008).
Long SA, Walker MR, Rieck M, James E, Kwok WW, Sanda S, Pihoker C, Greenbaum C, Nepom GT, Buckner JH. Functional islet-specific Treg can be generated from CD4(+)CD25(-) T cells of healthy and type 1 diabetic subjects. Eur. J. Immunol. 39: 612-620 (2009). *
Longhi E, Frison S, Andreini E, Karpasitou K, Serafini M, Poli F. Description of HLA-A*0127N, a novel nonexpressed allele identified by SBT. Hum. Immunol. 68: 913-914 (2007).
Longhi E, Frison S, Serafini M, Karpasitou K, Poli F. Identification of two novel HLA-DRB1*11 alleles (DRB1*110404 and DRB1*1161) in two Italian cord blood units. Int. J. Immunogenet. 34: 237-239 (2007). *
Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M; for the RegiSCAR study group. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet. Genomics 18: 99-107 (2008).
Lopez AS, Alegre E, Diaz-Lagares A, Garcia-Giron C, Coma MJ, Gonzalez A. Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages. Immunol. Lett. 117: 91-95 (2008).
Lopez D, Barber DF, Villadangos JA, Lopez de Castro JA. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2. J. Immunol. 150: 2675-2686 (1993).
Lopez D, Garcia-Hoyo R, Garcia F, Lopez de Castro JA. T cell allorecognition and endogenous HLA-B27-bound peptides in a cell line with defective HLA-B27-restricted antigen presentation. Eur. J. Immunol. 24: 1194-1199 (1994).
Lopez D, Garcia-Hoyo R, Lopez de Castro JA. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy. J. Immunol. 152: 5557-5571 (1994).
Lopez de Castro JA. The HLA-B27 peptidome: building on the cornerstone. Arthritis Rheum. 62: 316-319 (2010). *
Lopez de Castro JA. The pathogenetic role of HLA-B27 in chronic arthritis. Curr. Opin. Immunol. 10: 59-66 (1998).
Lopez de Castro JA. Structure, function, and disease association of HLA-B27. Curr. Opin. Rheumatol. 6: 371-377 (1994).
Lopez de Castro JA. HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol. Lett. 108: 27-33 (2007).
Lopez P, Gutierrez C, Suarez A. IFNalpha treatment generates antigen-presenting cellsinsensitive to atorvastatin inhibition of MHC-II expression. Clin. Immunol. 129: 350-359 (2008). *
Lopez-Alvarez MR, Moya-Quiles MR, Minguela A, Gil J, Miras M, Campillo JA, D�az-Alderete MA, Garcia-Alonso AM, Sanchez-Bueno F, Vicario JL, Muro M, Alvarez-Lopez MR. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation. Transplantation 88: S54-S61 (2009).
Lopez-Arbesu R, Ballina-Garcia FJ, Alperi-Lopez M, Lopez-Soto A, Rodriguez-Rodero S, Martinez-Borra J, Lopez-Vazquez A, Fernandez-Morera JL, Riestra-Noriega JL, Queiro-Silva R, Quinones-Lombrana A, Lopez-Larrea C, Gonzalez S. MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility. Rheumatology (Oxford) 46: 426-430 (2007). *
Lopez-Botet M, Bellon T, Llano M, Navarro F, Garcia P, de Miguel M. Paired inhibitory and triggering NK cell receptors for HLA class I molecules. Hum. Immunol. 61: 7-17 (2000).
Lopez-Cubero SO, Sullivan KM, McDonald GB. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 114: 433-440 (1998). *
Lopez-Escamez JA, Vilchez JR, Soto-Varela A, Santos-Perez S, Perez-Garrigues H, Aran I, Lopez-Nevot MA. HLA-DRB1*1101 allele may be associated with bilateral Meniere's disease in Southern European population. Otol. Neurotol. 28: 891-895 (2007).
Lopez-Mejias R, Martinez A, Del Pozo N, Fernandez-Arquero M, Ferreira A, Urcelay E, Fontan G, de la Concha EG, Nunez C. Interleukin-6 gene variation in Spanish patients with immunoglobulin-A deficiency. Hum. Immunol. 69: 301-305 (2008).
Lopez-Tello A, Rodriguez-Carreon AA, Jurado F, Yamamoto-Furusho JK, Castillo-Vazquez M, Chavez-Munoz C, Salgado N, Arellano-Campos O, Vargas-Alarcon G, Granados J. Association of HLA-DRB1*16 with chronic discoid lupus erythematosus in Mexican mestizo patients. Clin. Exp. Dermatol. 32: 435-438 (2007). *
Lopez-Vazquez A, Fuentes D, Rodrigo L, Gonzalez S, Moreno M, Fernandez E, Martinez-Borra J, Lopez-Larrea C. MHC class I region plays a role in the development of diverse clinical forms of celiac disease in a Saharawi population. Am. J. Gastroenterol. 99: 662-667 (2004). *
Lopez-Vazquez A, Rodrigo L, Fuentes D, Riestra S, Bousono C, Garcia-Fernandez S, Martinez-Borra J, Gonzalez S, Lopez-Larrea C. MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201. Gut 50: 336-340 (2002). *
Lopez-Vazquez A, Rodrigo L, Fuentes D, Riestra S, Bousono C, Garcia-Fernandez S, Martinez-Borra J, Gonzalez S, Lopez-Larrea C. MICA-A5.1 allele is associated with atypical forms of celiac disease in HLA-DQ2-negative patients. Immunogenetics 53: 989-991 (2002). *
Loranskaya I. Genetic factors in inflammatory bowel disease. Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, p. 35 (2006). *
Lorentzen AR, Celius EG, Ekstrom PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. J. Neuroimmunol. 166: 197-201 (2005).
Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. Ann. Neurol. 65: 658-666 (2009).
Lories RJ. Animal models of spondyloarthritis. Curr. Opin. Rheumatol. 18: 342-346 (2006).
Lorini R, Gastaldi R, Traggiai C, Perucchin PP. Hashimoto's thyroiditis. Pediatr. Endocrinol. Rev. 1 Suppl. 2: 205-211 (2003).
Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun. Rev. 8: 287-291 (2009).
Louis-Plence P, Kerlan-Candon S, Morel J, Combe B, Clot J, Pinet V, Eliaou JF. The down-regulation of HLA-DM gene expression in rheumatoid arthritis is not related to their promoter polymorphism. J. Immunol. 165: 4861-4869 (2000). *
Louka AS, Lie BA, Talseth B, Ascher H, Ek J, Gudjonsdottir AH, Sollid LM. Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics 55: 339-343 (2003). *
Louka AS, Moodie SJ, Karell K, Bolognesi E, Ascher H, Greco L, Momigliano-Richiardi P, Partanen J, Ciclitira PJ, Sollid LM; European Genetics Cluster on Celiac Disease. A collaborative European search for non-DQA1*05-DQB1*02 celiac disease loci on HLA-DR3 haplotypes: analysis of transmission from homozygous parents. Hum. Immunol. 64: 350-358 (2003).
Louka AS, Nilsson S, Olsson M, Talseth B, Lie BA, Ek J, Gudjonsdottir AH, Ascher H, Sollid LM. HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 60: 147-154 (2002). *
Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 61: 105-117 (2003). *
Louzada-Junior P, Freitas MV, Oliveira RD, Deghaide NH, Conde RA, Bertolo MB, Donadi EA. A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies. Braz. J. Med. Biol. Res. 41: 493-499 (2008). *
Lu CC, Sheu BS, Chen TW, Yang HB, Hung KH, Kao AW, Chuang CH, Wu JJ. Host TNF-a-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection, Am. J. Gastroenterol. 100: 1274-1282 (2005). *
Lu LY, Ding WZ, Fici D, Deulofeut R, Cheng HH, Cheu CC, Sung PK, Schur PH, Fraser PA. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum. 40: 1138-1145 (1997).
Lu M, Xia B. Polymorphism of HLA-DRB1 gene shows no strong association with ulcerative colitis in Chinese patients. Int. J. Immunogenet. 33: 37-40 (2006). *
Lu MC, Yang KL, Huang KY, Tung CH, Liu SQ, Lai NS. HLA haplotype A33-B58-Cw10 may modulate radiographic development of bamboo spine in Taiwanese patients with primary ankylosing spondylitis. Dis. Markers 26: 93-96 (2009).
Lu MC, Yang KL, Tung CH, Huang KY, Yu HC, Liu SQ, Lai NS. Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with -308(G/A) polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes. Rheumatol. Int. 29: 189-195 (2008). *
Lu S, Zhou W, Zhang Q, Yu XY, Liu DM, Liu XY. Juvenile psoriatic arthritis. Zhongguo Dang Dai Er Ke Za Zhi 9: 339-342 (2007).
Lu Y, Boehm J, Nichol L, Trucco M, Ringquist S. Multiplex HLA-typing by pyrosequencing. Methods Mol. Biol. 496: 89-114 (2009).
Lucas A, Nolan D, Mallal S. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity. J. Antimicrob. Chemother. 59: 591-593 (2007). *
Lucena DR, Paula JS, Silva GC, Rodrigues Mde L. Incomplete Vogt-Koyanagi-Harada syndrome associated with HLA DRB1*01 in a 4-year-old child: case report. Arq. Bras. Oftalmol. 70: 340-342 (2007).
Ludajic K, Balavarca Y, Bickeboller H, Pohlreich D, Kouba M, Dobrovolna M, Vrana M, Rosenmayr A, Fischer GF, Fae I, Kalhs P, Greinix HT. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br. J. Haematol. 142: 436-443 (2008). *
Ludovica S, Eulalia C, Annalisa F, Lara P, Marcello M, Sergio C. HLA-G 3' UTR haplotypes and HIV vertical transmission. AIDS 23: 1916-1918 (2009).
Ludvigsson J. Genetics of insulin-dependent diabetes mellitus in children. Pediatrician 12: 166-172 (1985).
Ludvigsson JF, Eylert M, Ilonen J, Ludvigson J, Vaarala O. Effect of HLA DQ2, dietary exposure and coeliac disease on the development of antibody response to gliadin in children. Scand. J. Gastroenterol. 41: 919-928 (2006). *
Lulli P, Mangano VD, Onori A, Batini C, Luoni G, Sirima BS, Nebie I, Chessa L, Petrarca V, Modiano D. HLA-DRB1 and -DQB1 loci in three West-African ethnic groups: genetic relationship with Sub-Saharan African populations and Europeans. Hum. Immunol. 70: 903-909 (2009).
Lundberg K, Roos AK, Pavlenko M, Leder C, Wehrum D, Guevara-Patino J, Andersen RS, Pisa P. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols. Vaccine 27: 1557-1565 (2009).
Lundin KE, R�nningen KS, Aono S, Spurkland A, Gaudernack G, Isshiki G, Thorsby E. HLA-DQ antigens and DQ beta amino acid 57 of Japanese patients with insulin-dependent diabetes mellitus: detection of a DRw8DQw8 haplotype. Tissue Antigens 34: 233-241 (1989).
Lundstrom E, Kallberg H, Alfredsson L, Klareskog L, Padyukov L. Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum. 60: 1597-1603 (2009). *
Lundstrom E, Kallberg H, Smolnikova M, Ding B, Ronnelid J, Alfredsson L, Klareskog L, Padyukov L. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum. 60: 924-930 (2009). *
Luo QZ, Li LX, Xie YB, Yan MY, Yu P. Association of HLA-A, B and DRB1 alleles with leukemia in Han population in Hunan Province. Nan Fang Yi Ke Da Xue Xue Bao 28: 1016-1018 (2008).
Luopajarvi K, Skarsvik S, Ilonen J, Akerblom HK, Vaarala O. Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes. Immunology 121: 189-196 (2007). *
Lupp A, Karge E, Hopf H, Machts H, Oelschlager H, Fleck C. Fibrates and their newly synthesized glycinate or glycinate-methylester derivatives: comparison of the interactions with liver cytochrome P450 dependent monooxygenase- and oxidase-functions in vitro. Exp. Toxicol. Pathol. 54: 433-440 (2003).
Luth S, Weiler-Normann C, Schramm C, Lohse AW. Autoimmune liver diseases. Internist (Berl.) 50: 310-317 (2009).
Lv WP, Dong JH, Shi S, Huang ZQ, Guo de Y. Gene expressions of DNA methyltransferase 1 and human leukocyte antigen-DRalpha in hepatocelluar carcinoma and their clinical significance. Beijing Da Xue Xue Bao 40: 543-547 (2008).
Lynch KF, Lernmark B, Merlo J, Cilio CM, Ivarsson SA, Lernmark A. Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype. J. Perinatol. 28: 211-217 (2008).
Ma JJ, Nishimura M, Mine H, Saji H, Ohta M, Saida K, Ozawa K, Kawakami H, Saida T, Uchiyama T. HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis. J. Neuroimmunol. 92: 109-112 (1998).
Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, Cheeseman P, Mieli-Vergani G, Vergani D. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type-2. Gastroenterology 130: 868-882 (2006). *
Maamouri N, Cheikh I, Belkahla N, Bouaziz S, Ouerghi H, Rahal K, Ben Romdhane K, Ben Ammar A. Isolated Crohn's disease of the stomach presented as plastic linitis. One case report. Tunis. Med. 84: 513-516 (2006).
Macaubas C, Nguyen K, Milojevic D, Park JL, Mellins ED. Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat. Rev. Rheumatol. 5: 616-626 (2009).
Maccalli C, Di Cristanziano V, Fodale V, Corsi D, D'Agostino G, Petrangeli V, Laurenti L, Guida S, Mazzocchi A, Arienti F, Perrone MP, Castelli C, Rivoltini L, Zagonel V, Tartaglia M, Parmiani G, Belardelli F. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1. Clin. Cancer Res. 14: 7292-7303 (2008). *
Macchini F, Selicorni A, Luzzani S, Milani D, Roggero P, Valade A. Coeliac disease and Cornelia de Lange syndrome: lack of association. Acta Paediatr. 96: 1518-1520 (2007). *
MacDonald MJ, Famuyiwa OO, Nwabuebo IA, Bella AF, Junaid TA, Marrari M, Duquesnoy RJ. HLA-DR associations in black type I diabetics in Nigeria. Further support for models of inheritance. Diabetes 35: 583-589 (1986).
MacDonald TT. The role of activated T lymphocytes in gastrointestinal disease. Clin. Exp. Allergy 20: 247-252 (1990).
MacDonald TT, Spencer J. The role of activated T cells in transformed intestinal mucosa. Digestion 46 Suppl. 2: 290-296 (1990).
MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J. Rheumatol. 22: 1032-1036 (1995).
MacHulla HK, Schonermarck U, Schaaf A, Muller LP, Kloss C, Kruger J, Kunze G, Schonermarck G, Langner J. HLA-A, B, Cw and DRB1, DRB3/4/5, DQB1, DPB1 frequencies in German immunoglobulin A-deficient individuals. Scand. J. Immunol. 52: 207-211 (2000). *
Mack R, Chowdary D, Samaan P, Podolak I, Dermody J. Prevalence of CTLA-4 polymorphism A49G in Ashkenazi Jews. Genet. Test. 5: 269-271 (2001).
Mack SJ, Tu B, Lazaro A, Yang R, Lancaster AK, Cao K, Ng J, Hurley CK. HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population. Tissue Antigens 73: 17-32 (2009). *
Mackay IR. Historical reflections on autoimmune hepatitis. World J. Gastroenterol. 14: 3292-3300 (2008). *
Mackay IR. Foreword. Contemporary liver immunology and immunopathology: obstacles and opportunities. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 1-14 (2007). *
Mackay IR, Tait BD. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology 79: 95-98 (1980).
MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, Barrett J, Lee D, White S, John S, Brown MA, Bell J, Silman A, Ollier W, Wordsworth P, Worthington J. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 46: 632-639 (2002). *
Mackensen F, Billing H. Tubulointerstitial nephritis and uveitis syndrome. Curr. Opin. Ophthalmol. 20: 525-531 (2009).
Mackie SL, Hensor EM, Haugeberg G, Bhakta B, Pease CT. Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study. Rheumatology (Oxford) Jan 11 [Epub ahead of print] (2010).
Maclaren NK, Riley WJ. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. J. Clin. Endocrinol. Metab. 62: 455-459 (1986).
MacMillan ML, Davies SM, Nelson GO, Chitphakdithai P, Confer DL, King RJ, Kernan NA. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol. Blood Marrow Transplant. 14: S16-S22 (2008).
Madigand M, Oger JJ, Fauchet R, Sabouraud O, Genetet B. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. J. Neurol. Sci. 53: 519-529 (1982).
Madrigal A, Shaw BE. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. Blood Cells Mol. Dis. 40: 40-43 (2008).
Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat. Genet. 23: 343-347 (1999). *
Maeda T, Onishi S, Saibara T, Iwasaki S, Yamamoto Y. HLA DRw8 and primary biliary cirrhosis. Gastroenterology 103: 1118-1119 (1992).
Maggiore G, Sciveres M. Autoimmune hepatitis: a childhood disease. Current Pediatric Reviews 1: 73-90 (2005). *
Maggs JR, Chapman RW. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 23: 310-316 (2007).
Magnusson PK, Enroth H, Eriksson I, Held M, Nyren O, Engstrand L, Hansson LE, Gyllensten UB. Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res. 61: 2684-2689 (2001). *
Magrin S, Nouri-Aria KT, Donaldson PT, Wilkinson ML, Portmann BC, Williams R, Eddleston AL. The relationship between HLA-DR3 and T-cell regulation of immunoglobulin production in primary sclerosing cholangitis. Clin. Immunol. Immunopathol. 50: 205-212 (1989).
Mahanonda R, Jitprasertwong P, Sa-Ard-Iam N, Rerkyen P, Charatkulangkun O, Jansisyanont P, Nisapakultorn K, Yongvanichit K, Pichyangkul S. Effects of IL-17 on human gingival fibroblasts. J. Dent. Res. 87: 267-272 (2008).
Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, Ronnelid J, Charles P, Ding B, Alfredsson L, Padyukov L, Symmons DP, Venables PJ, Klareskog L, Lundberg K. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat. Genet. 41: 1319-1324 (2009). *
Mahdi N, Al-Ola K, Al-Subaie AM, Ali ME, Al-Irhayim Z, Al-Irhayim AQ, Almawi WY. Distinct HLA class II associations with vaso-occlusion in children with sickle cell disease. Clin. Vaccine Immunol. 15: 729-731 (2008). *
Mahendra G, Kliskey K, Athanasou NA. Immunophenotypic distinction between pigmented villonodular synovitis and haemosiderotic synovitis. J. Clin. Pathol. 63: 75-78 (2010).
Maier JT, Haug M, Foll JL, Beck H, Kalbacher H, Rammensee HG, Dannecker GE. Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis. Immunogenetics 54: 67-73 (2002). *
Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum. Immunol. 68: 779-788 (2007).
Mailhol C, Tremeau-Martinage C, Paul C, Godel A, Lamant L, Giordano-Labadie F. Severe drug hypersensitivity reaction (DRESS syndrome) to doxycycline. Ann. Dermatol. Venereol. 137: 40-43 (2010).
Maisch B, Karatolios K. New possibilities of diagnostics and therapy of pericarditis. Internist (Berl.) 49: 17-26 (2008).
Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M, Kaufman DS, Burns LJ, Slungaard A, McGlave PB, Wagner JE, Weisdorf DJ. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol. Blood Marrow Transplant. 14: 282-289 (2008).
Majid A, Al Khalidi L, Ahmed BQ, Opelz G, Schaefer F. Outcomes of kidney transplant tourism in children: a single center experience. Pediatr. Nephrol. Sep 1 [Epub ahead of print] (2009).
Majumder P, Gomez JA, Boss JM. The human major histocompatibility complex class II HLA-DRB1 and HLA-DQA1 genes are separated by a CTCF binding enhancer-blocking element. J. Biol. Chem. 281: 18435-18443 (2006). *
Maker AV, Attia P, Rosenberg SA. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J. Immunol. 175: 7746-7754 (2005). *
Makhatadze NJ, Franco MT, Layrisse Z. HLA class I and class II allele and haplotype distribution in the Venezuelan population. Hum. Immunol. 55: 53-58 (1997).
Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Hopfl P, Knip M. Prevalence of celiac disease among children in Finland. N. Engl. J. Med. 348: 2517-2524 (2003). *
Makino S, Hamada S, Iwata M, Fujiwara M. A case of abrupt onset autoimmune type 1 diabetes mimicking fulminant type 1 diabetes. Endocr. J. 56: 1113-1117 (2009).
Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann. Rheum. Dis. 67: 1488-1492 (2008).
Maksymowych WP, Gorodezky C, Olivo A, Alaez C, Wong C, Burgos-Vargas R, Sanchez-Corona J, Ramos-Remus C, Russell AS. HLA-DRB1*08 influences the development of disease in Mexican Mestizo with spondyloarthropathy. J. Rheumatol. 24: 904-907 (1997).
Maksymowych WP, Suarez-Almazor ME, Buenviaje H, Cooper BL, Degeus C, Thompson M, Russell AS. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis. J. Rheumatol. 29: 2319-2326 (2002). *
Maksymowych WP, Tao S, Vaile J, Suarez-Almazor M, Ramos-Remus C, Russell AS. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis. J. Rheumatol. 27: 183-189 (2000).
Malamut G, Cellier C. Celiac disease. Rev. Prat. 58: 1199-1205 (2008).
Malamut G, Matysiak-Budnik T, Grosdider E, Jais JP, Morales E, Damotte D, Caillat-Zucman S, Brousse N, Cerf-Bensussan N, Jian R, Cellier C. Adult celiac disease with severe or partial villous atrophy: a comparative study. Gastroenterol. Clin. Biol. 32: 236-242 (2008).
Malanga D, Barba P, Harris PE, Maffei A, Del Pozzo G. The active translation of MHCII mRNA during dendritic cells maturation supplies new molecules to the cell surface pool. Cell. Immunol. 246: 75-80 (2007). *
Malerba G, Pignatti PF. A review of asthma genetics: gene expression studies and recent candidates. J. Appl. Genet. 46: 93-104 (2005). *
Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359: 727-732 (2002). *
Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jagel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A; PREDICT-1 Study Team. HLA-B*5701 screening for hypersensitivity to abacavir. N. Engl. J. Med. 358: 568-579 (2008). *
Mallegol J, Van Niel G, Lebreton C, Lepelletier Y, Candalh C, Dugave C, Heath JK, Raposo G, Cerf-Bensussan N, Heyman M. T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells. Gastroenterology 132: 1866-1876 (2007). *
Malleson PN, Fung MY, Petty RE, Mackinnon MJ, Schroeder ML. Autoantibodies in chronic arthritis of childhood: relations with each other and with histocompatibility antigens. Ann. Rheum. Dis. 51: 1301-1306 (1992). *
Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, Giachelli CM. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. J. Biol. Chem. 275: 20959-20962 (2000). *
Malysheva O, Pierer M, Wagner U, Wahle M, Wagner U, Baerwald C. Association between beta2-adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with HLA-DRB1 shared epitope. Ann. Rheum. Dis. 67: 1759-1764 (2008).
Mamata Y, Hakki A, Yamamoto Y, Newton C, Klein TW, Pross S, Friedman H. Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells. Int. Immunopharmacol. 5: 749-756 (2005).
Mamyrova G, O'hanlon TP, Monroe JB, Carrick DM, Malley JD, Adams S, Reed AM, Shamim EA, James-Newton L, Miller FW, Rider LG. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. Arthritis Rheum. 54: 3979-3987 (2006). *
Mamyrova G, O'Hanlon TP, Sillers L, Malley K, James-Newton L, Parks CG, Cooper GS, Pandey JP, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group. Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis Rheum. 58: 3941-3950 (2008). *
Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 48: 1015-1018 (2007).
Manabe K, Hibberd ML, Donaldson PT, Underhill JA, Doherty DG, Demaine AG, Mieli-Vergani G, Eddleston AL, Williams R. T-cell receptor constant beta germline gene polymorphisms and susceptibility to autoimmune hepatitis. Gastroenterology 106: 1321-1325 (1994).
Mandron M, Aries MF, Boralevi F, Martin H, Charveron M, Taieb A, Davrinche C. Age-related differences in sensitivity of peripheral blood monocytes to lipopolysaccharide and Staphylococcus aureus toxin B in atopic dermatitis. J. Invest. Dermatol. 128: 882-889 (2008). *
Mangalam A, Luckey D, Basal E, Behrens M, Rodriguez M, David C. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma. J. Immunol. 180: 7747-7756 (2008). *
Mangalam A, Luckey D, Basal E, Jackson M, Smart M, Rodriguez M, David C. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice. J. Immunol. 182: 5131-5139 (2009).
Mangalam A, Rodriguez M, David C. Role of MHC class II expressing CD4(+) T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice. Eur. J. Immunol. 36: 3356-3370 (2006). *
Mangalam A, Rodriguez M, David C. A new humanized HLA transgenic mouse model of multiple sclerosis expressing class II on mouse CD4 T cells. Ann. N. Y. Acad. Sci. 1103: 112-117 (2007). *
Mangalam AK, Khare M, Krco C, Rodriguez M, David C. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice. Eur. J. Immunol. 34: 280-290 (2004). *
Mangalam AK, Rajagopalan G, Taneja V, David CS. HLA class II transgenic mice mimic human inflammatory diseases. Adv. Immunol. 97C: 65-147 (2008).
Manger K, Repp R, Spriewald BM, Rascu A, Geiger A, Wassmuth R, Westerdaal NA, Wentz B, Manger B, Kalden JR, van de Winkel JG. Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms. Arthritis Rheum. 41: 1181-1189 (1998). *
Manguso F, Sanges M, Staiano T, Gargiulo S, Nastro P, Gargano D, Somma P, Mansueto G, Peluso R, Scarpa R, D'Armiento FP, Astarita C, Ayala F, Renda A, Mazzacca G, D'Arienzo A. Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am. J. Gastroenterol. 99: 327-334 (2004). *
Mannion A, Stevens FM, McCarthy CF, Grimes-O'Cearbhaill H, Killeen AA. Extended major histocompatibility complex haplotypes in celiac patients in the west of Ireland. Am. J. Med. Genet. 45: 373-377 (1993).
Manns MP. Viruses and autoimmune liver disease. Intervirology 35: 108-115 (1993).
Manns MP. Hepatotropic viruses and autoimmunity 1997. J. Viral Hepat. 4 Suppl. 1: 7-10 (1997).
Manns MP. Round table: classification of autoimmune liver diseases and diagnostic criteria. Subgroups of autoimmune hepatitis are important. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 56-57 (2004). *
Manns MP, Bremm A, Schneider PM, Notghi A, Gerken G, Prager-Eberle M, Stradmann-Bellinghausen B, Meyer zum Buschenfelde KH, Rittner C. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 101: 1367-1373 (1991).
Manns MP, Kruger M. Immunogenetics of chronic liver diseases. Gastroenterology 106: 1676-1697 (1994).
Manns MP, Obermayer-Straub P. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology 26: 1054-1066 (1997). *
Manns MP, Wiegand J. Novel approaches to the treatment of autoimmune hepatitis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 67-70 (2004). *
Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, Moutsopoulos HM. Sjogren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren's syndrome. Arthritis Rheum. 50: 882-891 (2004). *
Mant TG, Borozdenkova S, Bradford DB, Allen E, Amin DM, Toothaker RD, Collins RW, Hargreaves RE, Jurcevic S. Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers. Int. Immunopharmacol. 8: 701-707 (2008).
Mantovani V, Corazza GR, Bragliani M, Frisoni M, Zaniboni MG, Gasbarrini G. Asp57-negative HLA DQ beta chain and DQA1*0501 allele are essential for the onset of DQw2-positive and DQw2-negative coeliac disease. Clin. Exp. Immunol. 91: 153-156 (1993). *
Mantovani V, Corazza GR, Frisoni M, Zaniboni MG, Bragliani M, Valentini RA, Barboni P, Lambertini A, Gasbarrini G. HLA-DP polymorphism in northern Italian celiac patients. Tissue Antigens 40: 182-186 (1992).
Mantzourani ED, Blokar K, Tselios TV, Matsoukas JM, Platts JA, Mavromoustakos TM, Grdadolnik SG. A combined NMR and molecular dynamics simulation study to determine the conformational properties of agonists and antagonists against experimental autoimmune encephalomyelitis. Bioorg. Med. Chem. 16: 2171-2182 (2008). *
Mantzourani ED, Platts JA, Brancale A, Mavromoustakos TM, Tselios TV. Molecular dynamics at the receptor level of immunodominant myelin basic protein epitope 87-99 implicated in multiple sclerosis and its antagonists altered peptide ligands: Triggering of immune response. J. Mol. Graph Model. 26: 471-481 (2007). *
Manzoni Jacintho T, Gotho H, Gidlund M, Garc�a Marques C, Torrinhas R, Mirtes Sales M, Linetzky Waitzberg D. Anti-inflammatory effect of parenteral fish oil lipid emulsion on human activated mononuclear leukocytes. Nutr. Hosp. 24: 288-296 (2009). *
Marcenaro E, Cantoni C, Pesce S, Prato C, Pende D, Agaugue S, Moretta L, Moretta A. Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. Blood 114: 4108-4116 (2009). *
Marcilla M, Cragnolini JJ, Lopez de Castro JA. Proteasome-independent HLA-B27 ligands arise mainly from small basic proteins. Mol. Cell. Proteomics 6: 923-938 (2007). *
Marcilla M, Lopez de Castro JA. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens 71: 495-506 (2008). *
Marcilla M, Villasevil EM, de Castro JA. Tripeptidyl peptidase II is dispensable for the generation of both proteasome-dependent and proteasome-independent ligands of HLA-B27 and other class I molecules. Eur. J. Immunol. 38: 631-639 (2008). *
Mariani SM. Genes and autoimmune diseases - a complex inheritance. MedGenMed. 6: 18 (2004). *
Marin-Esteban V, Falk K, Rotzschke O. "Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules. J. Biol. Chem. 279: 50684-50690 (2004). *
Marinic I, Gagro A, Rabatic S. Regulatory T cells. Acta Med. Croatica 60: 447-456 (2006).
Marinovic B, Lipozencic J. Reminiscence on the Post IID 2008 Satellite International Meeting on Autoimmune Bullous Diseases Otsu Prince Hotel, Japan, May 17-19, 2008. Acta Dermatovenerol. Croat. 16: 170-171 (2008).
Markey KA, Macdonald KP, Hill GR. Impact of cytokine gene polymorphisms on graft-vs-host disease. Tissue Antigens 72: 507-516 (2008). *
Marmont AM, Gualandi F, Occhini D, Morandi F, Ferretti E, Pezzolo A, Strada P, Ravetti JL, Pistoia V, Falanga A, Bacigalupo A. Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome. Autoimmunity 39: 505-511 (2006).
Marotte H, Farge P, Gaudin P, Alexandre C, Mougin B, Miossec P. The association between periodontal disease and joint destruction in rheumatoid arthritis patients extends the link between the HLA-DR shared epitope and bone destruction severity. Ann. Rheum. Dis. 65: 905-909 (2006). *
Marotte H, Tournoud M, Cazalis MA, Mougin B, Roy P, Miossec P. Extensive multiallelic analysis of the relationship between HLA-DRB1 and rheumatoid arthritis using a Bayesian partition model. Genes Immun. 7: 487-493 (2006). *
Marouf W, Sieb JP. Myasthenia gravis and myasthenic syndromes. Z. Rheumatol. 68: 465-470 (2009).
Marrari M, Duquesnoy RJ. Why can sensitization by a HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1? Hum. Immunol. 70: 403-409 (2009).
Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum. Mol. Genet. 7: 1235-1237 (1998). *
Marrosu MG, Murru R, Costa G, Melis MC, Rolesu M, Schirru L, Solla E, Cuccu S, Secci MA, Whalen MB, Cocco E, Pugliatti M, Sotgiu S, Rosati G, Cucca F. Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population. BMC Genet. 8: 25 (2007). *
Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, Whalen M, Cocco E, Mancosu C, Schirru L, Solla E, Fadda E, Melis C, Porru I, Rolesu M, Cucca F. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum. Mol. Genet. 10: 2907-2916 (2001). *
Marsh JE, Andrews PA. HLA matching: still important despite modern immunosuppression. Transplantation 85: 312-313 (2008).
Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2002. Tissue Antigens 60: 407-464 (2002). *
Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2002. Hum. Immunol. 63: 1213-1268 (2002).
Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2000. Hum. Immunol. 62: 419-468 (2001).
Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, MacH B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2000. Eur. J. Immunogenet. 28: 377-424 (2001).
Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2000. Tissue Antigens 57: 236-283 (2001). *
Marshall KW, Liu AF, Canales J, Perahia B, Jorgensen B, Gantzos RD, Aguilar B, Devaux B, Rothbard JB. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J. Immunol. 152: 4946-4957 (1994).
Martel P, Gilbert D, Busson M, Loiseau P, Lepage V, Drouot L, Delaporte E, Prost C, Joly P, Charron D, Tron F. Epistasis between DSG1 and HLA class II genes in pemphigus foliaceus. Genes Immun. 3: 205-210 (2002). *
Marti M, Alvarez I, Lopez de Castro JA. A molecular insight on the association of HLA-B27 with spondyloarthropathies. Curr. Rheumatol. Rep. 1: 78-85 (1999).
Martin AM, Krueger R, Almeida CA, Nolan D, Phillips E, Mallal S. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenet. Genomics 16: 353-357 (2006).
Martin AM, Nolan D, Gaudieri S, Almeida CA, Nolan R, James I, Carvalho F, Phillips E, Christiansen FT, Purcell AW, McCluskey J, Mallal S. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc. Natl. Acad. Sci. U.S.A. 101: 4180-4185 (2004). *
Martin K, Radlmayr M, Borchers R, Heinzlmann M, Folwaczny C. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 66: 121-126 (2002).
Martin Martorell P, Roep BO, Smit JW. Autoimmunity in Addison's disease. Neth. J. Med. 60: 269-275 (2002). *
Martin RJ, Savage DA, Carson DJ, Maxwell AP, Patterson CC. Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population. Genes Immun. 6: 171-174 (2005). *
Martin TM, Zhang G, Luo J, Jin L, Doyle TM, Rajska BM, Coffman JE, Smith JR, Becker MD, Mackensen F, Khan MA, Levinson RD, Schumacher HR, Wade NK, Rosenbaum JT, Reveille JD. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum. 52: 269-274 (2005). *
Martin-Pagola A, Ortiz-Paranza L, Bilbao JR, de Nanclares GP, Estevez EP, Castano L, Vitoria JC. Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA. Autoimmunity 40: 117-121 (2007).
Martin-Villa JM, Ferre-Lopez S, Lopez-Suarez JC, Perez-Blas M, Castellano-Tortajada G, Sanchez-Gomez F, Arnaiz-Villena A. Successful in vitro immortalization of human intestinal mucosal lymphocytes with Herpesvirus saimiri. Tissue Antigens 52: 430-434 (1998).
Martinetti M, Biagi F, Badulli C, Feurle GE, Muller C, Moos V, Schneider T, Marth T, Marchese A, Trotta L, Sachetto S, Pasi A, De Silvestri A, Salvaneschi L, Corazza GR. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology 136: 2289-2294 (2009). *
Martinez A, Fernandez-Arquero M, Balsa A, Rubio A, Alves H, Pascual-Salcedo D, Martin-Mola E, de la Concha EG. Primary association of a MICA allele with protection against rheumatoid arthritis. Arthritis Rheum. 44: 1261-1265 (2001). *
Martinez A, Fernandez-Arquero M, Pascual-Salcedo D, Conejero L, Alves H, Balsa A, de la Concha EG. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum. 43: 1366-1370 (2000). *
Martinez A, Gual L, Fernandez-Arquero M, Nogales A, Ferreira A, Garcia-Rodriguez MC, Fontan G, de la Concha Ed EG. Epistatic effects occurring among susceptibility and protective MHC genes in IgA deficiency. Genes Immun. 4: 316-320 (2003). *
Martinez A, Nunez C, Martin MC, Mendoza JL, Taxonera C, Diaz-Rubio M, de la Concha EG, Urcelay E. Epistatic interaction between FCRL3 and MHC in Spanish patients with IBD. Tissue Antigens 69: 313-317 (2007). *
Martinez A, Salido M, Bonilla G, Pascual-Salcedo D, Fernandez-Arquero M, De Miguel S, Balsa A, De La Concha EG, Fernandez-Gutierrez B. Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients. Arthritis Rheum. 50: 1077-1082 (2004). *
Martinez D, Vermeulen M, von Euw E, Sabatte J, Maggini J, Ceballos A, Trevani A, Nahmod K, Salamone G, Barrio M, Giordano M, Amigorena S, Geffner J. Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12. J. Immunol. 179: 1950-1959 (2007). *
Martinez-Borra J, Gonzalez S, Lopez-Vazquez A, Gelaz MA, Armas JB, Kanga U, Mehra NK, Lopez-Larrea C. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Hum. Immunol. 61: 131-139 (2000).
Martinez-Laso J, Gazit E, Gomez-Casado E, Morales P, Martinez-Quiles N, Alvarez M, Martin-Villa JM, Fernandez V, Arnaiz-Villena A. HLA DR and DQ polymorphism in Ashkenazi and non-Ashkenazi Jews: comparison with other Mediterraneans. Tissue Antigens 47: 63-71 (1996).
Martinez-Taboda VM, Bartolome MJ, Lopez-Hoyos M, Blanco R, Mata C, Calvo J, Corrales A, Rodriguez-Valverde V. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis. Semin. Arthritis Rheum. 34: 454-464 (2004). *
Martinka E, Shawkatova I, Strakova J, Buc M, Mokan M. Latent autoimmune (type I) diabetes mellitus in adults. Part. II. Association of HLA antigens, status of cellular immunity and occurrence of other autoimmune diseases. Vnitr. Lek. 45: 103-109 (1999).
Martins EB, Chapman RW. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 16: 444-449 (2000).
Martins EB, Chapman RW. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 15: 436-441 (1999).
Martins L, Malheiro J, Henriques AC, Dias L, Dores J, Oliveira F, Seca R, Almeida R, Sarmento AM, Cabrita A, Teixeira M. Pancreas-kidney transplantation and the evolution of pancreatic autoantibodies. Transplant. Proc. 41: 913-915 (2009). *
Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C, Savi M, Buzio C, Neri TM. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum. 55: 126-130 (2006). *
Marttila J, Huttunen S, Vaarala O, Suzuki K, Elliott JF, Narvanen A, Knip M, Simell O, Ilonen J. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies. J. Autoimmun. 31: 142-148 (2008).
Marturano J, Longhi R, Casorati G, Protti MP. MAGE-A3(161-175 )contains an HLA-DRbeta4 restricted natural epitope poorly formed through indirect presentation by dendritic cells. Cancer Immunol. Immunother. 57: 207-215 (2008). *
Maruya E, Saji H, Yokoyama S. PCR-LIS-SSCP (low ionic strength single-stranded conformation polymorphism) - a simple method for high-resolution allele typing of HLA-DRB1, -DQB1, and -DPB1. Genome Res. 6: 51-57 (1996). *
Maruyama T. Analysis of HLA-DR, -DQA1, -DQB1 genes in Japanese IDDM patients. Nippon Rinsho 52: 2751-2757 (1994).
Maruyama T, Oak S, Hall TR, Banga JP, Ortqvist E, Ettinger RA, Endl J, Hampe CS. Autoantibody epitopes to the smaller isoform of glutamate decarboxylase do not differ in Swedish and Japanese type 1 diabetes patients and may be associated with high-risk human leucocyte antigen class II alleles. Clin. Exp. Immunol. 150: 416-421 (2007). *
Marzo-Ortega H, Baxter K, Strauss RM, Drysdale S, Griffiths B, Misbah SA, Gough A, Cunliffe WJ, Emery P. Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. Br. J. Dermatol. 156: 1005-1009 (2007). *
Mas A, Blanco E, Monux G, Urcelay E, Serrano FJ, de la Concha EG, Martinez A. DRB1-TNF-alpha-TNF-beta haplotype is strongly associated with severe aortoiliac occlusive disease, a clinical form of atherosclerosis. Hum. Immunol. 66: 1062-1067 (2005).
Masi AT, Medsger TA Jr. A new look at the epidemiology of ankylosing spondylitis and related syndromes. Clin. Orthop. Relat. Res. 143: 15-29 (1979).
Massa M, Passalia M, Manzoni SM, Campanelli R, Ciardelli L, Yung GP, Kamphuis S, Pistorio A, Meli V, Sette A, Prakken B, Martini A, Albani S. Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. Arthritis Rheum. 56: 1648-1657 (2007). *
Massardo L, Aguirre V, Garcia ME, Cervila V, Nicovani S, Gonzalez A, Rivero S, Jacobelli S. Clinical expression of rheumatoid arthritis in Chilean patients. Semin. Arthritis Rheum. 25: 203-213 (1995).
Mastaglia F, Price P, Walters S, Fabian V, Miller J, Zilko P. Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes. Neuromuscul. Disord. 16: 754-758 (2006).
Mastaglia FL. Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC. Acta Myol. 28: 66-71 (2009).
Mastaglia FL, Needham M, Scott A, James I, Zilko P, Day T, Kiers L, Corbett A, Witt CS, Allcock R, Laing N, Garlepp M, Christiansen FT. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype. Neuromuscul. Disord. 19: 763-765 (2009).
Masuda H, Ishii U, Aoki N, Nakayama H, Sato F, Karube H, Suzuki S, Kondo T. Ulcerative colitis associated with Takayasu's disease in two patients who received proctocolectomy. J. Gastroenterol. 37: 297-302 (2002).
Masuda H, Nakamura Y, Tanaka T, Hayakawa S. Distinct relationship between HLA-DR genes and intractability of ulcerative colitis. Am. J. Gastroenterol. 89: 1957-1962 (1994).
Matake H, Naito S, Ogawara S, Iida M, Matsui T, Okabe N, Yamamoto T, Fujita K, Okada M, Yao T. HLA study in 108 Japanese patients with Crohn's disease. Nippon Shokakibyo Gakkai Zasshi 86: 1448-1454 (1989).
Matoba K, Tojo K, Nemoto M, Tajima N. Familial Graves' disease associated with type 1 diabetes. Intern. Med. 48: 701-704 (2009). *
Matri S, Boubaker J, Hamzaoui S, Bardi R, Ayed K, Filali A. The role of major histocompatibility complex genes in the pathogenesis of chronic inflammatory bowel diseases. Tunis. Med. 81: 289-294 (2003).
Matsoukas J, Apostolopoulos V, Kalbacher H, Papini AM, Tselios T, Chatzantoni K, Biagioli T, Lolli F, Deraos S, Papathanassopoulos P, Troganis A, Mantzourani E, Mavromoustakos T, Mouzaki A. Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators. J. Med. Chem. 48: 1470-1480 (2005). *
Matsui M, Moriya O, Belladonna ML, Kamiya S, Lemonnier FA, Yoshimoto T, Akatsuka T. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J. Virol. 78: 9093-9104 (2004). *
Matsui Y, Alosco SM, Awdeh Z, Duquesnoy RJ, Page PL, Hartzman RJ, Alper CA, Yunis EJ. Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes. Immunogenetics 20: 623-631 (1984).
Matsumoto T, Kitano A, Nakamura S, Oshitani N, Obata A, Hashimura H, Hiki M, Okawa K, Nagura H, Kobayashi K. Immunocytochemical characterization of the DNA-polymerase alpha-positive colonic mucosal epithelial cells in patients with ulcerative colitis. Nippon Shokakibyo Gakkai Zasshi 86: 1611-1616 (1989).
Matsumoto T, Kitano A, Nakamura S, Oshitani N, Obata A, Hiki M, Hashimura H, Okawa K, Kobayashi K, Nagura H. Possible role of vascular endothelial cells in immune responses in colonic mucosa examined immunocytochemically in subjects with and without ulcerative colitis. Clin. Exp. Immunol. 78: 424-430 (1989). *
Matsumura S, Kita H, He XS, Ansari AA, Lian ZX, Van De Water J, Yamamoto K, Tsuji T, Coppel RL, Kaplan M, Gershwin ME. Comprehensive mapping of HLA-A0201-restricted CD8 T-cell epitopes on PDC-E2 in primary biliary cirrhosis. Hepatology 36: 1125-1134 (2002). *
Matsumura Y, Kinouchi Y, Nomura E, Negoro K, Kakuta Y, Endo K, Aizawa H, Takagi S, Takahashi S, Shimosegawa T. HLA-DRB1 alleles influence clinical phenotypes in Japanese patients with ulcerative colitis. Tissue Antigens 71: 447-452 (2008). *
Matsuoka T, Matsushita T, Osoegawa M, Kawano Y, Minohara M, Mihara F, Nishimura Y, Ohyagi Y, Kira J. Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis. Mult. Scler. 14: 1181-1190 (2008).
Matsuoka Y. Peripheral blood HLA-DR (+) monocytes in Crohn's disease. Nippon Shokakibyo Gakkai Zasshi 84: 940 (1987).
Matsushita M, Takakuwa H, Matsubayashi Y, Nishio A, Ikehara S, Okazaki K. Appendix is a priming site in the development of ulcerative colitis. World J. Gastroenterol. 11: 4869-4874 (2005). *
Matsushita M, Tsuchiya N, Nakayama T, Ohashi J, Shibue T, Shiota M, Oka T, Yamane A, Tokunaga K. Allele typing of human TNFA 5'-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese. Tissue Antigens 54: 478-484 (1999). *
Matsushita M, Tsuchiya N, Shiota M, Komata T, Matsuta K, Zama K, Oka T, Juji T, Yamane A, Tokunaga K. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 54: 578-584 (1999). *
Matsushita M, Uchida K, Okazaki K. Role of the appendix in the pathogenesis of ulcerative colitis. Inflammopharmacology 15: 154-157 (2007).
Matsushita S, Fujisao S, Nishimura Y. Molecular mechanisms underlying HLA-DR-associated susceptibility to autoimmunity. Int. J. Cardiol. 54 Suppl.: S81-S90 (1996).
Matsushita T, Matsuoka T, Isobe N, Kawano Y, Minohara M, Shi N, Nishimura Y, Ochi H, Kira J. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens 73: 171-176 (2009). *
Matsuzaka Y, Makino S, Nakajima K, Tomizawa M, Oka A, Kimura M, Bahram S, Tamiya G, Inoko H. New polymorphic microsatellite markers in the human MHC class II region. Tissue Antigens 56: 492-500 (2000). *
Matsuzaki J, Qian F, Luescher I, Lele S, Ritter G, Shrikant PA, Gnjatic S, Old LJ, Odunsi K. Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1. Cancer Immunol. Immunother. 57: 1185-1195 (2008). *
Mattey DL, Dawes PT, Clarke S, Fisher J, Brownfield A, Thomson W, Haajeer AH, Ollier WE. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheum. 47: 403-407 (2002). *
Mattey DL, Dawes PT, Fisher J, Brownfield A, Thomson W, Hajeer AH, Ollier WE. Nodular disease in rheumatoid arthritis: association with cigarette smoking and HLA-DRB1/TNF gene interaction. J. Rheumatol. 29: 2313-2318 (2002). *
Mattey DL, Dawes PT, Gonzalez-Gay MA, Garcia-Porrua C, Thomson W, Hajeer AH, Ollier WE. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. J. Rheumatol. 28: 232-239 (2001).
Mattey DL, Gonzalez-Gay MA, Hajeer AH, Dababneh A, Thomson W, Garcia-Porrua C, Ollier WE. Association between HLA-DRB1*15 and secondary Sjogren's syndrome in patients with rheumatoid arthritis. J. Rheumatol. 27: 2611-2616 (2000).
Mattey DL, Hajeer AH, Dababneh A, Thomson W, Gonzalez-Gay MA, Garcia-Porrua C, Ollier WE. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum. 43: 1749-1755 (2000). *
Mattey DL, Hassell AB, Dawes PT, Cheung NT, Poulton KV, Thomson W, Hajeer AH, Ollier WE. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis Rheum. 44: 1529-1533 (2001). *
Mattey DL, Hassell AB, Dawes PT, Jones PW, Yengi L, Alldersea J, Strange RC, Fryer AA. Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes. Arthritis Rheum. 43: 859-864 (2000). *
Mattey DL, Hassell AB, Dawes PT, Ollier WE, Hajeer A. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: influence on disease outcome. Arthritis Rheum. 42: 2698-2704 (1999). *
Mattey DL, Hassell AB, Plant M, Dawes PT, Ollier WR, Jones PW, Fryer AA, Alldersea JE, Strange RC. Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitope. Ann. Rheum. Dis. 58: 164-168 (1999). *
Mattey DL, Hassell AB, Plant MJ, Cheung NT, Dawes PT, Jones PW, Thomson W, Poulton KV, Hajeer AH, Ollier WE. The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis. Rheumatology (Oxford) 38: 1221-1227 (1999). *
Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH. Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun. 5: 147-149 (2004). *
Mattey DL, Thomson W, Ollier WE, Batley M, Davies PG, Gough AK, Devlin J, Prouse P, James DW, Williams PL, Dixey J, Winfield J, Cox NL, Koduri G, Young A. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study. Arthritis Rheum. 56: 1408-1416 (2007). *
Matthews AG, Li J, He C, Ott J, Andrade M. Adjusting for HLA-DRbeta1 in a genome-wide association analysis of rheumatoid arthritis and related biomarkers. BMC Proc. 3 Suppl. 7: S12 (2009). *
Matthews EJ, Kruhlak NL, Benz RD, Aragones Sabate D, Marchant CA, Contrera JF. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities. Regul. Toxicol. Pharmacol. 54: 43-65 (2009).
Matthews EJ, Ursem CJ, Kruhlak NL, Benz RD, Sabate DA, Yang C, Klopman G, Contrera JF. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities. Regul. Toxicol. Pharmacol. 54: 23-42 (2009).
Matthews PC, Prendergast A, Leslie A, Crawford H, Payne R, Rousseau C, Rolland M, Honeyborne I, Carlson J, Kadie C, Brander C, Bishop K, Mlotshwa N, Mullins JD, Coovadia H, Ndung'u T, Walker BD, Heckerman D, Goulder PJ. Central role of reverting mutations in HLA associations with human immunodeficiency virus setpoint. J. Virol. 82: 8548-8559 (2008). *
Matthews VB, Witt CS, French MA, Machulla HK, De la Concha EG, Cheong KY, Vigil P, Hollingsworth PN, Warr KJ, Christiansen FT, Price P. Central MHC genes affect IgA levels in the human: reciprocal effects in IgA deficiency and IgA nephropathy. Hum. Immunol. 63: 424-433 (2002).
Matusiewicz K, Iwanczak B, Matusiewicz M, Iwanczak F. Diagnostic validity of anti-tissue transglutaminase and anti-endomysium antibodies in children with celiac disease. Pol. Merkuriusz. Lek. 20: 17-21 (2006).
May E, Dulphy N, Frauendorf E, Duchmann R, Bowness P, Lopez de Castro JA, Toubert A, Marker-Hermann E. Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens 60: 299-308 (2002). *
Mayr A, Schlosser M, Grober N, Kenk H, Ziegler AG, Bonifacio E, Achenbach P. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes 56: 1527-1533 (2007). *
Mbanya JC, Sobngwi E, Mbanya DN. HLA-DRB1, -DQA1, -DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls. Eur. J. Immunogenet. 28: 459-462 (2001). *
McClain KL, Laud P, Wu WS, Pollack MS. Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter. Med. Pediatr. Oncol. 41: 502-507 (2003). *
McClure A, Lunt M, Eyre S, Ke X, Thomson W, Hinks A, Bowes J, Gibbons L, Plant D, Wilson AG, Marinou I, Morgan AW, Emery P; BIRAC consortium, Steer S, Hocking LJ, Reid DM, Wordsworth P, Harrison P, Worthington J, Barton A. Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci. Rheumatology (Oxford) 48: 1369-1374 (2009). *
McColl GJ, Hammer J, Harrison LC. Absence of peripheral blood T cell responses to "shared epitope' containing peptides in recent onset rheumatoid arthritis. Ann. Rheum. Dis. 56: 240-246 (1997). *
McCombe PA, Csurhes PA, Greer JM. Studies of HLA associations in male and female patients with Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J. Neuroimmunol. 180: 172-177 (2006).
McDaniel DO, Alarcon GS, Pratt PW, Reveille JD. Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope) Ann. Intern. Med. 123: 181-187 (1995).
McDaniel DO, Barger BO, Acton RT, Koopman WJ, Alarcon GS. Molecular analysis of HLA-D region genes in seropositive rheumatoid arthritis. Tissue Antigens 34: 299-308 (1989).
McDermott AB, Cohen SB, Zuckerman JN, Madrigal JA. Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine. Vaccine 17: 330-339 (1999).
McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 50: 8-14 (1997).
McDevitt HO. The genetics of the HLA system. J. Rheumatol. Suppl. 10: 50-53 (1983).
McDonagh AJ, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin. Exp. Dermatol. 27: 405-409 (2002). *
McDonald GB, Jewell DP. Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon. J. Clin. Pathol. 40: 312-317 (1987). *
McDonnell GV, Kirk CW, Middleton D, Droogan AG, Hawkins SA, Patterson CC, Graham CA. Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis. J. Neurol. 246: 1051-1058 (1999).
McFarlane IG, McFarlane BM, Haines AJ, Eddleston AL, Williams R. Relationship between primary biliary cirrhosis and chronic graft versus host disease: investigation of histocompatibility (HLA) antigenic determinants in biliary tract antigens. Clin. Sci. (Lond.) 64: 113-116 (1983).
McGarry F, Walker R, Sturrock R, Field M. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J. Rheumatol. 26: 1110-1116 (1999).
McGinnis R, McLaren W, Ranganath V, Whittaker P, Hunt S, Deloukas P; Diabetes Genetics Consortium. Haplotype-based search for SNPs associated with differential type 1 diabetes risk among chromosomes carrying a specific HLA DRB1-DQA1-DQB1 haplotype. Diabetes Obes. Metab. 11 Suppl. 1: 8-16 (2009). *
McGuigan C, Dunne C, Crowley J, Hagan R, Rooney G, Lawlor E, Hutchinson M. Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland. J. Neurol. 252: 1245-1248 (2005).
McHugh NJ, Owen P, Cox B, Dunphy J, Welsh K. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus. Ann. Rheum. Dis. 65: 488-494 (2006). *
McHugh NJ, Whyte J, Artlett C, Briggs DC, Stephens CO, Olsen NJ, Gusseva NG, Maddison PJ, Black CM, Welsh K. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study. Clin. Exp. Immunol. 96: 267-274 (1994). *
McIntyre JA, Hamilton RL, Dekosky ST. Redox-reactive autoantibodies in cerebrospinal fluids. Ann. N. Y. Acad. Sci. 1109: 296-302 (2007). *
McIntyre JA, Wagenknecht DR, Faulk WP. Redox-reactive autoantibodies: detection and physiological relevance. Autoimmun. Rev. 5: 76-83 (2006).
McKay FC, Swain LI, Schibeci SD, Rubio JP, Kilpatrick TJ, Heard RN, Stewart GJ, Booth DR. CD127 immunophenotyping suggests altered CD4(+) T cell regulation in primary progressive multiple sclerosis. J. Autoimmun. 31: 52-58 (2008).
McKinnon E, Morahan G, Nolan D, James I; Diabetes Genetics Consortium. Association of MHC SNP genotype with susceptibility to type 1 diabetes: a modified survival approach. Diabetes Obes. Metab. 11 Suppl. 1: 92-100 (2009). *
McLachlan G, Baker A, Tennant P, Gordon C, Vrettou C, Renwick L, Blundell R, Cheng SH, Scheule RK, Davies L, Painter H, Coles RL, Lawton AE, Marriott C, Gill DR, Hyde SC, Griesenbach U, Alton EW, Boyd AC, Porteous DJ, Collie DD. Optimizing aerosol gene delivery and expression in the ovine lung. Mol. Ther. 15: 348-354 (2007).
McLachlan JB, Catron DM, Moon JJ, Jenkins MK. Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity 30: 277-288 (2009). *
McLaughlan JM, Seth R, Vautier G, Robins RA, Scott BB, Hawkey CJ, Jenkins D. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J. Pathol. 181: 87-92 (1997).
McManus DP, Ross AG, Williams GM, Sleigh AC, Wiest P, Erlich H, Trachtenberg E, Guanling W, McGarvey ST, Li YS, Waine GJ. HLA class II antigens positively and negatively associated with hepatosplenic schistosomiasis in a Chinese population. Int. J. Parasitol. 31: 674-680 (2001). *
McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur. J. Immunol. 26: 2113-2118 (1996).
McNearney TA, Hunnicutt SE, Fischbach M, Friedman AW, Aguilar M, Ahn CW, Reveille JD, Lisse JR, Baethge BA, Goel N, Mayes MD. Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine. J. Rheumatol. 36: 2724-2732 (2009).
McTernan CL, Stewart LC, Mijovic CH, Barnett AH. Assessment of the non-HLA-DR-DQ contribution to IDDM1 in British Caucasian families: analysis of LMP7 polymorphisms. Diabet. Med. 17: 661-666 (2000). *
Mee JB, Johnson CM, Morar N, Burslem F, Groves RW. The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am. J. Pathol. 171: 32-42 (2007). *
Megiorni F, Mora B, Bonamico M, Barbato M, Montuori M, Viola F, Trabace S, Mazzilli MC. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am. J. Gastroenterol. 103: 997-1003 (2008). *
Megiorni F, Mora B, Bonamico M, Barbato M, Nenna R, Maiella G, Lulli P, Mazzilli MC. HLA-DQ and risk gradient for celiac disease. Hum. Immunol. 70: 55-59 (2009).
Megiorni F, Mora B, Bonamico M, Nenna R, Di Pierro M, Catassi C, Drago S, Mazzilli MC. A rapid and sensitive method to detect specific human lymphocyte antigen (HLA) class II alleles associated with celiac disease. Clin. Chem. Lab. Med. 46: 193-196 (2008). *
Mehal WZ, Gregory WL, Lo YM, Cross SJ, Fleming KA, Bassendine MF, James OF, Campbell RD, Chapman RW, Rosenberg WM. Defining the immunogenetic susceptibility to primary biliary cirrhosis. Hepatology 20: 1213-1219 (1994).
Mehal WZ, Lo YM, Wordsworth BP, Neuberger JM, Hubscher SC, Fleming KA, Chapman RW. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 106: 160-167 (1994).
Mehling M, Simon P, Mittelbronn M, Meyermann R, Ferrone S, Weller M, Wiendl H. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism? Acta Neuropathol. (Berl.) 114: 111-119 (2007).
Mehra NK, Kaur G, Jaini R. Genetic diversity in the human major histocompatibility complex: lessons for vaccination approaches to HIV infection. Community Genet. 5: 162-166 (2002).
Mehra NK, Kumar N, Kaur G, Kanga U, Tandon N. Biomarkers of susceptibility to type 1 diabetes with special reference to the Indian population. Indian J. Med. Res. 125: 321-344 (2007). *
Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB, Dave DM, Goyal RK. Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J. Dermatol. Venereol. Leprol. 75: 579-582 (2009).
Mei CL, He P, Cheng B, Liu W, Wang YF, Wan JJ. Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways. Cell Biol. Int. 33: 301-308 (2009). *
Mei H, Dorner T. Translational aspects on the role of B-cells in autoimmune diseases : "from bench to bedside" and "from bed to benchside". Z. Rheumatol. 68: 364-369 (2009).
Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 88: 23-29 (2009).
Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van Veen K, Abrahams M, Seldon R, Pepper DJ, Rebe K, Mouton P, van Cutsem G, Nicol MP, Maartens G, Wilkinson RJ. Type 1 helper T cells and FoxP3-positive T cells and the HIV-tuberculosis immune reconstitution inflammatory syndrome. Am. J. Respir. Crit. Care Med. 178: 1083-1089 (2008). *
Melchers I. Immunogenetics-HLA-association, molecular chaperones and "related" diseases. Z. Rheumatol. 64: 402-407 (2005).
Meletis J, Terpos E. Transplantation strategies for the management of patients with myelodysplastic syndromes. J. BUON 14: 551-564 (2009).
Melis L, Elewaut D. Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease? Arthritis Res. Ther. 11: 233 (2009).
Mellai M, Giordano M, D'Alfonso S, Marchini M, Scorza R, Giovanna Danieli M, Leone M, Ferro I, Liguori M, Trojano M, Ballerini C, Massacesi L, Cannoni S, Bomprezzi R, Momigliano-Richiardi P. Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Hum. Immunol. 64: 274-284 (2003).
Melo FM, Cavalcanti MS, Santos SB, Lopes AK, Oliveira FA. Association between serum markers for celiac and thyroid autoimmune diseases. Arq. Bras. Endocrinol. Metabol. 49: 542-547 (2005).
Melo KM, Carvalho KI, Bruno FR, Ndhlovu LC, Ballan WM, Nixon DF, Kallas EG, Costa-Carvalho BT. A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PLoS One 4: e6269 (2009). *
Melo N, Morais A, Alves H, Lima B, Tafulo S, Goncalves R. HLA - A, -C, -B, -DRB1 e -DQB polymorphisms in extrinsic allergic alveolitis (EAA). Rev. Port. Pneumol. 11: S29 (2005).
Menconi F, Monti MC, Greenberg DA, Oashi T, Osman R, Davies TF, Ban Y, Jacobson EM, Concepcion ES, Wun Li C, Tomer Y. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc. Natl. Acad. Sci. U.S.A. 105: 14034-14039 (2008). *
Mendez-Sanchez N, King-Mart�nez AC, Ramos MH, Pichardo-Bahena R, Uribe M. The Amerindian's genes in the Mexican population are associated with development of gallstone disease. Am. J. Gastroenterol. 99: 2166-2170 (2004). *
Meng E, Guo Z, Wang H, Jin J, Wang J, Wang H, Wu C, Wang L. High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cells Dev. 17: 805-813 (2008).
Menier C, Rouas-Freiss N, Favier B, Lemaoult J, Moreau P, Carosella ED. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens. Dec 30 [Epub ahead of print] (2009). *
Mentula P, Kylanpaa ML, Kemppainen E, Repo H, Puolakkainen P. Early inflammatory response in acute pancreatitis is little affected by body mass index. Scand. J. Gastroenterol. 42: 1362-1368 (2007). *
Meresse B, Ripoche J, Heyman M, Cerf-Bensussan N. Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol. 2: 8-23 (2009). *
Merino E, Galocha B, Vazquez MN, Lopez De Castro JA. Disparate folding and stability of the ankylosing spondylitis-associated HLA-B*1403 and B*2705 proteins. Arthritis Rheum. 58: 3693-3704 (2008). *
Merino E, Montserrat V, Paradela A, Lopez de Castro JA. Two HLA-B14 subtypes (B-1402 and B-1403) differentially associated with ankylosing spondylitis differ substantially in peptide specificity, but have limited peptide and T-cell epitope sharing with HLA-B27. J. Biol. Chem. 280: 35868-35880 (2005). *
Merryman P, Silver J, Gregersen PK, Solomon G, Winchester R. A novel association of DQ alpha and DQ beta genes in the DRw10 haplotype. Determination of a DQw1 specificity by the DQ beta-chain. J. Immunol. 143: 2068-2073 (1989).
Messer G, Kick G, Ranki A, Koskimies S, Reunala T, Meurer M. Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis. Dermatology 189 Suppl. 1: 135-137 (1994).
Metcalf JV, Howel D, James OF, Bhopal R. Primary biliary cirrhosis: epidemiology helping the clinician. BMJ 312: 1181-1182 (1996). *
Metskula K, Salur L, Mandel M, Uibo R. Demonstration of high prevalence of SS-A antibodies in a general population: association with HLA-DR and enterovirus antibodies. Immunol. Lett. 106: 14-18 (2006).
Meunier L, Bohjanen K, Voorhees JJ, Cooper KD. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation. J. Invest. Dermatol. 103: 775-779 (1994). *
Meurer M. Pemphigus diseases in children and adolescents. Hautarzt. 60: 208-216 (2009).
Mewar D, Marinou I, Lee ME, Timms JM, Kilding R, Teare MD, Read RC, Wilson AG. Haplotype-specific gene expression profiles in a telomeric major histocompatibility complex gene cluster and susceptibility to autoimmune diseases. Genes Immun. 7: 625-631 (2006). *
Meyer JM, Evans TI, Small RE, Redford TW, Han J, Singh R, Moxley G. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis. J. Rheumatol. 26: 1024-1034 (1999).
Meyer JM, Han J, Moxley G. Tumor necrosis factor markers show sex-influenced association with rheumatoid arthritis. Arthritis Rheum. 44: 286-295 (2001). *
Meyer JM, Han J, Singh R, Moxley G. Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis. Am. J. Hum. Genet. 58: 371-383 (1996). *
Meyer M, Czachurski D, Hien T, Opelz G, Mytilineos J. A new PCR-SSP typing method for six single-nucleotide polymorphisms impairing the blood-clotting cascade as well as T-cell stimulation. Tissue Antigens 66: 650-655 (2005). *
Meyer O. Superantigens and their implication in autoimmune diseases. Presse. Med. 24: 1171-1177 (1995).
Meyer O, Nicaise-Roland P, Santos MD, Labarre C, Dougados M, Goupille P, Cantagrel A, Sibilia J, Combe B. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Res. Ther. 8: R40 (2006). *
Meyer VS, Kastenmuller W, Gasteiger G, Franz-Wachtel M, Lamkemeyer T, Rammensee HG, Stevanovic S, Sigurdardottir D, Drexler I. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling. J. Immunol. 181: 6371-6383 (2008). *
Meyer zum Buschenfelde KH. Immunopathology of chronic liver diseases. Verh. Dtsch. Ges. Pathol. 79: 186-197 (1995).
Miakotkin VA, Moshnina MA, Krylov MIu, Guseva IA, Sharapova EP, Alekseeva LI. A search for genes of predisposition to rheumatoid arthritis. Vestn. Ross. Akad. Med. Nauk. 7: 27-30 (2003).
Miao KR, Pan QQ, Tang RC, Zhou XP, Fan S, Wang XY, Zhao X, Xue M, Zhou XY, Wang CY. The polymorphism and haplotype analysis of HLA-A, -B and -DRB1 genes of population in Jiangsu province of China. Int. J. Immunogenet. 34: 419-424 (2007). *
Miceli-Richard C, Comets E, Verstuyft C, Tamouza R, Loiseau P, Ravaud P, Kupper H, Becquemont L, Charron D, Mariette X. A single tumor necrosis factor haplotype influences response to adalimumab in rheumatoid arthritis. Ann. Rheum. Dis. 67: 478-484 (2008).
Michaels A, Levy C. Endoscopic and surgical management of primary sclerosing cholangitis. Medscape J. Med. 10: 242 (2008). *
Michalski JP, McCombs CC, Arai T, Elston RC, Cao T, McCarthy CF, Stevens FM. HLA-DR, DQ genotypes of celiac disease patients and healthy subjects from the West of Ireland. Tissue Antigens 47: 127-133 (1996).
Michels AW, Eisenbarth GS. Autoimmune polyendocrine syndrome type 1 (APS-1) as a model for understanding autoimmune polyendocrine syndrome type 2 (APS-2). J. Intern. Med. 265: 530-540 (2009). *
Michou L, Croiseau P, Petit-Teixeira E, du Montcel ST, Lemaire I, Pierlot C, Osorio J, Frigui W, Lasbleiz S, Quillet P, Bardin T, Prum B, Clerget-Darpoux F, Cornelis F; the European Consortium on Rheumatoid Arthritis Families. Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis. Arthritis Res. Ther. 8: R79 (2006). *
Michou L, Lasbleiz S, Rat AC, Migliorini P, Balsa A, Westhovens R, Barrera P, Alves H, Pierlot C, Glikmans E, Garnier S, Dausset J, Vaz C, Fernandes M, Petit-Teixeira E, Lemaire I, Pascual-Salcedo D, Bombardieri S, Dequeker J, Radstake TR, et al. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc. Natl. Acad. Sci. U.S.A. 104: 1649-1654 (2007). *
Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieude P, Prum B, Cornelis F, Petit-Teixeira E. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann. Rheum. Dis. 67: 466-470 (2008).
Michur H, Maslanka K, Szczepinski A, Marianska B. Reticulated platelets as a marker of platelet recovery after allogeneic stem cell transplantation. Int. J. Lab. Hematol. 30: 519-525 (2008).
Mickelson EM, Nisperos B, Layrisse Z, Kim SJ, Thomas ED, Hansen JA. Analysis of the HLA-DRw8 haplotype: recognition by HTC typing of three distinct antigen complexes in Caucasians, Native Americans, and Orientals. Immunogenetics 17: 399-410 (1983).
Middleton D, Savage DA, Cullen C, Trainor F, Mallon E, Hawkins S. Frequency of HLA-DPB1 alleles in multiple sclerosis patients from Northern Ireland. Eur. J. Immunogenet. 19: 323-326 (1992).
Mielants H, Veys EM. HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis. J. Rheumatol. 12: 287-293 (1985).
Mielants H, Veys EM, Cuvelier C, De Vos M. Macroscopic and histological changes of the ileum HLA-B27 related diseases: therapeutic consequences. Int. J. Clin. Pharmacol. Res. 4: 409-414 (1984).
Mieli-Vergani G, Mowat A. Primary sclerosing cholangitis in pediatrics: what is different? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 79. October 15-16 (2003). *
Migita K, Nakamura T, Koga T, Eguchi K. HLA-DRB1 alleles and rheumatoid arthritis-related pulmonary fibrosis. J. Rheumatol. 37: 205-207 (2010).
Migita K, Nakamura T, Maeda Y, Miyashita T, Origuchi T, Yatsuhashi H, Nakamura M, Ishibashi H, Eguchi K. HLA-DRB1*04 alleles in Japanese rheumatoid arthritis patients with AA amyloidosis. J. Rheumatol. 33: 2120-2123 (2006).
Mignarri A, Dotti MT, Battisti C, Vallone I, Federico A. Occurrence of ankylosing spondylitis and multiple sclerosis-like syndrome in a HLA-B27 positive patient. Neurol. Sci. May 15 [Epub ahead of print] (2009).
Mignogna MD, Fortuna G, Leuci S. Oral pemphigus. Minerva Stomatol. 58: 501-518 (2009).
Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20: 1012-1020 (1997).
Mignot E, Kimura A, Abbal M, Thorsby E, Lin X, Voros A, Macaubas C, Bouissou F, Sollid LM, Cambon-Thomsen A, et al. DQCAR microsatellite polymorphisms in three selected HLA class II-associated diseases. Tissue Antigens 46: 299-304 (1995).
Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu S, Leffell M, Grumet F, Fernandez-Vina M, Honda M, Risch N. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet. 68: 686-699 (2001). *
Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr. Opin. Rheumatol. 12: 281-286 (2000).
Milia AF, Ibba-Manneschi L, Manetti M, Benelli G, Generini S, Messerini L, Matucci-Cerinic M. Evidence for the prevention of enthesitis in HLA-B27/hbeta2m transgenic rats treated with a monoclonal antibody against TNFalpha. J. Cell. Mol. Med. Dec 8 [Epub ahead of print] (2009).
Milicic A, Lee D, Brown MA, Darke C, Wordsworth BP. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. J. Rheumatol. 29: 1821-1826 (2002). *
Milkiewicz P, Ahmed M, Hathaway M, Elias E. Factors associated with progression of the disease before transplantation in patients with autoimmune hepatitis. Liver 19: 50-54 (1999).
Milkiewicz P, Gunson B, Saksena S, Hathaway M, Hubscher SG, Elias E. Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors. Transplantation 70: 477-480 (2000).
Miller JD, Whitehair LH. Concurrent HLA-related response factors mediate recombinant hepatitis B vaccine major adverse events. Autoimmunity 38: 181-194 (2005).
Miller JW. Of race, ethnicity, and rash: the genetics of antiepileptic drug-induced skin reactions. Epilepsy Curr. 8: 120-121 (2008).
Miller LC, Kaplan MM. Serum interleukin-2 and tumor necrosis factor-alpha in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am. J. Gastroenterol. 87: 465-470 (1992).
Miller MM. Ankylosing spondylitis, Reiter's syndrome, psoriatic arthritis, and arthritis of inflammatory bowel disease. Prim. Care 11: 271-282 (1984).
Miller SJ, Zaloga GP, Hoggatt AM, Labarrere C, Faulk WP. Short-chain fatty acids modulate gene expression for vascular endothelial cell adhesion molecules. Nutrition 21: 740-748 (2005). *
Mimbacas A, Garc�a L, Zorrilla P, Acosta M, Airaudo C, Ferrero R, Pena A, Simonelli B, Soto E, Vitarella G, Fernandez J, Javiel G. Genotype and phenotype correlations in diabetic patients in Uruguay. Genet. Mol. Res. 8: 1352-1358 (2009).
Min HY, Niu NF, Liu Y, Zhang MF, Zhu XL, Zhao JL. Single nucleotide polymorphisms of promoter of human leukocyte antigen-DQB1 alleles in Chinese Han patients with Vogt-Koyanagi-Harada syndrome. Zhonghua Yan Ke Za Zhi 44: 870-875 (2008).
Min JY, Min KB, Sung J, Il Cho S. Linkage and association studies of joint morbidity from rheumatoid arthritis. J. Rheumatol. Dec 23 [Epub ahead of print] (2009).
Minden K, Niewerth M, Borte M, Singendonk W, Haas JP. Immunization in children and adolescents with rheumatic diseases. Z. Rheumatol. 66: 111-120 (2007).
Mira MT, Alcais A, di Pietrantonio T, Thuc NV, Phuong MC, Abel L, Schurr E. Segregation of HLA/TNF region is linked to leprosy clinical spectrum in families displaying mixed leprosy subtypes. Genes Immun. 4: 67-73 (2003). *
Miranda A, Amadeu TP, Schueler G, Alvarenga FB, Duppre N, Ferreira H, Nery JA, Sarno EN. Increased Langerhans cell accumulation after mycobacterial stimuli. Histopathology 51: 649-656 (2007).
Mirandola S, Osterreicher CH, Marcolongo M, Datz C, Aigner E, Schlabrakowski A, Realdon S, Gerotto M, Alberti A, Stickel F. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C. Liver Int. 29: 557-565 (2009). *
Mirel DB, Barcellos LF, Wang J, Hauser SL, Oksenberg JR, Erlich HA. Analysis of IL4R haplotypes in predisposition to multiple sclerosis. Genes Immun. 5: 138-141 (2004). *
Miretti MM, Walsh EC, Ke X, Delgado M, Griffiths M, Hunt S, Morrison J, Whittaker P, Lander ES, Cardon LR, Bentley DR, Rioux JD, Beck S, Deloukas P. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76: 634-646 (2005). *
Misharin AV, Nagayama Y, Aliesky HA, Rapoport B, McLachlan SM. Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for the autoimmune regulator in tolerance for thyroid autoantigens. Endocrinology 150: 2948-2956 (2009). *
Misharin AV, Rapoport B, McLachlan SM. Thyroid antigens, not central tolerance, control responses to immmunization in BALB/C versus C57BL/6 mice. Thyroid 19: 503-509 (2009).
Mitchell SA, Chapman RW. Primary sclerosing cholangitis. Clin. Rev. Allergy Immunol. 18: 185-214 (2000).
Mitchison NA, Ono SJ, Stephens HA. Does the polymorphism of MHC class II promoters matter? Cell. Immunol. 233: 162-165 (2005). *
Miterski B, Drynda S, Boschow G, Klein W, Oppermann J, Kekow J, Epplen JT. Complex genetic predisposition in adult and juvenile rheumatoid arthritis. BMC Genet. 5: 2 (2004). *
Mitra-Kaushik S, Cruz J, Stern LJ, Ennis FA, Terajima M. Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses. J. Immunol. 179: 1303-1312 (2007). *
Miura M, Hiwatashi N, Yamashita K, Kimura M. Immunohistologic characterization of epitheloid cells in Crohn's granulomas. J. Clin. Lab. Immunol. 28: 11-14 (1989).
Mix H, Weiler-Normann C, Thimme R, Ahlenstiel G, Shin EC, Herkel J, David CS, Lohse AW, Rehermann B. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology 135: 2107-2118 (2008). *
Miyagawa S, Amagai M, Niizeki H, Yamashina Y, Kaneshige T, Nishikawa T, Shirai T, Inoko H. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus. Tissue Antigens 54: 333-340 (1999).
Miyagawa S, Shinohara K, Kidoguchi K, Fujita T, Fukumoto T, Hashimoto K, Yoshioka A, Shirai T. Neonatal lupus erythematosus: studies on HLA class II genes and autoantibody profiles in Japanese mothers. Autoimmunity 26: 95-101 (1997).
Miyagawa S, Shinohara K, Nakajima M, Kidoguchi K, Fujita T, Fukumoto T, Yoshioka A, Dohi K, Shirai T. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum. 41: 927-934 (1998). *
Miyagawa T, Honda M, Kawashima M, Shimada M, Tanaka S, Honda Y, Tokunaga K. Polymorphism located in TCRA locus confers susceptibility to essential hypersomnia with HLA-DRB1*1501-DQB1*0602 haplotype. J. Hum. Genet. Nov 20 [Epub ahead of print] (2009).
Miyagawa T, Kawashima M, Nishida N, Ohashi J, Kimura R, Fujimoto A, Shimada M, Morishita S, Shigeta T, Lin L, Hong SC, Faraco J, Shin YK, Jeong JH, Okazaki Y, Tsuji S, Honda M, Honda Y, Mignot E, Tokunaga K. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat. Genet. 40: 1324-1328 (2008). *
Miyakawa H, Kawashima Y, Kitazawa E, Kawaguchi N, Kato T, Kikuchi K, Imai E, Fujikawa H, Hashimoto E, Schlumberger W. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. J. Autoimmun. 21: 77-82 (2003). *
Miyake Y, Iwasaki Y, Takaki A, Onishi T, Okamoto R, Takaguchi K, Ikeda H, Makino Y, Kobashi H, Sakaguchi K, Shiratori Y. Human leukocyte antigen DR status and clinical features in Japanese patients with type 1 autoimmune hepatitis. Hepatol. Res. 38: 96-102 (2008). *
Miyamori H, Kato Y, Kobayashi K, Hattori N. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion 26: 213-217 (1983).
Miyamoto K, Ishii H, Takata H, Takagi S, Shigeta Y, Sekiguchi S, Suyama K, Kohno H, Tsuchiya M. Association of HLA-B40 and DRW9 with Japanese alcoholic liver cirrhosis. Pharmacol. Biochem. Behav. 18 Suppl. 1: 467-471 (1983).
Miyamoto T, Maeda T, Onishi S, Yamamoto Y. T cell autoreactivity against a 28 kD biliary protein (B1-p28) in primary biliary cirrhosis. J. Hepatol. 22: 423-430 (1995). *
Miyamura N, Murata Y, Taketa K, Ichihara Y, Matsumura T, Tokunaga H, Matsumoto K, Sakakida M, Araki E. A case of insulin autoimmune syndrome with HLA DRB1*0404: impact on the hypothesis for the molecular pathogenesis involving DRB1 molecules. Diabet. Med. 23: 104-105 (2006). *
Mizuki N, Inoko H, Mizuki N, Tanaka H, Kera J, Tsuiji K, Ohno S. Human leukocyte antigen serologic and DNA typing of Behcet's disease and its primary association with B51. Invest. Ophthalmol. Vis. Sci. 33: 3332-3340 (1992). *
Mizuki N, Inoko H, Sugimura K, Nishimura K, Nakamura S, Tanaka H, Mizuki N, Mizuki H, Inaba G, Tsuji K, et al. RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behcet's disease. Invest. Ophthalmol. Vis. Sci. 33: 3084-3090 (1992). *
Mizuki N, Ohno S, Ando H, Kimura M, Ishihara M, Miyata S, Nakamura S, Mizuki N, Inoko H. HLA-C genotyping of patient with Behcet's disease in the Japanese population. Hum. Immunol. 50: 47-53 (1996).
Mizuki N, Ohno S, Tanaka H, Sugimura K, Seki T, Mizuki N, Kera J, Inaba G, Tsuji K, Inoko H. Association of HLA-B51 and lack of association of class II alleles with Behcet's disease. Tissue Antigens 40: 22-30 (1992).
Mizutori Y, Chen CR, Latrofa F, McLachlan SM, Rapoport B. Evidence that shed TSH receptor A-subunits drive affinity maturation of autoantibodies causing Graves' disease. J. Clin. Endocrinol. Metab. 94: 927-935 (2009).
Mjosberg J, Svensson J, Johansson E, Hellstrom L, Casas R, Jenmalm MC, Boij R, Matthiesen L, Jonsson JI, Ernerudh J. Systemic reduction of functionally suppressive CD4dimCD25high Foxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol. J. Immunol. 183: 759-769 (2009).
Mnasria K, Lagaraine C, Velge-Roussel F, Lebranchu Y, Baron C. Anti-CD25 antibodies decrease the ability of human dendritic cells to prime allogeneic CD4 T cells. Transplant. Proc. 41: 695-697 (2009). *
Mnasria K, Lagaraine C, Velge-Roussel F, Oueslati R, Lebranchu Y, Baron C. Anti-CD25 antibodies affect cytokine synthesis pattern of human dendritic cells and decrease their ability to prime allogeneic CD4+ T cells. J. Leukoc. Biol. 84: 460-467 (2008). *
Mobley JL. Is rheumatoid arthritis a consequence of natural selection for enhanced tuberculosis resistance? Med. Hypotheses 62: 839-843 (2004).
Mochida A, Kinouchi Y, Negoro K, Takahashi S, Takagi S, Nomura E, Kakuta Y, Tosa M, Shimosegawa T. Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502. Tissue Antigens 70: 128-135 (2007). *
Mochida S, Yoshimoto T, Mimura S, Inao M, Matsui A, Ohno A, Koh H, Saitoh E, Nagoshi S, Fujiwara K. Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis. Biochem. Biophys. Res. Commun. 317: 114-120 (2004). *
Mochizuki M, Amemiya S, Kobayashi K, Kobayashi K, Shimura Y, Ishihara T, Nakagomi Y, Onigata K, Tamai S, Kasuga A, Nanazawa S. Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care 26: 843-847 (2003). *
Modesto C, Patino-Garcia A, Sotillo-Pineiro E, Merino J, Garcia-Consuegra J, Merino R, Rua MJ, Sierrasesumaga L, Arnal C. TNF-alpha promoter gene polymorphisms in Spanish children with persistent oligoarticular and systemic-onset juvenile idiopathic arthritis. Scand. J. Rheumatol. 34: 451-454 (2005).
Moffatt MF, Schou C, Faux JA, Abecasis GR, James A, Musk AW, Cookson WO. Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample. Eur. J. Hum. Genet. 9: 341-346 (2001). *
Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S, Klaenhammer TR. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl. Acad. Sci. U.S.A. 102: 2880-2885 (2005). *
Mohammadi J, Pourpak Z, Jarefors S, Saghafi S, Zendehdel K, Pourfathollah AA, Amirzargar AA, Aghamohammadi A, Moin M, Hammarstrom L. Human leukocyte antigens (HLA) associated with selective IgA deficiency in Iran and Sweden. Iran J. Allergy Asthma Immunol. 7: 209-214 (2008).
Mohammadi J, Ramanujam R, Jarefors S, Rezaei N, Aghamohammadi A, Gregersen PK, Hammarstrom L. IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J. Clin. Immunol. Oct 16 [Epub ahead of print] (2009). *
Mohammed K, Pope J, le Riche N, Brintnell W, Cairns E, Coles R, Bell DA. Association of severe inflammatory polyarthritis in primary Sjogren's syndrome: clinical, serologic, and HLA analysis. J. Rheumatol. 36: 1937-1942 (2009).
Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, Baykal C, Lambert J, Bigliardi P, Willemsen M, Jones M, Buechner S, Colonna M, Gross WL, Cerundolo V. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules. Lancet 354: 1598-1603 (1999). *
Moise L, McMurry JA, Buus S, Frey S, Martin WD, De Groot AS. In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes. Vaccine 27: 6471-6479 (2009). *
Moisini I, Nguyen P, Fugger L, Geiger TL. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor. J. Immunol. 180: 3601-3611 (2008). *
Mojibian M, Chakir H, Lefebvre DE, Crookshank JA, Sonier B, Keely E, Scott FW. A diabetes-specific HLA-DR restricted pro-inflammatory T cell response to wheat polypeptides in tissue transglutaminase antibody negative patients with type 1 diabetes. Diabetes 58: 1789-1796 (2009).
Mok JW, Lee YJ, Kim JY, Lee EB, Song YW, Park MH, Park KS. Association of MICA polymorphism with rheumatoid arthritis patients in Koreans. Hum. Immunol. 64: 1190-1194 (2003).
Molberg O, Kett K, Scott H, Thorsby E, Sollid LM, Lundin KE. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 46: 103-109 (1997).
Molberg O, Lundin KE, Nilsen EM, Scott H, Kett K, Brandtzaeg P, Thorsby E, Sollid LM. HLA restriction patterns of gliadin- and astrovirus-specific CD4+ T cells isolated in parallel from the small intestine of celiac disease patients. Tissue Antigens 52: 407-415 (1998).
Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur. J. Immunol. 31: 1317-1323 (2001).
Molenaar ET, Voskuyl AE, van der Horst-Bruinsma IE, Schreuder GM, Zanelli E, Dijkmans BA. Influence of HLA polymorphism on persistent remission in rheumatoid arthritis. Ann. Rheum. Dis. 61: 351-353 (2002). *
Moll JM. Inflammatory bowel disease. Clin. Rheum. Dis. 11: 87-111 (1985).
Moller P, Vinje O, Berg K. HLA antigens, psoriasis and acute anterior uveitis in Bechterew's syndrome (ankylosing spondylitis). Clin. Genet. 21: 215-221 (1982).
Moloney MM, Thomson LJ, Strettell MJ, Williams R, Donaldson PT. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 28: 660-662 (1998). *
Molta CT, Khan MA, Aponte CJ, Reynolds TL, Macintyre SS. Familial occurrence of systemic sclerosis, rheumatoid arthritis and other immunological disorders: report of two kindreds with study of HLA antigens and review of the literature. Clin. Exp. Rheumatol. 7: 229-236 (1989).
Momburg F, Koretz K, Von Herbay A, Moller P. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain - an immunohistological study on normal and chronically inflamed small intestine. Clin. Exp. Immunol. 72: 367-372 (1988). *
Monneaux F, Hoebeke J, Sordet C, Nonn C, Briand JP, Maillere B, Sibillia J, Muller S. Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog. J. Immunol. 175: 5839-5847 (2005). *
Monneret G, Venet F. Statins and sepsis: do we really need to further decrease monocyte HLA-DR expression to treat septic patients? Lancet Infect. Dis. 7: 697-699 (2007).
Monos DS, Spielman RS, Gogolin KJ, Radka SF, Baker L, Zmijewski CM, Kamoun M. HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation. Immunogenetics 26: 299-303 (1987).
Monowarul Islam SM, Numaga J, Fujino Y, Masuda K, Ohda H, Hirata R, Maeda H, Mitsui H. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum. 38: 547-550 (1995).
Montano Loza AJ, Czaja AJ. Current therapy for autoimmune hepatitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 4: 202-214 (2007). *
Montano-Loza A, Czaja AJ, Carpenter HA, Piette A, Murphy D, Shums Z, Burlingame R, Norman GL. Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis. Autoimmunity 39: 341-348 (2006).
Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 46: 1138-1145 (2007). *
Montano-Loza AJ, Carpenter HA, Czaja AJ. Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis. Liver Int. 26: 1201-1208 (2006). *
Montano-Loza AJ, Sultan A, Falanga D, Loss G, Mason AL. Immunogenetic susceptibility to diabetes mellitus in patients with liver disease. Liver Int. 29: 1543-1551 (2009). *
Montes-Cano MA, Caro-Oleas JL, Romero-Gomez M, Diago M, Andrade R, Carmona I, Reina JA, Nunez-Roldan A, Gonzalez-Escribano MF. HLA-C and KIR genes in hepatitis C virus infection. Hum. Immunol. 66: 1106-1109 (2005).
Montoya CJ, Catano JC, Ramirez Z, Rugeles MT, Wilson SB, Landay AL. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin. Immunol. 127: 1-6 (2008). *
Montserrat V, Galocha B, Marcilla M, Vazquez M, Lopez de Castro JA. HLA-B*2704, an allotype associated with ankylosing spondylitis, is critically dependent on transporter associated with antigen processing and relatively independent of tapasin and immunoproteasome for maturation, surface expression, and T cell � J. Immunol. 177: 7015-7023 (2006). *
Moore L, Xu X, Davidson G, Moore D, Carli M, Ferrante A. Autoimmune enteropathy with anti-goblet cell antibodies. Hum. Pathol. 26: 1162-1168 (1995).
Morahan G, Mehta M, McKinnon E, James I; Diabetes Genetics Consortium. Effect of linkage status of affected sib-pairs on the search for novel type 1 diabetes susceptibility genes in the HLA complex. Diabetes Obes. Metab. 11 Suppl. 1: 67-73 (2009). *
Morais A, Alves H, Lima B, Delgado L, Goncalves R, Tafulo S. HLA class I and II and TNF-alpha gene polymorphisms in sarcoidosis patients. Rev. Port. Pneumol. 14: 727-746 (2008).
Morales-Buenrostro LE, Rodriguez-Romo R, de Leo-Cervantes C, Lopez M, Perez-Garrido J, Uribe-Uribe N, Alberu-Gomez J. Evidence on the role of HLA and MICA antibodies in renal graft loss. Gac. Med. Mex. 144: 315-322 (2008).
Moreau C, Drui D, Arnault-Ouary G, Charbonnel B, Chaillous L, Cariou B. Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab. 34: 529-532 (2008).
Morel E, Bellon T. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor. Allergy 62: 190-196 (2007). *
Morel E, Escamochero S, Cabanas R, Diaz R, Fiandor A, Bellon T. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J. Allergy Clin. Immunol. Feb 2 [Epub ahead of print] (2010). *
Morel J, Roch-Bras F, Molinari N, Sany J, Eliaou JF, Combe B. HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognostic factors in rheumatoid arthritis. Ann. Rheum. Dis. 63: 1581-1586 (2004). *
Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc. Natl. Acad. Sci. U.S.A. 85: 8111-8115 (1988). *
Morgan AW, Robinson JI, Barrett JH, Martin J, Walker A, Babbage SJ, Ollier WE, Gonzalez-Gay MA, Isaacs JD. Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res. Ther. 8: R109 (2006). *
Morgan AW, Thomson W, Martin SG, Carter AM, Erlich HA, Barton A, Hocking L, Reid DM, Harrison P, Wordsworth P, Steer S, Worthington J, Emery P, Wilson AG, Barrett JH. Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum. 60: 2565-2576 (2009). *
Mori I, Parizot C, Dorgham K, Demeret S, Amoura Z, Bolgert F, Gorochov G. Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barre syndrome. PLoS ONE 3: e2109 (2008). *
Mori K, Kizawa H, Ushiyama T, Chano T, Inoue H, Tsuchiya N, Okabe H, Matsusue Y, Ikegawa S. Association of CYP17 with HLA-B27-negative seronegative spondyloarthropathy in Japanese males. Am. J. Med. Genet. 130A: 169 (2004). *
Morioka D, Egawa H, Kasahara M, Jo T, Sakamoto S, Ogura Y, Haga H, Takada Y, Shimada H, Tanaka K. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl. 13: 80-90 (2007). *
Morishita Y, Uenaka A, Kaya S, Sato S, Aji T, Nakayama E. HLA-DRB1*0410-restricted recognition of XAGE-1b(37-48) peptide by CD4 T cells. Microbiol. Immunol. 51: 755-762 (2007). *
Morita Y, Yamamura M, Suwaki K, Mima A, Ishizu T, Hirohata M, Kashihara N, Makino H, Ota Z. Takayasu's arteritis associated with ulcerative colitis; genetic factors in this association. Intern. Med. 35: 574-578 (1996). *
Morling N, Andersen V, Fugger L, Georgsen J, Halberg P, Oxholm P, Odum N, Svejgaard A. Immunogenetics of rheumatoid arthritis and primary Sjogren's syndrome: DNA polymorphism of HLA class II genes. Dis. Markers 9: 289-296 (1991).
Morling N, Dalhoff K, Fugger L, Georgsen J, Jakobsen B, Ranek L, Odum N, Svejgaard A. DNA polymorphism of HLA class II genes in primary biliary cirrhosis. Immunogenetics 35: 112-116 (1992).
Morling N, Frentz G, Fugger L, Georgsen J, Jakobsen B, Odum N, Svejgaard A. DNA polymorphism of HLA class II genes in alopecia areata. Dis. Markers 9: 35-42 (1991).
Moroldo MB, Donnelly P, Saunders J, Glass DN, Giannini EH. Transmission disequilibrium as a test of linkage and association between HLA alleles and pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 41: 1620-1624 (1998). *
Morris AP, Zeggini E, Lindgren CM. Identification of novel putative rheumatoid arthritis susceptibility genes via analysis of rare variants. BMC Proc. 3 Suppl. 7: S131 (2009). *
Morris MA, Yiannakou JY, King AL, Brett PM, Biagi F, Vaughan R, Curtis D, Ciclitira PJ. Coeliac disease and Down syndrome: associations not due to genetic linkage on chromosome 21. Scand. J. Gastroenterol. 35: 177-180 (2000). *
Morse JH, Barst RJ, Fotino M, Zhang Y, Flaster E, Fritzler MJ. Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone. Clin. Exp. Immunol. 106: 389-395 (1996). *
Mortensen HB, Swift PG, Holl RW, Hougaard P, Hansen L, Bjoerndalen H, de Beaufort CE, Knip M; and Hvidoere Study Group on Childhood Diabetes. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatr. Diabetes Aug 25 [Epub ahead of print] (2008).
Mosconi G, Baraldi O, Fantinati C, Cappuccilli M, Corsini S, Zanelli P, Bassi A, Buscaroli B, Feliciangeli G, Stefoni S. Anti-HLA antibodies after bone graft and their impact on kidney transplant programs. G. Ital. Nefrol. 26: 58-63 (2009).
Moscoso J, Serrano-Vela JI, Pacheco R, Arnaiz-Villena A. HLA-G, -E and -F: allelism, function and evolution. Transpl. Immunol. 17: 61-64 (2006).
Moscoso J, Serrano-Vela JI, Perez-Saborido B, Moreno E, Arnaiz-Villena A. A novel HLA-G allele (HLA-G*0108) with an alpha-3 domain amino acid change. Tissue Antigens 70: 171-173 (2007). *
Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, Bruner GR, Fox J, Kelly J, Henshall S, Bacino D, Dietz M, Hogue R, Koelsch G, Nightingale L, Shaver T, Abdou NI, Albert DA, Carson C, Petri M, Treadwell EL, James JA, Harley JB. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl. Acad. Sci. U.S.A. 95: 14869-14874 (1998). *
Motala AA, Busson M, Al-Harbi EM, Khuzam MA, Al-Omari EM, Arekat MR, Almawi WY. Susceptible and protective human leukocyte antigen class II alleles and haplotypes in Bahraini type 2 (non-insulin-dependent) diabetes mellitus patients. Clin. Diagn. Lab. Immunol. 12: 213-217 (2005).
Moustakas AK, Papadopoulos GK. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells. Am. J. Med. Genet. 115: 37-47 (2002).
Moustakas AK, van de Wal Y, Routsias J, Kooy YM, van Veelen P, Drijfhout JW, Koning F, Papadopoulos GK. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int. Immunol. 12: 1157-1166 (2000). *
Moutsopoulos HM. Sjogren's syndrome: autoimmune epithelitis. Clin. Immunol. Immunopathol. 72: 162-165 (1994).
Moutsopoulos HM, Papadopoulos GK. Possible viral implication in the pathogenesis of Sjogren's syndrome. Eur. J. Med. 1: 219-223 (1992).
Moutsopoulos NM, Katsifis GE, Angelov N, Leakan RA, Sankar V, Pillemer S, Wahl SM. Lack of efficacy of etanercept in Sjogren's syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation. Ann. Rheum. Dis. 67: 1437-1443 (2008).
Movahedi M, Moin M, Gharagozlou M, Aghamohammadi A, Dianat S, Moradi B, Nicknam MH, Nikbin B, Amirzargar A. Association of HLA class II alleles with childhood asthma and total IgE levels. Iran J. Allergy Asthma Immunol. 7: 215-220 (2008).
Moya-Quiles MR, Alvarez R, Miras M, Gomez-Mateo J, Lopez-Alvarez MR, Marin-Moreno I, Martinez-Barba E, Sanchez-Mozo MP, Gomez M, Arnal F, Sanchez-Bueno F, Marin LA, Garcia-Alonso AM, Minguela A, Muro M, Parrilla P, Alonso C, Alvarez-Lopez MR. Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection. Hum. Immunol. 68: 51-58 (2007).
Mrazek F, Holla LI, Hutyrova B, Znojil V, Vasku A, Kolek V, Welsh KI, Vacha J, du Bois RM, Petrek M. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 65: 163-171 (2005). *
Mu H, Charmley P, King MC, Criswell LA. Synergy between T cell receptor beta gene polymorphism and HLA-DR4 in susceptibility to rheumatoid arthritis. Arthritis Rheum. 39: 931-937 (1996).
Mu H, Chen JJ, Jiang Y, King MC, Thomson G, Criswell LA. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum. 42: 438-442 (1999). *
Mu H, King MC, Criswell LA. Relative predispositional effects and mode of inheritance of HLA-DRB1 alleles among community-based Caucasian females with rheumatoid arthritis. Genet. Epidemiol. 15: 123-134 (1998).
Mueller RB, Skapenko A, Grunke M, Wendler J, Stuhlmuller B, Kalden JR, Schulze-Koops H. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor. Arthritis Rheum. 52: 451-460 (2005). *
Muhling O, El-Nounou M, Schafer C, Muhlbayer D, Tympner C, Behr J. A 52-year-old patient with positive troponin, iron deficiency anemia and known sarcoidosis. Internist (Berl.) 47: 1279-1283 (2006).
Muix� L, Alvarez I, Jaraquemada D. Chapter 6. Peptides presented in vivo by HLA-DR in thyroid autoimmunity. Adv. Immunol. 99C: 165-209 (2008).
Muix� L, Carrascal M, Alvarez I, Daura X, Mart� M, Armengol MP, Pinilla C, Abian J, Pujol-Borrell R, Jaraquemada D. Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands. J. Immunol. 181: 795-807 (2008). *
Mulder CJ, Cellier C. Coeliac disease: changing views. Best Pract. Res. Clin. Gastroenterol. 19: 313-321 (2005).
Mullarkey ME, Stevens AM, McDonnell WM, Loubiere LS, Brackensick JA, Pang JM, Porter AJ, Galloway DA, Nelson JL. Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens 65: 199-205 (2005). *
Mullighan CG, Bardy PG. New directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 13: 127-144 (2007).
Munoz LE, Lauber K, Schiller M, Manfredi AA, Schett G, Voll RE, Herrmann M. The role of incomplete clearance of apoptotic cells in the etiology and pathogenesis of SLE. Z. Rheumatol. Jan 28 [Epub ahead of print] (2010).
Munoz-Fernandez S, de Miguel E, Cobo-Ibanez T, Madero R, Ferreira A, Hidalgo MV, Schlincker A, Martin-Mola E. Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis. Arthritis Rheum. 60: 1985-1990 (2009). *
Muntasell A, Carrascal M, Alvarez I, Serradell L, van Veelen P, Verreck FA, Koning F, Abian J, Jaraquemada D. Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands. J. Immunol. 173: 1085-1093 (2004). *
Munthe-Kaas MC, Carlsen KL, Carlsen KH, Egeland T, Haland G, Devulapalli CS, Akselsen H, Undlien D. HLA DR-DQ haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy. Allergy 62: 991-998 (2007).
Murakami M, Mizuide M, Kashima K, Kojima A, Tomioka SI, Kohama T, Araki O, Ogiwara T, Mizuma H, Mori M. Identification of monoclonal insulin autoantibodies in insulin autoimmune syndrome associated with HLA-DRB1*0401. Horm. Res. 54: 49-52 (2000).
Muratori P, Czaja AJ, Muratori L, Pappas G, Maccariello S, Cassani F, Granito A, Ferrari R, Mantovani V, Lenzi M, Bianchi FB. Genetic distinctions between autoimmune hepatitis in Italy and North America. World J. Gastroenterol. 11: 1862-1866 (2005). *
Muratori P, Granito A, Quarneti C, Ferri S, Menichella R, Cassani F, Pappas G, Bianchi FB, Lenzi M, Muratori L. Autoimmune hepatitis in Italy: the Bologna experience. J. Hepatol. 50: 1210-1218 (2009).
Murdaca G, Contini P, Setti M, Cagnati P, Villa R, Lantieri F, Indiveri F, Puppo F. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome. Hum. Immunol. 68: 894-900 (2007).
Murgia C, Orru M, Portoghese E, Garau N, Zedda P, Berria R, Motzo C, Sulis S, Murenu M, Paoletti AM, Melis GB. Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report. Reprod. Biol. Endocrinol. 6: 24 (2008).
Muro M, Rivera J, Botella C, Campillo JA, Ferrer F, Alvarez-Lopez MR. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report. Transfus. Apher. Sci. 38: 209-212 (2008).
Muro Y, Ogawa Y, Sugiura K, Tomita Y. HLA-associated production of anti-DFS70/LEDGF autoantibodies and systemic autoimmune disease. J. Autoimmun. 26: 252-257 (2006).
Murota M, Watanabe S, Fujita J, Ohtsuki Y, Wu F, Yoshida S, Kita Y, Funakoshi F, Masaki T, Kurokohchi K, Uchida N, Ishida T, Kuriyama S. Aberrant cytokeratin expression and high susceptibility to apoptosis in autoimmune hepatitis. Hepatol. Res. 25: 271-280 (2003).
Murray JA. The widening spectrum of celiac disease. Am. J. Clin. Nutr. 69: 354-365 (1999). *
Murray KJ, Moroldo MB, Donnelly P, Prahalad S, Passo MH, Giannini EH, Glass DN. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum. 42: 1843-1853 (1999). *
Mustafa AS. Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis. Scand. J. Immunol. 69: 213-222 (2009). *
Mustafa AS. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. Med. Princ. Pract. 18: 385-392 (2009).
Mustafa AS, Al-Attiyah R, Hanif SN, Shaban FA. Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells. Clin. Vaccine Immunol. 15: 916-924 (2008). *
Mustafa AS, Shaban F. Mapping of Th1-cell epitope regions of Mycobacterium tuberculosis protein MPT64 (Rv1980c) using synthetic peptides and T-cell lines from M. tuberculosis-infected healthy humans. Med. Princ. Pract. 19: 122-128 (2010).
Muthukuru M, Cutler CW. Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance. Infect. Immun. 76: 477-485 (2008). *
Mutschlechner S, Egger M, Briza P, Wallner M, Lackner P, Karle A, Vogt AB, Fischer GF, Bohle B, Ferreira F. Naturally processed T-cell-activating peptides of the major birch pollen allergen. J. Allergy Clin. Immunol. Feb 2 [Epub ahead of print] (2010). *
Muxel SM, Borelli SD, Amarante MK, Voltarelli JC, Aoki MN, de Oliveira CE, Ehara Watanabe MA. Association study of CCR5 delta 32 polymorphism among the HLA-DRB1 Caucasian population in Northern Parana, Brazil. J. Clin. Lab. Anal. 22: 229-233 (2008). *
Myhre AG, Undlien DE, Lovas K, Uhlving S, Nedrebo BG, Fougner KJ, Trovik T, Sorheim JI, Husebye ES. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. J. Clin. Endocrinol. Metab. 87: 618-623 (2002). *
Myung SJ, Yang SK, Jung HY, Chang HS, Park B, Hong WS, Kim JH, Min I. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study. Int. J. Colorectal Dis. 17: 233-237 (2002). *
Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, David CS. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183: 27-37 (1996). *
Nadege A, Diane A, Saadia KR, Fanny B, Francoise R, Marc P. NF-kappaB plays a major role in the maturation of human dendritic cells induced by NiSO(4) but not by DNCB. Toxicol. Sci. 99: 488-501 (2007). *
Naderi N, Pourfathollah AA, Alimoghaddam K, Moazzeni SM. Cord blood dendritic cells prevent the differentiation of naive T-helper cells towards Th1 irrespective of their subtype. Clin. Exp. Med. 9: 29-36 (2009). *
Nagamine I, Yamaguchi Y, Ohara M, Ikeda T, Okada M. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer. Hiroshima J. Med. Sci. 58: 37-44 (2009).
Nagano H, Yoshifuku K, Kurono Y. Polymyositis with dysphagia treated with endoscopic balloon dilatation. Auris. Nasus. Larynx 36: 705-708 (2009).
Nagata M, Moriyama H, Kotani R, Yasuda H, Kishi M, Kurohara M, Hara K, Yokono K. Immunological aspects of 'fulminant type 1 diabetes'. Diabetes Res. Clin. Pract. 77 Suppl. 1: S99-S103 (2007).
Nagatomo Y, Yoshida T, Kodama K, Kambe H, Tanaka K. Possible association of specific HLA haplotype in a pedigree with familial polyposis coli. Am. J. Gastroenterol. 82: 910-911 (1987).
Nagy A, Kozma GT, Keszei M, Treszl A, Falus A, Szalai C. The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin. J. Allergy Clin. Immunol. 112: 729-734 (2003). *
Naiki Y, Sorrentino R, Wong MH, Michelsen KS, Shimada K, Chen S, Yilmaz A, Slepenkin A, Schroder NW, Crother TR, Bulut Y, Doherty TM, Bradley M, Shaposhnik Z, Peterson EM, Tontonoz P, Shah PK, Arditi M. TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J. Immunol. 181: 7176-7185 (2008). *
Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol. Pharmacol. 63: 732-741 (2003). *
Nakagawa H, Tokunaga K, Dewald G, Omoto K, Ishibashi Y, Matsuki K, Juji T. Genetic variants of the complement components and HLA-antigens associated in patients with psoriasis vulgaris in Japanese. Nippon Hifuka Gakkai Zasshi 99: 77-81 (1989).
Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 109: 1462-1467 (1995). *
Nakamaru Y, Maguchi S, Takizawa M, Fukuda S, Inuyama Y. The association between human leukocyte antigens (HLA) and cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener's granulomatosis in a Japanese population. Rhinology 34: 163-165 (1996).
Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren's syndrome. Transl. Res. 148: 281-288 (2006). *
Nakanishi K, Komatsu Y, Kogawa N, Matsushita H. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein. Biochem. Biophys. Res. Commun. 329: 356-361 (2005). *
Nakanishi K, Shima Y. Capture of type 1 diabetes-susceptible HLA DR-DQ haplotypes in Japanese subjects using a tag single nucleotide polymorphism. Diabetes Care Oct 16 [Epub ahead of print] (2009).
Nakanuma Y, Kono N. Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: an immunohistochemical study. Hum. Pathol. 22: 431-436 (1991).
Nakanuma Y, Yasoshima M, Morita T, Gershwin ME. Abnormal expression of pyruvate dehydrogenase on bile ducts opens new fields in the pathogenesis of primary biliary cirrhosis. Nippon Rinsho 53: 1287-1296 (1995).
Nalini R, Gaur LK, Maldonado M, Hampe CS, Rodriguez L, Garza G, Lernmark A, Balasubramanyam A. HLA class II alleles specify phenotypes of ketosis-prone diabetes (KPD). Diabetes Care 31: 1195-1200 (2008). *
Nanda A, Alsaleh QA, Al-Hasawi F, Al-Muzairai I. Thyroid function, autoantibodies, and HLA tissue typing in children with alopecia areata. Pediatr. Dermatol. 19: 486-491 (2002). *
Nanto-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, Korhonen S, Erkkola R, Sipila JI, Haavisto L, Siltala M, Tuominen J, Hakalax J, Hyoty H, Ilonen J, Veijola R, Simell T, Knip M, Simell O. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 372: 1746-1755 (2008). *
Narayan K, Perkins EM, Murphy GE, Dalai SK, Edidin M, Subramaniam S, Sadegh-Nasseri S. Staphylococcal enterotoxin A induces small clusters of HLA-DR1 on B cells. PLoS One 4: e6188 (2009). *
Narayan K, Su KW, Chou CL, Khoruzhenko S, Sadegh-Nasseri S. HLA-DM mediates peptide exchange by interacting transiently and repeatedly with HLA-DR1. Mol. Immunol. 46: 3157-3162 (2009). *
Nasef A, Mathieu N, Chapel A, Frick J, Francois S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84: 231-237 (2007).
Naujokat C, Berges C, Hoh A, Wieczorek H, Fuchs D, Ovens J, Miltz M, Sadeghi M, Opelz G, Daniel V. Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells. Immunology 120: 120-132 (2007). *
Naumova E, Pawelec G, Ivanova M, Constantinescu I, Bogunia-Kubik K, Lange A, Qguz F, Carin M. 14th International HLA and Immunogenetics Workshop: report on the immunogenetics of aging. Tissue Antigens 69 Suppl. 1: S304-S310 (2007).
Naumova EN, Gorski J, Naumov YN. Two compensatory pathways maintain long-term stability and diversity in CD8 T cell memory repertoires. J. Immunol. 183: 2851-2858 (2009).
Nedjai B, Hitman GA, Quillinan N, Coughlan RJ, Church L, McDermott MF, Turner MD. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 60: 619-625 (2009). *
Needham M, Corbett A, Day T, Christiansen F, Fabian V, Mastaglia FL. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. J. Clin. Neurosci. 15: 1350-1353 (2008).
Needham M, James I, Corbett A, Day T, Christiansen F, Phillips B, Mastaglia FL. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J. Neurol. Neurosurg. Psychiatry 79: 1056-1060 (2008).
Nejentsev S, Gombos Z, Laine AP, Veijola R, Knip M, Simell O, Vaarala O, Akerblom HK, Ilonen J. Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 49: 2217-2221 (2000). *
Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, Reynolds P, Hardy M, King E, Masters J, Hulme J, Maier LM, Smyth D, Bailey R, Cooper JD, Ribas G, Campbell RD, Clayton DG, Todd JA; The Wellcome Trust Case Control Consortium. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450: 887-892 (2007). *
Nejentsev S, Reijonen H, Adojaan B, Kovalchuk L, Sochnevs A, Schwartz EI, Akerblom HK, Ilonen J. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 46: 1888-1892 (1997).
Nelson DE, Virok DP, Wood H, Roshick C, Johnson RM, Whitmire WM, Crane DD, Steele-Mortimer O, Kari L, McClarty G, Caldwell HD. Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc. Natl. Acad. Sci. U.S.A. 102: 10658-10663 (2005). *
Nelson JL. Microchimerism and human autoimmune diseases. Lupus 11: 651-654 (2002). *
Nelson JL. HLA relationships of pregnancy, microchimerism and autoimmune disease. J. Reprod. Immunol. 52: 77-84 (2001).
Nelson JL. Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol. Med. 8: 109-113 (2002). *
Nelson JL, Dugowson CE, Koepsell TD, Voigt LF, Branchaud AM, Barrington RA, Wener MH, Hansen JA. Rheumatoid factor, HLA-DR4, and allelic variants of DRB1 in women with recent-onset rheumatoid arthritis. Arthritis Rheum. 37: 673-680 (1994).
Nelson JL, Gillespie KM, Lambert NC, Stevens AM, Loubiere LS, Rutledge JC, Leisenring WM, Erickson TD, Yan Z, Mullarkey ME, Boespflug ND, Bingley PJ, Gale EA. Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc. Natl. Acad. Sci. U.S.A. 104: 1637-1642 (2007). *
Nemati E, Taheri S, Pourfarziani V, Einollahi B. Human leukocyte antigen (HLA) B-27 and older age are associated with augmented cyclosporine blood bioavailability in renal allograft recipients: an attempt toward individualization of immunosuppression. Ann. Transplant. 13: 32-36 (2008). *
Nenna R, Mora B, Megiorni F, Mazzilli MC, Magliocca FM, Tiberti C, Bonamico M. HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease. J. Pediatr. Gastroenterol. Nutr. 47: 288-292 (2008). *
Nepom BS, Nepom GT, Coleman M, Kwok WW. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. U.S.A. 93: 7202-7206 (1996). *
Nepom GT. Determinants of genetic susceptibility in HLA-associated autoimmune disease. Clin. Immunol. Immunopathol. 53: S53-S62 (1989).
Nepom GT. The role of the DR4 shared epitope in selection and commitment of autoreactive T cells in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 27: 305-315 (2001).
Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum. 32: 15-21 (1989).
Nepom GT, Hansen JA, Nepom BS. The molecular basis for HLA class II associations with rheumatoid arthritis. J. Clin. Immunol. 7: 1-7 (1987).
Nepom GT, Seyfried CA, Nepom BS. Immunogenetics of disease susceptibility: new perspectives in HLA. Pathol. Immunopathol. Res. 5: 37-46 (1986).
Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M, Floreani A, Rosina F, Bianchi Porro G, Strazzabosco M, Okolicsanyi L. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig. Liver Dis. 35: 571-576 (2003).
Neuberger J. Chapter 32. Acute and chronic rejection of the liver allograft. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 423-431 (2007). *
Neuberger J. Recurrence of autoimmune liver diseases after liver transplantation. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 47-48. September 12 - 13 (2003). *
Neudeck BL, Loeb JM, Faith NG, Czuprynski CJ. Intestinal P glycoprotein acts as a natural defense mechanism against Listeria monocytogenes. Infect. Immun. 72: 3849-3854 (2004). *
Neumann J, Koch N. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain. J. Cell. Sci. 119: 4207-4214 (2006). *
Neumann UP, Guckelberger O, Langrehr JM, Lang M, Schmitz V, Theruvath T, Schonemann C, Menzel S, Klupp J, Neuhaus P. Impact of human leukocyte antigen matching in liver transplantation. Transplantation 75: 132-137 (2003).
Newman B, Silverberg MS, Gu X, Zhang Q, Lazaro A, Steinhart AH, Greenberg GR, Griffiths AM, McLeod RS, Cohen Z, Fernandez-Vina M, Amos CI, Siminovitch K. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. Am. J. Gastroenterol. 99: 306-315 (2004). *
Newton J, Brown MA, Milicic A, Ackerman H, Darke C, Wilson JN, Wordsworth BP, Kwiatkowski D. The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype. Arthritis Rheum. 48: 90-96 (2003). *
Newton JL, Harney SM, Timms AE, Sims AM, Rockett K, Darke C, Wordsworth BP, Kwiatkowski D, Brown MA. Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis. Arthritis Rheum. 50: 2122-2129 (2004). *
Newton JL, Harney SM, Wordsworth BP, Brown MA. A review of the MHC genetics of rheumatoid arthritis. Genes Immun. 5: 151-157 (2004). *
Neyfakh AA. Mystery of multidrug transporters: the answer can be simple. Mol. Microbiol. 44: 1123-1130 (2002). *
Ng SC, Plamondon S, Al-Hassi HO, English N, Gellatly N, Kamm MA, Knight SC, Stagg AJ. A novel population of human CD56(+) human leucocyte antigen D-related (HLA-DR(+)) colonic lamina propria cells is associated with inflammation in ulcerative colitis. Clin. Exp. Immunol. 158: 205-218 (2009). *
Nguyen XD, Muller-Berghaus J, Kalsch T, Schadendorf D, Borggrefe M, Kluter H. Differentiation of monocyte-derived dendritic cells under the influence of platelets. Cytotherapy 10: 720-729 (2008).
Ni LF, Na J, Deng R, Wu R, Liu XM. Expression of human leukocyte antigen-DR in idiopathic pulmonary fibrosis. Zhonghua Yi Xue Za Zhi 88: 622-624 (2008).
Nickerson CL, Luthra HS, David CS. Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice. Ann. Rheum. Dis. 49: 426-433 (1990).
Nicknam MH, Mahmoudi M, Amirzargar AA, Ganjalikhani Hakemi M, Khosravi F, Jamshidi AR, Amirkhani A, Ansaripour B, Pourpak Z, Moin M, Nikbin B. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis. Iran. J. Allergy Asthma Immunol. 7: 19-24 (2008).
Nie XM, Fang YH, Zhang Y, He WD, Zhu CF. A novel HLA-DRB1 allele, DRB1*1219, was identified by sequence-based typing in a Chinese leukaemia family. Tissue Antigens 74: 352-354 (2009). *
Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST. No allelic variation in genes with high gliadin homology in patients with celiac disease and type 1 diabetes. Immunogenetics 56: 375-378 (2004). *
Nielsen M, Lundegaard C, Blicher T, Lamberth K, Harndahl M, Justesen S, Roder G, Peters B, Sette A, Lund O, Buus S. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 2: e796 (2007). *
Nielsen M, Lundegaard C, Blicher T, Peters B, Sette A, Justesen S, Buus S, Lund O. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput. Biol. 4: e1000107 (2008). *
Nielsen M, Lundegaard C, Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 8: 238 (2007). *
Nielsen T, Rostgaard K, Askling J, Steffensen R, Oturai A, Jersild C, Koch-Henriksen N, Sorensen P, Hjalgrim H. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult. Scler. 15: 431-436 (2009). *
Nielsen TR, Pedersen M, Rostgaard K, Frisch M, Hjalgrim H. Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals. Mult. Scler. 13: 420-423 (2007). *
Niesen MI, Blanck G. Rescue of major histocompatibility-DR surface expression in retinoblastoma-defective, non-small cell lung carcinoma cells by the MS-275 histone deacetylase inhibitor. Biol. Pharm. Bull. 32: 480-482 (2009). *
Niesen MI, Osborne AR, Lagor WR, Zhang H, Kazemfar K, Ness GC, Blanck G. Technological advances in the study of HLA-DRA promoter regulation: extending the functions of CIITA, Oct-1, Rb, and RFX. Acta Biochim. Biophys. Sin. (Shanghai) 41: 198-205 (2009).
Nieto A, Blanco Quiros A, Arranz E, Alonso Franch M, Garrote JA, Calvo C. Study of HLA-DQA1 alleles in celiac children. J. Investig. Allergol. Clin. Immunol. 5: 209-215 (1995).
Nighland M, Grossman R. Tretinoin microsphere gel in facial acne vulgaris: a meta-analysis. J. Drugs Dermatol. 7: s2-s8 (2008).
Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J. Neurol. Sci. 177: 65-71 (2000).
Niizeki H, Naruse T, Hashigucci K, Yokoyama M, Yamasaki Y, Akiya K, Tojo T, Urushibara T, Yamazaki Y, Inoko H, Nishikawa T. Polymorphisms in the TNFA promoter region is not associated with palmoplantar pustulosis. Tissue Antigens 56: 162-165 (2000). *
Nikas SN, Alamanos Y, Voulgari PV, Pliakou XI, Papadopoulos CG, Drosos AA. Infliximab therapy in ankylosing spondylitis: an observational study. Ann. Rheum. Dis. 64: 940-942 (2005). *
Nikolova PN, Ivanova MI, Mihailova SM, Myhailova AP, Baltadjieva DN, Simeonov PL, Paskalev EK, Naumova EJ. Cytokine gene polymorphism in kidney transplantation - impact of TGF-beta1, TNF-alpha and IL-6 on graft outcome. Transpl. Immunol. 18: 344-348 (2008).
Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37: 766-776 (1995). *
Niro GA, Poli F, Andriulli A, Bianchi I, Bernuzzi F, Caliari L, Fontana R, Gioffreda D, Valvano MR, Podda M, Invernizzi P. TNF-alpha polymorphisms in primary biliary cirrhosis: a northern and southern Italian experience. Ann. N. Y. Acad. Sci. 1173: 557-563 (2009). *
Nishi H, Koga Y, Koyanagi T, Harada H, Imaizumi T, Toshima H, Sasazuki T, Kimura A. DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy. J. Mol. Cell. Cardiol. 27: 2385-2392 (1995). *
Nishida T, Murayama T, Hirai H, Okamoto S, Sao H, Hara M, Kanamori H, Atsuta Y, Matsuo K, Morishima Y, Kodera Y. Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients. Int. J. Hematol. 89: 98-105 (2009). *
Nishimaki K, Kawamura T, Inada H, Yagawa K, Nose Y, Nabeya N, Isshiki G, Tatsumi N, Niihira S. HLA DPB1*0201 gene confers disease susceptibility in Japanese with childhood onset type I diabetes, independent of HLA-DR and DQ genotypes. Diabetes Res. Clin. Pract. 47: 49-55 (2000).
Nishimoto H, Yamada G, Mizuno M, Tsuji T. Immunoelectron microscopic localization of MHC class 1 and 2 antigens on bile duct epithelial cells in patients with primary biliary cirrhosis. Acta Med. Okayama 48: 317-322 (1994).
Nishimura M, Maeda M, Matsuoka M, Mine H, Saji H, Matsui M, Kuroda Y, Kawakami H, Uchiyama T. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum. Immunol. 61: 1262-1269 (2000).
Nishimura Y. Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases. Nippon Rinsho 55: 1384-1396 (1997).
Nishimura Y, Nakatsura T, Senju S. Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma. Nihon Rinsho Meneki Gakkai Kaishi 31: 383-391 (2008).
Nishino J, Kato K, Yoshida H, Katayama M, Fukaya S, Yoshida S. Two cases with ankylosing spondylitis using infliximab (case report). Nihon Rinsho Meneki Gakkai Kaishi 32: 61-65 (2009).
Nishino M, Ikegami H, Fujisawa T, Kawaguchi Y, Kawabata Y, Shintani M, Ono M, Ogihara T. Functional polymorphism in Z-DNA-forming motif of promoter of SLC11A1 gene and type 1 diabetes in Japanese subjects: association study and meta-analysis. Metabolism 54: 628-633 (2005). *
Nishino S, Okuro M, Kotorii N, Anegawa E, Ishimaru Y, Matsumura M, Kanbayashi T. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol. (Oxf.) Jun 25 [Epub ahead of print] (2009). *
Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of primary biliary cirrhosis. Semin. Liver Dis. 22: 291-302 (2002). *
Nishio D, Izu K, Kabashima K, Tokura Y. T cell populations propagating in the peripheral blood of patients with drug eruptions. J. Dermatol. Sci. 48: 25-33 (2007).
Nistico L, Fagnani C, Coto I, Percopo S, Cotichini R, Limongelli MG, Paparo F, D'Alfonso S, Giordano M, Sferlazzas C, Magazzu G, Momigliano-Richiardi P, Greco L, Stazi MA. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55: 803-808 (2006). *
No authors listed. In this issue. Eur. J. Immunol. 40: 310-311 (2010). *
No authors listed. Rheumatoid arthritis and early death risk. In patients with RA, the mutated HLA-DRB1-SE gene is the suspect for higher incidence of heart disease and cancer. Health News 13: 10-11 (2007).
Nobili V, Marcellini M, Devito R, Comparcola D, Vento S. Co-occurrence of chronic hepatitis B virus infection and autoimmune hepatitis in a young Senegalese girl. Eur. J. Gastroenterol. Hepatol. 18: 927-929 (2006).
Noble CL, Nimmo ER, Drummond H, Ho GT, Tenesa A, Smith L, Anderson N, Arnott ID, Satsangi J. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn�s disease. Gastroenterology 129: 1854-1864 (2005). *
Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A, Lorini R, Pozzilli P, Buzzetti R, Erlich HA. Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum. Immunol. 69: 291-300 (2008). *
Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, Erlich HA. The HLA class I A locus affects susceptibility to type 1 diabetes. Hum. Immunol. 63: 657-664 (2002).
Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 59: 1134-1148 (1996). *
Noble JA, Valdes AM, Lane JA, Green AE, Erlich HA. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum. Immunol. 67: 999-1004 (2006).
Nocera A. Desensitization protocols in immunized living donor kidney transplant recipients. G. Ital. Nefrol. 26: 499-515 (2009).
Noguchi H, Hanai T, Honda H, Harrison LC, Kobayashi T. Fuzzy neural network-based prediction of the motif for MHC class II binding peptides. J. Biosci. Bioeng. 92: 227-231 (2001). *
Nolan D. HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects. Crit. Rev. Clin. Lab. Sci. 46: 153-165 (2009).
Nolte W, Polzien F, Sattler B, Ramadori G, Hartmann H. Recurrent episodes of acute hepatitis associated with LKM-1 (cytochrome P450 2D6) antibodies in identical twin brothers. J. Hepatol. 23: 734-739 (1995). *
Nomura E, Kinouchi Y, Negoro K, Kojima Y, Oomori S, Sugimura M, Hiroki M, Takagi S, Aihara H, Takahashi S, Hiwatashi N, Shimosegawa T. Mapping of a disease susceptibility locus in chromosome 6p in Japanese patients with ulcerative colitis. Genes Immun. 5: 477-483 (2004). *
Nomura S, Shouzu A, Omoto S, Matsuzaki T, Yamaoka M, Abe M, Hosokawa M, Nishikawa M, Iwasaka T, Fukuhara S. Genetic analysis of HLA, NA and HPA typing in type 2 diabetes and ASO. Int. J. Immunogenet. 33: 117-122 (2006). *
Nomura Y, Abe Y, Ishida Y, Kobayashi H, Harabuchi Y. Promiscuous peptides on the nontypeable Haemophilus influenzae P6 outer membrane protein. J. Clin. Immunol. 28: 361-369 (2008). *
Nooh MM, El-Gengehi N, Kansal R, David CS, Kotb M. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J. Immunol. 178: 3076-3083 (2007). *
Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, Haas JE, Emery LM, Sokol RJ, Erlich HA, Eisenbarth GS, Rewers M. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 293: 2343-2351 (2005). *
Norris JM, Yin X, Lamb MM, Barriga K, Seifert J, Hoffman M, Orton HD, Baron AE, Clare-Salzler M, Chase HP, Szabo NJ, Erlich H, Eisenbarth GS, Rewers M. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 298: 1420-1428 (2007). *
Nourizadeh M, Aghamohammadi A, Moazzeni SM, Mahdavi M, Jalili A, Rezaei N, Hadjati J. Altered dendritic cell function in response to sera of common variable immunodeficiency patients. Inflamm. Res. 56: 527-532 (2007). *
Novacek G, Miehsler W, Kapiotis S, Katzenschlager R, Speiser W, Vogelsang H. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am. J. Gastroenterol. 94: 685-690 (1999). *
Novota P, Cejkova P, Cerna M, Andel M. Genetic risk factors in autoimmune diabetes mellitus, their significance and function. Cas. Lek. Cesk. 143: 159-163 (2004).
Nowak J, Kalinka-Warzocha E, Juszczynski P, Bilinski P, Mika-Witkowska R, Zajko M, Bienvenu J, Coiffier B, Salles G, Warzocha K. Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma. Genes Chromosomes Cancer 46: 500-507 (2007). *
Nowak J, Kalinka-Warzocha E, Juszczynski P, Mika-Witkowska R, Zajko M, Graczyk-Pol E, Coiffier B, Salles G, Warzocha K. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome. Tissue Antigens 71: 16-26 (2008). *
Nowak J, Mika-Witkowska R, Polak M, Zajko M, Rogatko-Koros M, Graczyk-Pol E, Lange A. Allele and extended haplotype polymorphism of HLA-A, -C, -B, -DRB1 and -DQB1 loci in Polish population and genetic affinities to other populations. Tissue Antigens 71: 193-205 (2008). *
Nunez C, Alecsandru DM, Mendoza JL, Urcelay E, Diaz-Rubio M, de la Concha EG, Martinez A. Genetic markers linked to rheumatoid arthritis are also strongly associated with articular manifestations in ulcerative colitis patients. Hum. Immunol. 67: 324-330 (2006).
Nunez C, Oliver J, Mendoza JL, Gomez-Garcia M, Taxonera C, Gomez LM, Lopez-Nevot MA, G de la Concha E, Urcelay E, Martinez A, Martin J. CD209 in inflammatory bowel disease: a case-control study in the Spanish population. BMC Med. Genet. 8: 75 (2007). *
Nunez C, Rueda B, Martinez A, Maluenda C, Polanco I, Lopez-Nevot MA, Ortega E, Sierra E, Gomez de la Concha E, Urcelay E, Martin J. A functional variant in the CD209 promoter is associated with DQ2-negative celiac disease in the Spanish population. World J. Gastroenterol. 12: 4397-4400 (2006). *
Nwankwo JO. Significant transcriptional down-regulation of the human MDR1 gene by beta-naphthoflavone: a proposed hypothesis linking potent CYP gene induction to MDR1 inhibition. Med. Hypotheses 68: 661-669 (2007).
O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology 117: 1-10 (2006). *
O'Connor K, Fulcher D, Phoon RK. Development of anti-glomerular basement membrane disease after remission from perinuclear ANCA-associated glomerulonephritis in a patient with HLA susceptibility. Am. J. Kidney Dis. Sep 4 [Epub ahead of print] (2009).
O'Donnell BF, O'Neill CM, Francis DM, Niimi N, Barr RM, Barlow RJ, Kobza Black A, Welsh KI, Greaves MW. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br. J. Dermatol. 140: 853-858 (1999). *
O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RN, Mills PR. Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 47: 717-720 (2000). *
O'Hanlon TP, Carrick DM, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Dreyfuss J, Shamim EA, Rider LG, Chanock SJ, Foster CB, Bunch T, Plotz PH, Love LA, Miller FW. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in Caucasians. Medicine (Baltimore) 84: 338-349 (2005).
O'Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Rider LG, Chanock SJ, Foster CB, Bunch T, Blackshear PJ, Plotz PH, Love LA, Miller FW. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 85: 111-127 (2006).
O'Hanlon TP, Rider LG, Mamyrova G, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Chanock SJ, Foster CB, Bunch T, Reed AM, Love LA, Miller FW. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum. 54: 3670-3681 (2006). *
O'Keeffe J, Mills K, Jackson J, Feighery C. T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC). Clin. Exp. Immunol. 117: 269-276 (1999). *
O'Reilly RJ, Doubrovina E, Trivedi D, Hasan A, Kollen W, Koehne G. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants. Immunol. Res. 38: 237-250 (2007).
Oberhuber G, Puspok A, Peck-Radosavlevic M, Kutilek M, Lamprecht A, Chott A, Vogelsang H, Stolte M. Aberrant esophageal HLA-DR expression in a high percentage of patients with Crohn's disease. Am. J. Surg. Pathol. 23: 970-976 (1999).
Obermayer-Straub P, Manns MP. Autoimmune polyglandular syndromes. Baillieres Clin. Gastroenterol. 12: 293-315 (1998).
Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J. Hepatol. 32: S181-S197 (2000).
Ockinger J, Stridh P, Beyeen AD, Lundmark F, Seddighzadeh M, Oturai A, Sorensen PS, Lorentzen AR, Celius EG, Leppa V, Koivisto K, Tienari PJ, Alfredsson L, Padyukov L, Hillert J, Kockum I, Jagodic M, Olsson T. Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis. Genes Immun. Oct 29 [Epub ahead of print] (2009).
Odermarsky M, Nilson A, Sjoblad S, Liuba P. Atherogenic vascular and lipid phenotypes in young type 1 diabetics are associated with diabetes high risk HLA. Am. J. Physiol. Heart Circ. Physiol. 293: H3175-H3179 (2007). *
Odum N, Morling N, Georgsen J, Jakobsen BK, Frentz G, Jensen GF, Fugger L, Svejgaard A. HLA-DP antigens in patients with alopecia areata. Tissue Antigens 35: 114-117 (1990).
Oettinger R, Brunnberg A, Gerner P, Wintermeyer P, Jenke A, Wirth S. Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis. J. Autoimmun. 24: 79-84 (2005).
Ogilvie AL, Luft M, Antoni C, Schuler G, Kalden JR, Lorenz HM. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha. Int. J. Immunopathol. Pharmacol. 19: 271-278 (2006).
Ognjenovic M, Karelovic D, Cekic-Arambasin A, Tadin I, Vrebalov-Cindro V. Oral lichen planus and HLA DR. Coll. Antropol. 22: S97-S101 (1998).
Ognjenovic M, Karelovic D, Cindro VV, Tadin I. Oral lichen planus and HLA A. Coll. Antropol. 22: S89-S92 (1998).
Ognjenovic M, Karelovic D, Mikelic M, Tadin I, Vrebalov-Cindro V. Oral lichen planus and HLA B. Coll. Antropol. 22: S93-S96 (1998).
Ogra PL, Welliver RC. Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome. Nestle Nutr. Workshop Ser. Pediatr. Program 61: 145-181 (2008).
Oh JH, Han JW, Lee SJ, Lee KY, Suh BK, Koh DK, Lee JS, Oh CK, Kim TG, Choi HB. Polymorphisms of human leukocyte antigen genes in Korean children with Kawasaki disease. Pediatr. Cardiol. 29: 402-408 (2008). *
Oh JM, Kwon KH, Kim JE, Choi JH, Beom SH, Lee SH, Lee YJ, Park MY, Jung MK, Lee KH. Clinical outcomes of lamivudine therapy and HLA alleles in chronic hepatitis B patients. Korean J. Gastroenterol. 52: 368-375 (2008).
Ohira H, Takiguchi J, Rai T, Shishido S, Sato Y. Two cases of primary biliary cirrhosis complicated with syringomyelia. Am. J. Gastroenterol. 98: 224-226 (2003). *
Ohman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, Sjovall H, Simren M. T-cell activation in patients with irritable bowel syndrome. Am. J. Gastroenterol. 104: 1205-1212 (2009). *
Ohmura K. Is rheumatoid arthritis without anti-citrullinated peptide antibody a genetically distinct subset? Nihon Rinsho Meneki Gakkai Kaishi 32: 484-491 (2009).
Ohnishi Y, Tsutsumi A, Matsumoto I, Goto D, Ito S, Kuwana M, Uemura Y, Nishimura Y, Sumida T. Altered peptide ligands control type II collagen-reactive T cells from rheumatoid arthritis patients. Mod. Rheumatol. 16: 226-228 (2006). *
Ohno H, Nagata N, Isoda K. Epstein-Barr virus-associated T-cell lymphoma in an adult patient: prominent infiltrates within the liver portal area revealed by autopsy. Int. J. Hematol. 88: 88-94 (2008).
Ohtani H, Jin Z, Takegawa S, Nakayama T, Yoshie O. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3(+) T cells in lymphocyte-rich gastric carcinoma. J. Pathol. 217: 21-31 (2009). *
Ohtani M, Azuma T, Yamazaki S, Yamakawa A, Ito Y, Muramatsu A, Dojo M, Yamazaki Y, Kuriyama M. Association of the HLA-DRB1 gene locus with gastric adenocarcinoma in Japan. Dig. Liver Dis. 35: 468-472 (2003).
Okabe N, Matsuoka Y, Ueda I, Fujita K, Mashiba H, Matsunaga K, Yao T. Immunological studies on Crohn's disease. VII. Reduced immunologic activity in monocytes. J. Clin. Lab. Immunol. 25: 69-72 (1988).
Okada S, Kamb ML, Pandey JP, Philen RM, Love LA, Miller FW. Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms. Arthritis Rheum. 61: 1305-1311 (2009). *
Okada Y, Suzuki A, Yamada R, Kochi Y, Shimane K, Myouzen K, Kubo M, Nakamura Y, Yamamoto K. HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis. Ann. Rheum. Dis. Oct 22 [Epub ahead of print] (2009).
Okada Y, Yamada R, Suzuki A, Kochi Y, Shimane K, Myouzen K, Kubo M, Nakamura Y, Yamamoto K. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1. Arthritis Rheum. 60: 3582-3590 (2009). *
Okamoto A, Inaba T, Fujita N. The role of interleukin-6 in a patient with polyclonal hairy B-cell lymphoproliferative disorder: a case report. Lab. Hematol. 13: 124-127 (2007).
Okamoto K, Makino S, Yoshikawa Y, Takaki A, Nagatsuka Y, Ota M, Tamiya G, Kimura A, Bahram S, Inoko H. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am. J. Hum. Genet. 72: 303-312 (2003). *
Okazaki A, Miyagawa S, Yamashina Y, Kitamura W, Shirai T. Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid. J. Dermatol. 27: 149-156 (2000).
Okazaki K. Clinical relevance of autoimmune-related pancreatitis. Best Pract. Res. Clin. Gastroenterol. 16: 365-378 (2002).
Okazaki K. Autoimmune pancreatitis: etiology, pathogenesis, clinical findings and treatment. The Japanese experience. JOP 6: S89-S96 (2005). *
Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, Matsushima Y, Katamura K, Ohmori K, Chiba T. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118: 573-581 (2000). *
Oksanen AM, Haimila KE, Rautelin HI, Partanen JA. Immunogenetic characteristics of patients with autoimmune gastritis. World J. Gastroenterol. 16: 354-358 (2010). *
Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am. J. Hum. Genet. 74: 160-167 (2004). *
Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, Waubant E, Zamvil SS, Leppert D, Qualley P, Lincoln R, Gomez R, Caillier S, George M, Wang J, Nelson SJ, Cree BA, Hauser SL, Pelletier D. Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 132: 250-259 (2009).
Okumura M, Fujii Y, Shiono H, Inoue M, Minami M, Utsumi T, Kadota Y, Sawa Y. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen. Thorac. Cardiovasc. Surg. 56: 143-150 (2008).
Olafsson S, Gudjonsson H, Selmi C, Amano K, Invernizzi P, Podda M, Gershwin ME. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am. J. Gastroenterol. 99: 2143-2146 (2004). *
Olerup O, Olsson R, Hultcrantz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 108: 870-878 (1995). *
Olerup O, Smith CI, Bjorkander J, Hammarstrom L. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc. Natl. Acad. Sci. U.S.A. 89: 10653-10657 (1992). *
Olerup O, Smith CI, Hammarstrom L. Different amino acids at position 57 of the HLA-DQ beta chain associated with susceptibility and resistance to IgA deficiency. Nature 347: 289-290 (1990). *
Olerup O, Wallin J, Carlsson B, Marcusson J, Emtestam L, Bjornelius E, Moller E. Genomic HLA-typing by RFLP-analysis using DR beta and DQ beta cDNA probes reveals normal DR-DQ linkages in patients with psoriasis vulgaris. Tissue Antigens 30: 139-142 (1987).
Oling V, Marttila J, Knip M, Simell O, Ilonen J. Circulating CD4+CD25high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies. Ann. N. Y. Acad. Sci. 1107: 363-372 (2007). *
Oliveira RD, Junta CM, Oliveira FR, Silva LM, Donadi EA, Louzada-Junior P. Shared epitope, citrullinated cyclic peptide antibodies and smoking in Brazilian rheumatoid arthritis patients. Clin. Rev. Allergy Immunol. 34: 32-35 (2008). *
Oliveira RR, Gollob KJ, Figueiredo JP, Alcantara LM, Cardoso LS, Aquino CS, Campos RA, Almeida MC, Carvalho EM, Araujo MI. Schistosoma mansoni infection alters co-stimulatory molecule expression and cell activation in asthma. Microbes Infect. 11: 223-229 (2009). *
Oliveira-Prado R, Caldas IR, Teixeira-Carvalho A, Andrade MV, Gazzinelli A, Correa-Oliveira R, Cunha-Melo JR. CD4 and CD8 distribution profile in individuals infected by Schistosoma mansoni. Scand. J. Immunol. 69: 521-528 (2009). *
Ollier W, Silman A, Gosnell N, Currey H, Awad J, Doyle P, McCloskey D, Alonso A, Hossain MA, Festenstein H. HLA and rheumatoid arthritis: an analysis of multicase families. Dis. Markers 4: 85-98 (1986).
Ollier W, Thomson W. Population genetics of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 18: 741-759 (1992).
Ollier WE, Harrison B, Symmons D. What is the natural history of rheumatoid arthritis? Best Pract. Res. Clin. Rheumatol. 15: 27-48 (2001).
Ollier WE, MacGregor A. Genetic epidemiology of rheumatoid disease. Br. Med. Bull. 51: 267-285 (1995).
Ollikka P, Raussi HM, Laitala V, Jaakkola L, Hovinen J, Hemmila I, Ylikoski A. Genotyping of celiac disease-related-risk haplotypes using a closed-tube polymerase chain reaction analysis of dried blood and saliva disk samples. Anal. Biochem. 386: 20-29 (2009). *
Onishi S, Sakamaki T, Maeda T, Iwamura S, Tomita A, Saibara T, Yamamoto Y. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J. Hepatol. 21: 1053-1060 (1994).
Ono T, Zambenedetti MR, Yamasaki K, Kawano Y, Kamikawaji N, Ito H, Sakurai M, Nishimura Y, Kira J, Kanazawa I, Sasazuki T. Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type). Tissue Antigens 52: 539-542 (1998).
Ooi JD, Holdsworth SR, Kitching AR. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells. J. Autoimmun. 31: 295-300 (2008).
Opelz G, Dohler B. Impact of HLA mismatching on incidence of posttransplant non-Hodgkin lymphoma after kidney transplantation. Transplantation Jan 27 [Epub ahead of print] (2010).
Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 123: 714-718 (2002). *
Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 118: 274-278 (2000). *
Ordonez D, Sanchez AJ, Martinez-Rodriguez JE, Cisneros E, Ramil E, Romo N, Moraru M, Munteis E, Lopez-Botet M, Roquer J, Garc�a-Merino A, Vilches C. Multiple sclerosis associates with LILRA3 deletion in Spanish patients. Genes Immun. 10: 579-585 (2009).
Orlova EG, Shirshev SV. Leptin as an immunocorrecting agent during normal pregnancy. Bull. Exp. Biol. Med. 148: 75-78 (2009).
Orozco G, Eerligh P, Sanchez E, Zhernakova S, Roep BO, Gonzalez-Gay MA, Lopez-Nevot MA, Callejas JL, Hidalgo C, Pascual-Salcedo D, Balsa A, Gonzalez-Escribano MF, Koeleman BP, Martin J. Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. Hum. Immunol. 66: 1235-1241 (2005).
Orozco G, Pascual-Salcedo D, Lopez-Nevot MA, Cobo T, Cabezon A, Martin-Mola E, Balsa A, Martin J. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis. Rheumatology (Oxford) 47: 138-141 (2008). *
Orozco G, Rueda B, Martin J. Genetic basis of rheumatoid arthritis. Biomed. Pharmacother. 60: 656-662 (2006).
Orozco-Topete R, Cordova-Lopez J, Yamamoto-Furusho JK, Garcia-Benitez V, Lopez-Martinez A, Granados J. HLA-DRB1 *04 is associated with the genetic susceptibility to develop vitiligo in Mexican patients with autoimmune thyroid disease. J. Am. Acad. Dermatol. 52: 182-183 (2005).
Orru S, Giuressi E, Casula M, Loizedda A, Murru R, Mulargia M, Masala MV, Cerimele D, Zucca M, Aste N, Biggio P, Carcassi C, Contu L. Psoriasis is associated with a SNP haplotype of the corneodesmosin gene (CDSN). Tissue Antigens 60: 292-298 (2002). *
Ortega-Hernandez OD, Cuccia M, Bozzini S, Bassi N, Moscavitch S, Diaz-Gallo LM, Blank M, Agmon-Levin N, Shoenfeld Y. Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome. Ann. N. Y. Acad. Sci. 1173: 589-599 (2009). *
Ortega-Hernandez OD, Pineda-Tamayo R, Pardo AL, Rojas-Villarraga A, Anaya JM. Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. Clin. Rheumatol. 28: 767-775 (2009).
Orts Costa J, Zuniga Cabrera A, Alarcon Torres I. Autoimmune hepatitis. An. Med. Interna. 21: 340-354 (2004).
Osafo-Addo AD, Koram KA, Oduro AR, Wilson M, Hodgson A, Rogers WO. HLA-DRB1*04 allele is associated with severe malaria in Northern Ghana. Am. J. Trop. Med. Hyg. 78: 251-255 (2008).
Osame K, Takahashi Y, Takasawa H, Watanabe S, Kishimoto M, Yasuda K, Kaburagi Y, Nakanishi K, Kajio H, Noda M. Rapid-onset type 1 diabetes associated with cytomegalovirus infection and islet autoantibody synthesis. Intern. Med. 46: 873-877 (2007). *
Oshitani N, Hato F, Jinno Y, Sawa Y, Hara J, Nakamura S, Matsumoto T, Arakawa T, Kitano A, Kitagawa S, Kuroki T. Heterogeneity of HPLC profiles of human class II MHC-bound peptides isolated from intestine with inflammatory bowel disease. Dig. Dis. Sci. 47: 2088-2094 (2002). *
Oshitani N, Hato F, Kitagawa S, Maeda K, Higuchi K, Matsumoto T, Arakawa T. Analysis of intestinal HLA-DR bound peptides and dysregulated immune responses to enteric flora in the pathogenesis of inflammatory bowel disease. Int. J. Mol. Med. 11: 99-104 (2003). *
Oshitani N, Kitano A, Kakazu T, Hara J, Adachi K, Nakamura S, Matsumoto T, Kobayashi K. Functional diversity of infiltrating macrophages in inflamed human colonic mucosa ulcerative colitis. Clin. Exp. Pharmacol. Physiol. 25: 50-53 (1998).
Osorio Y Fortea J, Bukulmez H, Petit-Teixeira E, Michou L, Pierlot C, Cailleau-Moindrault S, Lemaire I, Lasbleiz S, Alibert O, Quillet P, Bardin T, Prum B, Olson JM, Cornelis F. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum. 50: 2757-2765 (2004). *
Ostankovitch M, Altrich-Vanlith M, Robila V, Engelhard VH. N-Glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase. J. Immunol. 182: 4830-4835 (2009).
Ostendorf B, Scherer A, Kellner H, Backhaus M. Project REMISSION(PLUS): clinical and radiological remission: new treatment goals in the management of rheumatoid arthritis. Z. Rheumatol. 67: 707-715 (2008).
Ostergaard PA, Eriksen J. Association between HLA-A1,B8 in children with extrinsic asthma and IgA deficiency. Eur. J. Pediatr. 131: 263-270 (1979).
Oswald-Richter K, Sato H, Hajizadeh R, Shepherd BE, Sidney J, Sette A, Newman LS, Drake WP. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101. J. Clin. Immunol. Jun 18 [Epub ahead of print] (2009). *
Ota M, Katsuyama Y, Hamano H, Umemura T, Kimura A, Yoshizawa K, Kiyosawa K, Fukushima H, Bahram S, Inoko H, Kawa S. Two critical genes (HLA-DRB1 and ABCF1) in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics 59: 45-52 (2007). *
Ota M, Katsuyama Y, Kimura A, Tsuchiya K, Kondo M, Naruse T, Mizuki N, Itoh K, Sasazuki T, Inoko H. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics 71: 263-270 (2001). *
Ota M, Seki T, Kiyosawa K, Furuta S, Hino K, Kondo T, Fukushima H, Tsuji K, Inoko H. A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis. Immunogenetics 36: 49-55 (1992).
Otley CC, Wenstrup RJ, Hall RP. DNA sequence analysis and restriction fragment length polymorphism (RFLP) typing of the HLA-DQw2 alleles associated with dermatitis herpetiformis. J. Invest. Dermatol. 97: 318-322 (1991).
Otte A. Drug trials in humans. Risks in the light of the London catastrophe. Internist (Berl.) 48: 636-641 (2007).
Oturai A, Larsen F, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Koch-Henriksen N, Sawcer S, Fugger L, Sorensen PS, Svejgaard A. Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann. Neurol. 46: 612-616 (1999).
Ouedraogo DD, Palazzo E, Nlome-Nze M, Somogyi-Demerjian N, Meyer O. Ankylosing spondylitis and systemic sclerosis: a rare combination. Joint Bone Spine. 76: 290-292 (2009). *
Ouyang Q, Standifer NE, Qin H, Gottlieb P, Verchere CB, Nepom GT, Tan R, Panagiotopoulos C. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes. Diabetes 55: 3068-3074 (2006). *
Ovsyannikova IG, Jacobson RM, Vierkant RA, O'Byrne MM, Poland GA. Replication of Rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine 27: 6926-6931 (2009). *
Ovsyannikova IG, Jacobson RM, Vierkant RA, Shane Pankratz V, Jacobsen SJ, Poland GA. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine 22: 1914-1920 (2004). *
Ovsyannikova IG, Johnson KL, Bergen HR 3rd, Poland GA. Mass spectrometry and peptide-based vaccine development. Clin. Pharmacol. Ther. 82: 644-652 (2007). *
Oxelius VA, Carlsson AM, Aurivillius M. Alternative G1m, G2m and G3m allotypes of IGHG genes correlate with atopic and nonatopic pathways of immune regulation in children with bronchial asthma. Int. Arch. Allergy Immunol. 115: 215-219 (1998).
Oyanagi H, Ishihata R, Ishikawa H, Suzuki S, Kondo Y, Miyata M, Obara K, Nishimaki T, Kasukawa R, Tanno Y, et al. Ulcerative colitis associated with Takayasu's disease. Intern. Med. 33: 127-129 (1994). *
Ozakbas S, Idiman E, Yulug B, Pakoz B, Bahar H, Gulay Z. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes. Tissue Antigens 68: 235-238 (2006). *
Ozaki Y, Ito T, Son Y, Amuro H, Shimamoto K, Sugimoto H, Katashiba Y, Ogata M, Miyamoto R, Murakami N, Amakawa R, Fukuhara S. Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sjogren's syndrome but not in the maintenance. Clin. Exp. Immunol. Dec 14 [Epub ahead of print] (2009). *
Ozgur BC, Gonenc F, Yazicioglu AH. HLA class I and II antigens expression in patients with renal cell carcinoma. Saudi J. Kidney Dis. Transpl. 20: 97-101 (2009).
Pablos JL, Carreira PE, Martin-Villa JM, Montalvo G, Arnaiz-Villena A, Gomez-Reino JJ. Polymorphism of the heat-shock protein gene HSP70-2 in systemic lupus erythematosus. Br. J. Rheumatol. 34: 721-723 (1995).
Pachot A, Barbalat V, Marotte H, Diasparra J, Gouraud A, Mougin B, Miossec P. A rapid semi automated method for DNA extraction from dried-blood spots: application to the HLA-DR shared epitope analysis in rheumatoid arthritis. J. Immunol. Methods 328: 220-225 (2007). *
Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L, for the Epidemiological Investigation of Rheumatoid Arthritis Study Group. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 50: 3085-3092 (2004). *
Pagel JM, Orgun N, Hamlin DK, Wilbur DS, Gooley TA, Gopal AK, Park SI, Green DJ, Lin Y, Press OW. A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations. Blood 113: 4903-4913 (2009). *
Painter CA, Cruz A, Lopez GE, Stern LJ, Zavala-Ruiz Z. Model for the peptide-free conformation of class II MHC proteins. PLoS ONE 3: e2403 (2008). *
Palikhe A, Lokki ML, Pussinen PJ, Paju S, Ahlberg J, Asikainen S, Seppanen M, Valtonen V, Nieminen MS, Sinisalo J. Lymphotoxin alpha LTA+496C allele is a risk factor for periodontitis in patients with coronary artery disease. Tissue Antigens 71: 530-537 (2008). *
Palikhe A, Lokki ML, Saikku P, Leinonen M, Paldanius M, Sepp�nen M, Valtonen V, Nieminen MS, Sinisalo J. Chlamydia pneumoniae infection is associated with HLA-B*35 in patients with coronary artery disease. Clin. Vaccine Immunol. 15: 55-59 (2008). *
Palikhe A, Sinisalo J, Seppanen M, Valtonen V, Nieminen MS, Lokki ML. Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease. Tissue Antigens 69: 47-55 (2007). *
Pallone F, Del Vecchio Blanco G, Vavassori P, Monteleone I, Fina D, Monteleone G. Genetic and pathogenetic insights into inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 487-492 (2003).
Pallone F, Fais S, Capobianchi MR. HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin. Exp. Immunol. 74: 75-79 (1988). *
Palmisano GL, Delfino L, Fiore M, Longo A, Ferrara GB. Single nucleotide polymorphisms detection based on DNA microarray technology: HLA as a model. Autoimmun. Rev. 4: 510-514 (2005).
Palova-Jelinkova L, Rozkova D, Pecharova B, Bartova J, Sediva A, Tlaskalova-Hogenova H, Spisek R, Tuckova L. Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J. Immunol. 175: 7038-7045 (2005). *
Pan C, Wu C, Chen H, Dang C, Chang F, Liu H, Chu C, Lin M, Lee Y. Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan. Lupus 18: 698-704 (2009). *
Panasiuk A, Prokopowicz D, Zak J. Peripheral blood T, B lymphocytes and NK cells in primary biliary cirrhosis. Rocz. Akad. Med. Bialymst. 46: 231-239 (2001).
Panasiuk A, Prokopowicz D, Zak J, Panasiuk B, Wysocka J. Lymphocyte subpopulations in peripheral blood in primary sclerosing cholangitis. Hepatogastroenterology 51: 1289-1291 (2004).
Panasiuk A, Zak J, Panasiuk B, Prokopowicz D. Increase in expression of monocytic tissue factor (CD142) with monocytes and blood platelet activation in liver cirrhosis. Blood Coagul. Fibrinolysis 18: 739-744 (2007).
Pando M, Larriba J, Fernandez GC, Fainboim H, Ciocca M, Ramonet M, Badia I, Daruich J, Findor J, Tanno H, Canero-Velasco C, Fainboim L. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 30: 1374-1380 (1999). *
Pangalos CG, Hagnefelt B, Kokkali G, Pantos K, Konialis CP. Birth of a healthy histocompatible sibling following preimplantation genetic diagnosis for chronic granulomatous disease at the blastocyst stage coupled to HLA typing. Fetal Diagn. Ther. 24: 334-339 (2008).
Pani MA, Van Autreve J, Van der Auwera BJ, Gorus FK, Badenhoop K. Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 45: 1340-1343 (2002). *
Pap T. Current trends in the design and development of monoclonal antibodies against inflammatory mediators for the treatment of rheumatoid arthritis. Z. Rheumatol. 69: 73-78 (2010).
Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT. Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 54: 3601-3611 (2006). *
Papadimitriou L, Morianos I, Michailidou V, Dionyssopoulou E, Vassiliadis S, Athanassakis I. Characterization of intracellular HLA-DR, DM and DO profile in K562 and HL-60 leukemic cells. Mol. Immunol. 45: 3965-3973 (2008). *
Paparo F, Petrone E, Tosco A, Maglio M, Borrelli M, Salvati VM, Miele E, Greco L, Auricchio S, Troncone R. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am. J. Gastroenterol. 100: 2294-2298 (2005). *
Papassavas EC, Spyropoulou-Vlachou M, Papassavas AC, Schipper RF, Doxiadis IN, Stavropoulos-Giokas C. MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data. Hum. Immunol. 61: 615-623 (2000).
Papiha SS, Murty GE, Ad'Hia A, Mains BT, Venning M. Association of Wegener's granulomatosis with HLA antigens and other genetic markers. Ann. Rheum. Dis. 51: 246-248 (1992). *
Parakkal D, Ehrenpreis ED, Thorpe MP, Putt KS, Hannon B. A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy. World J. Gastroenterol. 16: 136-137 (2010). *
Pardo-Govea T, Solis-Anez E. Immunogenetic aspects of autism. Review. Invest. Clin. 50: 393-406 (2009).
Park JY, Yoon SH, Kim EK, Yun SO, Park MY, Sohn HJ, Kim TG. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells. Immunol. Lett. 116: 33-40 (2008).
Park KS, Kang SY, Lee WI. HLA-B27 subtypes in Korean patients with ankylosing spondylitis. Korean J. Lab. Med. 28: 46-52 (2008).
Park MH, Oh MD, Song YW, Pai HJ, Takeuchi F, Tokunaga K, Hong GH, Park KS. Association of complement alleles C4AQ0 and C4B5 with rheumatoid arthritis in Koreans. Ann. Rheum. Dis. 55: 776-778 (1996). *
Park MH, Park YJ, Song EY, Park H, Kim TY, Park DJ, Park KS, Cho BY. Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum. Immunol. 66: 741-747 (2005).
Park Y. Prediction of the risk of type 1 diabetes from polymorphisms in candidate genes. Diabetes Res. Clin. Pract. 66: S19-S25 (2004).
Park Y. Why is type 1 diabetes uncommon in Asia? Ann. N. Y. Acad. Sci. 1079: 31-40 (2006). *
Park Y. Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes. Diabetes Res. Clin. Pract. 77 Suppl. 1: S110-S115 (2007).
Park Y, Choi H, Park H, Park S, Yoo EK, Kim D, Sanjeevi CB. Predominance of the group A killer Ig-like receptor haplotypes in Korean patients With T1D. Ann. N. Y. Acad. Sci. 1079: 240-350 (2006). *
Park Y, Eisenbarth GS. Genetic susceptibility factors of type 1 diabetes in Asians. Diabetes Metab. Res. Rev. 17: 2-11 (2001).
Park Y, Lee H, Sanjeevi CB, Eisenbarth GS. MICA polymorphism is associated with type 1 diabetes in the Korean population. Diabetes Care 24: 33-38 (2001). *
Park Y, Tait BD, Kawasaki E, Rowley M, Mackay IR. Closer association of IA-2 humoral autoreactivity with HLA DR3/4 than DQB1*0201/*0302 in Korean T1D patients. Ann. N. Y. Acad. Sci. 1037: 104-109 (2004). *
Park YS, Kim TW, Kim WB, Cho BY. Increased prevalence of autoimmune thyroid disease in patients with type 1 diabetes. Korean J. Intern. Med. 15: 202-210 (2000).
Park YS, Sanjeevi CB, Robles D, Yu L, Rewers M, Gottlieb PA, Fain P, Eisenbarth GS. Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease. Tissue Antigens 60: 155-163 (2002). *
Park YS, Wang CY, Ko KW, Yang SW, Park M, Yang MC, She JX. Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans. Hum. Immunol. 59: 794-801 (1998).
Parkes AB, Darke C, Othman S, Thomas M, Young N, Richards CJ, Hall R, Lazarus JH. Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis. Eur. J. Endocrinol. 134: 449-453 (1996).
Parkhomenko TA, Odintsova ES, Buneva VN, Kunder EV, Zhyltsov IV, Senkovich SA, Generalov II, Nevinsky GA. DNA-hydrolyzing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections. J. Cell. Mol. Med. 13: 2875-2887 (2009). *
Parkhurst MR, Joo J, Riley JP, Yu Z, Li Y, Robbins PF, Rosenberg SA. Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells. Clin. Cancer Res. 15: 169-180 (2009). *
Parks CG, Hudson LL, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP. CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. Lupus 13: 784-791 (2004).
Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Feghali-Bostwick CA, Cooper GS. Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum. Immunol. 65: 622-631 (2004).
Parmar S, de Lima M, Zou Y, Patah P, Liu P, Cano P, Rondon G, Pesoa S, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Kebriaei P, Shpall EJ, Giralt S, Champlin RE, Stastny P, Fernandez-Vina M. Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. Blood 114: 2884-2887 (2009). *
Parra-Campos V, Escobar-Gutierrez A, Dominguez-Lopez ML, Cancino-Diaz M, Burgos-Vargas R, Granados-Arreola J, Jimenez-Zamudio L, Garcia-Latorre E. Antibody response to nitrogenase-positive and -negative Klebsiella pneumoniae strains in juvenile-onset ankylosing spondylitis patients and their first degree relatives: lack of differential recognition of the bacterial nitrogenase. Rev. Latinoam. Microbiol. 38: 121-127 (1996).
Parry CS, Brooks BR. A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes. Biol. Direct 3: 42 (2008). *
Parry CS, Gorski J, Stern LJ. Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity. J. Mol. Biol. 371: 435-446 (2007). *
Partanen J, Milner C, Campbell RD, Maki M, Lipsanen V, Koskimies S. HLA-linked heat-shock protein 70 (HSP70-2) gene polymorphism and celiac disease. Tissue Antigens 41: 15-19 (1993).
Partanen J, Peterson P, Westman P, Aranko S, Krohn K. Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. Hum. Immunol. 41: 135-140 (1994).
Parveen S, Morshed SA, Arima K, Nishioka M, Czaja AJ, Chow WC, Ng HS. Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association. Dig. Dis. Sci. 43: 1322-1331 (1998). *
Pascual M, Martin J, Nieto A, Giphart MJ, van der Slik AR, de Vries RR, Zanelli E. Distribution of HERV-LTR elements in the 5'-flanking region of HLA-DQB1 and association with autoimmunity. Immunogenetics 53: 114-118 (2001).
Pascual M, Mataran L, Jones G, Shing D, van der Slik AR, Giphart MJ, Schreuder GM, de Vries RR, Breedveld FC, Roovers E, Zanelli E, Martin J. HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes. Scand. J. Rheumatol. 31: 275-278 (2002). *
Pascual M, Nieto A, Lopez-Nevot MA, Ramal L, Mataran L, Caballero A, Alonso A, Martin J, Zanelli E. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition. Arthritis Rheum. 44: 307-314 (2001). *
Pastorino R, Menni C, Barca M, Foco L, Saddi V, Gazzaniga G, Ferrai R, Mascaretti L, Dudbridge F, Berzuini C, Murgia SB, Piras ML, Ticca A, Bitti PP, Bernardinelli L. Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia. PLoS One 4: e6526 (2009). *
Patarroyo JC, Stuve O, Piskurich JF, Hauser SL, Oksenberg JR, Zamvil SS. Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA). Genes Immun. 3: 34-37 (2002). *
Pathan S, Gowdy RE, Cooney R, Beckly JB, Hancock L, Guo C, Barrett JC, Morris A, Jewell DP. Confirmation of the novel association at the BTNL2 locus with ulcerative colitis. Tissue Antigens 74: 322-329 (2009). *
Patil NS, Pashine A, Belmares MP, Liu W, Kaneshiro B, Rabinowitz J, McConnell H, Mellins ED. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles. J. Immunol. 167: 7157-7168 (2001). *
Patrucco L, Larriba J, Redal MA, Rojas JI, Argibay PF, Cristiano E. HLA-DRB1 and multiple sclerosis in Argentina. Eur. J. Neurol. 16: 427-429 (2009).
Patterson R, Germolec D. Review article toxic oil syndrome: review of immune aspects of the disease. J. Immunotoxicol. 2: 51-58 (2005).
Paulsson JM, Held C, Jacobson SH, Lundahl J. In vivo extravasated human monocytes have an altered expression of CD16, HLA-DR, CD86, CD36 and CXCR1. Scand. J. Immunol. 70: 368-376 (2009). *
Pausch J, Gatzen M. Treatment of cholestatic hepatic diseases: more than the substitution of fat soluble vitamins? Internist (Berl.) 47: 1239-1244 (2006).
Pavlov CS. Histopathology of primary sclerosing cholangitis (PSC). Falk Workshop "Primary Sclerosing Cholangitis: Complications and Consequences", Moscow (Russia), June 11, 2006, p. 6-7 (2006). *
Pavlova Y, Kolesar L, Striz I, Jabor A, Slavcev A. Distribution of KIR genes in the Czech population. Int. J. Immunogenet. 35: 57-61 (2008). *
Pavoni DP, Cerqueira LB, Roxo VM, Petzl-Erler ML. Polymorphism of the promoter region and exon 1 of the CTLA4 gene in endemic pemphigus foliaceus (fogo selvagem). Braz. J. Med. Biol. Res. 39: 1227-1232 (2006). *
Pavoni DP, Roxo VM, Marquart Filho A, Petzl-Erler ML. Dissecting the associations of endemic pemphigus foliaceus (Fogo Selvagem) with HLA-DRB1 alleles and genotypes. Genes Immun. 4: 110-116 (2003). *
Pavy S, Allanore Y, Kahan A. Spondylarthropathies and anti-TNFalpha drugs. Rev. Med. Interne. 26: 717-724 (2005).
Payami H, Joe S, Thomson G. Autoimmune thyroid disease in type I diabetic families. Genet. Epidemiol. 6: 137-141 (1989).
Payen D, Faivre V, Lukaszewicz AC, Villa F, Goldberg P. Expression of monocyte human leukocyte antigen-DR in relation with sepsis severity and plasma mediators. Minerva Anestesiol. 75: 484-493 (2009).
Payen D, Lukaszewicz AC, Belikova I, Faivre V, Gelin C, Russwurm S, Launay JM, Sevenet N. Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med. 34: 1371-1376 (2008).
Pazar B, Gergely P Jr, Nagy ZB, Gombos T, Pozsonyi E, Rajczy K, Balogh Z, Sevcic K, Orban I, Szodoray P, Poor G. Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients. Clin. Exp. Rheumatol. 26: 1146-1152 (2008).
Pease CT, Haugeberg G, Montague B, Hensor EM, Bhakta BB, Thomson W, Ollier WE, Morgan AW. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study. Rheumatology (Oxford) 48: 123-127 (2009). *
Pedrazzoli M, Pontes JC, Peirano P, Tufik S. HLA-DQB1 genotyping in a family with narcolepsy-cataplexy. Brain Res. 1165: 1-4 (2007).
Pedron B, Guerin V, Jacquemard F, Munier A, Daffos F, Thulliez P, Aujard Y, Luton D, Sterkers G. Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J. Infect. Dis. 196: 1033-1043 (2007). *
Pena AS, Garrote JA, Crusius JB. Advances in the immunogenetics of coeliac disease. Clues for understanding the pathogenesis and disease heterogeneity. Scand. J. Gastroenterol. Suppl. 225: 56-58 (1998). *
Pender MP, Greer AJ. Immunology of multiple sclerosis. Curr. Allergy Asthma Rep. 7: 285-292 (2007).
Peng J, Liu C, Zhu K, Zhu Y, Yu Y, Li J, Hou M, Chen X, Xu C, Zhang M. The TNF2 allele is a risk factor to severe aplastic anemia independent of HLA-DR. Hum. Immunol. 64: 896-901 (2003).
Penglis PS, Bond C, Humphreys I, McCluskey J, Cleland LG. Genetic susceptibility and the link between cat exposure and rheumatoid arthritis. Semin. Arthritis Rheum. 30: 111-120 (2000). *
Penzotti JE, Doherty D, Lybrand TP, Nepom GT. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J. Autoimmun. 9: 287-293 (1996).
Penzotti JE, Nepom GT, Lybrand TP. Use of T cell receptor/HLA-DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis. Arthritis Rheum. 40: 1316-1326 (1997).
Pera A, Sostegni R, Daperno M, Ercole E, Laudi C, Rocca R, Rigazio C, Astegiano M, Rocca G. Genotype-phenotype relationship in inflammatory bowel disease. Eur. J. Intern. Med. 11: 204-209 (2000).
Perdriger A. Do the HLA-DQ and DP genes play a role in rheumatoid arthritis? Joint Bone Spine 68: 12-18 (2001).
Perdriger A, Chales G, Semana G, Guggenbuhl P, Meyer O, Quillivic F, Pawlotsky Y. Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis. J. Rheumatol. 24: 1272-1276 (1997).
Perdriger A, Guggenbuhl P, Chales G, Le Dantec P, Yaouanq J, Genetet B, Pawlotsky Y, Semana G. The role of HLA-DR-DR and HLA-DR-DP interactions in genetic susceptibility to rheumatoid arthritis. Hum. Immunol. 46: 42-48 (1996).
Perdriger A, Guggenbuhl P, Chales G, Yaouanq J, Quelvennec E, Bonnard MN, Pawlotsky Y, Semana G. Positive association of the HLA DMB1*0101-0101 genotype with rheumatoid arthritis. Rheumatology (Oxford) 38: 448-452 (1999). *
Perdriger A, Werner-Leyval S, Rollot-Elamrani K. The genetic basis for systemic lupus erythematosus. Joint Bone Spine 70: 103-108 (2003).
Perez BF, Codner DE, Angel BB, Balic NI, Carrasco PE. +49 A/G genetic polymorphism of cytotoxic T lymphocyte associated antigen 4 (CTLA-4) in type 1 diabetes: association with autoantibodies and cytokines. Rev. Med. Chil. 137: 321-328 (2009).
Perez de Nanclares G, Martin-Pagola A, Ramon Bilbao J, Vazquez F, Castano L. No evidence of association of CTLA4 polymorphisms with Addison's disease. Autoimmunity 37: 453-456 (2004).
Perez F, Gutierrez-Lopez MD, Calvillan M, Martinez MT, Carrasco E, Lopez G, Serrano-Rios M. HLA and insulin-dependent diabetes mellitus. Rev. Med. Chil. 122: 1413-1420 (1994).
Perez-Jimenez F, Lopez PB, Tallo EP, Guzman JR, Molina JS, Pereperez JA. Selective IgA deficiency and the HLA-B8 antigen. Report of two cases with familial data. Arch. Intern. Med. 141: 509-510 (1981).
Pericak-Vance MA, Rimmler JB, Martin ER, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Goodkin DE, Hauser SL. Linkage and association analysis of chromosome 19q13 in multiple sclerosis. Neurogenetics 3: 195-201 (2001). *
Perniola R, Lobreglio G, Rosatelli MC, Pitotti E, Accogli E, De Rinaldis C. Immunophenotypic characterisation of peripheral blood lymphocytes in autoimmune polyglandular syndrome type 1: clinical study and review of the literature. J. Pediatr. Endocrinol. Metab. 18: 155-164 (2005).
Perri F, Annese V, Piepoli A, Napolitano G, Lombardi G, Ciavarella G, Di Giorgio G, Andriulli A. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital. J. Gastroenterol. Hepatol. 30: 56-61 (1998).
Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, Lafon M. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 287: 321-332 (2001). *
Peru H, Soylemezoglu O, Gonen S, Cetinyurek A, Bakkaloglu SA, Buyan N, Hasanoglu E. HLA class 1 associations in Henoch Schonlein purpura: increased and decreased frequencies. Clin. Rheumatol. 27: 5-10 (2008). *
Pescovitz MD. Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am. J. Transplant. 6: 859-866 (2006). *
Petanova J, Fucikova T, Bencko V, Sterzl I. The influence of metals on the expression of surface antigens on human lymphocytes in vitro. Neuro. Endocrinol. Lett. 27 Suppl. 1: 46-48 (2006).
Peterfalvi A, Gomori E, Magyarlaki T, Pal J, Banati M, Javorhazy A, Szekeres-Bartho J, Szereday L, Illes Z. Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells. Int. Immunol. 20: 1517-1525 (2008).
Peters MG, Di Bisceglie AM, Kowdley KV, Flye NL, Luketic VA, Munoz SJ, Garcia-Tsao G, Boyer TD, Lake JR, Bonacini M, Combes B; PUMPS Group. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology 46: 769-775 (2007). *
Petersdorf EW, Hansen JA. New advances in hematopoietic cell transplantation. Curr. Opin. Hematol. 15: 549-554 (2008).
Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med. 4: e8 (2007). *
Peterson P, Uibo R, Krohn KJ. Adrenal autoimmunity: results and developments. Trends Endocrinol. Metab. 11: 285-290 (2000). *
Petrone A, Battelino T, Krzisnik C, Bugawan T, Erlich H, Di Mario U, Pozzilli P, Buzzetti R. Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens 60: 244-253 (2002). *
Petrone A, Bugawan TL, Mesturino CA, Nistico L, Galgani A, Giorgi G, Cascino I, Erlich HA, Di Mario U, Buzzetti R. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region). Tissue Antigens 58: 385-394 (2001). *
Petrone A, Giorgi G, Galgani A, Alemanno I, Corsello SM, Signore A, Mario UD, Nistico L, Cascino I, Buzzetti R. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 15: 232-238 (2005).
Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 11: 171-175 (2001).
Petzelbauer P, Fodinger D, Rappersberger K, Volc-Platzer B, Wolff K. CD68 positive epidermal dendritic cells. J. Invest. Dermatol. 101: 256-261 (1993).
Pfohler C, Ugurel S. Cutaneous reactions to molecular targeted therapies. Hautarzt. 59: 814-820 (2008).
Phillips E, Mallal S. Drug hypersensitivity in HIV. Curr. Opin. Allergy Clin. Immunol. 7: 324-330 (2007).
Phillips EJ, Mallal SA. HLA and drug-induced toxicity. Curr. Opin. Mol. Ther. 11: 231-242 (2009).
Piao WH, Song XG, Liu MC, He Y, Zhang HH, Xu WX, Li ZL, Zhang HQ, Ling SG, Wang GQ. Cloning, expression, and purification of HLA-A2-BSP and beta-2m in Escherichia coli. Protein Expr. Purif. 35: 210-217 (2004). *
Pichard V, Royer PJ, Richou C, Cauchin E, Goebes K, Gaignerie A, Masliah C, Gournay J, Gregoire M, Ferry N. Detection, isolation, and characterization of alpha-fetoprotein-specific T cell populations and clones using MHC class I multimer magnetic sorting. J. Immunother. 31: 246-253 (2008).
Pichurin P, Pham N, David CS, Rapoport B, McLachlan SM. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T Cell epitopes and functional analysis of the CD40 Graves' polymorphism. Thyroid 16: 1221-1227 (2006).
Pierer M, Baerwald C. Biological therapy for the treatment of rheumatic diseases. Internist (Berl.) 49: 938-946 (2008).
Pierer M, Baerwald C, Wagner U. Familial clustering, genetic roots and insights into the pathogenesis of autoimmune diseases. Z. Rheumatol. 68: 758-762 (2009).
Pierer M, Kaltenhauser S, Arnold S, Wahle M, Baerwald C, Hantzschel H, Wagner U. Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients. Arthritis Res. Ther. 8: R75 (2006). *
Pieroni F, Stracieri AB, Moraes DA, Paton EJ, Saggioro FP, Barros GM, Barros JC, Oliveira MC, Coutinho MA, Castro NS, Vigoritto AC, Trabasso P, Souza CA, de Souza MP, Mauad MA, Colturato VA, Sim�es BP, Foss NP, Voltarelli JC. Six cases of leprosy associated with allogeneic hematopoietic SCT. Bone Marrow Transplant. 40: 859-863 (2007).
Piersma SJ, Welters MJ, van der Hulst JM, Kloth JN, Kwappenberg KM, Trimbos BJ, Melief CJ, Hellebrekers BW, Fleuren GJ, Kenter GG, Offringa R, van der Burg SH. Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element. Int. J. Cancer 122: 486-494 (2008). *
Piesche M, Hildebrandt Y, Chapuy B, Wulf GG, Trumper L, Schroers R. Characterization of HLA DR-restricted T-cell epitopes derived from human proteinase 3. Vaccine 27: 4718-4723 (2009). *
Piesche M, Hildebrandt Y, Zettl F, Chapuy B, Schmitz M, Wulf G, Trumper L, Schroers R. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin. Hum. Immunol. 68: 572-576 (2007).
Pietzak MM, Schofield TC, McGinniss TJ, Nakamura RM. Stratifying risk for celiac disease in a large at-risk US population using HLA alleles. Clin. Gastroenterol. Hepatol. 7: 966-971 (2009).
Pigatto P, Mazzi B, Fleischhauer K, Guzzi G. Linking allergy to mercury to HLA and burning mouth syndrome. J. Eur. Acad. Dermatol. Venereol. 21: 1118-1120 (2007). *
Pile KD, Wordsworth BP, Bell JI. Does the locus on chromosome 11 implicated in susceptibility to HLA-DR4 dependent type I diabetes mellitus also affect susceptibility to rheumatoid arthritis? Ann. Rheum. Dis. 51: 1250-1251 (1992). *
Pimtanothai N, Hurley CK, Leke R, Klitz W, Johnson AH. HLA-DR and -DQ polymorphism in Cameroon. Tissue Antigens 58: 1-8 (2001). *
Pinier M, Verdu EF, Nasser-Eddine M, David CS, Vezina A, Rivard N, Leroux JC. Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology 136: 288-298 (2009). *
Pinto FO, Roberts I. Cord blood stem cell transplantation for haemoglobinopathies. Br. J. Haematol. 141: 309-324 (2008). *
Pirmohamed M. Pharmacogenetics of idiosyncratic adverse drug reactions. Handb. Exp. Pharmacol. 196: 477-491 (2010). *
Pirmohamed M. Genetic factors in the predisposition to drug-induced hypersensitivity reactions. AAPS J. 8: E20-E26 (2006). *
Pirmohamed M, Arbuckle JB, Bowman CE, Brunner M, Burns DK, Delrieu O, Dix LP, Twomey JA, Stern RS. Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 8: 1661-1691 (2007).
Pirri A, Contieri FC, Benvenutti R, Bicalho MD. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. Transpl. Immunol. 20: 143-149 (2009).
Pistoia V, Morandi F, Wang X, Ferrone S. Soluble HLA-G: are they clinically relevant? Semin. Cancer Biol. 17: 469-479 (2007). *
Pitkaniemi J, Hakulinen T, Nasanen J, Tuomilehto-Wolf E, Tuomilehto J; DiMe Study Group. Class I and II HLA genes are associated with susceptibility and age at onset in Finnish families with type 1 diabetes. Hum. Hered. 57: 69-79 (2004). *
Pitkaniemi J, Varvio SL, Corander J, Lehti N, Partanen J, Tuomilehto-Wolf E, Tuomilehto J, Thomas A, Arjas E. Full likelihood analysis of genetic risk with variable age at onset disease - combining population-based registry data and demographic information. PLoS One 4: e6836 (2009). *
Pizzuti D, Buda A, D'Odorico A, D'Inca R, Chiarelli S, Curioni A, Martines D. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients. Scand. J. Gastroenterol. 41: 1305-1311 (2006). *
Platzer B, Richter S, Kneidinger D, Waltenberger D, Woisetschlager M, Strobl H. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J. Immunol. 183: 66-74 (2009).
Plenge RM. Recent progress in rheumatoid arthritis genetics: one step towards improved patient care. Curr. Opin. Rheumatol. 21: 262-271 (2009).
Plenge RM. Rheumatoid arthritis genetics: 2009 update. Curr. Rheumatol. Rep. 11: 351-356 (2009).
Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, Liew A, Khalili H, Chandrasekaran A, Davies LR, Li W, Tan AK, Bonnard C, Ong RT, Thalamuthu A, Pettersson S, Liu C, Tian C, Chen WV, Carulli JP, Beckman EM, Altshuler D, Alfredsson L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N. Engl. J. Med. 357: 1199-1209 (2007). *
Plensa I, Pavia C, Ercilla MG. Susceptibility to chronic HLA-system-associated lymphocytic thyroiditis. Its relationship with insulin-dependent diabetes mellitus. Med. Clin. (Barc.) 93: 761-764 (1989).
Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 110: 1053-1060 (1996). *
Pleyer U, Dutescu M. Sympathetic ophthalmia. Ophthalmologe 106: 167-176 (2009).
Ploski R, Flato B, Vinje O, Maksymowych W, Forre O, Thorsby E. Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Hum. Immunol. 44: 88-96 (1995).
Ploski R, Undlien DE, Vinje O, Forre O, Thorsby E, Ronningen KS. Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) genes and susceptibility to juvenile rheumatoid arthritis. Hum. Immunol. 39: 54-60 (1994).
Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun. 3: 235-249 (2002). *
Pociot F, Molvig J, Wogensen L, Worsaae H, Dalboge H, Baek L, Nerup J. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand. J. Immunol. 33: 37-49 (1991).
Pociot F, Wilson AG, Nerup J, Duff GW. No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur. J. Immunol. 23: 3050-3053 (1993).
Poeck H, Bscheider M, Gross O, Finger K, Roth S, Rebsamen M, Hannesschlager N, Schlee M, Rothenfusser S, Barchet W, Kato H, Akira S, Inoue S, Endres S, Peschel C, Hartmann G, Hornung V, Ruland J. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1beta production. Nat. Immunol. 11: 63-70 (2010). *
Poggi A, Zocchi MR. Antigen presenting cells and stromal cells trigger human natural killer lymphocytes to autoreactivity: evidence for the involvement of natural cytotoxicity receptors (NCR) and NKG2D. Clin. Dev. Immunol. 13: 325-336 (2006). *
Pohl A, Devaux PF, Herrmann A. Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochim. Biophys. Acta 1733: 29-52 (2005). *
Pohl A, Lage H, Muller P, Pomorski T, Herrmann A. Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line. Biochem. J. 365: 259-268 (2002). *
Pohlmann T, Bockmann RA, Grubmuller H, Uchanska-Ziegler B, Ziegler A, Alexiev U. Differential peptide dynamics is linked to major histocompatibility complex polymorphism. J. Biol. Chem. 279: 28197-28201 (2004). *
Pokorny CS, McCaughan GW, Gallagher ND, Selby WS. Sclerosing cholangitis and biliary tract calculi - primary or secondary? Gut 33: 1376-1380 (1992). *
Pokorny V, McQueen F, Yeoman S, Merriman M, Merriman T, Harrison A, Highton J, McLean L. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann. Rheum. Dis. 64: 487-490 (2005). *
Polansky JK, Huehn J. To be or not to be a Treg: epigenetic regulation of Foxp3 expression in regulatory T cells. Z. Rheumatol. 66: 417-420 (2007).
Poliani PL, Kisand K, Marrella V, Ravanini M, Notarangelo LD, Villa A, Peterson P, Facchetti F. Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells. Am. J. Pathol. Jan 21 [Epub ahead of print] (2010). *
Polko J, Vrlik M, Petriskova J, Strakova J, Mokan M. Importance of determination of lymphocytes in intestinal mucosa biopsy specimens using flow cytometry in the evaluation of ulcerative colitis activity. Vnitr. Lek. 48: 197-201 (2002).
Pollanen R, Sillat T, Pajarinen J, Levon J, Kaivosoja E, Konttinen YT. Microbial antigens mediate HLA-B27 diseases via TLRs. J. Autoimmun. 32: 172-177 (2009).
Pollara G, Handley ME, Kwan A, Chain BM, Katz DR. Autocrine type I interferon amplifies dendritic cell responses to lipopolysaccharide via the nuclear factor-kappaB/p38 pathways. Scand. J. Immunol. 63: 151-154 (2006). *
Ponsioen CY, Kuiper H, Ten Kate FJ, van Milligen de Wit M, van Deventer SJ, Tytgat GN. Immunohistochemical analysis of inflammation in primary sclerosing cholangitis. Eur. J. Gastroenterol. Hepatol. 11: 769-774 (1999).
Ponsioen CY, Stokkers PC, vd Horst AR, Tytgat GN, van Deventer SJ. A patient with hereditary hemochromatosis, ulcerative colitis, and primary sclerosing cholangitis: genetic aspects. Eur. J. Intern. Med. 12: 518-521 (2001). *
Poole JA, Thiele GM, Alexis NE, Burrell AM, Parks C, Romberger DJ. Organic dust exposure alters monocyte-derived dendritic cell differentiation and maturation. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L767-L776 (2009). *
Popat S, Hearle N, Wixey J, Hogberg L, Bevan S, Lim W, Stenhammar L, Houlston RS. Analysis of the CTLA4 gene in Swedish coeliac disease patients. Scand. J. Gastroenterol. 37: 28-31 (2002). *
Popat S, Hogberg L, McGuire S, Green H, Bevan S, Stenhammar L, Houlston RS. Germline mutations in TGM2 do not contribute to coeliac disease susceptibility in the Swedish population. Eur. J. Gastroenterol. Hepatol. 13: 1477-1479 (2001).
Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J. Rheumatol. 25: 1687-1693 (1998).
Portincasa P, Vacca M, Moschetta A, Petruzzelli M, Palasciano G, van-Erpecum KJ, van-Berge-Henegouwen GP. Primary sclerosing cholangitis: updates in diagnosis and therapy. World J. Gastroenterol. 11: 7-16 (2005). *
Posnett DN, Yarilin D. Amplification of autoimmune disease by infection. Arthritis Res. Ther. 7: 74-84 (2005). *
Poulain C, Johanet C, Delcroix C, Levy-Marchal C, Tubiana-Rufi N. Prevalence and clinical features of celiac disease in 950 children with type 1 diabetes in France. Diabetes Metab. 33: 453-458 (2007). *
Poulsen LO, Elling P, Sorensen FB, Hoedt-Rasmussen K. HLA-DR expression and disease activity in ulcerative colitis. Scand. J. Gastroenterol. 21: 364-368 (1986).
Poupon R. Autoimmune overlapping syndromes. Clin. Liver Dis. 7: 865-878 (2003).
Poupon R. Primary biliary cirrhosis. Schweiz. Med. Wochenschr. 121: 727-732 (1991).
Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 105: 1646-1651 (1998). *
Powis SH, Rosenberg WM, Hall M, Mockridge I, Tonks S, Ivinson A, Ciclitira PJ, Jewell DP, Lanchbury JS, Bell JI, et al. TAP1 and TAP2 polymorphism in coeliac disease. Immunogenetics 38: 345-350 (1993).
Powis SH, Tonks S, Mockridge I, Kelly AP, Bodmer JG, Trowsdale J. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 37: 373-380 (1993).
Pozo D, Anderson P, Gonzalez-Rey E. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide. J. Immunol. 183: 4346-4359 (2009).
Pozsonyi E, Gyorgy B, Berki T, Banlaki Z, Buzas E, Rajczy K, Hosso A, Prohaszka Z, Szilagyi A, Cervenak L, Fust G. HLA-association of serum levels of natural antibodies. Mol. Immunol. 46: 1416-1423 (2009). *
Prados J, Melguizo C, Fernandez JE, Carrillo E, Marchal JA, Boulaiz H, Martinez A, Rodriguez-Serrano F, Aranega A. Induction of drug resistance in embryonal rhabdomyosarcoma treated with conventional chemotherapy is associated with HLA class I increase. Neoplasma 53: 226-231 (2006). *
Prahalad S, Ryan MH, Shear ES, Thompson SD, Giannini EH, Glass DN. Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. Arthritis Rheum. 43: 2335-2338 (2000). *
Prandota J, Stolarczyk J. Autoimmune hepatitis associated with the odour of fish food proteins: a causal relationship or just a mere association? Allergol. Immunopathol. (Madr.) 30: 331-337 (2002).
Prantner D, Darville T, Nagarajan UM. STING is critical for induction of IFN-beta during Chlamydia muridarum infection. J. Immunol. Jan 27 [Epub ahead of print] (2010).
Prantner D, Darville T, Sikes JD, Andrews CW Jr, Brade H, Rank RG, Nagarajan UM. Critical role for IL-1beta during Chlamydia muridarum genital infection and bacterial replication-independent secretion of IL-1beta in mouse macrophages. Infect. Immun. 77: 5334-5346 (2009). *
Prat E, Tomaru U, Sabater L, Park DM, Granger R, Kruse N, Ohayon JM, Bettinotti MP, Martin R. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J. Neuroimmunol. 167: 108-119 (2005).
Pratsidou-Gertsi P, Kanakoudi-Tsakalidou F, Spyropoulou M, Germenis A, Adam K, Taparkou A, Siamopoulou A, Drakou C, Konstantinidis T, Prieur AM, Stavropoulos-Giokas C. Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece. Eur. J. Immunogenet. 26: 299-310 (1999). *
Prendergast A, Prado JG, Kang YH, Chen F, Riddell LA, Luzzi G, Goulder P, Klenerman P. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS Jan 11 [Epub ahead of print] (2010).
Presicce P, Taddeo A, Conti A, Villa ML, Bella SD. Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor. Mol. Immunol. 45: 1136-1145 (2008). *
Price P, Bolitho P, Jaye A, Glasson M, Yindom LM, Sirugo G, Chase D, McDermid J, Whittle H. A Gambian TNF haplotype matches the European HLA-A1,B8,DR3 and Chinese HLA-A33,B58,DR3 haplotypes. Tissue Antigens 62: 72-75 (2003). *
Price P, Calder DM, Witt CS, Allcock RJ, Christiansen FT, Davies GR, Cameron PU, Rogers M, Baluchova K, Moore CB, French MA. Periodontal attachment loss in HIV-infected patients is associated with the major histocompatibility complex 8.1 haplotype (HLA-A1,B8,DR3). Tissue Antigens 54: 391-399 (1999).
Price P, Cheong KY, Boodhoo A, Witt CS, McCann V, Christiansen FT, Allcock RJ. Can MHC class II genes mediate resistance to type 1 diabetes? Immunol. Cell Biol. 79: 602-606 (2001). *
Price P, Santoso L, Mastaglia F, Garlepp M, Kok CC, Allcock R, Laing N. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. Tissue Antigens 64: 575-580 (2004). *
Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167: 257-274 (1999).
Price P, Wong AM, Williamson D, Voon D, Baltic S, Allcock RJ, Boodhoo A, Christiansen FT. Polymorphisms at positions -22 and -348 in the promoter of the BAT1 gene affect transcription and the binding of nuclear factors. Hum. Mol. Genet. 13: 967-974 (2004). *
Price VH, Colombe BW. Heritable factors distinguish two types of alopecia areata. Dermatol. Clin. 14: 679-689 (1996).
Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N. Engl. J. Med. 322: 1842-1844 (1990).
Prochorec-Sobieszek M, Wagner T, Loukas M, Chwalinska-Sadowska H, Olesinska M. Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjogren's syndrome. Med. Sci. Monit. 10: BR115-BR121 (2004). *
Prots I, Skapenko A, Wendler J, Mattyasovszky S, Yone CL, Spriewald B, Burkhardt H, Rau R, Kalden JR, Lipsky PE, Schulze-Koops H. Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis Rheum. 54: 1491-1500 (2006). *
Proust B, Kennel A, Ladriere M, Kessler M, Perrier P. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant. Transpl. Immunol. 21: 166-168 (2009).
Pruunsild C, Uibo K, Liivamagi H, Tarraste S, Talvik T, Pelkonen P. Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scand. J. Rheumatol. 36: 7-13 (2007). *
Pryhuber KG, Murray KJ, Donnelly P, Passo MH, Maksymowych WP, Glass DN, Giannini EH, Colbert RA. Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J. Rheumatol. 23: 747-752 (1996).
Puga Yung GL, Fidler M, Albani E, Spermon N, Teklenburg G, Newbury R, Schechter N, van den Broek T, Prakken B, Billetta R, Dohil R, Albani S. Heat shock protein-derived T-cell epitopes contribute to autoimmune inflammation in pediatric Crohn's disease. PLoS One 4: e7714 (2009). *
Puglisi F, Capuano P, Simone M, Verzillo F, Laurentaci C, Catalano G. Immunogenetics of inflammatory bowel disease. Minerva Gastroenterol. Dietol. 45: 5-9 (1999).
Puolakkainen M, Lee A, Nosaka T, Fukushi H, Kuo CC, Campbell LA. Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors. Microb. Pathog. 44: 410-416 (2008). *
Purrmann J, Bertrams J, Borchard F, Cleveland S, Berges W, Strohmeyer G. Crohn's disease in four members of a family, two of whom are dizygotic twins. Hepatogastroenterology 37: 81-82 (1990).
Putschky N, Pott HG, Kuipers JG, Zeidler H, Hammer M, Wollenhaupt J. Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial. Ann. Rheum. Dis. 65: 1521-1524 (2006). *
Puttick A, Briggs D, Welsh K, Jacoby R, Williamson E, Jones V. Extended haplotypes in rheumatoid arthritis and preliminary evidence for an interaction with immunoglobulin genes. Dis. Markers 4: 139-144 (1986).
Puttick AH, Briggs DC, Welsh KI, Williamson EA, Jacoby RK, Jones VE. Genes associated with rheumatoid arthritis and mild inflammatory arthritis. II. Association of HLA with complement C3 and immunoglobulin Gm allotypes. Ann. Rheum. Dis. 49: 225-228 (1990). *
Puzanowska B, Prokopowicz D, Ziarko S, Radziwon P, Lapinski TW. The incidence of HLA DRB1*0103 in ulcerative colitis patients in north-eastern Poland. Hepatogastroenterology 50: 1436-1438 (2003).
Pyne S, Hu X, Wang K, Rossin E, Lin TI, Maier LM, Baecher-Allan C, McLachlan GJ, Tamayo P, Hafler DA, De Jager PL, Mesirov JP. Automated high-dimensional flow cytometric data analysis. Proc. Natl. Acad. Sci. U.S.A. 106: 8519-8524 (2009). *
Qasim W, Gaspar HB, Thrasher AJ. Progress and prospects: gene therapy for inherited immunodeficiencies. Gene Ther. 16: 1285-1291 (2009).
Qian BF, Tonkonogy SL, Sartor RB. Aberrant innate immune responses in TLR-ligand activated HLA-B27 transgenic rat cells. Inflamm. Bowel Dis. 14: 1358-1365 (2008). *
Qian BF, Tonkonogy SL, Sartor RB. Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules. Immunology 117: 319-328 (2006). *
Qiao B, Huang CH, Cong L, Xie J, Lo SH, Zheng T. Genome-wide gene-based analysis of rheumatoid arthritis-associated interaction with PTPN22 and HLA-DRB1. BMC Proc. 3 Suppl. 7: S132 (2009). *
Qiao Q, Osterholm AM, He B, Pitkaniemi J, Cordell HJ, Sarti C, Kinnunen L, Tuomilehto-Wolf E, Tryggvason K, Tuomilehto J. A genome-wide scan for type 1 diabetes susceptibility genes in nuclear families with multiple affected siblings in Finland. BMC Genet. 8: 84 (2007). *
Qiao SW, Bergseng E, Molberg O, Xia J, Fleckenstein B, Khosla C, Sollid LM. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J. Immunol. 173: 1757-1762 (2004). *
Qiao SW, Piper J, Haraldsen G, Oynebraten I, Fleckenstein B, Molberg O, Khosla C, Sollid LM. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease. J. Immunol. 174: 1657-1663 (2005). *
Qin OY, el-Youssef M, Yen-Lieberman B, Sapatnekar W, Youngman KR, Kusugami K, Fiocchi C. Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma. Dig. Dis. Sci. 33: 1528-1536 (1988).
Qiu D, Ma X. Relationship between type I autoimmune hepatitis and alleles of HLA-DRB1 in Chinese patients of Shanghai area. Zhonghua Gan Zang Bing Za Zhi 10: 347-349 (2002).
Qiu DK, Ma X. Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients. J. Gastroenterol. Hepatol. 18: 63-67 (2003). *
Qiu W, Bundell C, Wu JS, Castley A, James I, Hollingsworth P, Christiansen F, Carroll WM, Mastaglia FL, Kermode AG. Low level of systemic autoimmunity in Western Australian multiple sclerosis patients. Mult. Scler. Feb 11 [Epub ahead of print] (2010).
Qu HQ, Marchand L, Frechette R, Bacot F, Lu Y, Polychronakos C. No association of type 1 diabetes with a functional polymorphism of the LRAP gene. Mol. Immunol. 44: 2135-2138 (2007). *
Qu HQ, Marchand L, Szymborski A, Grabs R, Polychronakos C. The association between type 1 diabetes and the ITPR3 gene polymorphism due to linkage disequilibrium with HLA class II. Genes Immun. 9: 264-266 (2008). *
Qu HQ, Polychronakos C. The effect of the MHC locus on autoantibodies in type 1 diabetes. J. Med. Genet. 46: 469-471 (2009).
Quarsten H, Paulsen G, Johansen BH, Thorpe CJ, Holm A, Buus S, Sollid LM. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules. Int. Immunol. 10: 1229-1236 (1998). *
Queiro R, Gonzalez S, Lopez-Larrea C, Alperi M, Sarasqueta C, Riestra JL, Ballina J. HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis. Arthritis Res. Ther. 8: R185 (2006). *
Queiro R, Moreno P, Sarasqueta C, Alperi M, Riestra JL, Ballina J. Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile. Clin. Exp. Rheumatol. 26: 125-128 (2008).
Queiro R, Torre JC, Belzunegui J, Gonz�lez C, De Dios JR, Unanue F, Figueroa M. Clinical features and predictive factors in psoriatic arthritis-related uveitis. Semin. Arthritis Rheum. 31: 264-270 (2002). *
Queiro R, Torre JC, Gonzalez S, Lopez-Larrea C, Tinture T, Lopez-Lagunas I. HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis. J. Rheumatol. 30: 505-507 (2003).
Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I. The effect of HLA-DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis. Scand. J. Rheumatol. 33: 318-322 (2004). *
Quelvennec E, Bera O, Cabre P, Alizadeh M, Smadja D, Jugde F, Edan G, Semana G. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome. Tissue Antigens 61: 166-171 (2003). *
Quillinan N, Mohammad A, Mannion G, O'Keeffe D, Bergin D, Coughlan R, Mc Dermott MF, McGonagle D. Imaging evidence for persistent subclincal fasciitis and arthritis in TNF receptor-associated periodic syndrome (TRAPS) between febrile attacks. Ann. Rheum. Dis. Nov 12 [Epub ahead of print] (2009).
Quinones-Lombrana A, Lopez-Soto A, Ballina-Garcia FJ, Alperi-Lopez M, Queiro-Silva R, Lopez-Vazquez A, Lopez-Larrea C, Gonzalez S. BAT1 promoter polymorphism is associated with rheumatoid arthritis susceptibility. J. Rheumatol. 35: 741-744 (2008). *
Radwan P, Slomka M, Skrzydlo-Radomanska B. Expression of HLA-DR antigens by colonic epithelium in ulcerative colitis. Pol. Arch. Med. Wewn. 87: 358-364 (1992).
Raedler A, Fraenkel S, Klose G, Seyfarth K, Thiele HG. Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease. Gastroenterology 88: 978-983 (1985).
Rafatpanah H, Pravica V, Faridhosseini R, Tabatabaei A, Ollier W, Poulton K, Thomson W, Hutchinson I. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection. Iran J. Immunol. 4: 94-100 (2007).
Raffaele M, D'Amico M, Esposito K, Baldi A, Di Filippo C, Siniscalchi M, Sasso FC, Portoghese M, Cirillo F, Cacciapuoti F, Carbonara O, Crescenzi B, Baldi F, Ceriello A, Nicoletti GF, D'Andrea F, Verza M, Coppola L, Rossi F, Giugliano D. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. Diabetes 55: 622-632 (2006). *
Raffegerst SH, Hoelzlwimmer G, Kunder S, Mysliwietz J, Quintanilla-Martinez L, Schendel DJ. Diverse hematological malignancies including hodgkin-like lymphomas develop in chimeric MHC class II transgenic mice. PLoS One 4: e8539 (2009). *
Raghavan S, Selvaraj P, Swaminathan S, Narendran G. Association of HLA-A*1101 with resistance and B*4006 with susceptibility to HIV and HIV-TB: an in silico analysis of promiscuous T cell epitopes. AIDS Res. Hum. Retroviruses 25: 1023-1028 (2009).
Rahal M, Kervaire B, Villard J, Tiercy JM. DNA typing by microbead arrays and PCR-SSP: apparent false-negative or -positive hybridization or amplification signals disclose new HLA-B and -DRB1 alleles. Tissue Antigens 71: 238-241 (2008). *
Raine T, Allen R. MHC-I recognition by receptors on myelomonocytic cells: new tricks for old dogs? Bioessays 27: 542-550 (2005). *
Raine T, Brown D, Bowness P, Hill Gaston JS, Moffett A, Trowsdale J, Allen RL. Consistent patterns of expression of HLA class I free heavy chains in healthy individuals and raised expression in spondyloarthropathy patients point to physiological and pathological roles. Rheumatology (Oxford) 45: 1338-1344 (2006). *
Rajagopalan G, Iijima K, Singh M, Kita H, Patel R, David CS. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect. Immun. 74: 1284-1296 (2006). *
Rajagopalan G, Polich G, Sen MM, Singh M, Epstein BE, Lytle AK, Rouse MS, Patel R, David CS. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice. Tissue Antigens 71: 135-145 (2008). *
Rajagopalan G, Tilahun AY, Asmann YW, David CS. Early gene expression changes induced by the bacterial superantigen, staphylococcal enterotoxin B and its modulation by a proteasome inhibitor. Physiol. Genomics 37: 279-293 (2009). *
Rajalingam R, Du Z, Meenagh A, Luo L, Kavitha VJ, Pavithra-Arulvani R, Vidhyalakshmi A, Sharma SK, Balazs I, Reed EF, Pitchappan RM, Middleton D. Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations. Immunogenetics 60: 207-217 (2008). *
Rajapakse M, Schmidt B, Feng L, Brusic V. Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms. BMC Bioinformatics 8: 459 (2007). *
Rak JM, Maestroni L, Balandraud N, Guis S, Boudinet H, Guzian MC, Yan Z, Azzouz D, Auger I, Roudier C, Martin M, Didelot R, Roudier J, Lambert NC. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum. 60: 73-80 (2009). *
Rak JM, Pagni PP, Tiev K, Allanore Y, Farge D, Harle JR, Launay D, Hachulla E, Didelot R, Cabane J, Kahan A, Martin M, Granel B, Roudier J, Lambert NC. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset. Rheumatology (Oxford) 48: 363-366 (2009).
Rakhimova M, Esslinger B, Schulze-Krebs A, Hahn EG, Schuppan D, Dieterich W. In vitro differentiation of human monocytes into dendritic cells by peptic-tryptic digest of gliadin is independent of genetic predisposition and the presence of celiac disease. J. Clin. Immunol. 29: 29-37 (2009). *
Raki M, Schjetne KW, Stamnaes J, Molberg O, Jahnsen FL, Issekutz TB, Bogen B, Sollid LM. Surface expression of transglutaminase 2 by dendritic cells and its potential role for uptake and presentation of gluten peptides to T cells. Scand. J. Immunol. 65: 213-220 (2007). *
Raki M, Tollefsen S, Molberg O, Lundin KE, Sollid LM, Jahnsen FL. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 131: 428-438 (2006). *
Ramagopalan SV, Byrnes JK, Dyment DA, Guimond C, Handunnetthi L, Disanto G, Yee IM, Ebers GC, Sadovnick AD. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis. J. Hum. Genet. 54: 547-549 (2009).
Ramagopalan SV, Dyment DA, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Handunnetthi L, Chao MJ, Dessa Sadovnick A, Ebers GC. Parental non-inherited HLA resistance alleles do not confer protection against multiple sclerosis. J. Neuroimmunol. 196: 170-172 (2008).
Ramagopalan SV, Dyment DA, Morrison KM, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Handunnetthi L, Chao MJ, Sadovnick AD, Ebers GC. Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis. BMC Med. Genet. 9: 63 (2008). *
Ramagopalan SV, Dyment DA, Sadovnick AD, Ebers GC. HLA-DRB1 and multiple sclerosis in Malta. Neurology 71: 1379 (2008).
Ramagopalan SV, Ebers GC. Multiple sclerosis: major histocompatibility complexity and antigen presentation. Genome Med. 1: 105 (2009). *
Ramagopalan SV, Herrera BM, Bell JT, Dyment DA, Deluca GC, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC. Parental transmission of HLA-DRB1*15 in multiple sclerosis. Hum. Genet. 122: 661-663 (2008). *
Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 73: 2107-2111 (2009).
Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, Deluca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 5: e1000369 (2009). *
Ramagopalan SV, McMahon R, Dyment DA, Sadovnick AD, Ebers GC, Wittkowski KM. An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene. BMC Med. Genet. 10: 10 (2009). *
Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet. 3: e150 (2007). *
Ramagopalan SV, Sadovnick AD, Ebers GC, Giovannoni G. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult. Scler. 16: 127-128 (2010).
Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M, Taeb J, Aghakhani A, Gachkar L, Velayati AA. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J. Gastroenterol. Hepatol. 23: 1716-1721 (2008). *
Ramirez-Anguiano J, Yamamoto-Furusho JK, Barquera R, Beltran O, Granados J. Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. Otolaryngol. Head Neck Surg. 135: 90-93 (2006).
Ramos PS, Langefeld CD, Bera LA, Gaffney PM, Noble JA, Moser KL. Variation in the ATP-binding cassette transporter 2 gene is a separate risk factor for systemic lupus erythematosus within the MHC. Genes Immun. 10: 350-355 (2009).
Ramos-Arroyo MA, Feijoo E, Sanchez-Valverde F, Aranburu E, Irisarri N, Olivera JE, Valiente A. Heat-shock protein 70-1 and HLA class II gene polymorphisms associated with celiac disease susceptibility in Navarra (Spain). Hum. Immunol. 62: 821-825 (2001).
Rani R, Sood A, Goswami R. Molecular basis of predisposition to develop type 1 diabetes mellitus in North Indians. Tissue Antigens 64: 145-155 (2004). *
Rani R, Sood A, Lazaro AM, Stastny P. Associations of MHC class II alleles with insulin-dependent diabetes mellitus (IDDM) in patients from North India. Hum. Immunol. 60: 524-531 (1999).
Rantapaa Dahlqvist S, Strom H, Bjelle A, Moller E. HLA haplotypes in a family with ankylosing spondylitis and rheumatoid arthritis. J. Rheumatol. 12: 518-522 (1985).
Rao DA, Tracey KJ, Pober JS. IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. J. Immunol. 179: 6536-6546 (2007). *
Rao MS, Khan AA, Parveen N, Habeeb MA, Habibullah CM, Pande G. Characterization of hepatic progenitors from human fetal liver during second trimester. World J. Gastroenterol. 14: 5730-5737 (2008). *
Rao V, Gallagher M, Bhat P, Foster CS. Sensorineural hearing loss in a patient with HLA-B27 sclero-uveitis. Br. J. Ophthalmol. 92: 425 (2008).
Raphael SA, Blau EB, Zhang WH, Hsu SH. Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis. Am. J. Dis. Child. 147: 842-848 (1993).
Rapin N, Hoof I, Lund O, Nielsen M. MHC motif viewer. Immunogenetics 60: 759-765 (2008). *
Rapoport B, McLachlan SM. The thyrotropin receptor in Graves' disease. Thyroid 17: 911-922 (2007).
Raptopoulou A, Sidiropoulos P, Siakka P, Boki K, Drosos AA, Aslanidis S, Karras D, Pikazis D, Vassilopoulos D, Karassa F, Boumpas DT. Evidence-based recommendations for the management of ankylosing spondylitis: results of the Hellenic working group of the 3E Initiative in Rheumatology. Clin. Exp. Rheumatol. 26: 784-792 (2008).
Rasch A, Schimmer M, Sander CA. Simvastatin-induced dermatomyositis. Hautarzt. 60: 489-493 (2009).
Rashid T, Ebringer A. Rheumatoid arthritis in smokers could be linked to Proteus urinary tract infections. Med. Hypotheses 70: 975-980 (2008).
Rashtak S, Marietta EV, Cheng S, Camilleri MJ, Pittelkow MR, David CS, Grande JP, Murray JA. Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. Lupus Feb 8 [Epub ahead of print] (2010).
Rasmussen HB, Kelly MA, Francis DA, Clausen J. CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese. J. Neurol. Sci. 184: 143-147 (2001). *
Rassi DM, Junta CM, Fachin AL, Sandrin-Garcia P, Mello SS, Fernandes AP, Deghaide NN, Foss-Freitas MC, Foss MC, Sakamoto-Hojo ET, Passos GA, Donadi EA. Is HLA class II profile relevant for the study of large-scale differentially expressed genes in type 1 diabetes mellitus patients? Ann. N. Y. Acad. Sci. 1079: 305-309 (2006). *
Rassi DM, Wastowski IJ, Simoes RT, Rodrigues S, Deghaide NN, Mendes-Junior CT, Simoes AL, Soares CP, Passos GA, Donadi EA. TNFa-e microsatellite, HLA-DRB1 and -DQB1 alleles and haplotypes in Brazilian patients presenting recently diagnosed type 1 diabetes mellitus. Ann. N. Y. Acad. Sci. 1079: 300-304 (2006). *
Ratanachaiyavong S, Lloyd L, Darke C, McGregor AM. MHC-extended haplotypes in families of patients with Graves' disease. Hum. Immunol. 36: 99-111 (1993).
Ratanachaiyavong S, Lloyd L, McGregor AM. C4A gene deletion: association with Graves' disease. J. Mol. Endocrinol. 3: 145-153 (1989).
Rau H, Donner H, Usadel KH, Badenhoop K. Polymorphisms of tumor necrosis factor receptor 2 are not associated with insulin-dependent diabetes mellitus or Graves' disease. Tissue Antigens 49: 535-536 (1997).
Rau H, Nicolay A, Donner H, Usadel KH, Badenhoop K. Polymorphisms of TAP1 and TAP2 genes in German patients with type 1 diabetes mellitus. Eur. J. Immunogenet. 24: 229-236 (1997).
Rau R, Herborn G, Zueger S, Fenner H. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years. J. Rheumatol. 27: 2566-2575 (2000).
Rauner M, Stupphann D, Haas M, Fert I, Glatigny S, Sipos W, Breban M, Pietschmann P. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio. J. Rheumatol. 36: 120-126 (2009).
Ravelli A, Bolognini S, Gambarotti M, Villanacci V. Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy. Am. J. Gastroenterol. 100: 177-185 (2005). *
Ravindranath MH, Taniguchi M, Chen CW, Ozawa M, Kaneku H, El-Awar N, Cai J, Terasaki PI. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. Mol. Immunol. Nov 25 [Epub ahead of print] (2009). *
Raychaudhuri SP, Kundu-Raychaudhuri S, Tamura K, Masunaga T, Kubo K, Hanaoka K, Jiang WY, Herzenberg LA, Herzenberg LA. FR255734, a humanized, Fc-silent, anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model. J. Invest. Dermatol. 128: 1969-1976 (2008). *
Rayment R, Kooij TW, Zhang W, Siebold C, Murphy MF, Allen D, Willcox N, Roberts DJ. Evidence for the specificity for platelet HPA-1a alloepitope and the presenting HLA-DR52a of diverse antigen-specific helper T cell clones from alloimmunized mothers. J. Immunol. 183: 677-686 (2009).
Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV. Ancient haplotypes of the HLA class II region. Genome Res. 15: 1250-1257 (2005). *
Raziuddin S, Elawad ME, Benjamin B. T-cell abnormalities in antibody deficiency syndromes. Scand. J. Immunol. 30: 419-424 (1989).
Rebmann V, Bartsch D, Wunsch A, Mollenbeck P, Golda T, Viebahn R, Grosse-Wilde H. Soluble total HLA class I and HLA-G molecules in kidney and kidney/pancreas transplantation. Hum. Immunol. 70: 995-999 (2009).
Redman H, Marcus N, Marlowe M, Endres RO. A novel HLA-B*44 allele, B*4466, discovered in a potential donor for a hematopoietic stem cell transplant. Tissue Antigens 74: 347-348 (2009). *
Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog. Horm. Res. 56: 69-89 (2001). *
Reen DJ, O'Regan D. HLA antigen frequencies in an Irish population. Tissue Antigens 15: 369-372 (1980).
Regueiro JR, Arnaiz-Villena A. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population. Tissue Antigens 31: 14-25 (1988).
Reichenbach J, Van de Velde H, De Rycke M, Staessen C, Platteau P, Baetens P, Gungor T, Ozsahin H, Scherer F, Siler U, Seger RA, Liebaers I. First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching. Pediatrics 122: e778-e782 (2008). *
Reichert S, Stein J, Fuchs C, John V, Schaller HG, Machulla HK. Are there common human leucocyte antigen associations in juvenile idiopathic arthritis and periodontitis? J. Clin. Periodontol. 34: 492-498 (2007). *
Reil A, Bein G, Machulla HK, Sternberg B, Seyfarth M. High-resolution DNA typing in immunoglobulin A deficiency confirms a positive association with DRB1*0301, DQB1*02 haplotypes. Tissue Antigens 50: 501-506 (1997).
Reinisch VM, Schankin CJ, Felbinger J, Sostak P, Straube A. Headache in the elderly. Schmerz. 22 Suppl. 1: 22-30 (2008).
Reinke Y, Zimmer KP, Naim HY. Toxic peptides in Frazer's fraction interact with the actin cytoskeleton and affect the targeting and function of intestinal proteins. Exp. Cell Res. 315: 3442-3452 (2009).
Reinshagen M, Loeliger C, Kuehnl P, Weiss U, Manfras BJ, Adler G, Boehm BO. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut 38: 538-542 (1996). *
Rekha PL, Valluri V, Rakh SS, Pantula V, Ishaq M. Association of HLA DQ B1* and HLA DR B1* alleles with goitrous juvenile autoimmune hypothyroidism - a case control study. J. Clin. Immunol. 27: 486-489 (2007). *
Rellecke P, Strauer BE. Concomitant cardiovascular conditions in intestinal illness. Internist (Berl.) 48: 290-296 (2007).
Remoli ME, Gafa V, Giacomini E, Severa M, Lande R, Coccia EM. IFN-beta modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression. Eur. J. Immunol. 37: 3499-3508 (2007). *
Remus N, Alcais A, Abel L. Human genetics of common mycobacterial infections. Immunol. Res. 28: 109-129 (2003).
Ren Y, Yang S, Xu S, Gao M, Huang W, Gao T, Fang Q, Quan C, Zhang C, Sun L, Liang Y, Han J, Wang Z, Zhang F, Zhou Y, Liu J, Zhang X. Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet. 5: e1000523 (2009). *
Reneses S, Gonzalez-Escribano MF, Fernandez-Suarez A, Pestana L, Davila B, Wichmann I, Garc�a A. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis. J. Rheumatol. 36: 1143-1149 (2009).
Rengelshausen J, Lindenmaier H, Cihlar T, Walter-Sack I, Haefeli WE, Weiss J. Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine. Biochem. Biophys. Res. Commun. 320: 90-94 (2004). *
Reske A, Pollara G, Krummenacher C, Katz DR, Chain BM. Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J. Immunol. 180: 7525-7536 (2008). *
Reunanen K, Finnila S, Laaksonen M, Sumelahti ML, Wikstrom J, Pastinen T, Kuokkanen S, Saarela J, Uimari P, Ruutiainen J, Ilonen J, Peltonen L, Tienari PJ. Chromosome 19q13 and multiple sclerosis susceptibility in Finland: a linkage and two-stage association study. J. Neuroimmunol. 126: 134-142 (2002).
Reveille JD. The genetic basis of spondyloarthritis. Curr. Rheumatol. Rep. 6: 117-125 (2004).
Reveille JD. HLA-B27 and the seronegative spondyloarthropathies. Am. J. Med. Sci. 316: 239-249 (1998).
Reveille JD. Genetic studies in the rheumatic diseases: present status and implications for the future. J. Rheumatol. Suppl. 72: 10-13 (2005). *
Reveille JD. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr. Opin. Rheumatol. 10: 187-200 (1998).
Reveille JD. The genetic basis of autoantibody production. Autoimmun. Rev. 5: 389-398 (2006).
Reveille JD, Alarcon GS, Fowler SE, Pillemer SR, Neuner R, Clegg DO, Mikhail IS, Trentham DE, Leisen JC, Bluhm G, Cooper SM, Duncan H, Tuttleman M, Heyse SP, Sharp JT, Tilley B. HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum. 39: 1802-1807 (1996).
Reveille JD, Arnett FC. Spondyloarthritis: update on pathogenesis and management. Am. J. Med. 118: 592-603 (2005). *
Reviron D, Dormoy A, Andre M, Froelich N, Roudier J, Tongio MM, Mercier P. HLA-DRB1*1608: a new HLA-DRB1*16 allele with a short DRB1*03 sequence. Immunogenetics 46: 444-445 (1997).
Reviron D, Foutrier C, Guis S, Mercier P, Roudier J. DRB1 alleles in polymyalgia rheumatica and rheumatoid arthritis in southern France. Eur. J. Immunogenet. 28: 83-87 (2001). *
Reviron D, Perdriger A, Toussirot E, Wendling D, Balandraud N, Guis S, Semana G, Tiberghien P, Mercier P, Roudier J. Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum. 44: 535-540 (2001). *
Reviron D, Tezenas du Montcel S, Foutrier C, Guis S, Benazet JF, Auquier P, Busson M, Roux H, Mercier P, Roudier J. HLA DRB1, DMA, and DMB gene polymorphisms in rheumatoid arthritis. Hum. Immunol. 60: 245-249 (1999).
Reynolds RJ, Kelley JM, Hughes LB, Yi N, Bridges SL Jr. Genetic association of htSNPs across the major histocompatibility complex with rheumatoid arthritis in an African-American population. Genes Immun. Sep 10 [Epub ahead of print] (2009).
Ribas F, Oliveira LA, Petzl-Erler ML, Bicalho MG. Major histocompatibility complex class I chain-related gene A polymorphism and linkage disequilibrium with HLA-B alleles in Euro-Brazilians. Tissue Antigens 72: 532-538 (2008). *
Rich SS, Green A, Morton NE, Barbosa J. A combined segregation and linkage analysis of insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 40: 237-249 (1987). *
Rich SS, Weitkamp LR, Barbosa J. Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes. Am. J. Hum. Genet. 36: 1015-1023 (1984). *
Rider LG. The heterogeneity of juvenile myositis. Autoimmun. Rev. 6: 241-247 (2007).
Ridgway EC, Tomer Y, McLachlan SM. Update in thyroidology. J. Clin. Endocrinol. Metab. 92: 3755-3761 (2007). *
Riemersma SA, Jordanova ES, Haasnoot GW, Drabbels J, Schuuring E, Schreuder GM, Kluin PM. The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients. Hum. Immunol. 67: 303-310 (2006).
Rigby AS, Silman AJ, Voelm L, Gregory JC, Ollier WE, Khan MA, Nepom GT, Thomson G. Investigating the HLA component in rheumatoid arthritis: an additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genet. Epidemiol. 8: 153-175 (1991).
Rihl M, Klos A, Kohler L, Kuipers JG. Reactive arthritis. Best Pract. Res. Clin. Rheumatol. 20: 1119-1137 (2006).
Rihs HP, Chen Z, Rueff F, Cremer R, Raulf-Heimsoth M, Baur X, Moneret-Vautrin DA, Bruning T. HLA-DQ8 and the